Agrobacterium-mediated transformation -
Overview
Many methods and techniques can be used to transfer genes into cells. In
agricultural plant biotechnology, the most widely utilized technique is
Agrobacterium-mediated transfer, which is heavily patented. Use of
patented technologies can restrict the deliverability of products.
About this technology landscape
- This landscape was originally authored by Carolina Roa-Rodriguez with the
assistance of Dr. Carol Nottenburg. It was updated in 2003 by Dr. Jorge
Mayer. Further updating of some sections was done in 2005-2006 by Dr. Shoko
Okada with the assistance of Dr. Marie Connett Porceddu and Dr. Dianne Rees.
- Funding for this project was provided by the
Rockefeller Foundation.
The web version was originally produced by Doug Ashton and we are grateful for
web production assistance for the updates by Dr. Nick dos Remedios, Steve Irwin,
and Annet Maurer.
Introduction: Why an IP and Technology landscape on Agrobacterium-mediated transformation?
In our experience, the intellectual property landscape in biotechnology areas
is often not very well understood by the research community, especially the
public sector. All too often rumours and misstatements about patents are passed
along from researcher to researcher. This is an unfortunate situation, however
understandable. But with the increasing importance and emphasis on patents, it
is becoming necessary for scientists to be versed in the field of intellectual
property.
With this paper and others now present on or planned for the Patent Lens, we
strive to provide a readable and understandable overview of patents in some key
areas of biotechnology. In this way, we hope to contribute to the public
awareness of intellectual property issues that surround these key
biotechnological tools. The information in the white papers is not exhaustive,
but consists of selected documents found to broadly encompass the area. To
satisfy the myriad questions and issues raised by the research or the interests
of each person who visits this site would require a host of attorneys and an
enormous amount of time. Instead, this paper is provided in order to open the
door into the patent world and furnish platform knowledge from which additional
self-directed investigation can be performed.
This first technology landscape is focused on the intellectual property
concerning methods and materials used for Agrobacterium-mediated
transformation of plants. This transformation method is currently one of the
most widely used means of making transgenic plants. Although much of the basic
research and findings that led to Agrobacterium-mediated transformation
was done in public institutions, the private sector now holds many of the key
patent positions. The patents were obtained by the private sector either from
internal research and development or from public institutions in the form of a
license or occasionally as the assignee. Thus, the science and the patent
positions are of high interest to both public and commercial sectors.

Technology landscapes, by their very nature, become outdated. While this
landscape contains much useful information about the broad state of the art at
the time broad patents were issued (which is critically important to evaluate
the ongoing constraints to use of Agrobacterium technology), some
patents have lapsed and others have come into force. The version you see here
starts with a list of the updates to this landscape done in 2003, and pages
updated since 2003 show the dates of new searches. But as sections of this
landscape would need constant updating, an impossibility with CAMBIA's small
team, we welcome updates and inputs by others through the comments interface
available on every page of this version of the technology landscape.
For a way around the Agrobacterium patent morasse, see
CAMBIA's Transbacter project.
What is the present white paper about?
This white paper on Agrobacterium -mediated transformation of plants
explains the basic scientific aspects of transformation as well as the key
intellectual property aspects of methods and materials used in transformation.
This paper has been expanded to encompass transformation of organisms outside
the plant realm. Patents directed to the transformation of fungi and algae are
part of the new additions as well as patents related to improvements on plant
transformation efficiency. The latest version of the paper is organized into the
following 12 sections:
Introduction
The introduction first explains what the
CAMBIA intellectual property resource intends to accomplish in this white paper
and then provides brief summaries of each of the seven main sections of the
paper. Importantly, the introduction informs you of some of the topics and
subject matter areas you will not find analyzed within but that may
still be important for obtaining freedom to practice some of the inventions
described in this paper.
Because many web sites, workshops, and pamphlets that describe basic
intellectual property principles (e.g., what is a patent; the requirements and
standards for obtaining a patent) are widely available, we do not duplicate
those efforts here. We do present, however, as a companion tutorial, guidelines
on "How to read a patent". In addition, some key
facts about patents that are often overlooked or forgotten by newcomers to
patent literature are emphasized in the introduction. It is our belief that
familiarity with these concepts will assist you in navigating the sometimes
murky waters of patents.
Scientific
aspects
This section provides some historical perspective and
basic scientific information regarding Agrobacterium-mediated
transformation of plant cells. The structure and use of two basic types of
vectors, co-integrated vectors and binary vectors, are discussed.
The patent information in the following sections comprises an overview, a
summary page presenting the key issues raised by the patents and patent
applications (illustrated by comparing them and pointing out the most limiting
aspects of the claimed inventions), and provides detailed information on each
patent and patent application including bibliographic data, a summary of the
claimed invention and independent claims.
Types of tissues to be transformed
Agrobacterium infects some tissues more efficiently than
others. Reflecting this variability, specific protocols have been developed for
different tissue types. Some of these methods have been patented, and it is
these patents that are discussed in this section. The patents are generally
directed to transformation of callus, immature embryo, pollen, shoot apex and
live plants.
Binary vectors
Binary vectors
are the major vector system used in Agrobacterium-mediated gene
transfer. The binary vector system comprises two independent and complementing
vectors: one vector having a T-region and the gene of interest and the other
vector having a vir region. Two sets of patents and applications are
presented and analyzed. The first set is directed to basic vector designs and
methods of constructing them. The second set is directed to special applications
using these vectors or improvements on the basic vector design.
Co-integrated vectors
Although
historically the first vector system to be developed, co-integrated vectors are
less widely used. In this system, a recombined vector is constructed from a Ti
plasmid and a small plasmid containing a gene of interest between two T-DNA
borders. The patents and applications in this section are directed to the basic
forms of the vectors, including the primary elements of the plasmids, and to
basic methods for assembling the recombined, co-integrated vector. Additionally,
a set of patents and applications is discussed that claim improved vector design
and methods for their use.
Mobilisable vectors
This new
system of vectors appears to be an alternate system to the binary and
co-integrated vectors systems. The plasmids used in this system are derived from
plasmids belonging to the family Enterobacteriaceae (e.g., E. coli).
They are non-conjugative plasmids, thus, they are not able to transfer by
themselves into a cell host as derived Agrobacterium Ti-plasmids are
able to do. Mobilisable plasmids require the presence of a helper plasmid that
supplies the transfer genes required for the transformation of the host cell. In
addition, a gene of interest is not surrounded by T-DNA borders in a mobilisable
plasmid. Although there is currently (September 2001) only a European
application related to this vector system, we present it here as an alternative
to the crowded patent landscape of the traditional vector systems.
Improvements on transformation
efficiency
There are multiple protocols for
Agrobacterium-mediated transformation that vary according to the tissue
to be transformed, the plant and the purpose of transformation, among other
reasons. Improvements of transformation efficiency can be gained by using
compounds to control the growth of Agrobacterium and the undesired
effects of tissue browning, as well as by using physical procedures to
facilitate the inoculation of the bacterium into the host plant. The patents in
this section are directed to methods for improving transformation efficiency and
include methods of controlling Agrobacterium growth, inhibiting
necrosis of the transformed plant tissue, reducing the weight of the explant to
be transformed and applying physical treatments, such us sonication of the plant
tissue and vacuum infiltration, to promote the intimate contact between the
bacterium and the host plant cell.
Monocot transformation
The
world of flowering plants with protected seeds (Angiosperms) is sometimes neatly
divided into monocotyledonous (monocot) and dicotyledonous plants. Most of the
important staple crops of the world, that is, cereals, are monocots. Initially
it was difficult to transform monocots using Agrobacterium, but
eventually this constraint was overcome. Several key patents were awarded to the
entities able to accomplish this feat. The patents discussed in this section
include those broad patents directed to transformation of any monocot as well as
patents directed to transformation of any cereal plant (e.g., wheat, barley,
rice, maize) and to transformation of a particular individual monocot plant
(e.g., banana, pineapple, rice, sorghum).
Dicot transformation
The second
major classification of flowering plants with protected seeds (Angiosperms) is
dicotyledonous plants (dicots). Early on, dicots were readily transformed by
Agrobacterium and so in general, there are fewer patents in this area.
Following a presentation of the patents directed to general transformation
methods, which generally are limited to the use of co-integrated vectors or
binary vectors, patents and applications directed to particular dicot species
are presented. Some of these particular dicots are beans, cacao, cotton, peas,
roses, soybean, and tomato.
Conifer transformation
Non-flowering plants with naked seeds that appear in a cone are called
Gymnosperms. Conifers are the largest group of plants within the Gymnosperms.
Conifers such as Pines are very important as a source of timber for construction
and for paper pulp. Several chemical compounds extracted from pines are used in
the pharmaceutical, cosmetic and food industries. For many years,
Agrobacterium-mediated transformation of conifers was deemed impossible
but the barriers for their transformation have been overcome. Patents on this
area describe several methods to attain transformation of pines.
Marine algae transformation
Algae are organisms found in virtually every ecosystem, in ecosystems
as diverse as marine, freshwater and terrestrial habitats. Algae are
commercially very valuable. For example, marine algae or seaweeds are used in
many maritime countries as a source of food, for industrial applications and as
a fertilizer. Marine algae's products such as gums are very important in the
international market. Although Agrobacterium-mediated transformation of
eukaryotic organisms was initially confined to plants for a while, nowadays,
algae can also be transformed via this bacterium. Because transgenic marine
algae with a large biomass are a potential source for valuable pharmaceutical
and industrial products, patent activity in this area will possibly increase.
Currently, there is a patent application directed to methods for transforming
multicellular marine algae.
Fungus transformation
Fungi
constitute a separate life kingdom from animals and plants. Most fungi are
filamentous organisms that contain two nuclei per cell for most of their life
cycle. Fungi are essential organisms required for the continuous cycle of
nutrients through ecosystems. While they provide essential nutrients to vascular
plants through symbiosis, not all of their activity is beneficial. In this
regard, many fungi are the cause of plant, animal and human diseases. The
selected patents on Agrobacterium-mediated transformation of fungi are
mainly directed to the transformation of filamentous fungi, commonly known as
moulds. Transformation of yeasts, another group of fungi, is outside the scope
of this paper.
What is the present white paper NOT about?
|
This white paper is not intended to make the reader an expert in patents nor
will it serve as a legal opinion for the reader's particular issues. It should
not be substituted for legal advice. More
information
|
To learn more about patents and patentability, please visit our companion
tutorial, "How to read a patent" and web sites
such as the web site of the
United States Patent Office
and the web site of the World
Intellectual Property Organization. Other resource sites may be found on the
Links page.
The user should especially note that the materials provided in this site are
not comprehensive. In particular, we do not analyze patents directed to methods
of using or transforming eukaryotic cells or components of eukaryotic or
bacterial vectors that are also used in agricultural R&D. Some of these
patents may dominate the agricultural patents discussed on this site. As well,
we present only a selected set of patents and applications. The set represents
what we consider to be key in the field. It is inevitable that others would have
a different opinion about what is key and, as a result, may well have chosen a
different set of patents.
This white paper presents an overview of the field of
Agrobacterium- mediated transformation with respect to intellectual
property. The reader should gain an appreciation for the complexities of the
field and insight into the types of intellectual property directed to this
field.
What you NEED to know about patents
Claims define what is patented
|
The claims are the most important part of a patent. Not the
title, not the text, not the examples, and not the figures.
|
It is the claims that define the boundaries of the patent owner's rights.
Remember that the patent owner's rights are exclusionary: she may exclude others
from making, using, selling, offering to sell, and importing the patented
invention (e.g., a product or a process) and importing a product made by a
process patented in the importing country. To determine if someone is infringing
a patent, that is making, using, etc., without the patent owner's permission,
the allegedly infringing product or process is compared only to the claims.
Don't fall into the trap of concluding that the title or the abstract or the
general description found in the text of the patent indicates what is patented.
For example, United States Patent No.
6074877
is titled "Process for transforming monocotyledonous plants". From the title, it
sounds like these patent owners have protected a transformation process(es) for
transforming all monocot plants. Examination of the claims shows, however, that
only transformation of cereal plants is protected, and furthermore, that the
method involves wounding an embryogenic callus or treating an embryogenic callus
with an enzyme that degrades cell walls prior to transferring DNA into the cells
with Agrobacterium. A bit different from what the title implied.
Yet, claims cannot to be interpreted in a vacuum. Although claims define the
invention, the scope of the claimed invention is not always clear from reading
the plain language of the claim. Claim interpretation can be difficult; a proper
analysis is done by reading the claims in the context of the specification and
in the context of the "prosecution history" (the back and forth negotiations
between the patent applicant and the patent office regarding the claim
language). In the case above, for example, several terms in the claims (e.g.,
"cereal plants", " embryogenic callus", and "enzyme that degrades cell walls")
are unclear without additional insight hopefully provided by the specification
and prosecution history.
Claims in this white paper and the claims written in "plain English" were
analyzed from the plain language and the specification. The prosecution history
was not examined. Thus, scope of the claimed inventions may not have always been
precisely determined.
A patent application is not the same as a patent
|
A patent application is NOT the same as a patent. Claims in a published
patent application have not been examined by a national patent office and may
not be representative of a scope that will ultimately be granted.
|
During the application process, patent specifications are published 18 months
after the earliest filing. The publications contain the claims as filed.
Sometimes the claims are written much more broadly than is actually patentable.
As the application is examined by a patent office and claim language negotiated,
the claims may shrink in scope. In contrast, the specification of a granted
patent will usually be the same as when filed; new matter is not allowed to be
added to the text after it is filed.
Because the claims in an application are what the applicant hopes for and not
what she will necessarily receive, it is important to know whether you are
looking at a granted patent or a patent application.
How do you tell the difference between a granted patent and a patent
application? Although every country uses its own system of identifying
granted patents, some general guidelines will assist you for the major
jurisdictions.
-
United States: until 29 November 2000, all publications
were issued patents. Currently, the United States identifies patents with a
7-digit number followed by a B1 (indicates a patent not previously published) or
a B2 (indicates a patent previously published). E.g., US 6,174,724 B1, shown
below.

Patent applications
are indicated with the year as a 4-digit number and a publication number
followed by an A1 (for the first publication), A2 (for republication) or A9
(corrected publication). E.g., US 2001/0002490 A1, shown below.

-
Europe: patents are indicated with a 7-digit number
followed by a B1, e.g., EP 0 458 846 B1 (shown below). A B2 number indicates
that the claims have been modified after grant.

Patent applications use the same
numbering system but the number is followed by A1, A2, etc., e.g., EP 0 955 371
A1 (shown below).

-
World Intellectual Property Organization (WIPO): often
simply called PCT (Patent Cooperation Treaty) applications, publications from
WIPO are only patent applications. The publication numbers have a WO, which
stands for "world" followed by the year as 2 digits, followed by a publication
number, and A1 (first publication), A2 (second publication), etc. e.g., WO
00/34491 A2 (shown below).

The truth about international patents
|
There is no such thing as an international patent.
|
A patent is awarded by the government of a country and is valid only within
its territorial boundaries. To obtain a patent that is valid in a particular
country, a request must be made in that country's patent office.
The confusion and misunderstanding about "international patents" arises
sometimes from the PCT process of pursuing patents. When looking at a PCT
application, many people erroneously, but understandably, conclude that it is an
application for a patent that will be valid in multiple countries. Indeed on the
front page of a PCT application (presented below), in the upper right corner
there is a heading titled "Designated states" followed by a list of two letter
codes. Each of those codes stands for a country (e.g., AU, Australia; CA,
Canada; CN, China, and so on). There can be as many as about 110 countries
listed. However, this list does not mean that the application is a patent, or
even will become a patent, in all of these countries.
|
The international (PCT) application is a "placeholder" application for
national filings.
|
OK then, what does this list mean? Through an international treaty (Paris
Convention Treaty), a group of countries agreed to not discriminate against each
other by affording patent applicants in these countries a one-year period in
which to file an application in one of the other countries without losing the
benefit of their filing date. The advantage is that any "art" that became known
after the original filing date in the home country but before the filing date in
another country could not be cited against the application. Thus, for example,
if you originally file an application for your invention in Canada, you could
wait up to one year before filing the application in Mexico. This would give you
time to see if the costs of filing in other countries is justified.
Later, a second treaty (Patent Cooperation Treaty (PCT)) established another
route to delay the additional filings in other countries. In this method, an
international office was set up (World Intellectual Property Office (WIPO)) to
receive and process the applications. But now, the applicant has one year to
file at the WIPO office and by designating member countries she preserves her
rights and original filing date in those designated countries without having to
go to the expense of actually filing in each country. This saves an enormous
amount of money! Eventually to obtain a patent in these countries, the
application does need to be filed in the national patent offices (the process is
called "conversion"), pay fees, have translations done and comply with the
regulations of each individual office. Depending on some procedural issues and
fee payments, the applicant has either 20 months or 30 months from the original
filing date (the date the application was filed in the home country) to file in
each of these other countries. Given the costs, most applications are filed in a
few other countries at most.
What is ownership of a patent
The legal owner of a patent is designated as the "Assignee" on United States
patents and as the "Applicant" on patents in the rest of the world. However, the
rights of a patent holder are like a bundle of sticks, and only one of the
sticks is legal ownership.
Patent law gives the patent owner the right to exclude others from making,
using, offering for sale, selling, and importing the patented product and from
using the patented process, as well as using, offering for sale, selling, or
importing a product obtained directly from a patented process. These rights are
tradeable. The typical form of trade is a license, in which some or all of the
rights may be transferred. For example, the patent owner may license only some
of the claims in a patent, all of the claims but only in a particular field of
research, all of the rights but only in certain countries, or the right to make
and use but not the right to sell. Other types of licenses may also be granted.
Unlike the ownership of a patent, which is a matter of public record,
licenses can be private. Unless the parties to a license choose to reveal the
relationship, it is impossible to know about.
In this paper, the legal owner is noted. The cautionary note is that the
legal owner may not be the party that is in control of the rights you want
access to.
Except where otherwise noted, patent information is current
through to January 2003.
Summary
Both granted patents and pending patent applications are subject to
change. A granted patent is typically in force for a 20 year
term, calculated from the filing date, as long as the
maintenance fees are paid, although some patents have been issued under rules
that give them different terms (see tutorial).
An example of a patent that has taken advantage of a pre GATT-TRIPS filing
date is
US
Patent No. 6051757. For this patent, the filing date was June 5, 1995;
shortly before the June 8, 1995 GATT/TRIPS deadline in
the United States.
US
Patent No. 6051757 is a continuation application that claims priority to a
parent application with a January 14, 1983 filing date. Had this application
been filed three days later, it would have likely had a patent term that expired
on January 14, 2003.
However, since the application was filed before the GATT/TRIPS deadline, it
is entitled to a patent term calculated 17 years from the issue date, rather
than 20 years from the priority date.
The
application
data provided by PAIR reveals that this application took nearly five years
after the filing date to issue. Numerous extensions of time were granted by the
examiner during the prosecution of the application. This patent finally issued
on April 18, 2000, and is therefore likely entitled to a patent term that would
expire on April 18, 2017 (barring any litigation or lapses due to failure to pay
maintenance fees). Basically, an invention that was made in 1983 gave rise to a
patent that expires 34 years after the first filing date!
The patent term is a period during which the patentee has the right to
exclude others from using the technology. Technology described in a granted
patent that lapses due to lack of payment or expiration of the term moves into
the public domain, and unless the technology is covered by other patents still
in force, people may work inventions in the public domain without infringement.
From the moment of filing, patent applications go through an interactive
process between the applicant and the patent office, the so-called
"prosecution", which eventually leads to the grant or rejection of a patent
application. During this process, which may take several years, the claims,
which define the scope of desired protection for the invention, are likely to be
amended. Therefore, the claims of a published patent application may
differ from those finally granted by a patent office. In addition, an
application may be abandoned along the examination process if
the applicant decides not to seek patent protection for the invention in a
particular country.
This white paper on Agrobacterium-mediated transformation
of plants was updated in March 2002 and June 2003, and is undergoing another
revision now. The dynamic nature of intellectual property rights, especially in
a rapidly evolving area such as biotechnology, makes regular updates necessary
in order to keep abreast of new constraints to freedom to operate or of formerly
patented technology that becomes freely accessible.
The main changes registered are:
-
Abandonment, when the applicants have decided not to
continue with the prosecution process or when maintenance fees have not been
paid for granted patents;
-
Issuance of a patent, when applications listed in previous
versions of the paper have resulted in granted patents, which may have different
claims;
-
Entering European (EP) phase, or national phase in other
national patent offices (applications filed under the Patent Cooperation Treaty
may be converted to national patent applications after a maximum period of 30
months from the earliest priority date).
A summary table provides information on changes
between 2002 and 2003. For convenience, the documents are presented according to
the white paper sections to which they pertain and following the order set in
the table of contents/index of the document. You will find out more detailed
information by following the links provided for each patent application.
-
New patents and patent applications
Many new patents and patent applications have emerged in the field of
Agrobacterium-mediated transformation since 2002. Some of these patents
are directed to new methods for transformation of plant tissues and crops,
previously discussed in the white paper, and others are directed to new crops,
such as coffee, onions, turfgrass and woody tree species.
The new patent documents are presented in a summary
table. Documents are grouped according to the white paper sections set in
the table of contents/index. You will find out more detailed information on each
patent document by following the links provided in the table.
Changes in legal status of patents and patent applications since last update
| Document No. |
Topic / Assignee |
|
Change |
|
AU
597916 B
|
Transformation of poplar / Calgene
|
View Summary |
Abandoned
|
|
AU
606874 B
|
Transformation of Gramineae / Toledo Univ.
|
View Summary |
Abandoned
|
|
AU
633248 B
|
Transformation of Beans / Toledo Univ.
|
View Summary |
Abandoned
|
|
AU
648951 B
|
Transformation of Soybeans / Toledo Univ.
|
View Summary |
Abandoned
|
|
US
5376543
|
Transformation of Soybeans / Toledo Univ.
|
View Summary |
Abandoned
|
|
US
5340730
|
Transformation of Gladiolus / Toledo Univ.
|
View Summary |
Abandoned
|
New patents and patent applications (Update July 2003)
Note! Assignees listed in brackets are assumed (from related applications and
patents), because the assignee is often not recorded on US applications.
| Document No. and date of publication |
Assignee |
Title |
More information
|
| Methods |
|
|
|
|
US
2002/0088029 A1
(4 Jul 2002)
|
(Novartis Finance Corp (US))
|
Plant transformation methods.
|
See details
|
|
US
6353155 B1
(5 Mar 2002)
|
Paradigm Genetics, Inc. (US)
|
Methods for transforming plants.
|
See details
|
|
WO
02/066599 A2
(29 Aug 2002)
|
Scigen Harvest Co Ltd (KR)
|
Efficient method for the development of transgenic plants by gene
manipulation.
|
See details
|
|
EP 1236801 A2 (4 Sep 2002)
|
The Agri-Biotechnology Research Center of Shanxi (CN)
|
Method of Agrobacterium-mediated plant transformation through
treatment of germinating seeds.
|
See details
|
|
US
2002/0184663 A1
(5 Dec 2002)
|
(The Agri-Biotechnology Research Center of Shanxi (CN))
|
Method of Agrobacterium-mediated plant transformation through
treatment of germinating seeds.
|
See details
|
| Monocots |
|
|
US
2002/0178463 A1
(28 Nov 2002)
|
(Japan Tobacco Inc (JP))
|
Method for transforming monocotyledons.
|
See details
|
|
US
2002/0112261
(15 Aug 2002)
|
(Univ. of Guelph (CA))
|
Transformation of monocotyledoneous plants using Agrobacterium.
|
See details
|
|
WO
00/58484
(15 Aug 2002)
|
(Univ. of Guelph (CA))
|
Transformation of monocotyledoneous plants using Agrobacterium.
|
See details
|
|
EP 1198985 A1 (14 Apr 2002)
|
Natl Inst of Agrobiological Resources (JP)
|
Method for superrapid transformation of monocotyledon.
|
See details
|
| Gramineae |
|
|
US
2002/0002711
(3 Jan 2002)
|
(Univ. Toledo (US))
|
Process for transforming Gramineae and the products thereof.
|
See details
|
| Onion (Allium) |
|
|
NZ 513184 (27 Sep 2002)
|
NZ Inst for Crop & Food Res (NZ)
|
Transformation and regeneration of Allium plants.
|
See details
|
|
WO
00/65903
(9 Nov 2000)
|
Seminis Vegetable Seeds, Inc. (US)
|
Transformation of Allium sp. with Agrobacterium using
embryogenic callus cultures.
|
See details
|
| Barley |
|
|
US
6291244 B1
(18 Sep 2001)
|
Sapporo Breweries Ltd (JP)
|
Method of producing transformed cells of barley.
|
See details
|
| Maize |
|
|
US
2002/0104132
(1 Aug 2002)
|
Stine Biotechnology (US)
|
Methods for tissue culturing and transforming elite inbreds of Zea
mays L.
|
See details
|
|
US
2002/0104131
(1 Aug 2002)
|
Stine Biotechnology (US)
|
Methods for tissue culturing and transforming elite inbreds of Zea
mays L.
|
See details
|
|
US
6420630 B1
(16 Jul 2002)
|
Stine Biotechnology (US)
|
Methods for tissue culturing and transforming elite inbreds of Zea
mays L.
|
See details
|
| Rice |
|
|
US
6329571 B1
(11 Dec 2001)
|
Japan Tobacco, Inc. (JP)
|
Method for transforming indica rice.
|
See details
|
|
WO
02/057407
(25 Jul 2002)
|
Avestha Gengraine Technologies (IN)
|
Novel method for transgenic plants by transformation and regeneration of
indica rice plant shoot tips.
|
See details
|
| Sorghum |
|
|
US
2002/0138879 A1
(26 Sep 2002)
|
Pioneer Hi-Bred Intl.Inc. (US)
|
Agrobacterium-mediated transformed sorghum.
|
See details
|
|
US
6369298 B1
(9 Apr 2002)
|
Pioneer Hi-Bred Intl.Inc. (US)
|
Agrobacterium-mediated transformation of sorghum.
|
See details
|
| Dicots |
|
|
US
6323396 B1
(27 Nov 2001)
|
Nunhems Zaden BV (NL)
|
Agrobacterium-mediated transformation of plants.
|
See details
|
| Brassica |
|
|
US
6316694 B1
(13 Nov 2001)
|
AgrEvo Canada, Inc. (CA)
|
Transformed embryogenic microspores for the generation of fertile homozygous
plants.
|
See details
|
|
US
6455761 B1
(24 Sep 2002)
|
Helsinki Univ.Licensing Ltd. (FI)
|
Agrobacterium-mediated transformation of turnip rape.
|
See details
|
| Camelina sativa |
|
|
WO
02/38779
(16 May 2002)
|
Unicrop Ltd (FI)
|
A transformation system in Camelina sativa.
|
See details
|
| Coffee |
|
|
US
6392125 B1
(21 May 2002)
|
Nara Inst.of Science and Technology (JP)
|
Method for producing the transformants of coffee plants and transgenic coffee
plants.
|
See details
|
| Cotton |
|
|
US
6483013 B1
(19 Nov 2002)
|
Bayer BioScience N.V. (BE)
|
Method for Agrobacterium-mediated transformation of cotton.
|
See details
|
| Eucalyptus |
|
|
US
6255559 B1
(3 Jul 2001)
|
Genesis Research & Dev.Corp.NZ and Fletcher Challenge Forests Ltd. (NZ)
|
Methods for producing genetically modified plants, genetically modified
plants, plant materials and plant products produced thereby.
|
See details
|
| Guar |
|
|
US
2001/0034887 A1
(25 Oct 2001)
|
(Danisco A/S (DK))
|
Transformation of guar.
|
See details
|
|
US
6307127 B1
(23 Oct 2001)
|
Danisco A/S (DK)
|
Transformation of guar.
|
See details
|
| Melon |
|
|
US
6198022 B1
(6 Mar 2001)
|
Groupe Limagrain Holding (FR)
|
Transgenic plants belonging to the species Cucumis melo.
|
See details
|
| Soybeans |
|
|
US
2002/0157139
(24 Oct 2002)
|
Monsanto Co. (US)
|
Soybean transformation method.
|
See details
|
|
US
6384301 B1
(7 May 2002)
|
Monsanto Co. (US)
|
Soybean Agrobacterium transformation method.
|
See details
|
| Strawberry |
|
|
US
6274791 B1
(14 Aug 2001)
|
(VPP Corp.) DNA Plant Technology Corp. (US)
|
Methods for strawberry transformation using Agrobacterium
tumefaciens.
|
See details
|
| Woody trees |
|
|
WO
02/14463
(21 Feb 2002)
|
Companhia Suzano de Papel e Celulose BR and Univ.de Sao Paulo (BR)
|
Method for genetic transformation of woody trees.
|
See details
|
| Conifers (Pinus) |
|
|
US
6255559 B1
(3 Jul 2001)
|
Genesis Research & Dev. Corp.NZ and Fletcher Challenge Forests Ltd. (NZ)
|
Methods for producing genetically modified plants, genetically modified
plants, plant materials and plant products produced thereby.
|
See details
|
Assignees in parentheses are assumed, based on related applications and
patents, because they usually don't show on US applications
Scientific Aspects
Overview
Agrobacterium-mediated transformation of
plants: from a naturally occurring nuisance to a major tool for
plant transformation
Agrobacterium tumefaciens is a common soil bacterium that naturally
inserts its genes into plants and uses the machinery of plants to express those
genes in the form of compounds that the bacterium uses as nutrients. In the
process, Agrobacterium causes plant tumors commonly seen near the
junction of the root and the stem, deriving from it the name of crown gall
disease. The disease afflicts a great range of dicotyledonous plants, which
constitute one of the major groups of flowering plants.
In 1907, the bacterium was identified by Smith and Townsend as the causative
agent of the disease, but it was not until the end of the sixties that a
correlation between the tumor and the presence of genetic material of the
bacterium was established (Braun and Schilperoort).
|
During the 1970s, several laboratories investigated the biology,
biochemistry, and molecular biology of Agrobacterium. The combined
results of their investigations laid the foundation for generating transgenic
plants.
|
Between the 1970s and 1980s, some striking aspects were discovered about the
biology, biochemistry, and molecular biology of Agrobacterium. Tumorous
plant cells were found to contain DNA of bacterial origin integrated in their
genome. Furthermore, the transferred DNA
(named T-DNA) was originally part of a small molecule of DNA
located outside the chromosome of the bacterium. This DNA molecule was called
Ti (tumor-inducing) plasmid
(Zaenen et al., Chilton et al.).
The Ti plasmid contains most of the genes required for tumor formation.
Wounded plants exude phenolic compounds that stimulate the expression of the
virulence genes (vir -genes), which
are also located on the Ti plasmid (Wullems et al. , Hoekema et
al.). The vir genes encode a set of proteins responsible for the
excision, transfer and integration of the T-DNA into the plant genome. The genes
in the T-DNA region are responsible for the tumorigenic process. Some of them
direct the production of plant growth hormones that cause proliferation of the
transformed plant cells. The T-DNA region is flanked at both ends by 25 base
pairs (bp) of nucleotides called T-DNA borders (Zambryski
et al.). The T-DNA left border is not essential, but the right border
is indispensable for T-DNA transfer.

|
Early 1980's - "the golden molecular age of Agrobacterium-mediated
transformation." Major discoveries include finding that:
- a fragment of the Ti plasmid, the T-DNA, is responsible for plant tumor
growth and is equipped with plant specific promoters and terminators, and
- continuous tumor growth is not dependent on the presence of agrobacteria in
the tumor.
|
The study of Agrobacterium and its natural mechanism to alter the
biology of infected plant cells sparked the design of molecules that would
transfer genes of interest into plant cells. These engineered DNA molecules are
commonly referred to as vectors. The starting molecules can be
native Ti-plasmids present in Agrobacterium or native or modified
plasmids from other bacteria known to deliver DNA into transformed cells.
The basic elements of the vectors designed for
Agrobacterium-mediated transformation that were taken from the native
Ti-plasmid:

- the T-DNA border sequences, at least the right border,
which initiates the integration of the T-DNA region into the plant genome
- the vir genes, which are required
for transfer of the T-DNA region to the plant, and
- a modified T-DNA region of the Ti plasmid, in which the
genes responsible for tumor formation are removed by genetic engineering and
replaced by foreign genes of diverse origin, e.g., from plants, bacteria, virus.
When these genes are removed, transformed plant tissues or cells regenerate into
normal-appearing plants and, in most cases, fertile plants.
Although other methodologies for plant transformation have been devised,
Agrobacterium remains one of the preferred mechanisms to introduce
exogenous genes into the plant cells. One of the reasons for this is the wide
spectrum of plants that are susceptible to transformation by this bacterium.
Agrobacterium was initially believed to be restricted to the
transformation of certain dicotyledonous plants (flowering plants with two
cotyledons in their seeds and broad leaves) such as potato and tomato, but
nowadays, transformation of monocotyledonous plants (flowering plants with one
cotyledon in their seeds and narrow leaves with parallel veins), such as maize
and rice is routinely performed.
|
In summary, an Agrobacterium -mediated transformation system
normally involves:
- an Agrobacterium strain carrying a vir region and a T-DNA
with a gene of interest. The vir and T-DNA region are located either on
the same or separate vectors;
- transfer of T-DNA region into a plant cell or tissue and its integration
into the plant genome;
- expression of a gene of interest in the plant cell; and
- regeneration of the transformed plant cell or tissue into a complete plant.
|
Essential Features
Several essential features are required for Agrobacterium-mediated
transformation of plants:
-
vir genes. Approximately 35
vir genes map outside the T-DNA (transferred DNA) region and encode
products required for excision, transfer, and integration of T-DNA into a plant
genome. vir genes act in trans, meaning they do not need to be
physically attached to the T-DNA to cause integration into the plant genome.
-
T-DNA border sequences. These are sequences of 25 bp
imperfect repeats that flank the T-DNA and are required for its transfer. Border
sequences encompass the recognition sites for a site-specific endonuclease,
which is encoded by the vir D operon, part of the vir genes.
The endonuclease cleaves the lower DNA strand of the T-DNA marking the starting
point of the transfer.
-
|
Apart from the T-DNA border sequences, most of the genes of the T-DNA can be
replaced by genes of interest to be transferred into the plant. Such engineered
T-DNA is generally referred to as mutant T-DNA, engineered T-DNA or disarmed
T-DNA. However, the exact definition of the
terms in a patent application is often provided by the inventor.
|
-
cis-regulatory regions. These include the right
and left T-DNA borders, which are physically attached to the genes to be
transferred into the plant genome. Other cis -regulatory regions
include promoters and terminators that flank the transgenes and regulate their
expression. Commonly used promoters and terminators are the nopaline synthesis
gene (NOS) and Cauliflower Mosaic Virus (CaMV) 35S promoter.
-
Selectable marker genes. In plants, they allow the
identification and selection of cells with the gene of interest incorporated in
their genome. Bacterial selectable markers permit the identification of bacteria
transformed with a vector carrying the marker. Examples of plant and bacterial
selectable markers are hygromycin phosphotransferase and kanamycin,
respectively.
The above-mentioned elements are incorporated in two basic types of vectors
used to transform a wide range of plants via Agrobacterium:
-
Binary vectors. In this system, the T-DNA and the
vir region reside in separate plasmids within the same
Agrobacterium strain. The vir genes are located in a disarmed
(without tumor genes) Ti plasmid and the T-DNA with the gene of interest is
located in a small vector molecule.
-
Co-integrated vectors. These vectors result from the
recombination of a small vector plasmid, for example an E.
coli vector, and a Ti plasmid harbored in A. tumefaciens. The
recombination takes place through a homologous region present in both of the
plasmids. An engineered T-DNA containing the gene of interest can be in
either one of the plasmids.
References
Binary Vectors
The discovery that the vir genes do not need to be in the same
plasmid with a T-DNA region to lead its transfer and insertion into the plant
genome led to the construction of a system for plant transformation where the
T-DNA region and the vir region are on separate plasmids.
In the binary vector system, the two different plasmids employed are:
In general, the transformation procedure is as follows:
- the recombinant small replicon is transferred via bacterial conjugation or
direct transfer to
A. tumefaciens harboring a helper Ti plasmid,
- the plant cells are co-cultivated with the Agrobacterium, to allow
transfer of recombinant T-DNA into the plant genome, and
- transformed plant cells are selected under appropriate conditions.


Possible pitfalls
A possible disadvantage may ensue from the fact that the stability of wide
host range replicons in E. coli and Agrobacterium varies
considerably. Depending on the orientation, plasmids with two different origins
of replication may be unstable in E. coli where both origins are
active.
Advantages
Compared with co-integrated vectors, binary vectors present some advantages:
- No recombination process takes place between the molecules involved.
- Instead of a very large, recombinant, disarmed Ti plasmid, small vectors are
used, which increases transfer efficiency from E. coli to
Agrobacterium.
This vector system is most widely used nowadays. Different types of binary
vectors have been devised to suit different needs in a plant transformation
process.
Binary vector types
-
pGA series vectors, which contain:
- an ori derived from RK2 for replication in E. coli and
Agrobacterium,
- a tetracycline resistance gene,
- the cis-acting factor required for conjugal transfer,
- the right (RB) and left (LB) T-DNA borders,
- a neomycin phosphotransferase (nptII) gene, which confers
resistance to kanamycin and G418 in transformed plants, and
- a polylinker site (multicloning site).
Specific vectors in this series are designed for cloning large fragments (colE1
origin of replication and phage l cos), analyzing promoters (multiple cloning
site immediately upstream of a promoterless cat gene), and expressing a
gene of interest (polylinker site between a plant promoter and a terminator).
-
pCG series vectors, which contain:
- the origin of replication of the Agrobacterium rhizogenes root
-inducing plasmid pRiHRI, which confers more stability in Agrobacterium
than the ori derived from RK2, and a ColE1 origin of replication from the vector
pBR322 for maintenance in E. coli.
-
pCIT series which contain:
- the hygromycin (hph) resistance gene for plants,
- the lambda cos site for cloning long fragments.
-
pGPTV (glucuronidase plant transformation vector)
series , which have:
- different plant selectable marker genes close to the left T-DNA border. This
design overcomes problems inherent with the preferential right to left border
transfer of T-DNA and improves the chances of having the gene of interest
transferred to the plant cell in cells expressing the selectable marker gene.
-
pBECK2000 series, which contain:
- synthetic T-DNA borders and a bar gene, which confers the plants
resistance to the herbicide phosphinothricin. Also, the vectors use the phage P1
Cre/loxP site-specific recombinase system, which permits the transfer
and integration of a target and marker genes as a single T-DNA unit into the
plant genome or as two independent T-DNAs within a single
Agrobacterium. It also allows site-specific excision of marker genes
from the plant genome after transformation.
-
Binary-BAC (BiBAC) vector
- based on a bacterial artificial chromosome (BAC) vector and is suitable for
Agrobacterium-mediated transformation of high-molecular-weight DNA
- comprises low-copy number origins of replication for both E. coli
and Agrobacterium to ensure replication of the plasmid as a single-copy
in both bacteria; and
- a helper plasmid carrying additional copies of vir-genes in order
to clone very large T-DNAs (up to 150 kb) into the plant genome.
-
pGreen series, small plasmids of around 3.2 Kb containing:
- a broad host range replication origin (ori pSa) and a ColE1 origin derived
from pUC,
- a pSa replicase gene (rep A) that provides replication functions in
trans and is located in a compatible plasmid (pSoup) in
Agrobacterium, and
- multiple cloning sites based on the pBlueScript vector, which allow any
arrangement of selectable marker and reporter genes.
References
Co-integrated Vectors
Called co-integrated vectors or hybrid Ti
plasmids, these vectors were among the first types of modified and
engineered Ti plasmids devised for Agrobacterium -mediated
transformation, but are not widely used today.
These vectors are constructed by homologous recombination of a bacterial
plasmid with the T-DNA region of an endogenous Ti plasmid in
Agrobacterium. Integration of the two plasmids requires a region of
homology present in both.
Three vectors are necessary in this system:
-
Disarmed Agrobacterium Ti plasmids
In these
Ti plasmids, the oncogenes located in the T-DNA region have been replaced by
exogenous DNA.
Examples of these vectors include:
- SEV series: the right border of the T-DNA together with the phytohormone
genes coding for cytokinin and auxin are removed and replaced by a bacterial
kanamycin resistance gene while the left border and a small part of the left
segment (TL) of the original T-DNA (referred to as Left Inside
Homology (LIH)) are left intact.
- pGV series: the phytohormone genes are excised and substituted by part of
pBR322 vector sequence. The left and right border sequences as well as the
nopaline synthase gene of the Ti plasmid are conserved.
-
Intermediate vectors
These are small pBR322-based
plasmids (E. coli vectors) containing a T-DNA region. They are used to
overcome the problems derived from the large size of disarmed Ti plasmids and
their lack of unique restriction sites. Intermediate vectors are replicated in
E.coli and are transferred into Agrobacterium by conjugation.
They cannot replicate in A. tumefaciens and therefore, carry DNA
segments homologous to the disarmed T-DNA to permit recombination to form a
co-integrated T-DNA structure.
-
Helper vectors
These are small plasmids maintained in
E. coli that contain transfer (tra) and mobilization
(mob) genes, which allow the transfer of the conjugation-deficient
intermediate vectors into Agrobacterium.

A resulting co-integrated
plasmid assembled by in vitro manipulation normally contains:
- the vir genes,
- the left and right T-DNA borders,
- an exogenous DNA sequence between the two T-DNA borders, and
- plant and bacterial selectable markers.
Some drawbacks
Although co-integrated vectors have been designed to allow site-specific
recombination based on the recombination system of the phage P1 (e.g.,
wP1loxP-Cre series), co-integrated vectors in general are less popular
due to:
- long homologies required between the Ti plasmid and the E. coli
plasmids making them difficult to engineer and use, and
- relatively inefficient gene transfer compared to the binary vectors.
References
References
Essential features
Bevan, M. 1984. Binary Agrobacterium vectors for plant
transformation. Nucl. Acids. Res. 12: 8711-8721.
Bomhoff, G., Klapwijk, P.M., Kester, H.C.M., and Schilperoort, R.A. 1976.
Octopine and nopaline synthesis and breakdown genetically controlled by a
plasmid of Agrobacterium tumefaciens. Mol. Gen. Genet. 145: 177-181.
Braun, A.C.1958. A physiological basis for autonomous growth of the
crown-gall tumor cell. Proc. Nat. Acad. Sci. USA 44: 344-349.
Braun, A.C. 1969. Abnormal growth in plants. In: Plant Physiology-A Treatise
(Steward, F.C. Ed.) Acad. Press, N.Y., Vol VB: 379-420.
Chilton, M.D., Drummond, M.H., Merlo, D.J., Sciaky, D., Montoya, A.L.,
Gordon, M.P. and Nester, E.W. 1977. Stable incorporation of plasmid DNA into
higher plant cells: the molecular basis of crown gall tumorigenesis. Cell 11:
263-271.
Chilton, M.D. 1983. A vector for introducing new genes into plants.
Scientific American 248. 6: 36-45.
Drummond, M.H., Gordon, M.P., Nester, E.W., and Chilton, M.D. 1977. Foreign
DNA of bacterial plasmid origin is transcribed in crown gall tumors. Nature 269:
535-536.
Duan, X., Li, X., Xue, Q., Abo-El-Saad, M., Xu, D., and Wu, R. 1996.
Transgenic rice plants harboring an introduced potato proteinase inhibitor II
gene are insect resistant. Nature Biotechnology 14: 494-498.
Grimsley, N., Hohn., T., Davies, J.W., and Hohn, B. 1987.
Agrobacterium-mediated delivery of infectious maize streak virus into
maize plants. Nature 325: 177-179.
Greene, E.A. and Zambryski, P.C. 1993. Agrobacteria mate in opine dens.
Current Biology 3, 507-509. Herrera-Estrella, L., De Block, M., Messens, E.,
Hernalsteens, J.P., Van Montagu, M., and Schell, J. 1983a. Chimeric genes as
dominant selectable markers in plant cells. EMBO J. 2: 987-995.
Herrera-Estrella, L., Depicker, A., Van Montagu, M., and Schell, J. 1983b.
Expression of chimeric genes transferred into plant cells using a Ti
plasmid-derived vector. Nature 303: 209-213.
Hoekema, A., Hirsch, P.R., Hooykaas, P.J.J., and Schilperoort, R.A. 1983. A
binary plant vector strategy based on separation of vir- and T-region
of the Agrobacterium tumefaciens Ti plasmid. Nature 303: 179-180.
Hoekema, A., Hooykaas, P.J.J., and Schilperoort, R.A. 1984. Transfer or the
octopine T-DNA segment to plant cells mediated by different types of
Agrobacterium tumor- or root-inducing plasmids: Generality of virulence
systems. J. Bacteriol. 158: 383-385.
Hooykaas, P.J.J. and Schilperoort, R.A.1992. Agrobacterium and plant
genetic engineering. Plant Mol. Biol. 19, 15-38. Hooykass-Van Slogteren, G.M.S.,
Hooykaas, P.J.J., and Schilperoort, R.A. 1984. Expression of Ti plasmid genes in
monocotyledonous plants infected with Agrobacterium tumefaciens. Nature 311:
763-764.
Ishida, Y., Saitao, H., Ohta, S., Hiei, Y., Komari, T., and Kumashiro, T.
1996. High efficiency transformation of maize (Zea mays L.) mediated by
Agrobacterium tumefaciens . Nature Biotechnology 14: 745-750.
Ooms, G., Hooykaas, P.J.J., Moolenaar, G., and Schilperoort, R.A. 1981. Crown
gall plant tumors of abnormal morphology, induced by Agrobacterium
tumefaciens carrying mutated octopine Ti plasmids; analysis of T-DNA
functions. Gene 14: 33-50.
Schell, J., and Van Montagu, M. 1983. The Ti plasmids as natural and as
practical gene vectors for plants. Bio/Technology 1: 175-180.
Schilperoort, R.A., Veldstra, H., Warnaar, S.O., Mulder, G., and Cohen, J.A.
1967. Formation of complexes between DNA isolated from tobacco crown gall tumors
and RNA complementary to Agrobacterium tumefaciens DNA. Biochem.
Biophys. Acta 145: 523-525.
Smith, E.F. and Townsend, C.O. 1907. A plant tumor of bacterial origin.
Science 25: 671-673.
Van Larebeke, N., Engler, G., Holsters, M., Van den Elsacker, S., Zaenen, I.,
Schilperoort, R.A., and Schell, J. 1974. Large plasmid in Agrobacterium
tumefaciens essential for crown gall-inducing ability. Nature 252: 169-170.
Van Larebeke, N., Genetello, C., Schell, J., Schilperoort, R.A., Hermans,
A.K., Hernalstenns, J.P. and Van Montagu, M. 1975. Acquisition of tumor-inducing
ability by non-oncogenic agrobacteria as a result of plasmid transfer. Nature
255: 742-743.
Willmitzer, L., De Beuckeleer, M., Lemmers, M., Van Montagu, M., and Schell,
J. 1980. DNA from Ti plasmid present in nucleus and absent from plastids of
crown gall plant cells. Nature 287: 359-361.
Wullems, G.J., Molendijk, L., Ooms, G., and Schilperoort, R.A. 1981a.
Retention of tumor markers in F1 progeny plants from in vitro induced
octopine and nopaline tumor tissues. Cell 24: 719-727.
Wullems, G.J., Molendijk, L., Ooms, G., and Schilperoort, R.A. 1981b.
Differential expression of crown gall tumor markers in transformants obtained
after in vitro Agrobacterium tumefaciens induced
transformation of cell regenerating protoplasts derived from Nicotiana tabacum.
Proc. Natl. Acad. Sci. USA. 78: 4344-4348.
Yadav, N.S., Vanderleyden, J., Bennett, D.R., Barnes, W.M., and Chilton,
M.D.1982. Short direct repeats flank the T-DNA on a nopaline Ti plasmid. Proc.
Natl. Acad. Sci. USA 79: 6322-6326.
Zhu, J., Oger, P.M., Schrammeijer, B., Hooykaas, P.J., Farrand, S.K., and
Winans, S.C. 2000. The bases of crown gall tumorigenesis. J. Bacteriol. 182
(14): 3885-3895.
Zupan, J., Muth, T.R., Draper, O.,and Zambryski, P. 2000. The transfer of DNA
from Agrobacterium tumefaciens into plants: a feast of fundamental
insights. Plant J. 23: 11-28.
An, G. 1987. Binary Ti vectors for plant transformation and promoter
analysis. Methods Enzymol. 153: 292-305.
An, G., Watson, B.D., Stachel, S., Gordon, M.P., and Nester, E.W. 1985. New
cloning vehicles for transformation of higher plants. EMBO J. 4: 277-284.
An, G., Ebert, P.R., Mitra, A., and Ha, S.B. 1988. Binary vectors. In: Plant
Molecular Biology Manual A3: 1-19. Gelvin., S.B., Schilperoort, R., and Verma,
D. P. (Eds.), Kluwer Academic Pub., The Netherlands.
Becker, D., Kemper, E., Schell, J., and Masterson, R. 1992. New plant binary
vectors with selectable markers located proximal to the left T-DNA border. Plant
Mol. Biol. 20: 1195-1197.
Bevan, M. 1984. Binary Agrobacterium vectors for plant
transformation. Nucl. Acids Res. 12: 8711-8721.
Fütterer, J. 1995. Expression signals and vectors. In: Gene Transfer to
Plants, pp.311-324. Potrykus, I., Spangenberg, G. (Eds.), Springer-Verlag,
Berlin.
Hamilton, C.M., Frary, A., Lewis, C., and Tanksley, S.D. 1996. Stable
transfer of intact high molecular weight DNA into plant chromosomes. Proc. Natl.
Acad. Sci. USA 93: 9975-9979.
Hamilton, C.M. 1997. A binary-BAC system for plant transformation with
high-molecular-weight DNA. Gene 200: 107-116.
Hellens, R., and Mullineaux, P. 2000. A guide to Agrobacterium
binary Ti-vectors. Trends Plant Sci. 5: 446-451.
Hellens, R. et al. 2000. pGreen: a versatile and flexible binary Ti vector
for Agrobacterium-mediated plant transformation. Plant Mol. Biol. 42:
819-832.
Hoekema, A., Hirsh, P.R., Hooykaas, P.J.J., and Schilperoort, R.A. 1983. A
binary plant vector strategy based on separation of vir- and T-region
of the Agrobacterium tumefaciens Ti-plasmid. Nature 303: 179-180.
Ma, H., Yanofsky, M.F., Klee, H.J., Bowman, J.L., and Meyerowitz, E.M. 1992.
Vectors for plant transformation and cosmid libraries. Gene 117: 161-167.
McBride, K.E. and Summerfelt, K.R. 1990. Improved binary vectors for
Agrobacterium-mediated plant transformation. Plant Mol. Biol. 14:
269-276.
McCormac, A.C., Elliot, M.C., Chen, D.F. 1999. PBECKS2000: a novel plasmid
series for the facile creation of complex binary vectors, which incorporates "
clean-gene" facilities. Molecular and General Genetics 261: 226-235.
Christou, P. 1992. Genetic transformation of crop plants using
microprojectile bombardment. Plant J. 2: 275-281.
Klee, H.J., F.F. White, V.N. Iyer, M.P. Gordon, and E.W. Nester. 1983.
Mutational analysis of the virulence region of an Agrobacterium
tumefaciens Ti plasmid. J. Bacteriol. 153: 878-883.
Klee, H., Horsch, R., and Rogers, S. 1987. Agrobacterium-mediated
plant transformation and its further applications to plant biology. Ann. Rev.
Plant Physiol. 38: 467-486.
Klein, T.M., Wolf, E.D., Wu, R., and Sanford, J.C. 1987. High-velocity
microprojectiles for delivering nucleic acids into living cells. Nature 327:
70-73.
Mozo, T., and Hooykaas, P.J.J. 1992. Design of a novel system for the
construction of vectors for Agrobacterium -mediated plant
transformation. Mol. Gen. Genet. 236: 1-7.
Neuhaus, G., and Spangenberg, G. 1990. Plant transformation by microinjection
techniques. Physiol. Plant. 79: 213-217.
Ooms, G., P.M. Klapwijk, J.A. Poulis and R.A. Schilperoort. 1980.
Characterization of Tn904 insertions in octopine Ti plasmid mutants of
Agrobacterium tumefaciens J. Bacteriol. 144(1): 82-91.
Paszkowski, J., Saul, M.W., and Potrykus, I. 1989. Plant gene vectors and
genetic transformation: DNA-mediated direct gene transfer to plants. In: Cell
Culture and Somatic Cell Genetics of Plants (J. Schell and I.K. Vasil, Eds.). 6:
52-68.
Potrykus, I. 1995. Gene transfer to Plants. In: Gene transfer to Plants. I.
Potrykus G. Spangenberg (Eds.). Springer-Verlag, Germany, pag III-IX.
Rogers, S.G., Klee, H.J., Horsch, R.B., and R.T. Fraley. 1987. Improved
vectors for plant transformation: expression cassette vectors and new selectable
markers. Methods in Enzymology. 153: 253-292.
Stachel, S.E., Timmerman, B., and Zambryski, P. 1986. Generation of
single-stranded T-DNA molecules during the initial stages of T-DNA transfer from
Agrobacterium tumefaciens to the plant cells. Nature 322: 706-712.
Stachel, S.E., and Zambryski, P. 1986. Vir A and virG
control the plant induced activation of the T-DNA transfer process of
Agrobacterium tumefaciens. Cell 46: 325-333.
Van Haute, L., Joos, H., Maes, M., Warren, G., Van Montagu, M., and Schell,
J. 1983. Intergeneric transfer and exchange recombination of restriction
fragments cloned in pBR322: A novel strategy for the reversed genetics of the Ti
plasmids of Agrobacterium tumefaciens. EMBO Journal. 2: 411-417.
Yanofsky, M., Porter, S., Young, C., Albright, L., Gordon, M., and Nester, E.
1986. The virD operon of Agrobacterium tumefaciens encodes a
site-specific endonuclease. Cell 47: 471-77.
Types of Tissues to be transformed
Summary
The efficiency of T-DNA transfer via
Agrobacterium to a plant varies considerably, not only among plant
species and cultivars, but also among tissues. Various protocols for
Agrobacterium-mediated transformation of plants use leaves, shoot
apices, roots, hypocotyls, cotyledons, seeds and calli derived from various
parts of a plant. In other methods, the transformed tissue is not removed from
the plant but left in its natural environment, thus, the transformation takes
place in planta.
Patents directed specifically to methods of transforming different tissues
are relatively few, but the scope of their protection is rather broad. Some of
the patents referred to in this section are considered key patents for widely
used technologies by the research community.
The patents discussed in this section are directed to the transformation of
callus, immature embryo, pollen, seed,
shoot apex parts in culture as well as in
planta . With the exception of Japan Tobacco's
patents directed to callus and immature embryo transformation of a
monocotyledonous plant, claims in these patents are not restricted to the type
or species of plant to be transformed. Therefore, any plant arguably falls
within the scope of the claims of these patents. The bacterium used for
transformation is Agrobacterium or specifically A.
tumefaciens.
-
Callus
transformation. Japan Tobacco has two granted
patents, one in Australia and the other in the United States. The Australian
patent claims a method of transforming a monocot plant tissue with
Agrobacterium. The plant tissue can be from any portion of any type of monocot
plant and is either already dedifferentiated or is exposed to a
dedifferentiation process. In the United States patent the tissue to be
transformed must be not less than 7 days old.
-
Immature embryo
transformation. Japan Tobacco also has a patent
in Australia claiming transformation of the scutellum of an immature embryo of
a monocot plant with Agrobacterium. The transformation process takes
place before the tissue has differentiated into a callus.
-
Pollen transformation. A
patent related to this topic was granted to the United States Department
of Agriculture (USDA) in the US and a patent has also been
granted in Australia. In these patents,
transformed pollen fertilizes a second plant to obtain transgenic seed, which is
germinated to obtain a transgenic plant.
-
Shoot apex
transformation. Transformation of an excised shoot apical tissue by
inoculating the tissue with A. tumefaciens is disclosed by
Texas A & M University in a granted United States patent.
Applications filed in Europe and in Australia have been
abandoned.
-
In planta
transformation. Three different entities have filed patent
applications on in planta transformation. Cotton
Inc., Rhobio and Performance Plants
' patent applications refer to transformation of a plant tissue with
Agrobacterium in its natural environment. Performance
Plants' patent applications, however, were recently
abandoned. In contrast to Rhobio, which does
not claim a method of transforming a particular tissue of a plant,
Cotton Inc. claims the injection of Agrobacterium
into floral or meristematic tissue. Furthermore, Cotton
Inc. claims appear to require the transformed plant cells or tissue to
develop and regenerate within the plant, whereas Rhobio's
patent claims are directed to removing tissue from the plant and regenerating
it in vitro.
-
Floral transformation
(Update July 2003) is basically an in planta method that has become
very popular in the transformation of Arabidopsis thaliana
(Brassicaceae), one of the best known model plants in genomic studies. It is
also suitable for the transformation of monocotylenous plants. A US patent
assigned to Rhone-Poulenc Agro and a PCT application assigned
to Paradigm Genetics Inc. are described in the section "
General Transformation Methods for Monocots." A US patent granted to
Cotton Inc. which discloses transformation of floral or
meristematic tissue (mentioned in the preceding paragraph) is discussed in the
section "In planta transformation." A patent has been granted to
Paradigm Genetics Inc. in which a new method to transform
plants by direct treatment of flowers is described. The method is based on
published literature and represents a simple modification to the adjustment of
cell density of the Agrobacterium strain used in the transformation:
cells are diluted rather than centrifuged.
-
Seed transformation
(Update July 2003). Two groups have filed patent applications
on transformation of plants using seed as target tissue. The
Agri-Biotechnology Research Center of Shanxi (China) has filed a US and
an EP application based on a Chinese patent application. As filed, these two
applications contain general claims to applying Agrobacterium to
germinating seed, with no further treatment of the seed. A PCT application has
also been filed by Scigen Harvest Co Ltd from Korea on a method
using needle-wounded seed as target tissue in combination with
Agrobacterium tumefaciens.
In conclusion
- Transformation of pollen with Agrobacterium is fairly broadly
protected in the United States and in Australia. The situation is similar with
shoot apex transformation in the United States, except that the bacterium used
in this case is specifically A. tumefaciens. Thus, use of
other species of Agrobacterium to transform apical shoots from any
plant may fall outside the scope of the claimed invention.
- There appears to be more room to avoid infringing patents on in
planta and callus transformation. Although other entities may have
applications pending, only Cotton Inc. has been granted a
United States patent, which particularly claims:
- transformation of floral or meristematic tissue, and
- the use of a needleless device to inject Agrobacterium into the
tissue.
Thus, if one of these two elements is not part of an in planta
transformation process, the process may be well outside the scope of the claims
of Cotton Inc.'s patent.
With respect to callus transformation claimed by Japan
Tobacco, at least in the United States, the tissue must be at least
seven days old. Thus, if tissue can be used that is less than 7 days in culture,
literal infringement of this patent may be avoided.
- Patent applications for the transformation of the tissues mentioned above
are pending in Australia, Europe, United States and some other jurisdictions and
may become an issue for freedom to operate if they are granted as filed or may
be prior art for other inventions related to the Agrobacterium
transformation of these particular tissues.
- Transformation of germinating seed with Agrobacterium will be
protected broadly if pending applications are granted, especially the one to
The Agri-Biotechnology Research Center of Shanxi.
Callus Transformation - patents and application assigned to Japan Tobacco
Patents and application assigned to Japan Tobacco
In the disclosures, an explant of a monocot in the process of
dedifferentiation or already dedifferentiated is used for transformation with
Agrobacterium. A dedifferentiated tissue or a tissue in the process of
dedifferentiation is described in the disclosures as an explant cultured on a
dedifferentiation medium for not less than 7 days. Among the preferred tissues
are a callus, an adventitious embryo-like tissue, and suspension cells.
Callus Transformation - patents granted to Japan Tobacco
Specific patent information
|
Patent Number
|
Title, Independent Claims and Summary of Claims
|
Assignee
|
|
US
5591616 A
- Earliest priority - 7 July 1992
- Filed - 3 May 1994
- Granted - 7 January 1997
- Expected expiry - 6 July 2013
|
Title - Method of transforming monocotyledons
Claim 1
A method for transforming a monocotyledon callus, comprising contacting a
cultured tissue of a monocotyledon during dedifferentiation wherein said
dedifferentiation is obtained by culturing an explant on a
dedifferentiation-inducing medium for not less than 7 days or a dedifferentiated
cultured tissue of a monocotyledon, with a bacterium belonging to the genus
Agrobacterium containing a desired gene.
|
Claim 17
A method for transforming a monocotyledon with a desired gene, comprising:
contacting a cultured tissue of said monocotyledon during dedifferentiation
thereof, or a dedifferentiated cultured tissue of said monocotyledon, with a
suspension of Agrobacterium tumefaciens having a cell population of
106 to 1011 cells/ml for 3-10 minutes and then culturing
said cultured tissue of said monocotyledon during dedifferentiation thereof, or
said dedifferentiated cultured tissue of said monocotyledon, on a solid medium
for several days together with said Agrobacterium tumefaciens, or
adding said Agrobacterium tumefaciens to culture medium in which said
cultured tissue of said monocotyledon during dedifferentiation thereof or said
dedifferentiated cultured tissue of said monocotyledon is cultured, and
continuously culturing said cultured tissue of said monocotyledon during
dedifferentiation or said dedifferentiated cultured tissue of said monocotyledon
together with said Agrobacterium tumefaciens, wherein said
dedifferentiated cultured tissue of said monocotyledon is selected from the
group consisting of a tissue cultured during the process of callus formation
which is cultured for not less than 7 days after an explant is placed on a
dedifferentiation-inducing medium and a callus, and wherein said
Agrobacterium tumefaciens contains plasmid pTOK162, and said desired
gene is present between border sequences of the T region of said plasmid
pTOK162, or wherein said desired gene is present in another plasmid contained in
said Agrobacterium tumefaciens.
|
US 5591616 claims:
- a method for transforming monocotyledon callus by contacting
dedifferentiating tissue of not less than 7 days of culture or
dedifferentiated tissue with Agrobacterium having a desired gene; and
- a method of transforming such tissue or transforming a callus by
contacting the tissue/callus with a suspension of Agrobacterium cells
of 106 - 1011 cells/ml for 3-10 minutes. The bacterium
contains the desired gene either between the T- borders of the plasmid pTOK162
or in another plasmid.
|
Japan Tobacco
|
|
EP 604662 A1
- Earliest priority - 7 July 1992
- Filed - 6 July 1994
- Application pending
|
Title - Method of transforming monocotyledon
Claim 1
A method for transforming a monocotyledon comprising transforming a cultured
tissue during dedifferentiation process or a dedifferentiated cultured tissue of
said monocotyledon with a bacterium belonging to genus Agrobacterium
containing a desired gene.
|
The claims submitted in the European application EP 604662
A1 are the same as the claims of the Australian patent, below.
|
|
AU 667939 B
- Earliest priority - 7 July 1992
- Filed - 6 July 1993
- Granted - 18 April 1996
- Expected expiry- 6 July 2013
|
Title - Method of transforming monocotyledon
Claim 1
A method for transforming a monocotyledon comprising transforming a cultured
tissue during dedifferentiation process or a dedifferentiated cultured tissue of
said monocotyledon with a bacterium belonging to genus Agrobacterium
containing a desired gene.
|
The lead claim in the Australian patent AU 667 939 is broader than in the
United States patent. In the Australian patent, a dedifferentiating or
dedifferentiated tissue of a monocot is also used as the initial tissue for
transformation, but there is no restriction on the number of days of
culture in the medium to induce dedifferentiation.
|
|
US
2002/178463 A1
- Earliest priority - 7 July 1992
- Filed - 13 January 1999
- Application pending
|
Title - Method for transforming monocotyledons
Claim 1
A method for transforming a monocotyledon, comprising contacting a cultured
tissue of said monocotyledon during dedifferentiation thereof obtained by
culturing an explant on a dedifferentiation-inducing medium for less than 7 days
with a bacterium belonging to the genus Agrobacterium containing a
super binary vector having the virulence region of Ti plasmid pTiBo542 contained
in Agrobacterium tumefaciens A281, left and right border sequences of
T-DNA of a Ti plasmid or an Ri plasmid of a bacterium belonging to the genus
Agrobacterium, and a desired gene located between said left and right
border sequences.
|
Claim 13
A method for transforming a monocotyledon, comprising contacting a cultured
tissue of said monocotyledon during dedifferentiation thereof obtained by
culturing an explant derived from an immature tissue on a
dedifferentiation-inducing medium for less than 7 days with a bacterium
belonging to the genus Agrobacterium containing a desired gene and
containing a vector having the virulence region of Ti plasmid contained in
Agrobacterium tumefaciens.
|
This application is a continuation of abandoned US 08/668464, which was a
continuation of now granted US 5591616.
Claims in this applicaiton recite Agrobacterium-mediated
transformation of monocotyledon explants, where the explant is cultured on
dedifferentiation medium for less than 7 days, then infected with
Agrobacterium containing a vector that has the virulence region (in
particular a vector that contains the virulence region of Ti plasmid pTiBo542
from A. tumefaciens A281 in the case of claim 1).
|
| Remarks |
- National phase entry of WO 1994/00977 in Canada (CA 2121545) is pending.
- National phase entry of WO 1994/00977 in Japan (JP 2649287 B2) has been
published as granted on 3 September 1997.
|
Note: Patent information on this page was last updated on 21 February 2006.
Immature embryo transformation - patents and application assigned to Japan Tobacco
Patents and application assigned to Japan Tobacco
This family of patents discloses use of an immature embryo of a monocot for
Agrobacterium transformation. Within the embryo, the scutellum (name
given to the single massive cotyledon (seed leaf) of monocot plants) is
transformed. The scutellum is capable of producing dedifferentiated calli having
the ability to regenerate normal plants after transformation.
The bacterium used for transformation contains either a Ti or Ri
(root-inducing) plasmid with the desired gene and a plasmid having a virulence
region derived from the A. tumefaciens Ti plasmid pTiBo542.
Immature embryo transformation - claims in plain English
Immature embryo transformation
Patent and application assigned
to Japan Tobacco
Specific patent information
|
Patent Number
|
Title, Independent Claims and Summary of Claims
|
Assignee
|
|
EP
672752 B1
- Earliest priority - 3 September 1993
- Filed - 1 September 1994
- Granted - 26 May 2004
- Expected expiry - 3 September 2013
|
Title - Method of transforming monocotyledon by using
scutellum of immature embryo
Claim 1
A method for transforming monocotyledons comprising transforming scutellum of
an immature embryo of a monocotyledon with a bacterium belonging to genus
Agrobacterium containing a desired gene, which immature embryo has not
been subjected to a dedifferentiation treatment, to obtain a transformant.
|
EP B 672 752 contains the same independent claim as the Australian patent.
Designated States at the time of grant are: Austria, Belgium, Switzerland,
Germany, Denmark, Spain, France, United Kingdom, Greece (reported on INPADOC as
lapsed), Ireland, Italy, Liechtenstein, Luxembourg, Monaco (reported on INPADOC
as lapsed), Netherlands, Portugal, Sweden
|
Japan Tobacco
|
AU 687863
- Earliest priority - 3 September 1993
- Filed - 1 September 1994
- Granted - 5 March 1998
- Expected expiry - 3 September 2013
|
Title - Method of transforming
monocotyledon by using scutellum of immature embryo
Claim 1
A method for transforming monocotyledons comprising transforming scutellum of
an immature embryo of a monocotyledon with a bacterium belonging to genus
Agrobacterium containing a desired gene, which immature embryo has not
been subjected to a dedifferentiation treatment, to obtain a transformant.
|
The claims of the Australian patent AU-B-687 863 are directed to:
a method for transformation of a scutellum of an immature embryo of a
monocotyledon with Agrobacterium having a desired gene. The embryo is
not subjected to a dedifferentiation process prior the transformation with
Agrobacterium.
|
| Remarks |
- National phase entry of WO 95/06722 in Canada (CA 2148499) is pending.
- National phase entry of WO 95/06722 in Japan (JP 3329819 B2) has been
published as granted on 30 September 2002.
|
Note: Patent information on this page was last updated on 21 February 2006.
Pollen Transformation - patent granted to USDA
The invention is a method for the genetic transformation of any plant by
using pollen as starting material for transformation with
Agrobacterium. A culture medium useful for pollen germination and
pollen tube growth in presence of Agrobacterium is also claimed.
Pollen Transformation - patent granted to USDA - claims in plain English
Pollen transformation
Patents granted to the United States
Department of Agriculture (USDA)
Specific Patent Information
|
Patent Number
|
Title, Independent Claims and Summary of Claims
|
Assignee
|
AU733080
B2
- Earliest priority - 15 July 1997
- Filed - 14 July 1998
- Granted - 3 May 2001
- Expected expiry - 14 July 2018
|
Title - Pollen-based transformation system using solid media
Claim 1
A method for producing a transgenic plant comprising:
a. obtaining pollen from a first plant, b. applying a lawn of
Acrrobacteria to a solid pollen culture medium, the
Agrobacteria comprising at least one heterologous gene sequence capable
of being transferred to a plant cell, c. applying the pollen to the solid
medium, d. allowing the pollen to germinate and grow on the medium, thereby
producing transgenic pollen, e. applying the transgenic pollen to the
stigma of a second plant capable of being fertilized by the pollen of the first
plant, thereby fertilizing the second plant, f. obtaining transgenic seed
from the second plant, g. germinating the transgenic seed to obtain a
transgenic plant.
|
Claim 8
A medium for pollen germination and pollen tube growth comprising agarose,
sucrose, KNO3, MnSO4, H3BO3,
MgSO4, and gibberellic acid.
|
The Australian patent 733 080 claims the same method for transforming pollen
of a plant with Agrobacterium as the United States patent. However, the
Australian patent claims in addition a specific medium for pollen germination
and pollen tube growth.
|
United States Department of Agriculture (USDA)
|
EP
996328 B1
- Earliest priority - 15 July 1997
- Filed - 14 July 1998
- Granted - 5 March 2003
- Expected expiry - 14 July 2018
|
Title - Pollen-based transformation system
using solid media
Claim 1
A method for producing a transgenic plant comprising:
a. obtaining pollen from a first plant, b. applying a lawn of
Agrobacteria to a solid pollen culture medium, the
Agrobacteria comprising at least one heterologous gene sequence capable
of being transferred to a plant cell, c. applying the pollen to the solid
medium, d. allowing the pollen to germinate and grow on the medium, thereby
producing transgenic pollen, e. applying the transgenic pollen to the
stigma of a second plant capable of being fertilized by the pollen of the first
plant, thereby fertilizing the second plant, f. obtaining transgenic seed
from the second plant, g. germinating the transgenic seed to obtain a
transgenic plant.
|
The European patent 996328 claims the same method for transforming pollen of
a plant with Agrobacterium as the United States patent.
Designated contracting States at the time of grant are: Austria, Belgium,
Switzerland, Cyprus, Germany, Denmark, Spain, Finland, France, United Kingdom,
Greece, Ireland, Italy, Liechtenstein, Luxembourg, Monaco, Netherlands,
Portugal, Sweden
|
US
5929300
- Earliest priority - 15 July 1997
- Filed - 15 July 1997
- Granted - 27 July 1999
- Expected expiry - 15 July 2017
|
Title - Pollen-based transformation system
using solid media
Claim 1
A method for producing a transgenic plant comprising:
a. obtaining pollen from a first plant,
b. applying a lawn of Agrobacteria to a solid pollen culture medium,
the Agrobacteria comprising at least one heterologous gene sequence
capable of being transferred to a plant cell,
c. applying the pollen to the solid medium,
d. allowing the pollen to germinate and grow on the medium, thereby producing
transgenic pollen,
e. applying the transgenic pollen to the stigma of a second plant capable of
being fertilized by the pollen of the first plant, thereby fertilizing the
second plant,
f. obtaining transgenic seed from the second plant,
g. germinating the transgenic seed to obtain a transgenic plant.
|
Delta and Pine Land Co., acquired exclusive licensing rights to the
pollen-transformation system developed by the USDA in the United States.
(Source: Ag Biotech InfoNet, January 26, 2001).
The United States patent 5 929 300 claims:
- a method for producing a transgenic plant by transforming pollen of a plant
with Agrobacterium carrying a foreign gene and then fertilizing a second plant
with the transgenic pollen to obtain transgenic seed. The transgenic plant is
obtained by germination of the transgenic seeds. The Agrobacterium
must be applied as a lawn to a solid pollen culture medium and
the pollen must also be applied to the solid culture medium. Thus, it appears
that other methods of applying the Agrobacterium (e.g., by pipetting drops onto
the medium) might not fall within the scope of the claims.
|
WO
1999/03326
- Earliest priority - 15 July 1997
- Filed - 14 July 1998
- OPI - 28 January 1999
|
Title - Pollen-based transformation system
using solid media
Claim 1
A method for producing a transgenic plant comprising:
a. obtaining pollen from a first plant, b. applying a lawn of
Acrrobacteria [sic] to a solid pollen culture medium, the Agrobacteria
comprising at least one heterologous gene sequence capable of being transferred
to a plant cell, c. applying the pollen to the solid medium, d.
allowing the pollen to germinate and grow on the medium, thereby producing
transgenic pollen, e. applying the transgenic pollen to the stigma of a
second plant capable of being fertilized by the pollen of the first plant,
thereby fertilizing the second plant, f. obtaining transgenic seed from the
second plant, g. germinating the transgenic seed to obtain a transgenic
plant.
|
Claim 8
A medium for pollen germination and pollen tube growth comprising agarose,
sucrose, KNO3, MnSO4, H3BO3, MgSO4, and gibberellic acid.
|
|
| Remarks |
- National phase entry of WO 1999/03326 in Canada (CA 2296501) is pending.
- National phse entry of WO 1999/03326 in China (CN 1098029 C) has been
published as granted on 8 January 2003.
- Related patent documents also filed in Brazil (BR 9811791), The Hong Kong
Special Administrative Region of the People's Republic of China (HK 1026118),
Taiwan (TW 577922) and South Africa (ZA 9806240).
|
Note: Patent information on this page was last updated on 21 February 2006.
Patent application filed by the United States Department of Agriculture (USDA)
The invention disclosed in the European application is the same as in the
United States patent and the recently granted Australian patent
AU-B-733 080 (former Australian application AU 84005/98
A1).
Bibliographic data
|
EP 996 328 A1 |
| Title |
Pollen-based transformation system using solid media
|
Application No. & Filing Date
|
EP 934497 July 14, 1998
|
| Publication Date |
May 3, 2000
|
| Language |
English
|
| Remarks |
Applications also filed in Brazil (BR 9811791), China (CN 1263434), and South
Africa (ZA 9806240).
|
|
To view or download the patent document as a PDF file, click on
EP 996
328 (1,080 kb).
|
Summary of the invention
The independent claims as filed in the EP application 996 328
A1 are similar to the granted claims of its related United States and
Australian patents. As in the Australian patent, the EP application also
contains a filed claim referring to a medium for pollen germination and pollen
tube growth.
View Claims
EP Patent application filed by the United States Department of Agriculture (USDA)
Claims in plain English
| Disclaimer
THE FOLLOWING CLAIMS ARE MEANT ONLY TO ASSIST READING OF THE CLAIMS AND ARE
NOT MEANT AS A LEGAL INTERPRETATION OF THE CLAIM SCOPE.
|
| EP 996 328 A1 |
| Claim 1
A method for producing a transgenic plant by:
A) applying Agrobacteria having a foreign gene to a pollen culture on a solid
medium; B) allowing germination and growth of the transgenic pollen on the
medium; C) fertilizing a second plant with the transgenic pollen; D)
obtaining seed; and E) germinating the seed to obtain a transgenic plant.
|
| Claim 8
A medium for pollen germination and pollen tube growth having agarose,
sucrose, KNO3, MnSO4, H3BO3,
MgSO4, and gibberellic acid.
|
Actual pending claims
| EP 996 328 A1 |
| Claim 1*
A method for producing a transgenic plant comprising:
A) obtaining pollen from a first plant; B) applying a lawn of
Agrobacteria to a solid pollen culture medium, the Agrobacteria comprising at
least one heterologous gene sequence capable of being transferred to a plant
cell; C) applying the pollen to the solid medium; D) allowing the
pollen to germinate and grow on the medium, thereby producing transgenic
pollen; E) applying the transgenic pollen to the stigma of a second plant
capable of being fertilized by the pollen of the first plant, thereby
fertilizing the second plant; F) obtaining transgenic seed from the second
plant; G) germinating the transgenic seed to obtain a transgenic plant.
|
|
Claim 8**
A medium for pollen germination and pollen tube growth comprising agarose,
sucrose, KNO3, MnSO4 , H3BO3,
MgSO4, and gibberellic acid.
|
Note: The Australian application AU 84005/98 A1 was granted.
See Patents granted to the USDA for more information on this
new patent.
* Identical to claim 1 of the granted United States and Australian patents.
**Identical to claim 8 of the granted Australian patent.
Shoot apex transformation - patent granted to The Texas A & M University System
In the invention disclosed in this United States patent, shoot apex tissue
from any plant is subjected to gene transfer via Agrobacterium.
According to the inventors, the use of such tissue permits rapid propagation of
plants without encountering problems of somaclonal variation.
Shoot apex transformation - - claims in plain english - patent granted to The Texas A & M University System
Specific Patent Information
|
Patent Number
|
Title, Independent Claims and Summary of Claims
|
Assignee
|
|
US
5164310
- Earliest priority - 1 June 1988
- Filed - 5 February 1991
- Granted - 17 November 1992
- Expected expiry - 5 February 2011
|
Title - Method for transforming plants via the shoot apex
Claim 1
A method of transforming excised shoot apical tissue comprising:
a) excising shoot apical tissue consisting essential of the apical dome and
two or more primordial leaves,
b) placing said excised tissue in a suitable growth medium,
c) inoculating said apical tissue with Agrobacterium tumefaciens to
transform said tissue.
|
Claim 8
A method for transforming an excised shoot apex comprising:
a) excising a shoot apex, b) placing said apex in a suitable growth
medium, c) inoculating said apical tissue with Agrobacterium
tumefaciens to transform said tissue.
|
The United States patent 5 164 310 claims a method to transform shoot apices,
which contain the apical dome with meristematic tissue and some primordial
leaves, with A. tumefaciens. According to the inventors, shoot cultures
develop roots directly and rapidly, and plant regeneration is achieved within
six weeks after transformation.
|
Texas A&M Univeristy System
|
| Remarks |
- National phase entry of WO 89/12102 in Australia (AU 3756889) has lapsed on
26 April 1991.
- Related patent application filed in China (CN 1042638) is deemed withdrawn
on 1 April 1992.
- National phase entry of WO 89/12102 in Europe (EP 419533) is deemed
withdrawn on 10 April 1993.
- National phase entry of WO 89/12102 in Japan (JP 2996995) has been granted
on 29 October 1999.
- Other related patent applications filed in Denmark (DK 285590), Spain (ES
2017024, reported on INPADOC as lapsed), Ireland (IE 65516), Israel (IL 90440),
South Africa (ZA 8904379).
- Related patent in New Zealand (NZ 229340) has been granted and published as
registered on 26 May 2000.
|
Note: Patent information on this page was last updated on 22 February 2006.
In planta transformation
Overview
The following patents are directed to the transformation of a plant in
vivo with Agrobacterium, in which the inoculation and
co-cultivation process with Agrobacterium takes place as the plant
develops normally.
As described in some of the patents, some advantages of this methodology
derive from a close analogy to Agrobacterium's natural environment for
transformation and the production of non-chimeric transgenic progeny from seeds
of a treated plant when floral tissue is transformed.
Cotton Inc., Paradigm Genetics Inc , and
Rhobio patents and applications are presented here.
Cotton Inc. claims
- the introduction of Agrobacterium into the floral tissue of a plant
using a needleless-injection device. Development of transformed seed takes place
in the plant. More information about this
invention
Paradigm Genetics Inc claims (Update July 2003)
- a method for preparing a transformed plant or seed in which the
Agrobacterium carrying the DNA to be transformed is grown to a certain
density, diluted in an aqueous medium and then applied to floral tissues for
transformation. More information about this
invention
Rhobio claims
- the transformation of any tissue of a plant with
Agrobacterium at the time when the tissue is still in its natural plant
environment. Once transformed, the tissue is removed from the plant and
regenerated in vitro. More information
about this invention
The Australian and PCT applications filed
by Performance Plants Inc. disclosing a method to transform
plants in vivo with A. tumefaciens were
abandoned on June 1, 2000 and on
October 18, 2000, respectively.
In planta transformation - patent granted to Cotton Inc
Specific Patent Information
|
Patent Number
|
Title, Independent Claims and Summary of Claims
|
Assignee
|
|
US
5994624
- Earliest priority - 20 October 1997
- Filed - 20 October 1997
- Granted - 30 November 1999
- Expected expiry - 20 October 2017
|
Title - In planta method for the production of transgenic
plants
Claim 1
A method for producing a transformed plant comprising, injecting
Agrobacterium cells harboring a vector, comprising a nucleic acid
molecule capable of conferring a desired phenotypic trait to a plant, into a
plant floral or meristematic tissue using a needleless injection device, which
can be adapted for the injection of small volumes of material in a precise
manner without causing massive tissue damage.
|
Claim 16
A method for producing a transgenic seed comprising injecting a
Agrobacterium cells harboring a vector, comprising a gene capable of
conferring a desired phenotypic trait, into the floral tissues of a plant before
the division of the egg cell using a needleless-hypodermic injection device.
|
Claim 17
A method of producing a transgenic seed comprising injecting a recombinant
Agrobacterium into the foloral tissues of a plant using a
needleless-hypodermic injection device.
|
Claim 18
A method for producing a transgenic seed comprising injecting a
Agrobacterium cells harboring a vector, comprising a gene capable of
conferring a desired phenotypic trait, into the floral tissues of a plant before
the division of the egg cell using a needleless-hypodermic injection device.
|
The United States patent 5 994 624 discloses
- a method to transform floral or meristematic tissue in vivo by
injecting with Agrobacterium with a needleless hypodermic injection
device; and
- a method to transform floral tissue before the division of the egg cell
using the same procedure as above.
The transformed floral tissue develops normally, forming seeds after
pollination. Seeds are grown to generate a F1 transformed progeny.
Although claim 1 says that the injection device can
be adapted for the injection of small volumes of material in a
precise manner without causing massive tissue damage, it does not have
to be. The specification, further, does not explicitly define what
"massive tissue damage" is though it discloses that direct injection with a
needle or particle bombardment can cause such damage.
|
Cotton Inc.
|
|
AU
752717
- Earliest priority - 20 October 1997
- Filed - 19 October 1998
- Granted - 26 September 2002
- Patent reported as ceased - 27 May 2004
|
Title - In planta method for the production of
transgenic plants
Claim 1
A method for producing a transformed plant including injecting a transforming
agent comprising Agrobacterium cells harboring a vector having a
nucleic acid molecule capable of conferring a desired phenotypic trait to a
plant, into a plant floral or meristematic tissue using a needleless injection
device which can be adapted for the injection of small volumes of material in a
precise manner without causing massive tissue damage.
|
Claim 12
A method for producing a transgenic seed comprising injecting a recombinant
Agrobacterium into the floral tissues of a plant using a needleless
injection device which can be adapted for the injection of small volumes of
material in a precise manner without causing massive tissue damage.
|
Claim 13
A method for producing a transgenic seed comprising injecting
Agrobacterium cells harboring a vector, comprising a gene capable of
conferring a desired phenotypic trait, into the floral tissues of a plant before
the division of the egg cell using a needleless injection device.
|
Claim 14
An in planta germline transformation method including needleless
injection of a transforming agent comprising an Agrobacterium vector,
said injection being directly into a tissue including the floral or meristematic
germline cells of said plant, said injection being selected as to pressure,
volume and trajectory so as to limit penetration of said transforming agent to a
region of said tissue whereby said germline cells are transformed without
causing excessive tissue damage.
|
Claim 15
A method for producing a transformed plant or a transgenic seed substantially
as herein described in the detailed description of the invention with reference
to the drawings.
|
Unlike the US patent, the claims in the AU patent do not require that the
needleless injection device be a hypodermic device.
As in the US patent, although claim 1 and 12 say that the needleless
injection device can be adapted for the injection of small volumes of material
in a precise manner without causing massive tissue damage, the claims don't
require the injection device to have these features/functions.
The patent does not disclose what "excessive" tissue damage is other than to
generally describe that it may occur through using a needle to inject a tissue.
The patent does not explicitly state that "excessive" tissue damage and
"massive" tissue damage are the same.
|
| Remarks |
Related patent application in South Africa (ZA 9809517).
|
Note: Patent information on this page was last updated on 22 February 2006.
In planta transformation - patent application filed by Cotton Inc
Specific Patent Information
|
Patent Number
|
Title, Independent Claims and Summary of Claims
|
Assignee
|
EP
1025247
- Earliest priority - 20 October 1997
- Filed - 19 October 1998
- Application deemed to be withdrawn - 4 August 2004
|
Title - In planta method for the production of transgenic plants
Claim 1
A method for producing a transformed plant comprising, injecting a
transforming agent into a plant tissue using a needless injection device.
|
| Claim23
A method for producing a transgenic seed comprising injecting a recombinant
Agrobacterium into the floral tissues of a plant using a
needleless-hypodermic injection device.
|
Claim 28
A method for producing a transgenic seed comprising injecting a DNA molecule
comprising a gene capable of conferring a desired phenotypic trait into the
floral tissues of a plant using a needleless-hypodermic injection device.
|
The European application EP 1 025 247 A1 also recites the
transformation of floral tissues by injecting them with Agrobacterium.
Additionally, it includes the injection of any transforming agent or DNA
molecule having a gene of interest into the plant tissue.
|
Cotton Inc.
|
| Remarks |
- National phase entry of WO 1999/20776 in Canada (CA 2308702) is reported as
lapsed on 19 October 2004.
- National phase entry of WO 1999/20776 in Japan (JP 2001520049) is pending.
|
Note: Patent information on this page was last updated on 22 February 2006.
Patent Application filed by Rhobio
RhoBio owns a patent for a method of in planta transformation using
Agrobacterium. According to the specification of this patent, the
"target tissue" to be transformed "in its natural plant environment" is not
limited to a particular tissue, but "may be any tissue which can be subsequently
be placed in a tissue culture phase and a plant regenerated." Jursidictions
where the patents are currently in force include, but are not limited to, Europe
(see designated States below) and Australia.
Specific Patent Information
|
Patent Number
|
Title, Independent Claims and Summary of Claims
|
Assignee
|
|
EP
1171621 B1
- Earliest priority - 19 April 1999
- Filed - 19 April 2000
- Granted - 7 December 2005
- Expected expiry - 19 April 2020
|
Title - Plant transformation method
Claim 1
A transformation method comprising inoculation and co-cultivation of a target
tissue, from a target plant, with Agrobacterium, at a time when the
target tissue is in its natural plant environment, followed by generation of a
transgenic plant via dedifferentiation and regeneration of the target tissue,
wherein said inoculation is performed by injection of Agrobacterium
into said tissue, with minimal damages to said tissue.
|
Claim 3
A transformation method comprising inoculation and co-cultivation of a target
tissue, from a target plant, with Agrobacterium, at a time when the
target tissue is in its natural plant environment, followed by generation of
dedifferentiated tissue from the target tissue, wherein said inoculation is
performed by injection of Agrobacterium into said tissue, with minimal
damages to said tissue.
|
Claim 16
Use of Agrobacterium in a transformation method comprising
inoculation and co-cultivation of a target tissue, from a target plant, with
Agrobacterium, at a time when the target tissue is in its natural plant
environment, followed by generation of transgenic plant material via
dedifferentiation of the target tissue, wherein said inoculation is performed by
injection of Agrobacterium into said tissue, with minimal damages to
said tissue.
|
The patent does not describe what consitutes "minimal damage" to a tissue
Designated States at the time of grant are: Austria, Belgium, Switzerland,
Cyprus, Germany, Denmark, Spain, Finland, France, United Kingdom, Greece,
Ireland, Italy, Liechtenstein, Luxembourg, Monaco, Netherlands, Portugal,
Sweden.
|
RhoBio
|
|
AU
775949 B2
- Earliest priority - 19 April 1999
- Filed - 19 April 2000
- Granted - 19 August 2004
- Expected expiry - 19 April 2020
|
Title - Plant transformation method
Claim 1
A transformation method comprising inoculation and co-cultivation of a target
tissue, from a target plant, with Agrobacterium, at a time when the
target tissue is in its natural plant environment, followed by generation of a
transgenic plant via dedifferentiation and regeneration of the target tissue,
after isolation and culture of said target tissue, wherein said inolucation is
performed by injection of Agrobacterium into said tissue, with minimal
damage to said tissue.
|
Claim 3
A transformation method comprising inoculation and co-cultivation of a target
tissue, from a target plant, with Agrobacterium, at a time when the
target tissue is in its natural plant environment, followed by generation of
dedifferentiated tissue from the target tissue after isolation and culture of
said target tissue, wherein said inoculation is performed by injection of
Agrobacterium into said tissue, with minimal damage to said tissue.
|
Claim 15
Use of Agrobacterium in a transformation method comprising
inoculation and co-cultivation of a target tissue, from a target plant, with
Agrobacterium, at a time when the target tissue is in its natural plant
environment, followed by generation of transgenic plant material via
dedifferentiation of the target tissue, after isolation and culture of said
target tissue, wherein said inoculation is performed by injection of
Agrobacterium into said tissue, with minimal damage to said tissue.
|
|
|
WO
2000/63398
- Earliest priority - 19 April 1999
- Filed - 19 April 2000
- OPI - 16 October 2000
|
Title - Plant transformation method
Claim 1
A transformation method comprising inoculation and co-cultivation of a target
tissue, from a target plant, with Agrobacterium, at a time when the
target tissue is in its natural plant environment, followed by generation of a
transgenic plant via dedifferentiation and regeneration of the target tissue.
|
Claim 3
A transformation method comprising inoculation and co-cultivation of a target
tissue, from a target plant, with Agrobacterium, at a time when the
target tissue is in its natural environment, followed by generation of
dedifferentiated tissue from the target tissue.
|
Claim 14
Use of Agrobacterium in a transformation method comprising
inoculation and co-cultivation of a target tissue, from a target plant, with
Agrobacterium, at a time when the target tissue is in its natural
environment, followed by generation of transgenic plant material via
dedifferentiation of the target tissue.
|
The PCT application WO 0063398 (equivalent to the European
application EP 1 171 621 A1) includes claims to:
- a method to transform a plant tissue in vivo by inoculating and
co-cultivating Agrobacterium cells with the tissue. The transformed
tissue is separated from the plant and submitted to a dedifferentiation and
regeneration process.
|
| Remarks |
- National phase entry of WO 2000/66398 in Canada (CA 2369428) is pending.
- National phase entry of WO 2000/63398 in China (CN 1347457) is reported as
withdrawn on 22 September 2004.
- National phase entry of WO 2000/63398 in Japan (JP 2002541853) is pending.
- Other national phase entries include Bulgaria (BG 106105), Brazil (BR
200011140), Czech Republic (CZ 20013744), Hungary (HU 200200926), Israel (IL
145686), Poland (PL 351895), and the United States.
|
Note: Patent information on this page was last updated on 23 February 2006.
Floral Transformation - patent granted to Paradigm Genetics Inc.
The invention disclosed in this patent comprises an alternative protocol to
adjust the cell density of the Agrobacteria used in the transformation
step. This method should be useful in high throughput transformation protocols.
According to the INPADOC patent family information, this patent is granted only
in the United States.
Specific patent information
|
Patent Number
|
Title, Independent Claims and Summary of Claims
|
Assignee
|
|
US
6353155 B1
- Earliest priority - 30 June 2000
- Filed - 30 June 2000
- Granted - 5 March 2002
- Expected expiry - 30 June 2020
|
Title - Method for transforming plants
Claim 1
A method for preparing a transgenic plant or seed comprising:
a) growing a suspension of Agrobacterium cells until the optical
density of the suspension is about 2 to about 2.4 at a wavelength of 600
nanometers, wherein said Agrobacterium cells contain at least one
plasmid having a DNA sequence of interest flanked by T-DNA borders; b)
diluting said Agrobacterium cells of said suspension with an aqueous
medium so that the optical density of the suspension is reduced to about 0.6 to
about 1.5, wherein said diluting is not followed by pelleting via centrifugation
with subsequent resuspension; and c) treating the flower of said plant with
said diluted suspension so that the Agrobacterium cells in said diluted
suspension can transform said plant with the DNA-sequence of interest; d)
optionally, cultivating said treated plant to produce seed; and e)
optionally, growing plants from said seed and selecting for transgenic plants
having said DNA sequence of interest.
|
Claim 10
A method for preparing a transgenic plant or seed comprising:
a) growing a suspension of Agrobacterium cells until growth of
Agrobacterium cells in the suspension is substantially completed,
wherein said Agrobacterium cells contain at least one plasmid having a
DNA sequence of interest flanked by T-DNA borders; b) diluting said
suspension with an aqueous medium to reduce the concentration of
Agrobacterium cells and any other components in the growth medium and
allow the Agrobacterium cells to infect the plant without harming it,
wherein said diluting is not followed by pelleting via centrifugation with
subsequent resuspension; c) treating the flower of said plant with said
diluted suspension so that the Agrobacterium cells in said diluted
suspension can transform said plant with the DNA-sequence of interest; d)
optionally, cultivating said treated plant to produce seed; and e)
optionally, growing plants from said seed and selecting for transgenic plants
having said DNA sequence of interest.
|
Claim 17
A method for preparing a transgenic plant or seed comprising:
a) growing a suspension of Agrobacterium cells until growth of
Agrobacterium cells in the suspension is substantially completed,
wherein said Agrobacterium cells contains at least one plasmid having a
DNA sequence of interest flanked by T-DNA borders; b) diluting said
Agrobacterium cells in said suspension with about 2 to about 10 volumes
aqueous medium per volume of suspension, wherein said diluting is not followed
by pelleting via centrifugation with subsequent resuspension; c) treating
the flower of said plant with said diluted suspension so that the
Agrobacterium cells in said diluted suspension can transform said plant
with the DNA-sequence of interest; d) optionally, cultivating said treated
plant to produce seed; and e) optionally, growing plants from said seed and
selecting for transgenic plants having said DNA sequence of interest.
|
United States patent US 6353155 claims
- a method to transform floral tissue in vivo by treatment with an
Agrobacterium cell suspension adjusted to a certain density by dilution
with an aqueous solution.
- The claims exclude pelleting by centrifugation after the dilution step, but
not by other means.
- Claim 10 states that Agrobacterium should be allowed to infect
a plant without harming it. The patent does not define what "harm" means.
The invention comprises an alternative protocol to adjust the cell density of
the Agrobacteria used in the transformation step. According to the inventors,
centrifugation and resuspension are avoided by direct dilution of the bacteria
in an aqueous solution, thereby allowing sequential treatment of many more
plants. The method is well-suited for the transformation of Arabidopsis
thaliana (Brassicaceae), a model plant where such a high throughput
transformation protocol might be required. No other plants are used in the only
example provided as part of the patent specification.
|
Paradigm Genetics Inc.
|
Note: Patent information on this page was last updated on 23 February 2006.
Seed Transformation - patent application assigned to Scigen Harvest
PCT patent application WO 02/066599 discloses a method to transform plants by
wounding pre-germinated seeds with needles and treating the wounded areas with
Agrobacterium tumefaciens containing a vector with the desired gene.
The disclosure only describes wounding a cotyledonary node.
Specific Patent Application information
|
Patent Number
|
Title, Independent Claims and Summary of Claims
|
Assignee
|
|
WO
2002/066599
- Earliest priority - 16 February 2001
- Filed - 14 February 2002
- OPI - 29 August 2002
|
Title - Efficient method for the development of transgenic
plants by gene manipulation
Claim 1
A method for transforming plants, comprising the steps of:
1) selecting half a seed, which is germinated for one day as a target plant
tissue; 2) wounding the target plant tissue using a bundle of
needles; 3) inserting a target gene into the target plant tissue with
Agrobacterium tumefaciens vector containing the target gene; and
4) regenerating a whole plant from the target plant tissue.
|
The claims cover
- wounding half a seed which is selected and germinated for a day and are not
limited to wounding the node.
- In the examples, only soybean is transformed, but the independent claim is
unrestricted in terms of plant family or species. Dependent claims recite a long
list of commercially important crop plants, monocots and dicots.
- Wounding must be done with a bundle of needles, though it's not clear how
the needles are bundled (e.g., tied together? collected in some other fashion?)
and how many needles you need to form a bundle (more than two?).
- Step 3) in claim 1 recites '... with Agrobacterium tumefaciens
vector...', the claim is not limited to the use of Agrobacterium to
provide this vector, although the disclosure describes no other way of providing
the vector.
The numerous limitations in independent Claim 1 suggest various ways of
inventing around a patent that might issue with this claim language, e.g., by
using other than half a seed, pre-germinating for more or less than a day,
wounding with one needle or using two or more needles which are not bundled.
|
Scigen Harvest Co. Ltd
|
| Remarks |
Priority document published in Kuwait (KR 2002067303).
|
Note: Patent information on this page was last updated on 23 February 2006.
Seed Transformation - patent applications by The Agri-Biotechnology Research Center of Shanxi
The method disclosed in the following patent applications is based on
wounding the apical meristem of the appearing bud in pre-germinated seeds.
Although the patents only disclose how to transform one type of species, the
independent claims cover methods of transforming plants from any family or
species.
Specific Patent Information
|
Patent Number
|
Title, Independent Claims and Summary of Claims
|
Assignee |
|
US
2002/0184663 A1
- Earliest priority - 26 February 2001
- Filed - 19 February 2002
- Application pending
|
Title - Method of Agrobacterium mediated plant
transformation through treatment of germinating seeds
Claim 1
A plant transformation method mediated by Agrobacterium comprising:
(a) providing germinating seeds; and
(b) co-culturing the germinating seeds with an Agrobacterium strain
containing Ti plasmids with an inserted nucleic acid sequence so that the
foreign nucleic acid sequence carried by the Agrobacterium strain is
transferred and integrated into the genome of the germinating seeds through Ti
plasmids.
|
United States application US 2002/0184663 discloses
- a method to transform plants by treating pre-germinated seed with
Agrobacterium tumefaciens containing Ti plasmids with a
desired gene.
As described in the disclosure, the method is based on wounding the apical
meristem of the appearing bud. Independent Claim 1 does not require
wounding, merely contacting Agrobacterium containing a Ti plasmid
having a desired gene with germinating seeds. The source of the seeds is
unrestricted in terms of family or species of plants, whereas only maize seeds
are exemplified in the patent text.
Dependent claims recite monocots and dicots.
|
Agri-Biotechnology Research Center of Shanxi
|
EP 1 236 801 A2
- Earliest priority - 26 February 2001
- Filed - 25 February 2002
- Application deemed withdrawn - 2 January 2004
|
Title - Method of Agrobacterium mediated plant
transformation through treatment of germinating seeds
Claim 1
A plant transformation method mediated by Agrobacterium,
characterized in that germinating seeds were used as the receptors, an
Agrobacterium strain containing Ti plasmids with an inserted nucleic
acid sequence was used as the donor, the germinating seeds are co-cultured with
the Agrobacterium strain so that the foreign nucleic acid sequence
carried by the Agrobacterium strain can be transferred and integrated
into the genome of the receptor through Ti plasmids.
|
|
| Remarks |
- Related application in Canada (CA 2372793) is pending.
- Related patent in China (CN 1149918) has been granted on 19 May 2004.
|
Note: Patent information on this page was last updated on 23 February 2006.
Binary Vectors
Overview
Binary vector systems include the most commonly used vectors devised for
Agrobacterium gene transfer to plants. In these systems, the T-DNA
region containing a gene of interest is contained in one vector and the
vir region is located in a separate disarmed (without tumor-genes) Ti
plasmid. The plasmids co-reside in Agrobacterium and remain
independent.
We will now introduce you to the entities that have applied for, and in some
cases, been granted patents on binary vectors for plant
transformation via Agrobacterium.
The patent applications are characterized according to the following
criteria:
Summary of patents on basic binary vectors and methods
Important patents relating to basic binary vectors, which essentially claim
the basics of binary vectors, were granted to Mogen in the
United States (two patents) and in Europe (one patent). Mogen
is now called Syngenta Mogen B.V. and belongs to
Syngenta Company.
The claims are very broad and encompass basically any
two-vector system located in the same Agrobacterium strain having
- a T-region in one vector, and
- a vir region in another vector,
as illustrated below.


A limitation of the claims in these patents is that the binary vectors are
used for transformation of dicotyledonous
(dicots) plants.
While it is difficult to form a conclusion that will apply to every reader,
overall, these patents may encompass many transformation protocols in common
use. In the United States and Europe, users of this binary vector system should
keep these patents in mind when crafting a commercial research strategy.
Patents granted to Syngenta Mogen B.V.
The disclosed invention is directed to the transformation of dicots using an
Agrobacterium carrying binary vectors where the T-DNA is located in one
plasmid and the vir region is located in a different plasmid. The
separation of the T-DNA and the vir region on two different plasmids is
the basic principle of binary vector systems. The two United States patents are
still in force, while the European and Japanese patents have reached their
maximum 20 year protection term from filing and therefore have expired.
Specific Patent Information
|
Patent Number
|
Title, Independent Claims and Summary of Claims
|
Assignee
|
|
US
4940838
- Earliest priority - 24 February 1983
- Filed - 23 February 1984
- Granted - 10 July 1990
- Expected expiry - 10 July 2007
|
Title - Process for the incorporation of foreign DNA into
the genome of dicotyledonous plants
Claim 1
A process for the incorporation of foreign DNA into chromosomes of
dicotyledonous plants, comprising infecting the plants or incubating plant
protoplasts with Agrobacterium bacteria, which contain plasmids, said
Agrobacterium bacteria containing at least one plasmid having the
vir-region of a Ti plasmid but no T-region, and at least one other plasmid
having a T-region with incorporated therein foreign DNA but no vir-region.
|
Claim 13
A process for the production of Agrobacterium bacteria which
contains at least one plasmid which has the vir-region of a Ti-plasmid but no
T-region and at least one other plasmid which has a T-region with foreign DNA
incorporated in it but no vir-region, comprising:
(a) using Escherichia coli as a host and incorporating foreign DNA
into a plasmid therein which contains a T-region and a replicator having a broad
bacterial host range (b) introducing the resulting plasmid into
Agrobacterium bacteria which contain at least one plasmid which has the
vir-region of a Ti-plasmid but no T-region.
|
The United States patent 4 940 838 claims
- an Agrobacterium having binary vectors where the T-DNA region and
the vir region are located in two different plasmids. The plasmid that
contains the T-region lacks the vir region, and vice versa. The
vir region is fundamental for the transfer of the T-region into the
plant genome.
- the integration of foreign DNA into the genome of a dicot plant. The foreign
DNA is located in the T-region
|
Syngenta Mogen B.V.
|
|
US
5464763
- Earliest priority - 24 February 1983
- Filed - 23 December 1993
- Granted - 7 November 1995
- Expected expiry - 10 July 1997
|
Title - Process for the incorporation of foreign DNA into
the genome of dicotyledonous plants
Claim 1
A process for incorporating into the genome of dicotyledonous plants foreign
DNA, comprising infecting the plants or plant cells or incubating plant
protoplasts with Agrobacterium strains, which contain plasmids, said
Agrobacterium strains containing at least one plasmid having the
vir-region of a Ti plasmid but no T-region, and at least one other plasmid
having a T-region but no vir-region, said T-region being composed of naturally
occurring border sequences consisting of about 23 base pairs at the extremities
of said T-region and only foreign DNA between said border sequences, the
vir-region plasmid and the T-region plasmid containing no homology which could
lead to cointegrate formation.
|
Claim 2
Agrobacterium strains, comprising at least one plasmid having the
vir-region of a Ti plasmid but no T-region, and at least one other plasmid
having a T-region but no vir-region, said T-region being composed of naturally
occurring border sequences consisting of about 23 base pairs at the extremities
of said T-region and only foreign DNA between said sequences, the vir-region
plasmid and the T-region plasmid containing no homology which could lead to
cointegrate formation.
|
Claim 3
A process for the production of Agrobacterium strains comprising at
least one plasmid having the vir-region of a Ti plasmid but no T-region, and at
least one other plasmid having a T-region but no vir-region, said T-region being
composed of naturally occurring border sequences consisting of about 23 base
pairs at the extremities of said T-region and only foreign DNA between said
border sequences, the vir-region plasmid and the T-region plasmid containing no
homology which could lead to cointegrate formation, said process comprising:
(a) incorporating non-Agrobacterium foreign DNA into a plasmid
having a T-region and a replicator having a broad bacterial host range, wherein
said foreign DNA becomes part of the T-region,
(b) cloning the resulting plasmid in Escherichia coli; and
(c) introducing the resulting plasmid into Agrobacterium strains
which contain at least one plasmid which has the vir-region of a Ti-plasmid but
no T-region.
|
Claim 12
A process for incorporating in the genome of dicotyledonous plants foreign
DNA, comprising infecting the plants or plant cells or incubating plant
protoplasts with Agrobacterium strains, which contain plasmids, said
Agrobacterium strains containing at least one plasmid having the
vir-region of a Ti-plasmid but no T-region, and at least one other plasmid
having a single T-region but no vir-region, said single T-region being composed
of naturally occurring border sequences at the extremities of said single
T-region, the vir-region plasmid and the T-region plasmid containing no homology
which could lead to cointegrate formation.
|
Granted US 5464763 is a continuation of US 07/550736 (now
abandoned), which is a continuation of now granted US 4940838
(see above).
The United States patent US 5464763 includes the elements
and methods claims of the United States patent US 4940838 and
additionally claims
- the presence of only foreign DNA between the 23 bp borders of the T-region,
and
- the absence of a region of homology between the plasmid having the T-region
and the plasmid bearing the vir region that might lead to cointegrate
formation. This characteristic is essential to maintain the two plasmids as
individual molecules.
|
|
EP
120516
- Earliest priority - 24 February 1983
- Filed - 21 February 1984
- Granted - 23 October 1991
- Expired - 21 February 2004
|
Title - A process for the incorporation of foreign DNA into
the genome of dicotyledonous plants; Agrobacterium tumefaciens
bacteria and a process for the production thereof
Claim 1
A process for the incorporation of foreign DNA into chromosomes of
dicotyledonous plants comprising infecting the plants or incubating plant
protoplasts with Agrobacterium bacteria, which contain plasmids, said
Agrobacterium bacteria containing at least one plasmid having the
vir-region of a Ti-plasmid but no T-region, and at least one other plasmid
having an artificial T-region with only foreign DNA between the 23 base pairs at
the extremeties of the wild type T-region, but no vir-region, the vir-region
plasmid and the T-region plasmid containing no homology which could lead to
cointegrate formation.
|
Claim 2
Agrobacterium bacteria, comprising at least one plasmid having the
vir-region of a Ti-plasmid but no T- region, and at least one other plasmid
having an artificial T-region with only foreign DNA between the 23 base pairs at
the extremeties of the wild type T-region, but no vir-region, the vir-region
plasmid and the T-region plasmid containing no homology which could lead to
cointegrate formation.
|
Designated States at the time of grant are: Austria (cancelled as reported on
INPADOC), Belgium (expired as reported on INPADOC), Switzerland (ceased as
reported on INPADOC), Germany, France, United Kingdom (expired as reported on
INPADOC), Italy, Liechtenstein, Luxembourg, Netherlands (lapsed as reported on
INPADOC), Sweden
The subject matter claimed in the European patent 120516 B1
is a combination of the claims of the United States patents. In the European
patent, the T-region of one of the binary vectors is claimed as an artificial
T-region, which contains only foreign DNA between the 23 bp T-border sequences.
|
| Remarks |
Related patents granted in Japan (JP 7036751 and JP 7046993, both expired on
23 February 2004 as reported by the Japan Patent Office).
|
Note: Patent information on this page was last updated on 24 February 2006.
Summary of patents on modified binary vectors and methods
Several patents claim inventions built on the basic components of the binary
vector system and methods for their use. The patents referred under this section
are:
-
Agrobacterium with more than one T-DNA or vir
region. Leiden University and Schilperoort have a
granted United States patent and a granted European patent on this subject
matter. The multiple T-DNA or vir regions are integrated into the
chromosome of Agrobacterium. Thus, the T-DNA and vir regions
are present not only in the binary vectors, but also in the bacterial
chromosome. Agrobacterium with these features is used for
transformation of dicots and monocots of the families Liliaceae and
Amaryllidaceae.

The main
limitations of the patent claims are that they generally require having at least
one of either T-DNA or vir region in the bacterial chromosome and that
they only cover transforming monocots belonging to the families Liliaceae and
Amaryllidaceae.
-
Integration of foreign DNA in a plant target locus by homologous
recombination. The United States and European patents granted to
Mogen, now called Syngenta Mogen B.V., claim a
vector with a region homologous to a part of the sequence of a target locus in
the plant allowing homologous recombination between the target locus and the
vector. This permits insertion of a gene of interest or a specific mutation in a
particular locus of a plant genome.
The claims require use of
sequences from a plant target locus as part of an Agrobacterium vector
in order to allow homologous recombination between the vector and the plant
locus.
A series of binary vectors have been devised to suit different needs in a
plant transformation. Different origins of replication for a plasmid, the size
of the insert a binary plasmid can carry and the size of the plasmid itself are
among the features considered for the design of plasmids that are highly stable,
easy to manipulate and transfer across diverse host bacteria. For example,
origins of replication that allow low copy or high copy number of plasmids in a
host cell are the subject of several granted patents and patent applications.
Specifically United States patent
6165780
(as PDF) and its related patent and applications filed by The
National Institute of Agrobiological Resources (Japan) are directed to
binary shuttle vectors containing two different origins of replication that
confer stability and a low copy number of plasmids in both E. coli and
Agrobacterium host cells. One of the claimed binary vectors can be used
to insert a clone from a genome library into a plant for a complementation test.
More patents referring to this topic are likely to appear in the future as
new combinations of origins of replication, number of restriction sites,
capacity of the vector in terms of length of the carried insert, and number and
nature of marker and reporter genes are envisioned and assembled in vector
molecules according to the purpose or requirements of the research.
We analyze here one of those patents that refer to a binary vector maintained
as a single copy in E. coli as well as in Agrobacterium and
capable of carrying a large genome fragment.
-
Binary vectors based on the bacterial artificial chromosome
(BAC). Two United States patents and a European application assigned to
Cornell refer to this topic. The binary vector that contains
the T-DNA region has
- origins of replication for E. coli and Agrobacterium,
wherein the plasmids are maintained as a single copy, and
- a unique restriction site for insertion of an exogenous sequence located
between a right and a left T-DNA borders
Although binary BAC vectors are devised for cloning long fragments of DNA
(around 150 Kb), this feature is not part of the claim scope and the claims are
unrestricted as to the size of the plasmid. As a result, the claimed vector type
has a fairly broad scope except that the origins of replication are very
specific, that is, they must maintain plasmids as a single copy.

-
Co-transformation with two binary vectors . The PCT and
Australian applications recently filed by Pioneer Hi-Bred
disclose the use of an Agrobacterium with two different binary vectors
and a helper plasmid for co-transformation of plants. Because these are still
applications, the scope of claims that may be granted is unknown.
A
related United States patent was granted to Pioneer Hi-Bred in July 2001. The
granted claims are directed to the same subject matter as the filed claims of
the Australian and the PCT application. Thus, the scope of the claims has
already been defined in the United States.
Remember that any of the inventions referred to are protected only in the
countries or jurisdictions where the patent rights have been conferred.
Patents granted to Leiden University & Schilperoort
Disclosing binary vector systems, the following patents use an
Agrobacterium having either the T-region or the vir region
integrated in the chromosome of the bacterium. The target plants are dicots and
monocot plants from the families Amaryllidaceae (e.g., onion, garlic)
and Liliaceae (e.g., asparagus).
Specific Patent Information
|
Patent Number
|
Title, Independent Claims and Summary of Claims
|
Assignee
|
|
US
5149645
- Earliest priority - 4 June 1984
- Filed - 5 December 1989
- Granted - 22 September 1992
- Expected expiry - 4 December 2009
|
Title - Process for introducing foreign DNA into the genome
of plants
|
Claim 1
Agrobacteria comprising a T-region and a vir-region in their DNA,
the T-region being stably integrated into the bacterial chromosome.
|
|
Claim 2
Agrobacteria comprising a T-region and a vir-region in their DNA,
the vir-region being stably integrated into the bacterial chromosome.
|
|
Claim 3
A process for the transfer of recombinant DNA into the cells or protoplasts
of plants selected from the group consisting of dicotyledonous plants and
monocotyledonous plants of the families Liliaceae and
Amaryllidaceae, said process comprising infecting the plants or plant
cells, or incubating protoplasts from the plants, with Agrobacterium
bacteria which contain in their genetic material a vir-region from the Ti
plasmid of Agrobacterium and at least one T-region, wherein said
T-region comprises said recombinant DNA flanked on both sides by border
sequences as present in wild-type of Agrobacterium, and wherein said
vir-region is integrated into the chromosome of said Agrobacterium
bacteria prior to said infecting or incubating step.
|
|
Claim 5
A process for the transfer of recombinant DNA into the cells or protoplasts
of plants selected from the group consisting of dicotyledonous plants and
monocotyledonous plants of the families Liliaceae and
Amaryllidaceae, said process comprising infecting the plants or plant
cells, or incubating protoplasts from the plants, with Agrobacterium
bacteria which contain in their genetic material a vir-region from the Ti
plasmid of Agrobacterium and at least one T-region, wherein said T-region
comprises said recombinant DNA flanked on both sides by border sequences as
present in wild-type T-region of Agrobacterium, and wherein each of
said T-region is integrated into the chromosome of said Agrobacterium
bacteria prior to said infecting or incubating step.
|
The United States patent 5 149 645 claims:
-
Agrobacterium having either a T-region or a vir region as
part of the chromosome of the bacterium and further containing a T-region or
vir region, respectively, as part of the Agrobacterium's DNA.
The claims to Agrobacterium don't exclude both the T-region and vir
region being part of the bacterial chromosome.
- a process to transfer recombinant DNA that is part of a T-region in
Agrobacterium into dicot cells and monocot cells of the families
Amaryllidaceae and Liliaceae.
- process claims require that the border sequences flanking the
T-region/recombinant DNA are as present in wild-type Agrobacterium and
so mutated sequences that nevertheless could function as border sequences might
be outside of the scope of the claims in the US.
|
Leiden University and Schilperoort
|
|
EP
176112
- Earliest priority - 4 June 1984
- Filed - 3 June 1985
- Granted - 16 May 1990
- Expected expiry - 2 June 2005
|
Title - Process for introducing foreign DNA into the genome
of plants
|
Claim 1
A process for the incorporation of foreign DNA into the genome of plants by
infecting the plants or by incubating plant protoplasts with
Agrobacterium bacteria, characterized in that Agrobacterium
bacteria are used, which contain in their chromosome at least one T-region or a
vir-region or both, on the understanding that in the first two cases the
bacteria contain a plasmid comprising a vir-region or a T-region resp.
|
|
Claim 4
Agrobacterium bacteria containing in their chromosomes at least one
T-region or a vir-region or both.
|
Designated States at the time of grant are: Austria (lapsed as reported by
EPO), Belgium, Switzerland (lapsed as reported by EPO), Germany, France, United
Kingdom (expired as reported by INPADOC), Italy, Liechtenstein (lapsed as
reported by EPO), Luxembourg (lapsed as reported by EPO), Netherlands (lapsed as
reported by INPADOC), Sweden (lapsed as reported by INPADOC)
In the European patent EP 176 112 B1, claims recite:
- either a T-region or a vir region or both integrated into genome of
Agrobacterium;
- A process for transforming plants (any type) - wild-type T border sequences
are not required in the broadest claim.
|
|
Remarks
|
Related patent granted in Japan (JP 2006294, term expired as reported by the
Japan Patent Office).
|
Note: Patent information on this page was last updated on 24 February 2006.
Patents granted to Syngenta Mogen B.V.
The following United States and EP patents assigned to Syngenta Mogen
B.V. are directed to the insertion of specific sequences into a target
locus of a plant genome through homologous recombination. The gene of interest
and the homologous sequences are part of a recombinant DNA engineered in a
T-region of a Ti plasmid. The vir region is located in a different
plasmid within Agrobacterium.
Specific Patent Information
|
Patent Number
|
Title, Independent Claims and Summary of Claims
|
Assignee
|
|
US
5501967
- Earliest priority - 26 July 1989
- Filed - 6 July 1993
- Granted - 26 March 1996
- Expected expiry - 5 July 2013
|
Title - Process for the site-directed integration of DNA
into the genome of plants
Claim 1
A process for introducing a defined DNA sequence in a selected target locus
of a nuclear plant cell genome by integrating at least a part of a recombinant
DNA into said genome through homologous recombination at the target locus,
comprising the steps of:
a) coincubating plant protoplasts or plant cells under transforming
conditions, with a strain of the genus Agrobacterium capable of
T-region transfer and containing a plant transformation vector which comprises
recombinant DNA of the formula:

wherein boxes 1 and 7 are T-DNA border sequences, and wherein one of box 1 or
7 may be absent; and wherein box 3 comprises a DNA sequence sufficiently
homologous to a DNA sequence inside the target locus and sufficiently long to
promote homologous recombination; and wherein box 4 comprises a DNA sequence not
homologous to sequences occurring in the target locus; and wherein the lines
connecting the boxes shown may comprise any number of nucleotides or basepairs,
and b) identifying protoplasts or cells that have obtained the said defined
DNA sequence in their genomes at said target locus.
|
Claim 4
A process for introducing a defined mutation in a selected target locus of a
nuclear plant cell genome by integrating at least a part of a recombinant DNA
into said genome through homologous recombination at the target locus,
comprising the steps of:
a) coincubating plant protoplasts or plant cells under transforming
conditions, with a strain of the genus Agrobacterium capable of
T-region transfer and containing a plant transformation vector which comprises
recombinant DNA of the formula:

wherein boxes 1 and 7 are T-DNA border sequences, and wherein one of box 1 or
7 may be absent; and wherein box 3 comprises a DNA sequence sufficiently
homologous to a DNA sequence inside the target locus and sufficiently long to
promote homologous recombination; and wherein box 4 comprises a DNA sequence
sufficiently homologous to promote homologous recombination with a corresponding
sequence in the target locus and wherein box (4) comprises the said defined
mutation; and wherein the lines connecting the boxes shown may comprise any
number of nucleotides or basepairs, and b) identifying protoplasts or cells
that have obtained the said defined mutation in their genome at the said target
locus.
|
Claim 9
A recombinant DNA capable of introducing a defined mutation in a selected
target locus of a nuclear plant cell genome through homologous recombination at
the target locus, which recombinant DNA has the formula:

wherein box i comprises the said defined mutation; and wherein boxes 1 and 7
are T-DNA border sequences, and wherein one of box 1 or 7 may be absent; and
wherein each of boxes 3 and 4 individually is a DNA sequence sufficiently
homologous to a DNA sequence inside the target locus and sufficiently long to
promote homologous recombination; and wherein the DNA sequences of the boxes 3
and 4 have the same 5'-to-3' orientation, but wherein said boxes 3 and 4 are
rearranged with respect to the homologous sequences in the target locus.
|
The patent US 5 501 967 claims
- methods to introduce a defined sequence or a desired mutation into a target
locus in a plant genome using constructs having at least one T-border, a
sequence homologous to a sequence in the plant target locus, a sequence which is
not homologous to the plant target locus sequence or which is homologous but
which has a defined mutation;
- a recombinant DNA having the defined mutation or sequence in a plant
transformation vector within Agrobacterium . The recombinant DNA also
contains:
(i) at least one T-border, and (ii) a sequence homologous to a sequence
in the plant target locus. The sequence to be inserted in the target locus
is located between the homologous sequences in the vector. These sequences are
in the same orientation but they are rearranged with respect to the orientation
of the homologous sequence in the target locus.
|
Syngenta Mogen B.V.
|
|
EP
436007
- Earliest priority - 26 July 1989
- Filed - 26 July 1990
- Granted - 26 March 1997
- Expected expiry - 25 July 2010
|
Title - Process for the site-directed integration of DNA
into the genome of plants
|
Claim 1
A method for introducing a defined mutation in a selected target locus of a
nuclear plant genome by integrating at least a part of a recombinant DNA into
said genome through homologous recombination at the target locus, which
recombinant DNA has the following general structure,

in which the boxes 1 and 7 and the connecting lines represent DNA sequences
that are capable of functioning as a T-DNA border in the DNA transfer process,
in which box 1 or 7 may be absent but not both, in which box 3 comprises a DNA
sequence which is sufficiently homologous to a DNA sequence inside the target
locus and sufficiently long to promote homologous recombination, in which box 4
represents a DNA sequence that is not homologous to sequences occurring in the
target locus, and in which the lines connecting the boxes may represent any
number of basepairs, or no basepairs, and identifying transformants having the
defined mutation in said target locus using known methods.
|
|
Claim 8
A recombinant DNA capable of integrating a part of itself into the genome of
a plant host via homologous recombination at the target locus,

in which the boxes 1 and 7 represent DNA sequences that are capable of
functioning as a T-DNA border in the DNA transfer process, in which box 1 or 7
may be absent but not both, in which both box 3 and 4 represent DNA sequences
which are sufficiently homologous and sufficiently long to promote homologous
recombination with the target locus, in which the DNA sequences within the boxes
have the same 5' to 3' orientation as in the target locus, but the order of the
boxes themselves have been changed with respect to the situation in the target
locus, resulting in insertion of box i in the target locus after homologous
recombination, in which the lines connecting the boxes may represent any number
of basepairs, or no basepairs.
|
Designated contracting States at the time of grant are: Austria, Belgium,
Switzerland, Germany, Denmark, Spain, France, United Kingdom, Italy,
Liechtenstein, Luxembourg, Netherlands, Sweden.
|
| Remarks |
National phase entry of WO 1991/02070 in Japan (JP 3412134) has been
published as granted on 3 June 2003.
|
Note: Patent information on this page was last updated on 24 February 2006.
Patents granted to Cornell
The patents disclose a vector (BiBAC) based on a bacterial artificial
chromosome (BAC) and designed for Agrobacterium -mediated plant
transformation.
The patents disclose that:
- heterologous DNA cloned into the vector can be maintained in E.
coli as a single copy,
- the vectors can be transferred from E. coli to
Agrobacterium (e.g., by triparental mating or by isolation from E.
coli and electroporation into Agrobacterium), and
-
Agrobacterium used for plant transformation contains the BiBAC
vector having a heterologous gene and a helper plasmid to facilitate the
transfer of the foreign gene into the plant (a binary vector system).
Specific Patent Information
|
Patent Number
|
Title, Independent Claims and Summary of Claims
|
Assignee
|
|
US
5733744
- Earliest priority - 13 January 1995
- Filed - 13 January 1995
- Granted - 31 March 1998
- Expected expiry - 30 March 2015
|
Title - Binary BAC vector
Claim 1
A vector for transferring heterologous DNA into a plant cell, said vector
comprising:
- a backbone which includes a first origin of replication for maintaining
heterologous DNA as a single copy in an Escherichia coli host cell, and which
further includes a second origin of replication for maintaining heterologous DNA
as a single copy in an Agrobacterium tumefaciens host cell;
- a unique restriction endonuclease cleavage site for insertion of
heterologous DNA; and
- left and right Agrobacterium T-DNA border sequences flanking said
unique restriction endonuclease cleavage site, said left and right T-DNA border
sequences allowing introduction of heterologous DNA located between said left
and right T-DNA border sequences into a plant cell.
|
The United States patent US 5733744 claims elements of a
vector for transferring heterologous DNA into a plant. The elements are:
- two different origins of replication, one for Agrobacterium and the
other one for E. coli, each maintaining a plasmid as a single copy;
- a unique restriction site where the heterologous DNA is inserted; and
- right and left Agrobacterium T-borders flanking the heterologous
DNA.
The patent discloses that "maintenance as a single copy refers to a
non-replicating cell, i.e. a cell not undergoing cell division; during cell
division, the copy per cell increases to nearly two complete copies per cell.
It's not clear whether an "Agrobacterium T-border sequence" is one
which must be found naturally in Agrobacterium. The disclosure
describes cloned sequences that were so derived. A reading of the file history
might be instructive.
|
Cornell
|
|
US
5977439
- Earliest priority - 13 January 1995
- Filed - 22 December 1997
- Granted - 2 November 1999
- Expected expiry - 21 December 2017
|
Title - Binary BAC vector
Claim 1
A method of making a transgenic plant transformed with a vector comprising:
(1) providing a vector comprising: a backbone which includes a first origin
of replication capable of maintaining heterologous DNA as a single copy in an
Escherichia coli host cell, and which further includes a second origin
of replication capable of maintaining heterologous DNA as a single copy in an
Agrobacterium tumefaciens host cell, a unique restriction endonuclease
cleavage site for insertion of heterologous DNA, a heterologous DNA encoding a
gene product inserted into the unique restriction site, and left and right
Agrobacterium T-DNA border sequences flanking said unique restriction
endonuclease cleavage site, said left and right T-DNA border sequences allowing
introduction of heterologous DNA located between said left and right T-DNA
border sequences into a plant cell; (2) introducing said vector into plant
cells; and (3) propagating plants from said plant cells.
|
Claim 17
A method of introducing heterologous DNA into a plant cell comprising:
(1) providing a vector comprising: a backbone which includes a first origin
of replication capable of maintaining heterologous DNA as a single copy in an
Escherichia coli host cell, and which further includes a second origin
of replication capable of maintaining heterologous DNA as a single copy in an
Agrobacterium tumefaciens host cell, a unique restriction endonuclease
cleavage site for insertion of heterologous DNA, a heterologous DNA encoding a
gene product inserted into the unique restriction endonuclease cleavage site,
and left and right Agrobacterium T-DNA border sequences flanking said
unique restriction endonuclease cleavage site, said left and right T-DNA border
sequences allowing introduction of heterologous DNA located between said left
and right T-DNA border sequences into a plant cell; and (2) introducing
said vector into plant cells.
|
Methods for transforming a plant with the vector and obtaining transformed
plants are claimed in the United States patent 5 977 439.
|
|
EP
805851 B1
- Earliest priority - 13 January 1995
- Filed - 11 January 1996
- Granted - 26 May 2004
- Expected expiry - 10 January 2016
|
Title - Binary BAC vector
|
Claim 1
A vector for transferring heterologous DNA into a plant cell, said vector
comprising:
- a backbone which includes a first origin of replication capable of
maintaining heterologous DNA as a single copy in an Escherichia coli
host cell, and which further includes a second origin of replication capable of
maintaining heterologous DNA as a single copy in an Agrobacterium
tumefaciens host cell;
- a unique restriction endonuclease cleavage site for insertion of
heterologous DNA; and
- left and right Agrobacterium T-DNA border sequences flanking said
unique restriction endonuclease cleavage site, said left and right T-DNA border
sequences allowing introduction of heterologous DNA located between said left
and right T-DNA border sequences into a plant cell.
|
Designated contracting States at the time of grant are: Austria (patent
ceased as reported by EPO), Belgium (patent lapsed as reported by EPO),
Switzerland (patent ceased as reported by INPADOC), Germany, Denmark (patent
lapsed as reported by EPO), Spain (patent lapsed as reported by EPO), France,
United Kingdom, Greece (patent lapsed as reported by EPO), Ireland (patent
lapsed as reported by INPADOC), Italy, Liechtenstein (patent lapsed as reported
by INPADOC), Luxembourg, Monaco (patent lapsed as reported by EPO), Netherlands
(patent lapsed as reported by INPADOC), Portugal, Sweden (patent lapsed as
reported by INPADOC).
|
EP
805851 A1
- Earliest priority - 13 January 1995
- Filed - 11 January 1996
- Granted as EP 805851 (see above)
|
Title - Binary BAC vector
|
Claim 1
A vector for transferring heterologous DNA into a plant cell, said vector
comprising:
- a backbone which includes a first origin of replication capable of
maintaining heterologous DNA as a single copy in an Escherichia coli
host cell, and which further includes a second origin of replication capable of
maintaining heterologous DNA as a single copy in an Agrobacterium
tumefaciens host cell;
- a unique restriction endonuclease cleavage site for insertion of
heterologous DNA; and
- left and right Agrobacterium T-DNA border sequences flanking said
unique restriction endonuclease cleavage site, said left and right T-DNA border
sequences allowing introduction of heterologous DNA located between said left
and right T-DNA border sequences into a plant cell.
|
|
| Remarks |
National phase entry of WO 1996/21725 in Japan (JP H11/500306) is pending.
|
Note: Patent information on this page was last updated on 24 February 2006.
Granted patent and patent applications filed by Pioneer Hi-Bred Int.
The United States patent discloses a co-transformation method in which an
Agrobacterium strain has two binary vectors, each of them carrying a
T-DNA region with a different heterologous sequence, and a helper plasmid. A
plant scorable marker used for the selection of the transformed plant tissue is
one of the heterologous sequences that can be present in the T-DNA region. The
heterologous regions integrate into the genome of a plant in an unlinked manner,
facilitating the retention of the genes of interest and the elimination of
undesirable genes in the progeny.
The PCT application, also converted into European, Canadian and Australian
patents, are also directed to the same topic.
Patents on modified binary vectors and methods - Granted patent and patent applications filed by Pioneer Hi-Bred Int.
Claims in plain English
Specific Patent Information
|
Patent Number
|
Title, Independent Claims and Summary of Claims
|
Assignee
|
|
US
6265638
- Earliest priority - 1 October 1998
- Filed - 28 September 1999
- Granted - 24 July 2001
- Expected expiry - 27 September 2019
|
Title - Method of plant transformation
Claim 1
An Agrobacterium strain comprising a helper plasmid and at least two
binary vector plasmids that are stably inherited, wherein each of said binary
vector plasmids comprises at least one T-DNA region comprising a heterologous
nucleotide sequence of interest.
|
Claim 12
A method for co-transformation of a plant with at least two unique
heterologous nucleotide sequences of interest, said method comprising the steps
of
a) contacting a tissue from said plant with an Agrobacterium strain
comprising a helper plasmid and at least two binary vector plasmids that are
stably inherited, wherein each of said binary vector plasmids comprises at least
one T-DNA region, wherein each of said T-DNA regions comprises one of said
unique nucleotide sequences, wherein at least one of said nucleotide sequences
comprises at least an expression cassette comprising a plant scorable marker
gene; b) co-cultivating said tissue with said Agrobacterium;
c) culturing the tissue in a culture medium comprising an antibiotic capable of
inhibiting the growth of Agrobacterium; d) screening the tissue
for expression of said plants scorable marker gene; and e) regenerating a
transformed plant from tissue that expresses said plant scorable marker gene.
|
The present United States patent claims:
- an Agrobacterium strain having at least two binary vectors with
T-DNA regions containing a heterologous sequence each (which are not necessarily
genes and further, are not necessarily different sequences), and a helper
plasmid; and
- a method to co-transform a plant tissue by co-cultivating the tissue with an
Agrobacterium strain as described above, where at least one of the
heterologous sequences is an expression cassette comprising scorable marker and
is used to screen for the transformed tissue. A transformed plant is regenerated
from the selected transformed tissue.
Without specifying that limits of the heterologous sequences in claim 1,
possible ambiguities arise. For example, how large a sequence does a
heterologous sequence have to be before it falls within the scope of the claim?
A single nucleotide? The claim also could cover scenarios where the two vectors
each have identical heterologous sequences and so be anticipated by art to a
single type of binary plasmid vector including a heterologous sequence provided
with a helper plasmid.
|
Pioneer Hi-Bred International
|
|
EP
1117816
- Earliest priority - 1 October 1998
- Filed - 28 September 1999
- Granted - 21 December 2005
- Expected expiry - 27 September 2019
|
Title - Method of plant transformation
Claim 1
An Agrobacterium strain comprising a helper plasmid and at least two
binary vector plasmids, wherein each of said binary vector plasmids comprises at
least one T-DNA region comprising a heterologous nucleotide sequence of
interest.
|
Claim 12
A method for co-transformation of a plant with at least two unique
heterologous nucleotide sequences of interest, said method comprising the steps
of:
a) contacting a tissue from said plant with an Agrobacterium strain
comprising a helper plasmid and at least two binary vector plasmids, wherein
each of said binary vector plasmids comprises at least one T-DNA region, wherein
each of said T-DNA regions comprises one of said unique nucleotide sequences,
wherein at least one of said nucleotide sequences comprises at least an
expression cassette comprising a plant scorable marker gene; b)
co-cultivating said tissue with said Agrobacterium; c) culturing
the tissue in a culture medium comprising an antibiotic capable of inhibiting
the growth of Agrobacterium; d) screening the tissue for
expression of said plant scorable marker gene; and e) regenerating a
transformed plant from tissue that expresses said plant scorable marker gene.
|
Designated contracting States at the time of grant are: Austria, Belgium,
Switzerland, Cyprus, Germany, Denmark, Spain, Finland, France, United Kingdom,
Greece, Ireland, Italy, Liechtenstein, Luxembourg, Monaco, Netherlands,
Portugal, Sweden.
|
|
AU
764100
- Earliest priority - 1 October 1998
- Filed - 28 September 1999
- Granted - 7 August 2003
- Expected expiry - 27 September 2019
|
Title - Method of plant transformation
Claim 1
An Agrobacterium strain comprising a helper plasmid and at least two
binary vector plasmids, wherein each of said binary vector plasmids comprises at
least one T-DNA region comprising a heterologous nucleotide sequence of
interest.
|
Claim 12
A method for co-transformation of a plant with at least two unique
heterologous nucleotide sequences of interest, said method comprising the steps
of:
a) contacting a tissue from said plant with an Agrobacterium strain
comprising a helper plasmid and at least two binary vector plasmids, wherein
each of said binary vector plasmids comprises at least one T-DNA region, wherein
each of said T-DNA regions comprises one of said unique nucleotide sequences,
wherein at least one of said nucleotide sequences comprises at least an
expression cassette comprising a plant scorable marker gene; b)
co-cultivating said tissue with said Agrobacterium;
c) culturing
the tissue in a culture medium comprising an antibiotic capable of inhibiting
the growth of Agrobacterium;
d) screening the tissue for
expression of said plant scorable marker gene; and e) regenerating a
transformed plant from tissue that expresses said plant scorable marker gene.
|
|
CA 2344700
- Earliest priority - 1 October 1998
- Filed - 28 September 1999
- Granted - 29 March 2005
- Expected expiry - 27 September 2019
|
Title - Method of plant transformation
Claim 1
An Agrobacterium strain comprising a helper plasmid and at least two
binary vector plasmids, wherein each of said binary vector plasmids comprises at
least one T-DNA region comprising a heterologous nucleotide sequence of
interest.
|
Claim 12
A methid for co-transformation of a plant with at least two unique
heterologous nucleotide sequences of interest, said method comprising the steps
of:
a) contacting a tissue from said plant with an Agrobacterium strain
comprising a helper plasmid and at least two binary vector plasmids, wherein
each of said binary vector plasmids comprises at least one T-DNA region, wherein
each of said T-DNA regions comprises one of said unique nucleotide sequences,
wherein at least one of said nucleotide sequences comprises at least an
expression cassette comprising a plant scorable marker gene; b)
co-cultivating said tissue with said Agrobacterium; c) culturing
the tissue in a culture medium comprising an antibiotic capable of inhibiting
the growth of Agrobacterium; d) screening the tissue for
expression of said plants scorable marker gene; and e) regenerating a
transformed plant from tissue that expresses said plant scorable marker gene.
|
|
|
WO
2000/18939
- Earliest priority - 1 October 1998
- Filed - 28 September 1999
- OPI - 14 September 2000
|
Title - Method of plant transformation
Claim 1
An Agrobacterium strain comprising a helper plasmid and at least two
binary vector plasmids that are stably inherited, wherein each of said binary
vector plasmids comprises at least one T-DNA region comprising a heterologous
nucleotide sequence of interest.
|
Claim 12
A method for co-transformation of a plant with at least two unique
heterologous nucleotide sequences of interest, said method comprising the steps
of:
a) contacting a tissue from said plant with an Agrobacterium strain
comprising a helper plasmid and at least two binary vector plasmids that are
stably inherited, wherein each of said binary vector plasmids comprises at least
one T-DNA region, wherein each of said T-DNA regions comprises one of said
unique nucleotide sequences, wherein at least one of said nucleotide sequences
comprises at least an expression cassette comprising a plant scorable marker
gene; b) co-cultivating said tissue with said Agrobacterium;
c) culturing the tissue in a culture medium comprising an antibiotic capable of
inhibiting the growth of Agrobacterium; d) screening the tissue
for expression of said plants scorable marker gene; and e) regenerating a
transformed plant from tissue that expresses said plant scorable marker gene.
|
|
Note: Patent information on this page was last updated on 27 February 2006.
Co-integrated Vectors
Overview
In general, these vectors are constructed by recombining an
Agrobacterium Ti plasmid lacking tumor-causing genes ("disarmed" Ti
plasmid) and a small vector plasmid, which is engineered to carry a gene of
interest between a right and a left T-DNA border of the T-DNA region (engineered
or modified T-DNA region). Recombination takes place through a single crossover
event between a homologous region present in both plasmids.
Although co-integrated vectors have become less popular in recent years due
to some difficulties encountered in engineering them, they are still used to a
certain extent when modified, for example, to allow site-specific recombination
of the plasmids within the Agrobacterium genome.
The granted patents and patent applications directed to methods and
components for the assembling of co-integrated vectors presented under this
section are divided as follows:
-
Patents on basic vectors and
methods. This group encompasses granted patents and patent
applications directed to the basic forms of co-integrated vectors, including the
primary elements of the plasmids that recombine and basic methods for their
assembling.
-
Patents on modified vectors and
methods. This group includes granted patents and patent
applications directed to improved co-integrated vectors and methods for their
use.
Summary of patents on basic co-integrated vectors and methods
Max-Planck Society and Monsanto Company
have both been granted basic patents on co-integrated vectors.
A co-integrated plasmid is the product of homologous recombination through a
single crossover between a small plasmid of bacterial origin and an
Agrobacterium Ti plasmid. In the patents filed by both entities, the
resulting co-integrated plasmid or hybrid Ti plasmid contains at least:
- a gene of interest between the left and right T-DNA border sequences, and
- a vir region, which allows the transfer of the gene of interest
located between the two border sequences into the plant genome.
Both entities claim two plasmids involved in the assembly of a co-integrated
plasmid:
- a vector molecule containing a gene of interest to be transferred into a
plant, called an intermediate cloning vector by Max-Plank and a
first plasmid by Monsanto, and
- a Ti plasmid containing the vir region and free of tumor-inducing
genes, which is called an acceptor Ti plasmid by Max-Plank and
a Ti plasmid by Monsanto.
In addition, they both claim a homologous region present in both plasmid
types through which the recombination of the plasmids takes place to form a
co-integrated vector. The main difference lies in the source of the homologous
DNA sequence:
-
Max-Planck claims a homologous region derived from a small
vector molecule of bacterial origin different from Agrobacterium.
-
Monsanto claims a homologous region derived from the
external and attached left side to the left T-DNA border of
Agrobacterium Ti plasmid, called left inside homology (LIH) region.
In conclusion
- Claims in both patents require the use of a co-integrated plasmid with a
homologous region derived either
- from a vector molecule, i.e. E. coli-derived vector, or
- from a LIH region of a Ti-plasmid.
Neither Max-Planck nor Monsanto has a
patent in the United States. Until 2001, the United States did not publish
patent applications and the application process is secret. Many rumors abound
about possible interferences in the United States between
Max-Planck and Monsanto. An interference is a
procedure in which the inventor who is earliest-in-time is determined. That
inventor is then awarded the patent. The interference process can be extremely
lengthy. Thus, there may yet be a patent issuing in the United States.
Patents granted to Max-Planck
Two patents granted to the Max-Planck
Society (Germany) related to basic forms of co-integrated
vectors have issued in Europe (EP) and in Australia (AU).
In general, the claims of both patents are directed to the same invention:
- hybrid plasmids that are the product of co-integration, through a single
crossover event, of acceptor Ti plasmids and intermediate cloning vectors.
The difference between the two patents lies in the way the claims are
written. In the European patent, the plasmids are claimed as vector
combinations. In the Australian patent, each vector that is part of the
co-integration process is independently claimed.
Two European applications were directed to basic features of co-integrated
vectors, both of which are now granted with amendments in the independent
claims. One application disclosed a recombinant plant DNA that results from
transformation with Agrobacterium having a hybrid vector that has a
gene of interest.
The second application disclosed a non-oncogenic Ti plasmid and an
intermediate vector used for the formation of a co-integrated vector. Either the
plasmid or the vector contains a plant-expressible gene under the control of a
promoter that is linked to at least a right T-DNA border.
Patents on basic co-integrated vectors and methods - Patents granted to Max-Planck
Specific Patent Information
|
Patent Number
|
Title, Independent Claims and Summary of Claims
|
Assignee
|
|
EP
116718 B2
- Earliest priority - 13 January 1983
- Filed - 22 December 1983
- Granted - 8 May 1996
- Expected expiry - 21 December 2003
|
Title - Process for the introduction of expressible genes
into plant cell genomes and agrobacterium strains carrying hybrid Ti plasmid
vectors useful for this process
| Claim 1
A vector combination consisting of:
A) an acceptor Ti plasmid which is substantially free of internal T-DNA
sequences of wild-type Ti plasmid and incapable of inducing tumors in plants
comprising: (i) the two border sequences of the T-region of the wild-type
Ti plasmid; (ii) a DNA sequence derived from a cloning vehicle, located
between the two border sequences; and (iii) a DNA segment of a wild type Ti
plasmid containing DNA sequences essential for the transfer by
Agrobacterium of the T-region of wild-type Ti plasmids into plant cell
genomes, and
B) an intermediate cloning vector, said cloning vector comprising: (i)
at least one gene of interest under the control of a promoter capable of
directing gene expression in plants; and (ii) a cloning vehicle segment
containing a DNA sequence which is homologous with the DNA sequence (ii) in said
acceptor Ti plasmid permitting a single crossover event.
|
| Claim 5
A vector combination consisting of:
A) an acceptor Ti plasmid which is incapable of inducing tumors in plants
being free of border sequences and internal T-DNA sequences of a wild-type Ti
plasmid, comprising: (i) a DNA segment of a wild-type Ti plasmid without
the T-region and without the two border sequences of the T-region; and
(ii) a DNA sequence derived from a cloning vehicle, and
B) an intermediate cloning vector comprising: (i) a cloning vehicle
segment containing the two border sequences of the T-region of a wild-type Ti
plasmid; and (ii) a DNA sequence located between said two border sequences
which is homologous with the DNA sequence (ii) in said acceptor Ti plasmid
permitting a single crossover event, wherein the region between said border
sequences is substantially free of internal T-DNA sequences of a wild-type Ti
plasmid; and (iii) at least one gene of interest under the control of a
promoter capable of directing gene expression in plants located between the two
border sequences in a manner allowing its integration into the plant genome.
|
| Claim 15
A hybrid Ti plasmid vector obtained by cointegration either between
A) an acceptor Ti plasmid which is incapable of inducing tumors in plants
comprising: (i) the two border sequences of the T-region of the wild-type
Ti plasmid; (ii) a DNA sequence devoid of oncogenic internal T-DNA regions
of the wild-type T-DNA, derived from a cloning vehicle, located between the two
border sequences, and containing a DNA sequence which is homologous with at
least a part of a DNA sequence in an intermediate cloning vector permitting a
single crossover event; and (iii) a DNA segment of the wild-type Ti plasmid
containing DNA sequences essential for the transfer by Agrobacterium
of the T-region of wild-type Ti plasmids into plant cell genomes; and
B) an intermediate cloning vector comprising (i) at least one gene of
interest under the control of a promoter capable of directing gene expression in
plants; and (ii) a cloning vehicle segment containing a DNA sequence which
is homologous with the above DNA sequence (ii) in the acceptor Ti plasmid;
or between I) an acceptor Ti plasmid comprising: (a) a DNA
segment of the wild-type Ti plasmid without the T-region and without the two
border sequences of the T-region; and (b) a DNA sequence derived from a
cloning vehicle; and II) an intermediate cloning vector comprising: (a) a
cloning vehicle segment containing the two border sequences of the T-region of a
wild-type Ti plasmid and a DNA sequence located between said two border
sequences which is homologous with the above DNA sequence (b) in the acceptor Ti
plasmid permitting a single crossover event, wherein the region between said
border sequences is substantially free of internal T-DNA sequences of a
wild-type Ti plasmid; and (b) at least one gene of interest under the
control of a promoter capable of directing gene expression in plants located
between the two border sequences in a manner allowing its integration into the
plant genome; III) said hybrid Ti plasmid vector comprising at least: (1)
the two border sequences in the T-region of a wild-type Ti plasmid; (2)
non-oncogenic DNA sequences derived from a cloning vehicle; (3) a DNA
segment of the wild-type Ti plasmid containing DNA sequences essential for the
transfer of the T-region of wild type Ti plasmid by Agrobacterium into
plant cell genomes; and (4) at least one gene of interest under the control
of a promoter capable of directing gene expression in plants which is located
between the two border sequences.
|
Designated contracting States at the time of grant are: Austria, Belgium
(patent lapsed as reported on INPADOC), Switzerland (patent lapsed as reported
on INPADOC), Germany, France, United Kingdom (patent lapsed as reported on
INPADOC), Italy, Liechtenstein, Luxembourg, Netherlands (patent lapsed as
reported on INPADOC), Sweden (patent lapsed as reported on INPADOC).
The invention claimed in patent EP 116 718 B2 relates to
vector combinations consisting of acceptor Ti plasmids and intermediate cloning
vectors that result in the formation of a hybrid Ti plasmid. The hybrid plasmid
is also claimed.
In certain claims, the region between border sequences is said to be
substantially free of internal T-DNA sequences of a wild type Ti plasmid. How
free "substantially free" is, is not defined in the disclosure. Further, the
claims do not exclude the presence of sequences from a mutated Ti plasmid.
The co-integration of both plasmid types is achieved through a single
crossover event. The homologous region derives from a cloning vector and is
present in both the acceptor plasmid and the intermediate cloning vector.
The resultant hybrid plasmid contains at least:
- a gene of interest under the control of a promoter, located between two
T-DNA borders which must be from a wild-type Ti plasmid; and
- a DNA sequence from Ti plasmid that is essential for T-DNA transfer into the
plant genome.
|
Max-Planck-Gesellschaft zur Förderung der Wissenschaften E.V.
|
|
AU
546542 B
- Earliest priority - 13 January 1983
- Filed - 13 January 1984
- Granted - 5 September 1985
- Patent expired - 12 August 2004
|
Title - Introduction of exressible genes into plant genomes
and Agrobacterium strains carrying hybrid Ti plasmid
| Claim 1
Acceptor Ti plasmid comprising: (i) two border sequences of the T-region of
the wild-type Ti plasmid; and (ii) a non-oncogenic DNA segment derived from
a cloning vehicle located between the two border sequences containing a DNA
sequence which is homologous with at least a part of a DNA in an intermediate
cloning vector permitting a single crossover event; and (iii) a segment of
the wild type Ti plasmid containing DNA sequences essential for the transfer by
Agrobacterium of the T-region of wild-type Ti plasmids into plant cell
genomes.
|
| Claim 2
Acceptor Ti plasmid comprising: (i) a DNA segment of a wild-type Ti plasmid
without the T-region and without the two border sequences of the T-region; and
(ii) a DNA sequence derived from a cloning vehicle which is homologous
with a DNA sequence of an intermediate cloning vector which contains the two
border sequences of the T-region of the wild-type Ti plasmid.
|
| Claim 9
Hybrid Ti plasmid vector comprising: (i) the two border sequences of the
T-region of the wild-type Ti plasmid; (ii) non-oncogenic DNA segments
derived from a cloning vehicle; (iii) a segment of the wild-type Ti plasmid
containing DNA sequences essential for the transfer by Agrobacterium
of the T-region of wild-type Ti plasmids into plant cell genomes; and (iv)
at least one gene of interest which is located between the two border sequences.
|
The patent AU-B-546 542 claims acceptor Ti plasmids and
intermediate cloning vector molecules that through a single crossover event form
a co-integrated or hybrid Ti plasmid. The hybrid plasmid contains a gene of
interest located between two border sequences.
The resulting hybrid plasmid disclosed in both of the patents is incapable of
inducing tumors in plants transformed via Agrobacterium; however, the
"comprising" language used in the claims doesn't exclude the addition of
oncogenic sequences.
|
|
EP
290799 B1
- Earliest priority - 13 January 1983
- Filed - 22 December 1983
- Granted - 26 November 2003
- Reprinted (B9) - 1 September 2004
- Expected expiry - 21 December 2003
|
Title - Transgenic dicotyledonous plant cells and plants
Claim 1
A cell of a dicotyledonous plant, obtainable by Agrobacterium
transformation, which contains stably integrated into its genome a foreign DNA
which is characterised in that:
(a) it does not contain T-DNA genes that control neoplastic growth and it is
substantially free of internal T-DNA sequences of a wild-type Ti-plasmid; and
(b) it comprises at least one gene of interest containing: (i) a
coding sequence; and (ii) a promoter region that contains a promoter
sequence other than the natural promoter sequence of said coding sequence, and
wherein said promoter sequence regulates transcription of downstream sequences
containing said coding sequence to produce an RNA in said cell.
|
This granted patent is a divisional of now granted EP 116718
(see above).
Designated contracting States at the time of grant are: Austria, Belgium
(patent lapsed as reported on INPADOC), Switzerland (patent lapsed as reported
on INPADOC), Germany, France, United Kingdom, Italy, Liechtenstein, Luxembourg,
Netherlands (patent lapsed as reported on INPADOC), Sweden (patent lapsed as
reported on INPADOC).
Independent claim 1 of granted EP 290799 B2 does not claim a
co-integrated vector system (see application EP 290799 A2
below), but a transformed cell of a dicotoledonous plant that:
- is substantially free of T-DNA from a wild-type Ti plasmid (as above, the
definition of term "substantially free" is unclear, and the construct could
include T-DNA from a non-wild-type Ti plasmid),
- contains a gene of interest that has a coding sequence (so might not cover a
siRNA-producing sequence), and
- a promoter that regulates expression of the gene of interest.
|
|
EP
320500 B1
- Earliest priority - 13 January 1983
- Filed - 22 December 1983
- Granted - 17 November 2004
- Expected expiry - 21 December 2003
|
Title - Non-oncogenic Ti plasmid vector system and
recombinant DNA molecules for the introduction of expressible genes into plant
cell genomes
Claim 1
A cloning vector which comprises:
(a) a cloning vehicle segment (3') containing a left border sequence (1) and
a right border sequence (2) of a T-region of a wild-type Ti-plasmid, and
(b) a DNA segment which is located between said border sequences in a manner
allowing its integration into a plant genome, wherein said DNA segment does not
contain T-DNA genes that control neoplastic growth and wherein said DNA segment
is substantially free of internal T-DNA sequences of a wild-type Ti-plasmid,
except for promoter sequences, and which contains at least one gene of interest
which comprises: (i) a coding sequence, and (ii) a promoter region
that contains a promoter sequence other than the natural promoter sequence of
said coding sequence, and wherein said promoter sequence regulates transcription
of downstream sequences containing said coding sequence to produce an RNA in a
cell of a plant.
|
|
Claim 9
A vector combination consisting of (i) an acceptor Ti
plasmid, which is incapable of inducing tumors in plants being free of border
sequences and intemal T-DNA sequences of a wild-type Ti plasmid,
comprising: (a) a DNA segment (4) of a wild-type Ti plasmid without the
T-region and without the two border sequences of the T-region; and (b) a
DNA sequence (3) derived from a cloning vehicle, and (ii) an intermediate
cloning vector comprising: (c) a cloning vehicle segment (3') containing
the two border sequences of the T-region of a wild-type Ti plasmid (1; 2) and a
DNA sequence located outside of said two border sequences which is homologous
with the DNA sequence (b) in said acceptor Ti plasmid permitting a single
cross-over event wherein the region between said border sequences is
substantially free of internal T-DNA sequences of a wild-type Ti plasmid;
and (d) at least one gene of interest (5) under the control of a promoter
capable of directing gene expression in plants located between the two border
sequences in a manner allowing its integration into the plant genome.
|
|
Claim 16
A hybrid Ti plasmid vector obtained by co-integration between an acceptor Ti
plasmid comprising: (a) a DNA segment (4) of a wild-type Ti plasmid without
the T-region and without the two border sequences of the T-region; and (b)
a DNA sequence (3) derived from a cloning vehicle; and an intermediate cloning
vector comprising: (a') a cloning vehicle segment (3') containing the two
border sequences of the T-region of a wild-type Ti plasmid (1; 2) and a DNA
sequence located outside of said two border sequences which is homologous with
the above DNA sequence (b) in the acceptor Ti plasmid permitting a single
crossover event, wherein the region between said border sequences is
substantially free of internal T-DNA sequences of a wild-type Ti plasmid; and
(b') at least one gene of interest (5) under the control of a promoter
capable of directing gene expression in plants located between the two border
sequences in a manner allowing its integration into the plant genome;
said hybrid Ti plasmid vector comprising at least:
(1) the two border sequences (1; 2) of the T-region of a wild-type Ti
plasmid;
(2) non-oncogenic DNA sequences (3; 3') derived from a cloning vehicle;
(3) a DNA segment (4) of the wild-type Ti plasmid containing DNA sequences
essential for the transfer of the T-region of wild-type Ti plasmids by
Agrobacterium into plant cell genomes; and
(4) at least one gene of interest (5) under the control of a promoter capable
of directing gene expression in plants which is located between the two border
sequences (1; 2).
|
This granted patent is a divisional of now granted EP 116718
(see above).
Designated contracting States at the time of grant are: Austria (patent
lapsed as reported on INPADOC), Belgium (patent lapsed as reported on INPADOC),
Switzerland (patent lapsed as reported on INPADOC), Germany, France, United
Kingdom, Italy, Liechtenstein, Luxembourg, Netherlands (patent lapsed as
reported on INPADOC), Sweden.
|
EP
290799 A2
- Earliest priority - 13 January 1983
- Filed - 22 December 1983
- Granted as EP 290799 B1 (see above)
|
Title - Process for the production of expressible genes into
plant cell genomes and Agrobacterium strains carrying hybrid Ti plasmid
vectors useful for this process
Claim 1
Recombinant plant DNA genome being free of oncogenic internal T-DNA regions
of the wild-type Ti plasmid containing an integrated gene of interest foreign to
said plant DNA obtainable by infecting a plant cell with an Agrobacterium
harboring a hybrid Ti plasmid vector created by homologous recombination
between:
A) an acceptor Ti plasmid which is incapable of inducing tumors in plants and
comprises: (i) the two border sequences of the T-region of the wild-type Ti
plasmid; (ii) a DNA segment devoid of oncogenic internal T-DNA regions of
the wild-type T-DNA, derived from a cloning vehicle, located between the two
border sequences, and containing a DNA sequence "A" which is homologous with at
least a part of a DNA sequence in an intermediate cloning vector permitting a
single crossover event; and (iii) a segment of the wild-type Ti plasmid
containing DNA sequences essential for the transfer by Agrobacterium
of the T-region of wild-type Ti plasmid into plant cell genomes, and
B) an intermediate cloning vector which comprises: (i) at least one gene
of interest; and (ii) a cloning vehicle segment containing a DNA sequence
which is homologous to the DNA sequence "A" in said acceptor Ti plasmid,
or a hybrid Ti plasmid vector created by homologous recombination between:
I) an acceptor Ti plasmid which is incapable of inducing tumors in plants and
which comprises: (a) a DNA segment of a wild-type Ti plasmid without the
T-region and without the two border sequences of the T-region; and (b) a
DNA sequence derived from a cloning vehicle which is homologous with at least a
part of a DNA sequence of an intermediate cloning vector which contains the two
border sequences of the T-region of the wild-type Ti plasmid, and II) an
intermediate cloning vector which comprises: (a) a cloning vehicle segment
containing the two border sequences of the T-region of the wild-type Ti plasmid
and a DNA sequence which is homologous with the DNA sequence (b) in said
acceptor Ti plasmid; and (b) at least one gene of interest located between
the two border sequences in a manner allowing its integration into the plant
genome; said hybrid Ti plasmid comprising at least: 1) the two border
sequences of the T-region of the wild-type Ti plasmid; 2) non-oncogenic DNA
segments derived from a cloning vehicle; 3) a segment of the wild-type Ti
plasmid containing DNA sequences essential for the transfer by Agrobacterium of
the T-region of wild-type Ti plasmid into plant cell genomes, and 4) at
least one gene of interest which is located between the two border sequences.
|
The European application EP 290 799 A2 claims a recombinant
plant genome obtained after infection of plant cells with an
Agrobacterium strain having a hybrid Ti plasmid. The recombinant genome
contains an exogenous gene of interest and is free of oncogenic sequences. The
hybrid plasmid is the product of homologous recombination between an acceptor
plasmid and an intermediate cloning vector. The elements of the combined
acceptor plasmids and intermediate cloning vectors are set out in Claim 1.
|
EP
320500 A2
- Earliest priority - 13 January 1983
- Filed - 22 December 1983
- Granted as EP 320500 B1 (see above)
|
Title - Non-oncogenic Ti plasmid vector system and
recombinant DNA molecules for the introduction of expressible genes into plant
cell genomes
Claim 1
A non-oncogenic Ti plasmid vector system free of T-DNA genes controlling
neoplastic growth of transformed plants which comprises:
(i) DNA sequences coding for functions which are essential for the transfer
of the T-region of a wild-type Ti plasmid by Agrobacterium into a plant cell
genome; and (ii) at least one gene of interest which has been inserted into
said vector system and which is capable of being expressed in plants which are
susceptible to infection by Agrobacterium, said gene being under
the control of at least one promoter capable of directing the expression of said
gene in the plant and associated with at least the right border sequence of the
T-region of a wild-type Ti plasmid, said border sequence allowing the
integration of said gene into the plant genome.
|
Claim 4
An intermediate cloning vector comprising:
(i) a cloning vehicle segment containing the right border sequence of the
T-region of a wild-type Ti plasmid and a DNA sequence which is homologous with a
DNA sequence in an acceptor Ti plasmid; and (ii) at least one gene of
interest under the control of a promoter capable of directing gene expression in
plants which is associated with said border sequence in a manner allowing its
integration into the plant genome.
|
The European application EP 320 500 A2 claims a
non-oncogenic Ti plasmid vector containing a gene of interest and its
controlling promoter associated with at least the right border of the wild type
T-region. The border allows the integration of the gene into the plant genome.
Also, the Ti plasmid contains the sequences needed for transfer of T-region into
plant genome (claim 1).
In another independent claim, a gene of interest and its promoter that is
associated with a right T-border are contained in an intermediate cloning vector
(claim 4).
|
| Remarks |
- Related patent of EP 116718 B2 in Canada (CA 1341419) has been granted.
- Related patent of EP 116718 B2 in Japan and their status are:
- JP 1633546 C - granted and expired
- JP 2726267 B2 - granted and expired
- JP 2769539 B2 (divisional of now granted JP 1633546) - granted and expired
- JP (H)03/108478 A (divisional of now granted JP 2769539) - application
rejected
- JP (H)06/105629 A (divisional of now granted JP 2769539) - application
rejected
- JP 2001/029092 A (divisional of JP (H)06/105629 A) - application rejected
|
Note: Patent information on this page was last updated on 28 February 2006.
Patents granted to Monsanto
Monsanto Company has been granted three patents related to
co-integrated vectors in Europe (EP) and in Australia (AU). These patents are:
- directed to elements of a co-integrated plasmid and methods for transforming
plants using co-integrated plasmids (EP 131 620 B1 and AU-B-559 562) and
- directed to the elements of a co-integrated plasmid and the plasmids used to
generate the co-integrated (EP 131 624 B1).
Specific Patent Information
|
Patent Number
|
Title, Independent Claims and Summary of Claims
|
Assignee
|
|
EP
131620 B1
- Earliest priority - 17 January 1983
- Filed - 16 January 1984
- Granted - 21 August 1991
- Expected expiry - 16 January 2004
|
Title - Genetically transformed plants
Claim 1
A method for transforming plant cell which comprises
- contacting plant cells, which are susceptible to genetic transformation by
Agrobacterium cells, with Agrobacterium tumefaciens cells
containing a co-integrated Ti plasmid comprising a disarmed T-DNA region which
comprises in sequence:
(i) a left Agrobacterium T-DNA border sequence, (ii) a chimeric
selectable marker gene which functions in plant cells comprising: (a) a promoter
which functions in plant cells; (b) a structural coding sequence encoding a
neomycin phosphotransferase; and (c) a 3í non-translated region encoding a
polyadenylation signal, and (iii) a right Agrobacterium T-DNA border
sequence.
|
Designated contracting States at the time of grant are: Austria (patent
lapsed as reported by INPADOC), Belgium, Switzerland (patent lapsed as reported
by INPADOC), Germany, France (patent lapsed as reported by INPADOC), United
Kingdom (patent lapsed as reported by INPADOC), Liechtenstein, Luxembourg,
Netherlands (patent lapsed as reported by INPADOC), Sweden (patent lapsed as
reported by INPADOC)
The patents EP 131 620 B1 and AU-B-559 562
are both directed to methods for transforming plant cells. The patent
EP 131 620 B1 claims transformation methods by contacting plant
cells with Agrobacterium harboring a co-integrated plasmid. The
AU-B-559 562 patent further specifies a series of steps to
carry out such transformation. In addition, both of the patents claim
elements of the co-integrated plasmid used in the transformation process. One of
the differences between them is that the EP 131 620 B1 limits
the gene to be expressed in plants to a chimeric selectable marker gene that
includes:
- a promoter,
- a sequence coding for neomycin phosphotransferase; and
- a polyadenylation signal coding sequence.
|
Monsanto
|
AU-B 559562
- Earliest priority - 17 January 1983
- Filed - 16 January 1984
- Granted - 12 March 1987
- Patent expired - 14 August 2003
|
Title - Genetically transformed plants
Claim 1
A method of creating transformed plant cells, comprising the following steps:
(i) culturing a microorganism containing
- a first plasmid containing:
(a) at least one first gene that is expressed in plant cells and (b) at
least one second gene which serves as a marker in a selected microorganism, and
- a Ti second plasmid, under conditions which allow the first plasmid to
recombine with the Ti second plasmid in the microorganism, thereby creating a
third plasmid having at least one T-DNA border on each side of the first gene,
said gene being located in said first plasmid between a region of homology from
the T-region of the Ti plasmid and a T-DNA border;
(ii) selecting those microorganisms containing the third plasmid; (iii)
inserting the third plasmid, or a portion thereof, into plant cells; and
(iv) culturing the plant cells under conditions which allow a segment of DNA
from the third plasmid to be inserted into the genome of the plant cells.
|
Claim 13
A method of transforming plant cells, comprising
- inserting into the plant cells a co-integrated plasmid, or a portion
thereof, which was formed by a single crossover event between a first plasmid
and a Ti second plasmid, wherein the co-integrated plasmid contains a region
comprising:
(i) a first T-DNA border; (ii) a gene which expressed in plant cells;
and (iii) a second T-DNA border which is complementary to the first T-DNA
border, wherein the region does not contain any sequences which would
render the plant cells incapable of being regenerated into morphologically
normal plants.
|
Remarks on related patents of
WO
1984/02920:
- WO 1984/02920 entered national phase in Japan (JP (S)60/500795) and Union of
Soviet Socialist Republics (SU 1582990).
|
|
EP
131624 B1
- Earliest priority - 17 January 1983
- Filed - 16 January 1984
- Granted - 16 September 1992
- Expected expiry - 15 January 2004
|
Title - Plasmids for transforming plant cells
Claim1
A co-integrated plasmid for use in transforming plant cells, and produced by
recombination by a single crossover event of:
A) a chimeric plasmid comprising a gene which functions in plants to express
an encoded polypeptide, said plasmid comprising in sequence:
(i) a region of DNA which is homologous to T-DNA located near the left T-DNA
border of a tumor-inducing plasmid of Agrobacterium and which is
capable of causing in vivo recombination of the chimeric plasmid with said
tumor-inducing plasmid of Agrobacterium by a single crossover event; (ii) a
gene comprising a promoter which functions in plant cells, a structural coding
sequence and a 3í non-translated region encoding a polyadenylation signal, said
promoter and polyadenylation signal being operably linked to said structural
coding sequence; and (iii) an Agrobacterium plasmid T-DNA right
border sequence which enables the transfer and incorporation of T-DNA into the
genome of a plant cell; said chimeric plasmid containing no plant
tumorigenic genes between and including the region (i), the gene (ii) and the
border sequence (iii), and
B) a Ti plasmid capable of transferring the T-DNA region into the genome of a
plant cell,
such that the co-integrated plasmid comprises a T-DNA region having the
following elements in sequence: 1) a left T-DNA border sequence; 2)
the gene (ii) of the chimeric plasmid; 3) at least one right T-DNA border
sequence; wherein said T-DNA border sequences enable the transfer of the
T-DNA region into the genome of a plant cell, and wherein, between and including
the left T-DNA border sequence, the gene (ii) and the right T-DNA border
sequence or (if there is more than one right T-DNA border sequence) between the
gene (ii) and the right T-DNA border sequence which is nearest to the left T-DNA
border sequence, there are no genes which would render a transformed plant cell
tumorous or incapable of regeneration into a morphologically normal plant, and
there is no duplication of DNA sequences, which duplication could, through
homologous recombination, result in loss of the gene (ii).
|
Designated contracting States at the time of grant are: Austria (patent
lapsed as reported by INPADOC), Belgium, Switzerland (patent lapsed as reported
by INPADOC), Germany, France (patent lapsed as reported by INPADOC), United
Kingdom (patent lapsed as reported by INPADOC), Liechtenstein, Luxembourg,
Netherlands (patent lapsed as reported by INPADOC), Sweden (patent lapsed as
reported by INPADOC)
The patent EP 131 624 B1 claims elements of a chimeric
plasmid that produce a co-integrated plasmid by recombination with a Ti plasmid.
The chimeric plasmid comprises in order:
- a left-inside homology (LIH) region, which is naturally located near the
left T-DNA border of a Ti plasmid
- a gene of interest with a promoter and a polyadenylation signal; and
- a right T-DNA border
The elements present in the T-region of the co-integrated plasmid are also
part of the claims.
Remarks on related patents of WO1984/02919:
- WO 1984/02919 entered national phase in Japan (JP (S)60/500438)
|
Note: Patent information on this page was last updated on 1 March 2006.
Summary of patents on modified co-integrated vectors and methods
Several entities own inventions built on the basic components of
co-integrated vectors and the basic methods to assemble them. Three different
inventions are referred to in this section:
-
Stable co-integrated vector. The invention of
Schilperoort and Hille in the United States and in Europe
discloses a way to combine in E. coli a vector molecule (pR772) having
a modified T-region with a Ti plasmid (pTiB6). After the recombination of the
molecules, the co-integrated plasmid pAL969 is transferred to an
Agrobacterium strain lacking a native Ti-plasmid. The co-integrated
vector and its derivatives are stable in both E.coli and
Agrobacterium and are used for transformation of dicot plants.
The very narrow scope of this patent will not present undue difficulties
for most researchers. Quite simply, by using different plasmids than those
claimed, infringement of this patent can likely be avoided.
-
Site-specific co-integrated vector. The granted United
States patent and the European application assigned to Mogen,
now called Syngenta Mogen B.V., discloses an alternate way to
attain homologous recombination in order to form a co-integrated vector. The
recombination process is triggered by the action of Cre (causing
recombination) recombinase on recombination sites (i.e. lox P) present in
both a small vector and a disarmed (tumor-genes free) Ti plasmid. The following
diagram illustrates this method.

In conclusion, the most limiting factor in this patent is the presence and use
of the Cre recombinase system to form a stable co-integrated plasmid within an
Agrobacterium strain.
-
Co-transformation with two different T-DNAs. Japan
Tobacco has one United States granted patent and a European application
directed to this subject matter. This invention discloses an
Agrobacterium strain containing a first T-DNA, which has a selectable
marker, e.g. a drug resistance gene, and a second T-DNA, which has a desired
gene or a cloning site and is part of a co-integrated vector. The first T-DNA
may or may not be part of the same vector as the second T-DNA. Although when
both are in the same co-integrated vector, they are distant enough to be
inherited independently.
Thus, an Agrobacterium strain
having two different T-DNAs as described above is very likely to fall within the
scope of the claimed invention in the United States patent. Note, however, that
the second vector used in this invention must be a co-integrated vector.
Table of patents on modified co-integrated vectors
The following table presents an overview of six patents and patent
applications that claim co-integrated vectors having
variations on their basic elements.
This analysis is limited by being based only upon the published specification
and claims of the issued patents and patent applications.
| Assigned to Schilperoort & Hille |
| Issued Patents Overview |
|
US
4693976
Method for incorporating foreign DNA into a dicot genome via A.
tumefaciens using a stable co-integrated plasmid. The co-integrated
plasmid, composed of a Ti-plasmid (pTiB6) and a broad host range plasmid (R772),
contains foreign DNA in the T-region of the Ti component of the co-integrated
plasmid. The insertion of the new genes into the T-region of the R::Ti
co-integrate is achieved by homologous recombination of an engineered
E.coli vector with a modified T-region and the R::Ti co-integrate.
EP
120515 B1
Process for incorporating foreign DNA into a dicot
genome by infecting plant protoplasts with A. tumefaciens containing a
plasmid derived from the co-integrated plasmid pAL969. Such plasmid contains
only foreign DNA between the 23 base pairs of the wild-type T-region from the Ti
plasmid pTiB6.
More detailed information on these
patents.
|
| Assigned to Syngenta Mogen B.V. |
| Issued Patents Overview |
|
US
5635381
Agrobacterium strains having a site-specific recombinase (Cre)
capable of causing recombination between two different recombination sites (i.e.
loxP site) present in the same strains. The site-specific recombination event
between two separated DNA molecules each carrying a recombination site results
in the formation of a site-specific co-integrated plasmid.
EP
628082 B1
This recently granted patent (former application
EP 628082 A1 ) is directed to an Agrobacterium strain
having a gene encoding a recombinase and a sequence capable of controlling its
expression. The recombinase causes site-specific recombination between two
recombination sites. The scope of the claims as granted is the same as the
claims filed in the EP application.
More detailed information on these
patents.
|
| Assigned to Japan Tobacco Inc. |
| Issued Patents Overview |
Patent Applications Overview |
|
US
5731179
Method for co-transforming plant cells with two T-DNAs via
Agrobacterium where the first T-DNA contains a selectable marker, and
the second T-DNA has a gene of interest. Either both T-DNAs are located in the
same hybrid vector or at least the second T-DNA is in a hybrid vector, which is
the product of homologous recombination between an acceptor vector and an
intermediate vector.
More detailed information on
this patent.
|
EP 687 730 A1
Method for co-transforming plant cells with a first T-DNA containing a drug
resistance gene and a second T-DNA containing a desired gene and contained in a
hybrid vector prepared by homologous recombination between an acceptor vector
and an intermediate vector. A hybrid vector with a first T-DNA as described and
a second T-DNA with a cloning site is further
claimed.
More detailed
information on this patent.
|
Patents granted to Schilperoort & Hille
Two patents granted to Schilperoort & Hille are related
to transformation of dicotyledonous (dicot) plants using stable co-integrated
plasmids. The granted patents were obtained in Europe (EP) and in the United
States of America (US). The European patent was assigned to the
University of Leiden and Prof. Dr. R.
Schilperoort.
In general, both patents disclose transformation of dicot plant protoplasts
by infecting them with an A. tumefaciens strain containing a stable
co-integrated plasmid. The co-integrated plasmid results from the combination of
the Ti plasmid pTiB6 and the broad host range plasmid R772. In the European
patent, the A. tumefaciens strain used for plant transformation
contains a plasmid derived from the co-integrated plasmid pAL969, which has a
T-region from pTiB6 and contains only foreign DNA between the border sequences.
Specific Patent Information
|
Patent Number
|
Title, Independent Claims and Summary of Claims
|
Assignee
|
|
US
4693976
- Earliest priority - 24 February 1983
- Filed - 23 February 1984
- Granted - 15 September 1987
- Expected expiry - 14 September 2007
|
Title - Process for the incorporation of foreign DNA into
the genome of dicotyledonous plants using stable cointegrate plasmids
Claim 1
A process for the incorporation of foreign DNA into the genome of
dicotyledonous plants comprising
- infecting the plants or incubating plant protoplasts with A.
tumefaciens bacteria, which contain one or more Ti (tumor inducing)
plasmids, characterized in that as Ti plasmid a stable co-integrated plasmid
composed of the plasmid R772 and the plasmid pTiB6 with foreign DNA incorporated
in the T-region of the Ti component of the co-integrated plasmid is applied.
|
Claim 3
A process for the production of Agrobacterium tumefaciens bacteria,
which contain one or more Ti plasmids, comprising
- combining in Escherichia coli a vector known per se for use in
E. coli, provided with T-DNA region in which foreign DNA has been
incorporated, with co-integrated plasmid pAL969 and the co-integrated plasmid
with foreign DNA incorporated by double crossing-over in the T-region of the Ti
component of transferring the co-integrated plasmid to A. tumefaciens.
|
Claims of the US patent 4693976 recite
- the incorporation of foreign DNA into the dicot genome by infecting or
incubating plant protoplasts with A. tumefaciens having a stable
co-integrated plasmid (R772::pTiB6). Such plasmid bears a modified T-region with
foreign DNA. The co-integrated is formed within E. coli by homologous
recombination (double crossing) of R772, a broad host range plasmid, and pTiB6,
a Ti plasmid with an engineered T-region.
- the process for the production of A. tumefaciens bacteria
comprising:
-
- combining in E. coli a vector having a T-region with foreign DNA
and the co-integrated plasmid pAL969; and
- transferring the recombinant to A. tumefaciens.
|
Schilperoort & Hille
|
|
EP
120515 B1
- Earliest priority - 24 February 1983
- Filed - 23 February 1984
- Granted - 22 November 1990
- Expected expiry - 22 February 2004
|
Title - A process for the incorporation of foreign DNA into
the genome of dicotyledonous plants; a process for the production of
Agrobacterium tumefaciens bacteria
Claim 1
A process for the incorporation of foreign DNA into the genome of
dicotyledonous plants comprising
- infecting the plants or incubating plant protoplasts with Agrobacterium
tumefaciens bacteria containing at least one plasmid which is derived from
the co-integrated plasmid pAL969 by the incorporation of foreign DNA in the
T-region of the component pTiB6 characterized in that the co-integrated plasmid
with foreign DNA contains only foreign DNA between the 23 base pairs of the
wild-type T-region.
|
Designated contracting States at the time of grant are: Austria, Belgium
(patent lapsed as reported by INPADOC), Switzerland (patent lapsed as reported
by INPADOC), Germany, France, United Kingdom (patent lapsed as reported by
INPADOC), Italy, Liechtenstein, Luxembourg, Netherlands (patent lapsed as
reported by INPADOC), Sweden (patent lapsed as reported by INPADOC)
The claims of the patent EP 120515 recite:
- a process for foreign DNA incorporation into a dicot genome by infecting
plant protoplasts with A. tumefaciens containing a plasmid derived from
the co-integrated plasmid pAL969. The transferred plasmid contains only foreign
DNA between the 23 bp ends of the wild-type T-region of the Ti plasmid pTiB6.
|
University of Leiden and Schilperoort
|
|
Remarks
|
Related patents include:
-
JP 2523468 B2 - granted and expired
-
JP 2528270 B2 (divisional of now granted JP 2523468 B2) - granted and expired
-
NL 8300699 A - application lapsed as reported by INPADOC
|
|
Note: Patent information on this page was last updated on 1 March 2006.
Patent granted to Mogen Int. (now Syngenta Mogen B.V.)
The United States patent granted to Syngenta Mogen B.V., is
directed to the use of a Cre (c ausing
recombination)-recombinase capable of causing site-specific
recombination of two separated DNA molecules present in the same
Agrobacterium strain. The resulting plasmid is a co-integrated plasmid
having a gene of interest and is useful for plant transformation.
The related European patent is similar to the United States patent as both
disclose a site-specific recombination system for the generation of a
site-specific co-integrated plasmid for plant transformation. In the European
patent, however, the recombinase is not limited to Cre
recombinase.
Specific Patent Information
|
Patent Number
|
Title, Independent Claims and Summary of Claims
|
Assignee
|
|
US
5635381
- Earliest priority - 26 February 1992
- Filed - 20 January 1995
- Granted - 3 June 1997
- Expected expiry - 19 January 2015
|
Title - Agrobacterium bacteria capable of
site-specific recombination
Claim 1
An Agrobacterium strain comprising: (i) a structural DNA sequence
encoding a site-specific recombinase that is Cre recombinase; and
(ii) a DNA sequence linked thereto which operationally controls expression of
said Cre recombinase, said strain further comprising (iii) a first
recombination site.
|
The patent discloses that a first plasmid bearing a recombination site
combines, in a site-specific fashion, with a second plasmid also bearing a
recombination site to generate a site-specific co-integrated plasmid. The second
plasmid contains a gene of interest linked to a right T-border. The production
of the co-integrated plasmid does not require homologous
recombination. The Agrobacterium strains used for plant transformation
contain the site-specific co-integrated plasmid with the exogenous DNA to
plants.
The patent claims an Agrobacterium strain with
- a DNA sequence encoding Cre recombinase linked to a sequence that controls
its expression and
- a first recombination site (which can be on a plasmid or in the genome).
The claim is a bit ambigious in that it doesn't state that the recombination
site is necessarily recognized by the Cre recombinase, though the specification
discloses that an exemplary site is a loxP seqence.
|
Syngenta Mogen B.V.
|
|
EP
628082 B1
- Earliest priority - 26 February 1992
- Filed - 25 February 1993
- Granted - 16 May 2001
- Expected expiry - 24 February 2013
|
Title - Agrobacterium strains capable of
site-specific recombination
Claim 1
An Agrobacterium strain capable of producing a site-specific
recombinase capable of effecting site-specific recombination of a first and
second recombination site in said Agrobacterium strain, when present
therein, comprising a structural DNA sequence encoding said recombinase and a
DNA sequence capable of controlling expression in said Agrobacterium
strain.
|
Designated contracting States at the time of grant are: Austria (patent
lapsed as reported by INPADOC), Belgium, Switzerland, Germany, Denmark (patent
lapsed as reported by INPADOC), Spain, France, United Kingdom, Greece, Ireland
(patent lapsed as reported by INPADOC), Italy, Liechtenstein, Luxembourg,
Monaco, Netherlands, Portugal, Sweden (patent lapsed as reported by INPADOC).
Both of Syngenta Mogen's patents in the United States and in
Europe encompass Agrobacterium strains having a plasmid with a gene
encoding a recombinase, a sequence to control its expression, vir
functions, and a first recombination site.
Unlike the United States patent, the claims of the European patent are
broader as the recombinase is not limited to a Cre recombinase.
Other site-specific recombinases may be encompassed by the European patent
claims. The European patent does explicitly claim that the recombinase can
mediate recombination between the first recombination site and a second
recombination site but claim 1 does not require that the first or second site be
on a plasmid.
|
Note: Patent information on this page was last updated on 1 March 2006.
Patent granted to Japan Tobacco Inc.
The United States patent granted to Japan Tobacco discloses
a method commonly called co-transformation. In this method, two T-DNAs
containing genes that encode different products (e.g. gene of interest and
selectable marker) are inserted into the plant genome via
Agrobacterium. The method results in transformed plants having the gene
of interest and lacking the selectable marker gene.
Specific Patent Information
|
Patent Number
|
Title, Independent Claims and Summary of Claims
|
Assignee
|
|
US
5731179
- Earliest priority - 8 December 1993
- Filed - 8 August 1995
- Granted -24 March 1998
- Expected expiry - 7 August 2015
|
Title - Method for introducing two T-DNAs into plants and
vectors therefor
Claim 1
A method for transforming and cultivating a plant using a bacterium belonging
to the genus Agrobacterium, comprising:
co-transforming plant cells with a first T-DNA (1) and a second T-DNA (2);
and
selecting cells based on a selection marker gene;
said first T-DNA (1) containing a selection marker gene which functions in
said plant;
said second T-DNA (2) containing a desired DNA fragment to be introduced into
said plant, the second T-DNA (2) being contained in a hybrid vector; said hybrid
vector being prepared by homologous recombination between an acceptor vector and
an intermediate vector in said bacterium belonging to the genus
Agrobacterium; said acceptor vector containing at least
(a) a DNA region having a replication origin allowing replication of a
plasmid in both a bacterium belonging to the genus Agrobacterium and in
Escherichia coli,
(b) a DNA region containing virB gene and virG gene in virulence region of
Ti plasmid pTiBo542 of Agrobacterium tumefaciens, and
(c) a DNA region which is homologous with a part of said intermediate
vector, which is subjected to homologous recombination in said bacterium
belonging to the genus Agrobacterium; said intermediate vector
containing at least
(i) a DNA region having a replication origin allowing replication of a
plasmid in Escherichia coli, which does not function in said bacterium
belonging to the genus Agrobacterium,
(ii) a DNA region which is homologous with a part of said acceptor
vector, which is subjected to homologous recombination in said bacterium
belonging to the genus Agrobacterium, and
(iii) a DNA region which constitutes at least a part of said second
T-DNA;
obtaining a plant transformed with said selection marker gene and said
desired DNA fragment; and
cultivating said plant and selecting a plant in the next generation, which
contains said desired DNA fragment but does not contain said selection marker
gene.
|
Claim 16
A hybrid vector comprising:
a first T-DNA containing
(1) a selection marker gene which functions in a plant, and
(2) a second T-DNA having a restriction site; wherein there is sufficient
distance on said hybrid vector between said first T-DNA and said second T-DNA to
allow said first T-DNA and said second T-DNA to be independently inherited, said
hybrid vector being prepared by homologous recombination between an acceptor
vector and an intermediate vector in a bacterium belonging to the genus
Agrobacterium; said acceptor vector containing at least
(a) a DNA region having a replication origin allowing replication of a
plasmid in both a bacterium belonging to the genus Agrobacterium and in
Escherichia coli,
(b) a DNA region containing virB gene and virG gene in virulence region of
Ti plasmid pTiBo542 of Agrobacterium tumefaciens, and
(c) a DNA region which is homologous with a part of said intermediate
vector, which is subjected to homologous recombination in said bacterium
belonging to the genus Agrobacterium; said intermediate vector
containing at least
(i) a DNA region having a replication origin allowing replication of a
plasmid in Escherichia coli, which does not function in said bacterium
belonging to the genus Agrobacterium,
(ii) a DNA region which is homologous with a part of said acceptor
vector, which is subjected to homologous recombination in said bacterium
belonging to the genus Agrobacterium, and
(iii) a DNA region which constitutes at least a part of said second
T-DNA.
|
Claim 24
A method for transforming and cultivating a plant using a bacterium belonging
to the genus Agrobacterium, comprising
- co-transforming plant cells with a first T-DNA (1) and a second T-DNA (2);
and
- selecting the cells which acquired drug resistance; said first T-DNA (1)
containing a gene giving said drug resistance, which functions in said plant;
said second T-DNA (2) containing a desired DNA fragment to be introduced into
said plant, the second T-DNA (2) being contained in a hybrid vector; said hybrid
vector being prepared by homologous recombination between an acceptor vector and
an intermediate vector in said bacterium belonging to the genus
Agrobacterium; said acceptor vector being pSB3 or pSB4; and said
intermediate vector being pSB21, pSB22, pSB24, pTOK170, pYS151, pTOK235, pTOK245
or pTOK246;
- obtaining a plant transformed with said drug resistance gene and said
desired DNA fragment; and
- cultivating said plant and selecting a plant in the next generation, which
contains said desired DNA fragment but does not contain said drug resistance
gene.
|
Claim 25
A hybrid vector comprising:
a first T-DNA containing (1) a gene giving a drug resistance, which
functions in a plant; and (2) a second T-DNA having a restriction site;
wherein there is sufficient distance on said hybrid vector between said first
T-DNA and said second T-DNA to allow said first T-DNA and said second T-DNA to
be independently inherited, said hybrid vector being prepared by homologous
recombination between an acceptor vector and an intermediate vector in a
bacterium belonging to the genus Agrobacterium; said acceptor vector
being pSB3 or pSB4; and said intermediate vector being pSB21, pSB22, pSB24,
pTOK170, pYS151, pTOK235, pTOK245 or pTOK246.
|
The patent US 5731179 claims
- a method for transforming plants via Agrobacterium by inserting two
different T-DNAs. The first T-DNA contains a plant selectable marker gene and
the second T-DNA contains a "desired DNA fragment" (claim 1) and may comprise a
restriction site. The second T-DNA is contained in a hybrid vector formed by
homologous recombination between an acceptor vector and an intermediate vector;
- a transformed plant with both of the T-DNAs and the subsequent selection of
transformed plants in the next generation that contain the desired gene but not
contain the selectable marker gene;
- the elements of the hybrid vector, the acceptor vector, and the intermediate
vector.
The independent claims don't limit the size of the DNA fragment contained by
the second T-DNA.
The claims to the hybrid vector state that the T-DNAs are sufficiently far
apart to allow them to be independently inherited. The patent disclosure
doesn't describe what minimum distance would allow this but does provide the
example, where the borders are separated by an origin of replication and
sequences that contain the virB and virG gene (i.e., about 15 kb) and the T-DNAs
are independently inherited. The claims are a bit ambiguous because they
don't require independent segregation to occur at any particular frequency
(e.g., 100% of the time? 50%? rarely?).
Some of the hybrid vector claims require specifically named plasmids
disclosed in the specification. Deposit information is not provided in the
disclosure of the US patent.
|
Japan Tobacco Inc.
|
|
AU
733623 B2
- Earliest priority - 8 December 1993
- Filed - 14 October 1998
- Granted - 17 May 2001
- Expected expiry - 5 December 2014
|
Title - Method for transforming plants and vector therefor
|
Claim 1
A method for transforming a plant through a bacterium belong to genus
Agrobacterium, comprising co-transfonming plant cells with a single
hybrid vector comprising a first T-DNA (1) and second T-DNA (2); and selecting
the cells which acquired drug resistance;
said first T-DNA (1) containing a gene giving said drug resistance, which
functions in said plant;
said second T-DNA (2) containing a desired DNA fragment to be introduced
into said plant, the second T-DNA (2) being contained in a hybrid vector;
said hybrid vector being prepared by homologous recombination between an
acceptor vector and an intermediate vector in said bacterium belong to genus
Agrobacterium;
said acceptor vector containing at least
(a) a DNA region having a function to replicate a plasmid in said bacterium
belonging to genus Agrobacterium and Escherichia coli,
(b) a DNA region containing virB gene and virG gene in virulence region of Ti
plasmid pTiBo542 of Agrobacterium tumefaciens, and
(c) a DNA region which is homologous with a part of said intermediate vector,
which is subjected to homologous recombination in said bacterium belonging to
genus Agrobacterium; said intermediate vector containing at least
(i) a DNA region having a function to replicate a plasmid in Escherichia
coli, which does not function in said bacterium belonging to genus
Agrobacterium,
(ii) a DNA region which is homologous with a part of said acceptor vector,
which is subjected to homologous recombination in said bacterium belonging to
genus Agrobacterium, and
(iii) a DNA region which constitutes at least a part of said second T-DNA.
|
|
Claim 13
A hybrid vector comprising a first T-DNA containing (1) a gene giving a
drug resistance, which functions in a plant, and (2) a second T-DNA having
a restriction site; said hybrid vector being prepared by homologous
recombination between an acceptor vector and an intermediate vector in a
bacteria belonging to the genus Agrobacterium;
|
This granted patent is a divisional of now abandoned AU
11213/95 A1 (OPI of the national phase entry of
WO
1995/16031).
|
|
AU
771116 B2
- Earliest priority - 8 December 1993
- Filed - 22 May 2001
- Granted - 11 March 2004
- Expected expiry - 5 December 2014
|
Title - Agrobacterium mediated method of plant
transformation
Claim 1
A method of Agrobacterium mediated transformation of a plant with a
desired DNA fragment comprising:
(i) co-transforming plant cells with a vector comprising a first T-DNA (1)
that contains a gene that encodes drug resistance in a plant and a hybrid vector
comprising a second T-DNA (2) containing a desired DNA fragment that is to be
introduced into said plant, wherein said first T-DNA and said second T-DNA are
not contained in the same vector; and (ii) selecting those cells which
acquire drug resistance; and wherein said hybrid vector is prepared by
homologous recombination between an acceptor vector and an intermediate vector
in Agrobacterium, said acceptor vector containing at least the three
DNA regions: (a) a DNA region that is capable of conferring replication on
a plasmid in Agrobacterium and Escherichia coli; (b) a
DNA region containing the virB gene and virG gene in virulence
region of Ti plasmid pTiBo542 of Agrobacterium tumefaciens; and
(c) a DNA region that having homology to at least a part of said intermediate
vector sufficient for homologous recombination to occur between said
intermediated vector and said acceptor vector in Agrobacterium;
and said intermediate vector containing at least the three DNA regions:
(d) a DNA region that is capable of conferring replication on a plasmid in
Escherichia coli but not in Agrobacterium; (e) a DNA
region having homology to at least a part of said acceptor vector sufficient for
homologous recombination to occur between said intermediate vector and said
acceptor vector in Agrobacterium; and (f) a DNA region that
constitutes at least a part of said second T-DNA.
|
This granted patent is a divisional of now granted AU 733623
B2.
|
| Remarks |
- National phase entry of
WO
1995/16031 in Canada (CA 2155570) is pending.
- National phase entry of
WO
1995/16031 in Europe (EP 687730) is pending (see next page).
- National phase entry of
WO
1995/16031 in Japan (JP 3102888) has been granted.
|
Note: Patent information on this page was last updated on 2 March 2006.
Patent application filed by Japan Tobacco Inc.
The European application filed by Japan Tobacco discloses
methods for co-transforming plants with two T-DNAs. One of the T-DNAs has a gene
conferring drug-resistance and the other has a gene of interest and is part of a
hybrid plasmid. The hybrid plasmid is constructed by homologous recombination of
an acceptor and an intermediate plasmid.
Specific Patent Information
|
Patent Number
|
Title, Independent Claims and Summary of Claims
|
Assignee
|
EP 687730 A1
- Earliest priority - 8 December 1993
- Filed - 6 December 1994
- Application pending
|
Title - Method of transforming plant and vector therefor
Claim 1
A method for transforming a plant through a bacterium belonging to the genus
Agrobacterium, comprising:
A) co-transforming plant cells with a first T-DNA (1) and a second T-DNA (2);
and B) selecting the cells which acquired drug resistance; said first T-DNA
(1) containing a gene giving said drug resistance, which function in said plant;
said second T-DNA (2) containing a desire DNA fragment to be introduced into
said plant, the second T-DNA (2) being contained in a hybrid vector; said
hybrid vector being prepared by homologous recombination between an acceptor
vector and an intermediate vector in said bacterium belonging to genus
Agrobacterium; said acceptor vector containing at least: (i) a DNA
region having a function to replicate a plasmid in said bacterium belonging to
the genus Agrobacterium and Escherichia coli, (ii) a DNA region containing
vir B gene and vir G gene in virulence region of Ti plasmid pTiBo542 of
Agrobacterium tumefaciens, and (iii) a DNA region which is homologous with
a part of said intermediate vector, which is subjected to homologous
recombination in said bacterium belonging to genus Agrobacterium; said
intermediate vector containing at least: (i) a DNA region having a function
to replicate a plasmid in Escherichia coli, which does not function in said
bacterium belonging to genus Agrobacterium, (ii) a DNA region which is
homologous with a part of said acceptor vector, which is subjected to homologous
recombination in said bacterium belonging to genus Agrobacterium, and
(iii) a DNA region which constitutes at least a part of said second T-DNA.
|
Claim 16
A hybrid vector comprising a first T-DNA containing: 1) a gene giving a drug
resistance, which functions in plant, and
2) a second T-DNA giving a restriction site; said hybrid vector being
prepared by homologous recombination between an acceptor vector and an
intermediate vector in a bacterium belonging to genus Agrobacterium;
said acceptor vector containing at least: (i) a DNA region having a
function to replicate a plasmid in said bacterium belonging to the genus
Agrobacterium and Escherichia coli, (ii) a DNA region containing vir B
gene and vir G gene in virulence region of Ti plasmid pTiBo542 of Agrobacterium
tumefaciens, and (iii) a DNA region which is homologous with a part of said
intermediate vector, which is subjected to homologous recombination in said
bacterium belonging to genus Agrobacterium; said intermediate vector
containing at least: (i) a DNA region having a function to replicate a
plasmid in Escherichia coli, which does not function in said bacterium belonging
to genus Agrobacterium, (ii) a DNA region which is homologous with a part
of said acceptor vector, which is subjected to homologous recombination in said
bacterium belonging to genus Agrobacterium, and (iii) a DNA region which
constitutes at least a part of said second T-DNA.
|
The claims of the application EP 687 730 A1 recite the
transformation of a plant with two different T-DNAs via Agrobacterium.
The first T-DNA contains a gene conferring drug resistance to the plant and the
second one contains a DNA fragment of interest. In the method claim (claim 1),
the second T-DNA is part of a hybrid vector formed by homologous recombination
between an acceptor vector and an intermediate vector.
A hybrid vector (claim 16) harboring the first T-DNA as described and a
second T-DNA with a cloning site is also formed by homologous recombination of
the vectors mentioned above.
Elements of the acceptor vector and the intermediate vector are also recited
in the claims.
|
Japan Tobacco Inc.
|
Note: Patent information on this page was last updated on 2 March 2006.
Mobilisable Vectors
Summary
This section introduces a new type of vector for
Agrobacterium-mediated transformation. Some scientific information and
patenting aspects are discussed.
Background
Conjugation is a bacterial mechanism through which a plasmid genome or a host
chromosome is transferred from one bacterial cell to another. Conjugation
requires a whole complex of sequences and gene products. Some bacterial plasmids
are conjugative plasmids that have the ability of
transfer themselves into another host.
Mobilisable plasmids are not able to
promote their own transfer unless an appropriate conjugation
system is provided by a helper plasmid. Mobilisable vectors contain a site for
transfer initiation called origin of transfer ,
oriT, and have sequences encoding proteins
(Mob) involved in the mobilization of the DNA during the
conjugative process. Mob proteins alone are not sufficient to
achieve the transfer of the genome. Additional proteins for transfer
(Tra ) are involved in the formation of a pore or pilus through
which the genome passes to the recipient bacteria. Mobilisable plasmids do not
encode Tra proteins and for this reason they require a helper
plasmid providing the tra genes. In general, the process involves the
following steps:
- double-stranded plasmid DNA is nicked at a specific site in oriT
- a single-strand DNA is released to the recipient through a pore or pilus
structure
The enzyme that cleaves the double-stranded circular DNA at oriT and
binds to an exposed 5' end is called relaxase, and the
intermediate structure formed is called a relaxosome. A complex
of auxiliary proteins assemble at oriT and assist in the nicking
process to form this intermediate in the DNA transfer.
Agrobacterium T-DNA transfer
The transfer of the Agrobacterium T-DNA to a host cell is comparable
to a conjugation process. The virulence (vir) genes are involved in the
mobilization and transfer of the T-DNA to the host plant cell. The
virD operon contains genes that
encode:
- proteins for DNA cleavage at T-DNA borders: virD1 and
virD2;
- a protein that remains covalently bound to the 5' end of the T-strand and
contains a nuclear localization site: virD2; and
- a coupling protein, which binds to the T-DNA complex (T-strand plus
vir proteins attached to it) and mediates its transfer through the
mating bridge: virD4.
The T-DNA transfer apparatus is encoded by the
virB operon. The proteins of the
virB genes are located in the inner and outer membrane of the bacterium
and are involved in the production of the pilus/pore structure. They also play
an essential role in tumorigenesis.
IP aspects
Leiden University, in The Netherlands, have national phase
entries of a PCT application related to the use of mobilisable
plasmids for genetic transformation of eukaryotic
cells. The invention disclosed by the applicant combines mobilisable
plasmids with Agrobacterium-mediated
transformation. A mobilisable plasmid contains at
least an oriT and some mob
genes, and Agrobacterium
provides the transfer genes, basically a
virB operon.
Unlike the binary and co-integrate vector systems described previously, there
is no Agrobacterium T-DNA or
nucleotide sequences surrounded by T-borders transferred in the
mobilisable vector system. The mobilisable plasmid is engineered into an
Agrobacterium and the genetic material contained in the mobilisable
plasmid is transferred to the eukaryotic host using the transfer machinery of
Agrobacterium. VirD4, the coupling factor, and mobilization functions
can either be part of the mobilisable plasmid or can be provided by
Agrobacterium.
A mobilisable plasmid is defined in the patent as "a plasmid that has the
capability of forming a relaxosome in a suitable surrounding such as
Agrobacterium and being capable of being transferred by an
Agrobacterium vir-like system into eukaryotic cells."
According to the applicant, the advantages of mobilisable plasmids such as
the plasmid CloDF13 include:
- small size;
- easy to manipulate;
- can be maintained at high copy number in enterobacteria (e.g., E.
coli);
- can be transferred using the Agrobacterium virulence system;
- their transfer to fungi and plants is very efficient compared to other
plasmids;
- can be used for nuclear and organelle transformation as well as homologous
and site-specific recombination.
Mobilisable vectors - Patent Application filed by University of Leiden
Specific Patent Information
|
Patent Number
|
Title, Independent Claims and Summary of Claims
|
Assignee
|
|
US
2003/87439 A1
- Earliest priority - 1 March 2000
- Filed - 3 September 2002
- Application pending
|
Title - Transformation of eukaryotic cells by mobilizable
plasmids
Claim 1
A method for transferring genetic material, which is not a typical T-DNA
surrounded by Agrobacterium T-borders from an Agrobacterium
virulence system, to a eukaryotic host cell, said method comprising:
- providing said genetic material on a mobilizable plasmid capable of forming
a relaxosome;
- bringing said mobilizable plasmid into an Agrobacterium having at
least the activity of the transfer genes of Agrobacterium not present
on said mobilizable plasmid so that the necessary gene products providing the
same or similar activity as a functional virB operon are also present;
and
- co-cultivating said Agrobacterium with the eukaryotic host cell.
|
Claim 11
A mobilizable plasmid comprising:
- genetic material to be transferred into a eukaryotic cell by
Agrobacterium transfer;
- a functional oriT;
- sequences encoding functional virD-like mobilization products;
- a virD4-like coupling factor; and
- sequences encoding functional virB-like activity.
|
The independent claims of the present patent application recite:
- a method for transferring material to a eukaryotic cell by:
- using a mobilisable plasmid capable of forming a relaxosome;
- placing the plasmid into Agrobacterium , which provides the same or
similar functions of the virB operon; and
- co-cultivating the Agrobacterium with the eukaryotic host.
- a mobilisable plasmid for Agrobacterium -mediated transfer to an
eukaryotic host comprising:
-
virD-like mobilization products;
-
virD4-like coupling factor; and
If the claims are granted as submitted, the resulting patent would provide
protection for a broad spectrum of plasmids used for transformation via
Agrobacterium. Binary and co-integrated vectors are based on the
Ti-plasmid of Agrobacterium and the DNA transferred is always
surrounded by T-DNA borders, while the plasmids of the present invention are
derived from other bacterial sources, mainly bacteria from the family
Enterobacteriaceae and do not use T-DNA borders for DNA transfer. Notice that
the invention as filed is not limited to plants; all eukaryotic organisms may be
encompassed by the claims in case of being granted as filed.
The structural and functional constraints on vir-like proteins are
not disclosed- e.g., how much sequence difference/functional difference is
tolerated for a protein to still be considered vir-like? The
application merely repeats the claim language in the disclosure. The disclosure
is also vague about the nature of gene products that would have activities
"similar" to that of a functional virB operon though it indicates that
homologues from other species are contemplated.
|
University of Leiden
|
| Remarks |
- Priority application of
WO
2001/64925 from Europe (EP 1130105 A1) is deemed to be withdrawn on 15
January 2003.
- National phase entry of
WO
2001/64925 A1 in Europe (EP 1407031 A1) is pending.
- National phase entry of
WO
2001/64925 A1 in Australia (AU 41271/01) and Canada (CA 2401909) are
pending.
|
Note: Patent information on this page was last updated on 2 March 2006.
Improvements on transformation efficiency
Overview
New update July 2003
As in any technology for plant
transformation, there are multiple factors involved in
Agrobacterium-mediated transformation that influence the success or
failure of the transfer of gene of interest into plants and their subsequent
stable integration and expression. The different factors can affect
transformation differently, depending in part on the plant species.
Aspects of transformation that affect success include:
- Maturity of the plant - as a general rule young plants are easier to
transform than old ones;
- Selected tissue to be transformed;
-
Agrobacterium strain selected for transformation;
- Extent of time and conditions for inoculation of the tissue with
Agrobacterium;
- Growth of Agrobacterium with respect to the transformed plant
cells. If there is overgrowth of Agrobacterium, the chances of
regenerating complete plants from the transformed tissue dwindle;
- Plant tissue necrosis caused by Agrobacterium.
In this section we present patents and patent applications disclosing
improvements related to one or more of the factors mentioned above. The
inventors were motivated by a need to enhance the efficiency of
Agrobacterium-mediated transformation of plants. The selected
inventions refer to:
-
Inhibition of plant necrosis caused by
Agrobacterium. Novartis (now
Syngenta) and the University of Minnesota
each have several granted patents and patent applications filed in the United
States, Europe and Australia that disclose methods for inhibiting
Agrobacterium-induced necrosis. The methods entail heat shock treatment
of the plant tissue, chemical inhibitors, and gene products expressed in the
transformed plants that inhibit necrosis and enzyme inhibitors.
-
Inhibition of Agrobacterium
growth. Overgrowth of Agrobacterium has a negative effect
on the survival rate of the transformed plant cells and increases the number of
copies of T-DNA inserts in the transformed plant. Nunhems Zaden
has granted patents describing the use of auxotrophic Agrobacterium
mutants that allow control of their growth by omission of defined vital
nutrients. Monsanto has a PCT application describing the use of
compounds containing heavy metals and antibiotics to control the growth rate of
Agrobacterium.
-
Reduction of the weight of the
transformed explant. Weight reduction of the explant to be
transformed facilitates DNA transfer and favors embryogenic callus formation.
Monsanto's applications filed in United States and Europe
discuss methods for reducing the weight of the explant during the co-cultivation
period by extracting moisture from the explant.
-
Sonication of the plant
tissue. In this improvement, the target tissue is subjected to
ultrasound before, during, or after immersion in an Agrobacterium
suspension. The Ohio State Research Foundation has a United
States patent and a European patent application on this subject matter.
-
Vacuum infiltration of
Agrobacterium into the plant. Agrobacterium
establishes a more intimate contact with the cells of a plant when subjected to
a vacuum environment. The method is applied in planta, thus avoiding
both in vitro culture and regeneration steps. The Samuel Robert
Noble Foundation and Paradigm Genetics Inc. have
patent applications on the use of vacuum to assist the transformation of any
plant, monocots and some particular crops with Agrobacterium.
In conclusion,
The granted patents and patent
applications discussed in this section are directed to fairly specific methods
applied in Agrobacterium-mediated transformation protocols. With regard
to these patents and any patents yet to issue, freedom to operate will become an
issue only if any one of the particular procedures as claimed is part of a
transformation protocol carried out in the countries where the patents
have been granted. Remember that claims as filed in patent applications
do not have a defined scope and may change considerably as the applications are
prosecuted and become granted patents.
Inhibition of Agrobacterium-induced necrosis
Summary
In plant biology, necrosis means death of a plant tissue; the tissue first
turns brown and subsequently dies. Disrupted plant cells of a tissue at the cut
edge release colorless phenolic compounds that come into contact with each other
and in the presence of oxygen suffer brown discoloration accumulating in brown
spots in the cells. Oxidation extends throughout the tissue and the culture
media, and, if not controlled, the tissue finally dies. Enzyme activity and
polymerization of phenolic compounds are some of the causes of the
oxidation-browning process.
Inoculation of a plant tissue with Agrobacterium is in itself a
disruptive process and triggers a hypersensitive response in the tissue. As a
result, there is a poor survival rate of the target tissue. Therefore, the
design of an adequate artificial environment to minimize damage due to the
interaction of Agrobacterium with the plant tissue is critical for the
success of genetic transformation experiments. Anti-necrotic/anti-browning
treatments, applied during the transformation process, include addition of
reducing agents, heat inactivation of enzymes participating in the oxidative
process, lowering pH and the addition of enzyme inhibitors.
IP aspects
There are two entities with patents directed to reducing browning/necrosis
induced by Agrobacterium:
-
Syngenta (formerly Novartis) has patents in the United
States, Australia and Europe and patent applications in the United States and
Europe on different methods for overcoming the
necrosis induced by Agrobacterium, especially in
Gramineae plants. According to the applicant, Agrobacterium induces in
some plants a necrotic process analogous to apoptosis in animal cells, where
cell death is characterized by DNA fragmentation and defined morphological
changes. The claimed methods for controlling plant cell death include:
- heat shock treatment of the plant tissue;
- addition of chemical inhibitors, such as ethylene inhibitors; and
- expression of foreign gene products in the transformed plants.
- The University of Minnesota has PCT, United States, and
Australian patent applications disclosing the use of agents to inhibit
enzymatic browning of plant tissue during
Agrobacterium-mediated transformation. The agents include:
- sulfhydryl-containing agents (e.g. L-cysteine); and
- iron and copper chelators.
Granted patent and applications filed by Syngenta (formerly Novartis)
According to the applicants the necrosis seen in some plants, i.e. Gramineae,
upon Agrobacterium exposure is a programmed cell death that is
different from the passive death experienced during oxidative browning and
exposure to toxins. It is an active process in which the cells undergo
morphological changes in part as a result of de novo gene expression
and DNA cleavage.
The patents and patent applications disclose the use of physical and
chemical methods for inhibiting Agrobacterium-induced necrosis
(AIN). Heat shock treatment is one of the physical
methods and among the chemical methods;chemical compounds are
used as inhibiting agents of AIN. Nucleotide sequences such as p35 and
iap (see below) stably or transiently expressed in the cell to be
transformed also inhibit AIN. In addition, the applicants teach the use of
Agrobacterium strains that are less
likely to induce necrosis in the transformed tissue.
Specific Patent Information
|
Patent Number
|
Title, Independent Claims and Summary of Claims
|
Assignee
|
|
US
6162965
- Earliest priority - 2 June 1997
- Filed - 2 June 1998
- Granted - 19 December 2000
- Expected expiry - 1 June 2018
|
Title - Plant transformation methods
|
Claim 1
A method for transforming a plant cell or
tissue with a gene construct, comprising heat shocking said plant cell or tissue
before co-cultivating with Agrobacterium, wherein said heat shock
treatment inhibits Agrobacterium induced necrosis in said plant cell or
tissue, and said Agrobacterium comprises a vector comprising said gene
construct.
|
Claim 2
A method for producing a fertile transgenic plant comprising a gene
construct, which method comprises: (a) transforming a plant cell or tissue
comprising heat shocking said plant cell or tissue before co-cultivating with
Agrobacterium, wherein said heat shock treatment inhibits
Agrobacterium induced necrosis in said plant cell or tissue and said
Agrobacterium comprises a vector comprising said gene construct; and
(b) regenerating the transformed plant cell or tissue to produce said fertile
transgenic plant.
|
|
Claim 12
A method for transforming a maize cell or
tissue with a gene construct, comprising heat shocking said maize cell or tissue
before co-cultivating with Agrobacterium, wherein said heat shock
treatment inhibits Agrobacterium induced necrosis in said maize cell or
tissue, and said Agrobacterium comprises a vector comprising said gene
construct.
|
|
Claim 13
A method for producing a fertile transgenic
maize plant comprising a gene construct, which method comprises: (a)
transforming a maize cell or tissue comprising heat shocking said maize cell or
tissue before co-cultivating with Agrobacterium, wherein said heat
shock treatment inhibits Agrobacterium induced necrosis in said maize
cell or tissue, and said Agrobacterium comprises a vector comprising
said gene construct; and (b) regenerating the transformed maize cell or tissue
to produce said fertile transgenic maize plant.
|
Claim 14
A method for transforming a plant cell or tissue with a gene construct,
comprising exposing said plant cell or tissue to Agrobacterium under
conditions which inhibit Agrobacterium induced necrosis, wherein said
conditions comprise delivering to or expressing in said plant cell or tissue a
nucleotide sequence comprising a coding sequence of a p35, iap or dad-1 gene,
said delivery or expression of said nucleotide sequence inhibits
Agrobacterium induced necrosis in said plant cell or tissue, and said
Agrobacterium comprises a vector comprising said gene construct.
|
Claim 15
A method for producing a fertile transgenic plant comprising a gene
construct, which method comprises: (a) transforming a plant cell or tissue
comprising exposing said plant cell or tissue to Agrobacterium under
conditions which inhibit Agrobacterium induced necrosis, wherein said
conditions comprise delivering to or expressing in said plant cell or tissue a
nucleotide sequence comprising a coding sequence of a p35, iap or dad-1 gene,
said delivery or expression of said nucleotide sequence inhibits
Agrobacterium induced necrosis in said plant cell or tissue, and said
Agrobacterium comprises a vector comprising said gene construct; and
(b) regenerating the transformed plant cell or tissue to produce said fertile
transgenic plant.
|
|
Claim 24
A method for transforming a maize cell or
tissue with a gene construct, comprising exposing said maize cell or tissue to
Agrobacterium under conditions which inhibit Agrobacterium
induced necrosis, wherein said conditions comprise delivering to or expressing
in said maize cell or tissue a nucleotide sequence comprising a coding sequence
of a p35, iap or dad-1 gene, said delivery or expression of said nucleotide
sequence inhibits Agrobacterium induced necrosis in said maize cell or
tissue, and said Agrobacterium comprises a vector comprising said gene
construct.
|
|
Claim 25
A method for producing a fertile transgenic
maize plant comprising a gene construct, which method comprises: (a)
transforming a maize cell or tissue comprising exposing said maize cell or
tissue to Agrobacterium under conditions which inhibit
Agrobacterium induced necrosis, wherein said conditions comprise
delivering to or expressing in said maize cell or tissue a nucleotide sequence
comprising a coding sequence of a p35, iap or dad-1 gene, said delivery or
expression of said nucleotide sequence inhibits Agrobacterium induced
necrosis in said maize cell or tissue, and said Agrobacterium
comprises a vector comprising said gene construct; and (b) regenerating the
transformed maize cell or tissue to produce said fertile transgenic maize plant.
|
|
Claim 26
A method for transforming a gramineceous plant
cell or tissue with a gene construct, comprising exposing said plant cell or
tissue to Agrobacterium under conditions which inhibit
Agrobacterium induced necrosis, wherein said conditions comprise
culturing said plant cell or tissue in a necrosis inhibiting medium, said
necrosis inhibiting medium comprises (i) an ethylene inhibitor other than silver
nitrate, or (ii) an ethylene synthesis inhibitor, and said
Agrobacterium comprises a vector comprising said gene construct.
|
|
Claim 27
A method for producing a fertile transgenic
gramineceous plant comprising, a gene construct, which method comprises: (a)
transforming a gramineceous plant cell or tissue comprising exposing said plant
cell or tissue to Agrobacterium under conditions which inhibit
Agrobacterium induced necrosis, wherein said conditions comprise
culturing said plant cell or tissue in a necrosis inhibiting medium, said
necrosis inhibiting medium comprises (i) an ethylene inhibitor other than silver
nitrate, or (ii) an ethylene synthesis inhibitor, and said
Agrobacterium comprises a vector comprising said gene construct; and
(b) regenerating the transformed plant cell or tissue to produce said fertile
transgenic gramineceous plant.
|
|
Claim 33
A method for transforming a maize cell or
tissue with a gene construct, comprising exposing said maize cell or tissue to
Agrobacterium under conditions which inhibit Agrobacterium
induced necrosis, wherein said conditions comprise culturing said maize cell or
tissue in a necrosis inhibiting medium, said necrosis inhibiting medium
comprises (i) an ethylene inhibitor other than silver nitrate, or (ii) an
ethylene synthesis inhibitor, and said Agrobacterium comprises a vector
comprising said gene construct.
|
|
Claim 34
A method for producing a fertile transgenic
maize plant comprising a gene construct, which method comprises: (a)
transforming a maize cell or tissue comprising exposing said maize cell or
tissue to Agrobacterium under conditions which inhibit
Agrobacterium induced necrosis, wherein said conditions comprise
culturing said maize cell or tissue in a necrosis inhibiting medium, said
necrosis inhibiting medium comprises (i) an ethylene inhibitor other than silver
nitrate, or (ii) an ethylene synthesis inhibitor, and said
Agrobacterium comprises a vector comprising said gene construct.; and
(b) regenerating the transformed maize cell or tissue to produce said fertile
transgenic maize plant.
|
Claim 35
A transgenic plant, plant tissue or plant cell comprising a nucleotide
sequence of heterologous origin which comprises a coding sequence of a p35, iap
or dad-1 gag.
|
Claim 36
A transgenic plant, plant tissue or plant cell comprising a genome having a
stably integrated nucleotide sequence of heterologous origin which comprises a
coding sequence of a p35, iap or dad-1 gene.
|
|
Claim 40
A transgenic maize plant, tissue or cell
comprising a genome having a stably integrated nucleotide sequence of
heterologous origin comprising a coding sequence of a p35 gene.
|
|
Claim 41
A transgenic maize plant, tissue or cell
comprising a genome having a stably integrated nucleotide sequence of
heterologous origin which comprises a coding sequence of an iap gene.
|
|
Claim 42
A transgenic maize plant, tissue or cell
comprising a genome having a stably integrated nucleotide sequence of
heterologous origin which comprises a coding sequence of a dad-1 gene.
|
|
Claim 44
A gramineceous plant cell or tissue culture
medium, comprising (a) (i) an ethylene inhibitor other than silver nitrate, or
(ii) an ethylene synthesis inhibitor; and (b) an Agrobacterium
comprising a plasmid comprising a gene construct.
|
United States patent US 6162965 claims several methods to
inhibit AIN in plants:
-
heat shock to treat plant cells or tissues before
co-cultivating with Agrobacterium
- transformation of a plant cell via Agrobacterium with
sequences such as:
-
p35 and iap, which are
apoptosis-inhibiting genes from baculovirus; and
-
dad-1, a gene capable of suppressing disease response in
plants.
The patent also claims methods for inhibiting AIN in
Gramineae in general and in maize in
particular. Besides the methods mentioned above, gramineaceous plants and maize
may be cultured in a necrosis inhibiting medium containing an inhibitor of
ethylene or ethylene biosynthesis.
|
Syngenta
|
|
US
2002/88029 AA
- Earliest priority - 2 June 1997
- Filed - 19 December 2000
- Publication date - 4 Jul 2002
- Expected Expiry - N/A
- Status -Application abandoned 25 July 2005
|
Title - Plant transformation methods
|
Claim 1
A method of transforming a plant cell with a gene of interest, comprising
- exposing said plant cell to Agrobacterium under conditions which
inhibit Agrobacterium induced necrosis (AIN), wherein said
Agrobacterium comprises a vector comprising said gene of interest.
|
Claim 8
A method of making a fertile, transgenic plant comprising
- transforming plant tissue by exposing the tissue to Agrobacterium
under conditions which inhibit Agrobacterium induced necrosis (AIN) and
regenerating tissue thus transformed, wherein said Agrobacterium
comprises a vector comprising a gene of interest.
|
Claim 9
A plant, plant tissue or plant cell comprising a nucleotide sequence of
heterologous origin which inhibits AIN.
|
Claim 10
A plant cell or tissue culture medium, comprising
a) a chemical inhibitor of AIN, b) an Agrobacterium comprising
a plasmid comprising a gene of interest, and c) water and essential salts.
|
|
Claim 11 A method of transforming a totipotent cell of a plant of the
family Gramineae, comprising exposing a population of said totipotent cells to
Agrobacterium comprising a plasmid comprising a gene of interest,
wherein the Agrobacterium is of a strain which does not induce
significant levels of necrosis in said population at an exposure duration and
concentration sufficient to achieve transformation of said cell.
|
|
Claim 12 A method for determining the suitability of an
Agrobacterium strain for use in the transformation of a regenerable
cell of a plant of the family Gramineae comprising exposing a population of said
regenerable cells of the plant to the Agrobacterium strain and
observing the necrosis in said cell population.
|
Claim 13
An Agrobacterium strain which has been genetically modified to
reduce or eliminate expression of the Agrobacterium necrosis factor or
a derivative of such a modified strain.
|
United States application US 2002/88029 is a continuation of
application No. 09/089,111, which is now patent US 6162965
described above. The additional elements in this application include a method to
select an Agrobacterium strain with reduced necrosis-inducing capacity
from a population of regenerable plant cells from the family Gramineae. Further,
the application also claims the Agrobacterium strain with reduced or
eliminated production of the necrosis factor, obtained through the selection
process or through genetic manipulation. Finally, a method is claimed to
transform regenerable cells from the family Gramineae using such strains.
The "Agrobacterium necrosis factor" is disclosed as "the heat labile factor
observed in concentrated supernatant capable of inducing necrosis, e.g.,
programmed cell death, in maize embryos." The application discloses sequences
cloned into three BAC vectors associated with affects on cell death. The
sequences are reported to have homology with virB1,
xylA-xylB and acvB respectively. It's not clear if the
Agrobacterium strain referred to in claim 13 is required to reduce or
eliminate the expression of one or all of these sequences since none of these
sequences are clearly identified as "the" factor. The genetic structure of a
strain having the properties recited in the claims is not disclosed nor is a way
of identifying such a strain disclosed.
|
|
AU
735472 B
- Earliest priority - 2 June 1997
- Filed - 29 May 1998
- Granted - 12 July 2001
- Expected expiry - 28 May 2018
|
Title - Plant transformation methods
|
Claim 1
A method of transforming a plant cell or tissue with a gene of interest,
comprising:
- exposing said plant cell or tissue to Agrobacterium under
conditions which inhibit Agrobacterium-induced necrosis (AIN), wherein
said Agrobacterium comprises a vector comprising said gene of
interest, wherein said conditions which inhibit AIN comprise:
- exposing said plant cell or tissue to Agrobacterium after heat
shock treatment; or
- exposing said plant cell or tissue to Agrobacterium in the presence
of an agent inhibiting AIN, wherein said agent comprises:
- a chemical inhibitor, wherein said chemical inhibitor is a compound selected
from the group consisting of ethylene inhibitors other than silver nitrate,
ethylene synthesis inhibitors, gibberellin antagonists, and phosphatase
inhibitors; or
- a nucleotide sequence encoding mRNA or protein inhibiting AIN.
|
| Claim 18
A method of making a fertile, transgenic plant comprising: A) transforming
plant tissue by exposing the tissue to Agrobacterium under conditions
which inhibit Agrobacterium -induced necrosis (AIN); and B)
regenerating tissue thus transformed, wherein said Agrobacterium
comprises a vector comprising said gene of interest, wherein said
conditions which inhibit AIN comprise:
- exposing said plant cell or tissue to Agrobacterium after heat
shock treatment; or
- exposing said plant cell or tissue to Agrobacterium in the presence
of an agent inhibiting AIN, wherein said agent comprises:
- a chemical inhibitor, wherein said chemical inhibitor is a compound selected
from the group consisting of ethylene inhibitors other than silver nitrate,
ethylene synthesis inhibitors, gibberellin antagonists, and phosphatase
inhibitors; or
- a nucleotide sequence encoding mRNA or protein inhibiting AIN.
|
| Claim 39
A plant, plant tissue or plant cell comprising a nucleotide sequence of
heterologous origin which inhibits AIN.
|
| Claim 50
A plant cell or tissue culture medium, comprising:
- a chemical inhibitor, wherein said chemical inhibitor is a compound selected
from the group consisting of ethylene inhibitors other than silver nitrate,
ethylene synthesis inhibitors, gibberellin antagonists, and phosphatase
inhibitors;
- an Agrobacterium comprising a plasmid comprising a gene of
interest; and
- water and essentials salts.
|
The methods for inhibiting AIN claimed in the granted Australian
patent are similar to the ones claimed in the
United States patent. However, the group of chemical inhibitors
additionally includes gibberellin antagonists and
phosphatase inhibitors. Also, the nucleotide sequences whose
products inhibit AIN are not limited to specific genes, but encode any
mRNA or protein inhibiting AIN. Furthermore, unlike
the United States patent, the Australian patent does
not claim transformation of Gramineae or maize in particular.
|
|
WO
1998/54961 A2
- Earliest priority - 2 June 1997
- Filed - 29 May 1998
- Publication date - 10 December 1998
|
Title - Plant transformation methods
|
Claim 1
A method of transforming a plant cell with a gene of interest, comprising
- exposing said plant cell to Agrobacterium under conditions which
inhibit Agrobacterium induced necrosis (AIN), wherein said
Agrobacterium comprises a vector comprising said gene of interest.
|
Claim 8
A method of making a fertile, transgenic plant comprising
- transforming plant tissue by exposing the tissue to Agrobacterium
under conditions which inhibit Agrobacterium induced necrosis (AIN) and
regenerating tissue thus transformed, wherein said Agrobacterium
comprises a vector comprising a gene of interest.
|
Claim 9
A plant, plant tissue or plant cell comprising a nucleotide sequence of
heterologous origin which inhibits AIN.
|
Claim 10
A plant cell or tissue culture medium, comprising
a) a chemical inhibitor of AIN, b) an Agrobacterium comprising a plasmid
comprising a gene of interest, and c) water and essential salts.
|
|
Claim 11 A method of transforming a totipotent cell of a plant of the
family Gramineae, comprising exposing a population of said totipotent cells to
Agrobacterium comprising a plasmid comprising a gene of interest,
wherein the Agrobacterium is of a strain which does not induce
significant levels of necrosis in said population at an exposure duration and
concentration sufficient to achieve transformation of said cell.
|
|
Claim 12 A method for determining the suitability of an
Agrobacterium strain for use in the transformation of a regenerable
cell of a plant of the family Gramineae comprising exposing a population of said
regenerable cells of the plant to the Agrobacterium strain and
observing the necrosis in said cell population.
|
Claim 13
An Agrobacterium strain which has been genetically modified to
reduce or eliminate expression of the Agrobacterium necrosis factor or
a derivative of such a modified strain.
|
The claims as filed in the PCT application are
broader in scope than the granted claims of both the Australian
and the US patents. For example, one claim broadly recites "conditions which
inhibit AIN" without specifying details of suitable conditions. In another claim
the culture medium for the plant cell or tissue contains a chemical inhibitor
without defining what sort of chemical. A couple of claims of the European
application make reference to the use of an Agrobacterium
strain that does not induce significant levels of
necrosis. The Agrobacterium strain has been modified
to reduce or eliminate expression of a necrosis factor. This strain of
Agrobacterium may be used for transforming a totipotent Gramineae cell.
|
| Remarks |
- National phase entries of WO 1998/54961 in Canada (CA 2290863), Europe (EP
986299) and Japan (JP 2002502252) are pending.
- National phase entry of WO 1998/54961 in China (CN 1150320) has been granted
on 19 May 2004.
- Other national phase entries listed in INPADOC include: Hungary (HU
200002903), Israel (IL 132768), Poland (PL 336979), Russian Federation (RU
2226549), Turkey (TR 200402566), Ukraine (UA 72443), South Africa (ZA 9804681).
|
Note: Patent information on this page was last updated on 3 March 2006.
Inhibition of Agrobacterium-induced necrosis - actual pending claims
Patent application filed by Novartis
Actual pending claims
|
EP 986 299 A2
|
| Claim 1
A method of transforming a plant cell with a gene of interest, comprising
- exposing said plant cell to Agrobacterium under conditions which
inhibit Agrobacterium-induced necrosis (AIN), wherein
said
Agrobacterium comprises a vector comprising said gene of interest.
|
| Claim 8
A method of making a fertile, transgenic plant comprising: A) transforming
plant tissue by exposing the tissue to Agrobacterium under conditions
which inhibit Agrobacterium- induced necrosis (AIN); and B)
regenerating tissue thus transformed, wherein said Agrobacterium
comprises a vector comprising a gene of interest.
|
| Claim 9
A plant, plant tissue or plant cell comprising a nucleotide sequence of
heterologous origin which inhibits AIN.
|
| Claim 10
A plant cell or tissue culture medium, comprising: A) a chemical
inhibitor of AIN; B) an Agrobacterium comprising a plasmid
comprising a gene of interest; and C) water and essential salts.
|
| Claim 11
A method of transforming a totipotent cell of a plant of the family
Gramineae, comprising
- exposing a population of said totipotent cells to Agrobacterium
comprising a plasmid comprising a gene of interest, wherein
the
Agrobacterium is of a strain which does not induce significant levels
of necrosis in said population at an exposure duration and concentration
sufficient to achieve transformation of said cell.
|
| Claim 12
A method for determining the suitability of an Agrobacterium strain
for use in the transformation of a regenerable cell of a plant of the family
Gramineae comprising: A) exposing a population of said regenerable cells of the
plant to the Agrobacterium strain; and B) observing the necrosis
in said cell population.
|
| Claim 13
An Agrobacterium strain which has been genetically modified to
reduce or eliminate expression of the Agrobacterium necrosis factor or
a derivative of such a modified strain.
|
Patent Applications filed by the University of Minnesota
The present applications describe methods for inhibiting enzymatic
browning of plant tissue, cells or parts of a plant in response to
wounding. The disclosure describes agents that inhibit the activity or
production of enzymes associated with browning such as polyphenol oxidase (PPO)
and peroxidase (POD), chelators of metals required for enzymatic activity, and
sulphydryl-containing agents that also inhibit PPO activity.
Specific Patent Information
|
Patent Number
|
Title, Independent Claims and Summary of Claims
|
Assignee
|
|
US
2004/187177 AA
- Earliest priority - 15 December 1999
- Filed - 30 March 2004
- Application pending
|
Title - Method to enhance Agrobacterium -mediated
transformation of plants
|
Claim 1
A method for transforming plant explant tissue,
comprising:
a) contacting a cotyledon explant from a plant seedling infected with an
Agrobacterium containing DNA to be introduced into the explant with an
agent that inhibits enzymatic browning of a wounded plant, plant tissue or plant
cell so as to yield transformed explant tissue; and
b) identifying transformed explant tissue.
|
|
Claim 22
A method to identify an agent that enhances
Agrobacterium-mediated transformation of a plant cell, plant tissue or
plant part, comprising:
a) contacting the plant cell, plant tissue or plant part with
Agrobacterium containing DNA to be introduced into the plant cell,
plant tissue or plant part and the agent so as to yield a transformed plant
cell, plant tissue or plant, wherein the agent is not a phenolic compound; and
b) detecting or determining whether the agent enhances
Agrobacterium-mediated transformation of the plant cell, plant tissue
or plant part relative to Agrobacterium-mediated transformation of a
plant cell, plant tissue or plant part in the absence of the agent.
|
|
Claim 37
A method for the stable transformation of
plant tissue or cells, comprising:
a) contacting plant tissue or cells with an Agrobacterium
containing DNA and an agent selected from the group consisting of a
sulfhydryl-containing agent, an iron chelator, a copper chelator, an inhibitor
of plant polyphenol oxidase and an inhibitor of plant peroxidase; and
b) identifying stably transformed plant tissue or cells.
|
|
Claim 44
A plant medium comprising: an amount of an
agent effective to inhibit the enzymatic browning of a plant organ, tissue or
cell, wherein the agent is selected from the group consisting of a
sulfhydryl-containing agent, an iron chelator, a copper chelator, an inhibitor
of polyphenol oxidase and an inhibitor of peroxidase.
|
|
Claim 57
A method for the stable transformation of
monocot plant tissue or cells, comprising:
a) contacting monocot plant tissue or cells with an Agrobacterium
containing a recombinant DNA and one or more agents selected from the group
consisting of a sulfhydryl-containing agent, methionine, an iron chelator, a
copper chelator, an inhibitor of plant polyphenol oxidase and an inhibitor of
plant peroxidases, which one or more agents are present in solid media in an
amount effective to enhance the stable transformation of the monocot plant
tissue or cells relative to corresponding monocot plant tissue or cells
contacted with Agrobacterium in the absence of the one or more agents;
and
b) identifying stably transformed plant tissue or cells.
|
|
Claim 62
A method for the stable transformation of
plant tissue or cells, comprising:
a) contacting plant tissue or cells with an Agrobacterium
containing a recombinant DNA and one or more agents selected from the group
consisting of a sulfhydryl-containing agent, methionine, an iron chelator, a
copper chelator, an inhibitor of plant polyphenol oxidase and an inhibitor of
plant peroxidases, which one or more agents are present in solid media in an
amount effective to enhance the stable transformation of the tissue or cells
relative to corresponding tissue or cells contacted with Agrobacterium
in the absence of the one or more agents; and
b) identifying stably transformed plant tissue or cells.
|
This application is a continuation of now granted US 6759573
(see below).
The claims are not limited to the transformation any particular plant type.
|
Regents of the University of Minnesota
|
|
US
6759573
- Earliest priority - 15 December 1999
- Filed - 15 December 2000
- Granted - 6 July 2004
- Expected expiry - 15 July 2021 (213 day-extension from 14 December 2020)
|
Title - Method to enhance Agrobacterium -mediated
transformation of plants
Claim 1
A method for stable transformation of leguminous plant tissue or
cells, comprising:
a) contacting leguminous plant tissue or cells with an
Agrobacterium comprising a recombinant DNA and one or more
sulfhydryl-containing agents which one or more agents are present in solid media
in an amount effective to enhance the stable transformation of the leguminous
plant tissue or cells relative to corresponding plant tissue or cells contacted
with the Agrobacterium in the absence of the one or more agents,
wherein the plant tissue or cells are embryogenic somatic cells, immature
embryo, meristem, or a cotyledon explant, and wherein the stable transformation
is enhanced by at least 0.5%; and b) identifying stably transformed plant
tissue or cells.
|
Granted patent US 6759573 recites a method of
Agrobacterium-mediated transformation that is limited to those of leguminous
plant tissue or cells.
The claims require that the sulfhydryl-containing agents are in a solid
media. Thus, if the agents are added in solution such a method might not be
covered by the claim.
The patent was first published as
US
2001/34888 A1.
|
|
WO
2001/44459 A2
- Earliest priority - 15 December 1999
- Filed - 15 December 2000
- Publication date - 21 June 2001
- Expected expiry- N/A
|
Title - Method to enhance Agrobacterium -mediated
transformation of plants
|
Claim 1
A method for transforming plant explant tissue, comprising:
a) contacting a cotyledon explant from a plant seedling infected with an
Agrobacterium containing DNA to be introduced into the explant with an
agent that inhibits enzymatic browning of a wounded plant, plant tissue or plant
cell so as to yield transformed explant tissue; and b) identifying
transformed explant tissue.
|
Claim 22
A method to identify an agent that enhances Agrobacterium-mediated
transformation of a plant cell, plant tissue or plant part, comprising:
a) contacting the plant cell, plant tissue or plant part with
Agrobacterium containing DNA to be introduced into the plant cell,
plant tissue or plant part and the agent so as to yield a transformed plant
cell, plant tissue or plant, wherein the agent is not a phenolic compound; and
b) detecting or determining whether the agent enhances
Agrobacterium-mediated transformation of the plant cell, plant tissue
or plant part relative to Agrobacterium-mediated transformation of a
plant cell, plant tissue or plant part in the absence of the agent.
|
Claim 37
A method for the stable transformation of plant tissue or cells, comprising:
a) contacting plant tissue or cells with an Agrobacterium
containing DNA and an agent selected from the group consisting of a
sulfhydryl-containing agent, an iron chelator, a copper chelator, an inhibitor
of plant polyphenol oxidase and an inhibitor of plant peroxidase; and b)
identifying stably transformed plant tissue or cells.
|
Claim 44
A plant medium comprising: an amount of an agent effective to inhibit the
enzymatic browning of a plant organ, tissue or cell, wherein the agent is
selected from the group consisting of a sulfhydryl-containing agent, an iron
chelator, a copper chelator, an inhibitor of polyphenol oxidase and an inhibitor
of peroxidase.
|
The claims as filed of the PCT application recite:
- a method for inhibiting enzymatic browning in cotyledon explant to be
infected with Agrobacterium by introducing an agent that inhibits
browning
- a method to identify an agent that enhances Agrobacterium-mediated
transformation of a plant cell, tissue or plant part so long as the agent is
not a phenolic compound
- methods where agents that inhibit browning are either put into contact with
the explant to be transformed or present in the plant medium. The agents are
metal chelators, sulphydryl-containing agents or other enzyme inhibitors.
- The degree of enhancement required to fall within the scope of the claims is
unclear (only that it's more transformation than observed without the agent) and
the disclosure provides a number of different assays to judge enhancement by.
|
| Remarks |
- National phase entry of WO 2001/44459 in Australia (AU 200122672) has lapsed
on 15 August 2002.
- National phase entry of WO 2001/44459 in Canada (CA 2394367) and EP (EP
1240341) are pending.
- Other national phase entries of WO 2001/44459 include: Brazil (BR 200016367)
|
Note: Patent information on this page was last updated on 6 March 2006.
Inhibition of enzymatic browning of Agrobacterium-transformed tissue
Patent applications filed by the University of Minnesota
Actual pending claims
| US 20010034888 A1
& WO 0144459 A2
|
| Claim 1
A method for transforming plant explant tissue, comprising:
A) contacting a cotyledon explant from a plant seedling infected with an
Agrobacterium containing DNA to be introduced into the explant with an
agent that inhibits enzymatic browning of a wounded plant, plant tissue or plant
cell so as to yield transformed explant tissue; and B) identifying
transformed explant tissue.
|
| Claim 22
A method to identify an agent that enhances Agrobacterium -mediated
transformation of a plant cell, plant tissue or plant part, comprising:
A) contacting the plant cell, plant tissue or plant part with
Agrobacterium containing DNA to be introduced into the plant cell,
plant tissue or plant part and the agent so as to yield a transformed plant
cell, plant tissue or plant, wherein the agent is not a phenolic compound; and
B) detecting or determining whether the agent enhances
Agrobacterium-mediated transformation of the plant cell, plant tissue
or plant part relative to Agrobacterium-mediated transformation of a
plant cell, plant tissue or plant part in the absence of the agent.
|
| Claim 37
A method for the stable transformation of plant tissue or cells, comprising:
A) contacting plant tissue or cells with an Agrobacterium
containing DNA and an agent selected from the group consisting of a
sulthydryl-containing agent, an iron chelator, a copper chelator, 10 an
inhibitor of plant polyphenol oxidase and an inhibitor of plant peroxidase; and
B) identifying stably transformed plant tissue or cells.
|
| Claim 44
A plant medium comprising: an amount of an agent effective to inhibit
the enzymatic browning of a plant organ, tissue or cell, wherein the agent is
selected from the group consisting of a sulfhydryl-containing agent, an iron
chelator, a copper chelator, an inhibitor of polyphenol oxidase and an inhibitor
of peroxidase.
|
Inhibition of Agrobacterium growth
PCT and US application filed by Monsanto
Overgrowth of Agrobacterium jeopardizes the survival of the
transformed plant cells and also has an effect on the T-DNA transfer process.
Insertion of multiple copies of a gene of interest into a plant cell is
influenced by the frequency of T-DNA transfer into the cell.
Agrobacterium-mediated transformation protocols strive to attain
transformation events with a limited number of copies of DNA entering into any
one cell. The presence of multiple inserts can lead to gene silencing or reduce
expression levels of transformed genes, which is caused by several mechanisms
including recombination between the multiple copies. Inhibiting agents of
Agrobacterium growth should be effective against the bacterium but
remain neutral with respect to plant cell growth.
Monsanto's applications relate to the control of
Agrobacterium growth during the transformation process in
order to improve transformation efficiency. The use of inhibiting agents during
inoculation and co-culture of Agrobacterium with a transformable plant
cell results, according to the disclosure, in increased transformation
efficiencies and a low copy number of an introduced genetic component in several
plant systems. Preferred growth-inhibiting agents are compounds containing heavy
metals such as silver nitrate or silver thiosulfate, antibiotics such as
carbenicillin, and a combination of antibiotics and a clavulanic acid such as
augmentin or timentin.
PCT Application Information
|
Patent Number
|
Title, Independent Claims and Summary of Claims
|
Assignee
|
|
WO
2001/09302
- Earliest priority - 29 July 1999
- Filed - 28 July 2000
- OPI - 8 February 2001
- Expected Expiry - N/A
|
Title - A novel Agrobacterium-mediated plant transformation
method
|
Claim 1
A method of transforming a plant cell or plant tissue using an
Agrobacterium mediated process comprising the steps of: A)
inoculating a transformable plant cell or tissue with Agrobacterium
containing at least one genetic component capable of being transferred to the
plant cell or tissue in the presence of at least one growth inhibiting agent;
B) co-culturing the transformable plant cell or tissue after inoculation
in a media capable of supporting growth of plant cells or tissue expressing the
genetic component, said media not containing a growth inhibiting agent; C)
selecting transformed plant cells or tissue; and D) regenerating a
transformed plant expressing the genetic component from the selected transformed
plant cells or tissue.
|
| Claim 23
A method of transforming a plant cell or plant tissue using an
Agrobacterium mediated process comprising the steps of: A) inoculating
a transformable plant cell or tissue with Agrobacterium containing at
least one genetic component capable of being transferred to the plant cell or
tissue; B) co-culturing the transformable plant cell or tissue after
inoculation in a media capable of supporting growth of plant cells or tissue
expressing the genetic component, said media further containing a growth
inhibiting agent; C) selecting transformed plant cells or tissue;
and D) regenerating a transformed plant expressing the genetic component
from the selected transformed cells or tissue.
|
| Claim 45
A method of transforming a plant cell or plant tissue using an
Agrobacterium mediated process comprising the steps of: A)
inoculating a transformable plant cell or tissue with Agrobacterium
containing at least one genetic component capable of being transferred to the
plant cell or tissue in the presence of at least one growth inhibiting agent;
B) co-culturing the transformable plant cell or tissue after inoculation
in a media capable of supporting growth of the plant cells or tissue expressing
the genetic component, said media further containing a growth inhibiting agent;
C) selecting transformed plant cells or tissue; and D) regenerating a
transformed plant expressing the genetic component from the selected transformed
cells or tissue.
|
The claims as filed of the PCT application recite:
- methods of transforming plant cells or tissues with Agrobacterium
, where the growth of Agrobacterium cells is inhibited during:
- the inoculation phase, where Agrobacterium and plant cells are
first brought into contact with each other;
- the co-cultivation phase, where Agrobacterium and plant cells are
grown together for for an unspecified period; or
- both the inoculation and co-cultivation phases.
|
Monsanto
|
|
US
2003204875 AA
- Earliest priority - 29 July 1999
- Filed - 17 April 2003
- Published -30 Oct 2003
- Status -pending
|
Title - Novel Agrobacterium-mediated plant transformation
method
|
Claim 1
A method of transforming a plant cell or plant tissue using an
Agrobacterium mediated process comprising the steps of:
- inoculating a transformable plant cell or tissue with Agrobacterium
containing at least one genetic component capable of being transferred to the
plant cell or tissue in the presence of at least one growth inhibiting agent;
- co-culturing the transformable plant cell or tissue after inoculation in a
media capable of supporting growth of plant cells or tissue expressing the
genetic component, said media not containing a growth inhibiting agent;
- selecting transformed plant cells or tissue; and
- regenerating a transformed plant expressing the genetic component from the
selected transformed plant cells or tissue.
|
Claim 23
A method of transforming a plant cell or plant tissue using an
Agrobacterium mediated process comprising the steps of:
- inoculating a transformable plant cell or tissue with Agrobacterium
containing at least one genetic component capable of being transferred to the
plant cell or tissue;
- co-culturing the transformable plant cell or tissue after inoculation in a
media capable of supporting growth of plant cells or tissue expressing the
genetic component, said media further containing a growth inhibiting agent;
- selecting transformed plant cells or tissue; and
- regenerating a transformed plant expressing the genetic component from the
selected transformed cells or tissue.
|
Claim 45
A method of transforming a plant cell or plant tissue using an
Agrobacterium mediated process comprising the steps of:
- inoculating a transformable plant cell or tissue with Agrobacterium
containing at least one genetic component capable of being transferred to the
plant cell or tissue in the presence of at least one growth inhibiting agent;
- co-culturing the transformable plant cell or tissue after inoculation in a
media capable of supporting growth of the plant cells or tissue expressing the
genetic component, said media further containing a growth inhibiting agent;
- selecting transformed plant cells or tissue; and
- regenerating a transformed plant expressing the genetic component from the
selected transformed cells or tissue.
|
This application is a division of
US
6603061, which is the priority document of
WO
2001/09302. Claims of granted US 6603061 recite a method of
Agrobacterium-mediated transformation that is limited to that transforming
a corn plant (claim 1) or a dicotyledonous plant (claim 4).
|
| Remarks |
- National phase entry of
WO
2001/09302 in Australia (AU 200063892) has lapsed on 3 April 2003.
- National phase entry of
WO
2001/09302 in Canada (CA 2381254) is deemed dead on 28 July 2004.
- National phase entry of
WO
2001/09302 in Europe (EP 1200613) and Japan (JP 2003506035) are
pending.
- Other national phase entry of
WO
2001/09302 includes: Brazil (BR 200013187).
|
Note: Patent information on this page was last updated on 6 March 2006.
Patent granted to Nunhems Zaden BV
The present United States patent granted to Nunhems Zaden
from Holland discloses a process to obtain transgenic plants by using
Agrobacterium mutants deficient in the biosynthesis of specified vital
biomolecules. This allows a controlled systemic infection of the tissues to be
transformed to be maintained for longer periods, thereby increasing the
probability of successful infection. The Agrobacterium can then be
eliminated by omission of those nutrients from the incubation medium.
Specific Patent Information
|
Patent Number
|
Title, Independent Claims and Summary of Claims
|
Assignee
|
|
US
6323396 B1
- Earliest priority - 25 August 1997
- Filed - 24 February 2000
- Granted - 27 November 2001
- Expected expiry - 23 February 2020
|
Title - Agrobacterium-mediated transformation of
plants
Claim 1
A process to produce a dicotyledonous transgenic plant, said plant comprising
- a foreign DNA fragment integrated into the genome of at least some of its
cells, said process comprising the following steps:
1) providing a plant which is systemically infected with an
Agrobacterium strain auxotrophic for methionine or cysteine, or adenine
and histidine, harboring a DNA of interest which is operably linked to at least
one T-DNA border sequence; and 2) generating a transgenic plant from a
single cell or a group of cells isolated from said systemically infected plant.
|
Claim 11
Bacterial strain LBA4404metHV, deposited as LMG P-18486.
|
Claim 12
Bacterial strain ATHV ade,his, deposited as LMG P-18485.
|
Claim 13
A method for producing a transgenic plant, said plant comprising
- a foreign DNA fragment integrated into the genome of at least some of its
cells, said process comprising:
a. cocultivating a plant cell, plant tissue, explant or plant with an
Agrobacterium strain auxotrophic for methionine or cysteine, or for
adenine and histidine, to generate a transgenic cell; and b. regenerating a
transgenic plant from said transgenic cell.
|
The United States patent
US
6323396 B1 claims
- A process for the production of transgenic plants (Claims 1 and 13)
utilizing an Agrobacterium strain deficient in the biosynthesis of one
of the following:
- methionine
- cysteine
- adenosine and histidine
- Co-cultivating a plant or plant tissue with one of the auxotrophic
Agrobacterium mutants described above carrying a desired foreign DNA
and regenerating a transgenic plant from such a treated tissue (Claim 13).
- Systemically infecting a plant with one of the auxotrophic
Agrobacterium mutants described above carrying a desired foreign DNA
and regenerating a transgenic plant from such a treated tissue (Claim 1).
- Two auxotrophic Agrobacterium strains as described (Claims 11 and
12).
|
Nunhems Zadens B.V.
|
|
AU
736349 B2
- Earliest priority - 25 August 1997
- Filed - 25 August 1998
- Granted - 26 July 2001
- Expected expiry - 24 August 2018
|
Title - Improved Agrobacterium-mediated
transformation of plants
Claim 1
A process to produce a transgenic plant comprising
- a foreign DNA fragment integrated into the genome of at least some of its
cells, said process comprising the following steps:
1) providing a plant which is systemically infected with an auxotrophic
Agrobacterium strains harbouring a DNA of interest which is operably
linked to at least one T-DNA border sequence; and 2) generating a
transgenic plant from a single cell or a group of cells isolated from said
systemically infected plant.
|
Claim 12
Bacterial strain LBA4404met.
|
Claim 13
Bacterial strain ATHVade, his.
|
Claim 14
The use of an Agrobacterium strain auxotrophic for methionine or
cysteine or for adenine and histidine in Agrobacterium-mediated
transformation of plants.
|
|
Claim 15 The use of Agrobacterium strain auxotrophic for
methionine or cysteine or for adenine and histidine in Agrobacterium
mediated transformation of callus from sugarbeet.
|
|
Claim 16 The use of Agrobacterium strain auxotrophic for
methionine or cysteine or for adenine and histidine in Agrobacterium
mediated transformation of corn protoplasts.
|
Claim 1 in granted AU 736349 does not have a limit to the
type of nutrient (or nutrients) the Agrobacterium strain is auxotrophic
for.
"Systemically infected plant" is defined in the specification as 'a plant
wherein the Agrobacterium strains is present in at least some part of the
plant'.
|
|
EP
1009844 B1
- Earliest priority - 25 August 1997
- Filed - 25 August 1998
- Granted - 16 June 2004
- Expected expiry - 24 August 2018
|
Title - Improved Agrobacterium-mediated
transformation of plants
Claim 1
A process to produce a transgenic plant comprising
- a foreign DNA fragment integrated into the genome of at least some of its
cells, said process comprising the following steps:
1) providing a plant which is systemically infected with an auxotrophic
Agrobacterium strain harbouring a DNA of interest which is operably
linked to at least one T-DNA border sequence; and 2) generating a
transgenic plant from a single cell or a group of cells isolated from said
systemically infected plant.
|
Claim 12
Bacterial strain LBA4404metHV, deposited as BCCM/LMG P-18486.
|
Claim 13
Bacterial strain ATHV ade,his, deposited as BCCM/LMG
P-18485.
|
Claim 14
The use of an Agrobacterium strain auxotrophic for methionine or
cysteine, or for adenine and histidine, in Agrobacterium-mediated
transformation of plants.
|
|
Claim 15 The use of an Agrobacterium strain auxotrophic for
methionine or cysteine, or for adenine and histidine, in Agrobacterium
mediated transformation of callus from sugarbeet.
|
|
Claim 16 The use of an Agrobacterium strain auxotrophic for
methionine or cysteine, or for adenine and histidine, in Agrobacterium
mediated transformation of corn protoplasts.
|
Designated contracting States at the time of grant are: Austria (patent
lapsed as reported by INPADOC), Belgium (patent lapsed as reported by EPO),
Switzerland (patent lapsed as reported by INPADOC), Cyprus, Germany (patent
lapsed as reported by EPO), Denmark (patent lapsed as reported by EPO), Spain
(patent lapsed as reported by EPO), Finland (patent lapsed as reported by EPO),
France (patent lapsed as reported by EPO), United Kingdom (patent lapsed as
reported by INPADOC), Greece (patent lapsed as reported by EPO), Ireland (patent
lapsed as reported by INPADOC), Italy, Liechtenstein (patent lapsed as reported
by INPADOC), Luxembourg, Monaco (patent lapsed as reported by EPO), Netherlands
(patent lapsed as reported by INPADOC), Portugal, Sweden (patent lapsed as
reported by INPADOC)
Granted EP 1009844 recites the same method of
Agrobacterium-mediated transformation as that of AU
736349.
|
|
WO
1999/010512 A1
- Earliest priority - 25 August 1997
- Filed - 25 August 1998
- OPI - 4 March 1999
- Predicted expiry - N/A
|
Title - Improved Agrobacterium-mediated
transformation of plants
|
Claim 1
A process to produce a transgenic piant comprising a foreign DNA fragment
integrated into the genome of at least some of its cells, said process
comprising the following steps: 1) providing a plant which is systemically
infected with an auxotrophic Agrobacterium strain harbouring a DNA of
interest which is operably linked to at least one T-DNA border sequence;
and 2) generating a transgenic plant from a single cell or a group of cells
isolated from said systemically infected plant.
|
|
Claim 12
Bacterial strain LBA44O4met.
|
|
Claim 13
Bacterial strain ATHVade, his.
|
|
Claim 14
The use of an Agrobacterium strain auxotrophic for methionine or
cysteine or for adenine and histidine in Agrobacterium-mediated
transformation of plants.
|
|
Claim 15 The use of Agrobacterium strain auxotrophic for
methionine or cysteine or for adenine and histidine in Agrobacterium
mediated transformation of calius from sugarbeet.
|
|
Claim 16 The use of Agrobacterium strain auxotrophic for
methionine or cysteine or for adenine and histidine in Agrobacterium
mediated transformation of corn protoplasts.
|
|
| Remarks |
- National phase entry of
WO
1999/010512 A1 in Canada (CA 2301707) is pending.
- National phase entry of
WO
1999/010512 A1 in China (CN 1188525) has been granted on 9 February
2005.
- National phase entry of
WO
1999/010512 A1 in Japan (JP 2001514009) is deemed to be withdrawn
on 1 November 2005.
|
Note: Patent information on this page was last updated on 7 March 2006.
Weight reduction of the transformed plant tissue
Patent applications filed by Monsanto
During co-cultivation of plant tissue with Agrobacterium it is
desirable to reduce the weight of the explant in order to facilitate the DNA
transfer process and the formation of embryogenic callus.
Monsanto's disclosure teaches methods for
reducing the weight of the explant during the
co-cultivation period. Preferred methods of the inventors include
reduction of moisture conditions, applying vacuum, increasing the osmotic
potential of the media by use of mannitol, sorbitol or polyethylene glycol, air
drying the explant by evaporation or applied air, or applying chemicals
(desiccants) such as calcium oxide to extract moisture from the explant.
Specific Patent Information
|
Patent Number
|
Title, Independent Claims and Summary of Claims
|
Assignee
|
|
US
2001/054186 AA
- Earliest priority - 11 December 1998
- Filed - 10 December 1999
- Published - 20 December 2001
- Expected expiry - N/A
- Status -pending
WO
200034491 A2
- Earliest priority - 11 December 1998
- Filed - 9 December 1999
- OPI - 15 June 2000
- Expected expiry - N/A
|
Title - An improved efficiency
Agrobacterium-mediated plant transformation method
Claim 1
A method for producing a fertile transgenic plant, comprising the steps of:
(a) introducing one or more genetic component(s) one desires to introduce
into the genome of a plant by co-culturing a regenerable plant cell or tissue
with Agrobacterium containing said genetic component(s); (b)
co-culturing said Agrobacterium and regenerable plant cells or tissues
of step (a) under conditions that decrease the weight of said
Arobacterium-inoculated explant; (c) identifying or selecting a
transformed cell line; and (d) regenerating a fertile transgenic plant
therefrom.
|
The claims as filed of both the United States and PCT applications recite a
method for producing a fertile transgenic plant by co-culturing a plant cell or
tissue with Agrobacterium having the genes of interest under conditions
that decrease the weight of the explant. The transformed cell lines are selected
and regenerated into a fertile transgenic plant.
According to the specification, the method to reduce the weight of the
inoculated explant 'comprises any method that reduces the weight of the
inoculated explant and facilitates the DNA transfer process.'
Preferred methods to reduce the weight of the explant are
(but not limited to):
-
restricting exogenous moisture to the explant during co-culture
-
reducing the weight of the explant by applying a vacuum during
co-culture
-
increasing the osmotic potential of the media, for example, by use of
mannitol, sorbitol, raffinose, or polyethylene glycol or combinations
thereof
-
air drying the explant to reduce the weight of the explant by
evaporation or applied air
-
chemical means of extracting moisture from the explant during
co-culture, for example, by placing the explant in a dessicating
environment
|
Monsanto
|
|
AU
773764
- Earliest priority - 11 December 1998
- Filed - 9 December 1999
- Granted - 3 June 2004
- Expected expiry - 8 December 2019
|
Title - An improved efficiency
Agrobacterium-mediated plant transformation method
|
Claim 1
A method for producing a fertile transgenic plant, comprising the steps of:
(a) introducing one or more genetic component(s) into the genome of a plant
by co-culturing a regenerable plant cell or tissue with Agrobacterium
containing said genetic component(s); (b) co-culturing said
Agrobacterium and regenerable plant cells or tissues of step (a) in a
manner controlling a reduction in the weight of said
Agrobacterium-inoculated explant of from about 20% to 35% of the weight
of the plant cell or tissue prior to co-culture, wherein the manner for
controlling a reduction in the weight of the Agrobacterium-inoculted
explant comprises limitation or removal of water from the explant;
(c) identifying or selecting a transformed cell line; and (d)
regenerating a fertile transgenic plant therefrom.
|
Granted AU 773764 recites a method for producing a fertile
transgenic plant using Agrobacterium, where the method of weight
reduction of the inoculated explant is limited to 'limitation or removal of
water from the explant'.
|
| Remarks |
- National phase entries of
WO
2000/34491 in Canada (CA 2353796), Europe (EP 1137790) and Japan (JP
2002531132) are pending.
- Other national phase entries of
WO
2000/34491 include: Brazil (BR 9916103), South Africa (ZA 200104091).
|
Note: Patent information on this page was last updated on 7 March 2006.
Sonication of plant tissue
Granted patent and patent application filed by The Ohio State Research
Foundation
The inventors describe a method called sonication-assisted
Agrobacterium-mediated transformation. It consists of subjecting the
target tissue to ultrasound while immersed in an Agrobacterium
suspension. The enhanced transformation rates probably result from
micro-wounding both on the surface of and deep within the target tissue caused
by the energy released in the process. High intensity ultrasound results in cell
lysis, but sublethal doses cause temporary suppression of mRNA and protein
synthesis as well as moderate rupture of the cell wall. The wounding caused by
lower energy ultrasonic frequency may aid in the production of signal phenolics
and enhance the accessibility of putative cell-wall binding factors to the
bacterium.
The disclosure describes a method for transforming a plant sample with
Agrobacterium by sonicating the plant in the presence of
Agrobacterium. Preferably, the process does not take longer than 60
seconds and not less than 0.1 seconds.
Specific Patent Information
|
Patent Number
|
Title, Independent Claims and Summary of Claims
|
Assignee
|
|
US
5693512 A
- Earliest priority - 1 March 1996
- Filed - 1 March 1996
- Granted - 2 December 1997
- Expected expiry - 28 February 2016
|
Title - Mehod for transforming plant tissue by sonication
Claim 1
A method for transforming a plant sample comprising the following steps:
a. providing a non-tumor inducing vector containing nucleic acid to be
transferred to the plant sample, wherein the vector is a non-tumor inducing
Agrobacterium; b. combining the plant sample with said
vector; c. sonicating the plant sample; wherein the vector is combined with
the plant sample before, during, or after sonication; d. lastly growing the
plant sample and selecting for the transformed plant sample.
|
The United States patent claims
- a method for transforming a plant where the plant sample is combined with a
non-oncogenic Agrobacterium and sonicated. The sonication is applied
before, during or after the plant sample is combined with
Agrobacterium.
|
The Ohio State Research Foundation
|
|
EP
904362 B1
- Earliest priority - 1 March 1996
- Filed - 28 February 1997
- Granted - 21 January 2004
- Expected expiry - 27 February 2017
|
Title - Method for transforming plant tissue
Claim 1
A method for transforming a plant sample comprising the following steps:
a. providing a non-tumor inducing vector containing nucleic acid to be
transferred to the plant sample, wherein the vector is a non-tumor inducing
Agrobacterium; b. combining the plant sample with said
vector; c. sonicating the plant sample, wherein the vector is combined with
the plant sample before, during or after sonication; d. lastly growing the
plant sample.
|
Designated contracting States at the time of grant are: Belgium, Switzerland
(patent lapsed as reported by INPADOC), France, United Kingdom, Italy,
Liechtenstein (patent lapsed as reported by EPO), Netherlands, Portugal, Sweden
(patent lapsed as reported by INPADOC)
The difference in claim 1 between EP 904362 and US
5693512 is the last step, where US 5693512 includes
selecting for the transformed plant sample, which is not included in that of
WO 904362.
|
|
WO
1997/32016 A1
- Earliest priority - 1 March 1996
- Filed - 28 February 1997
- OPI - 4 September 1997
|
Title - Method for transforming plant tissue
Claim 1
A method for transforming a plant sample
comprising the following steps:
a. providing a non-tumor inducing vector containing nucleic
acid to be transferred to the plant sample; b. combining the plant sample
with said vector; c. sonicating the plant sample; d. lastly growing
the plant sample.
|
PCT application WO 1997/32016 recites a method of
transforming a plant sample which includes sonicating the plant
sample (which, according to the specification 'includes whole
plants as well as all the parts and portions thereof...').
According to the specification, the term 'vector' in claim 1 'is a
non-tumor inducing bacteria or strain of bacteria...'.
Sonication of the plant sample can take place before, during, or after
introducing the vector to the plant sample as follows - 'The vector is
combined with the plant sample before, during or after sonication...'
|
Note: Patent information on this page was last updated on 8 March 2006.
Agrobacterium-mediated transformation assisted by vacuum infiltration
Summary
Vacuum infiltration had already been used by plant physiologists before
researchers interested in improving transformation efficiency started using it.
Plant physiologists use the method to allow the penetration of pathogenic
bacteria into the inter cell spaces and in that way study the interaction
between plants and pathogenic bacteria.
Physically, vacuum generates a negative atmospheric pressure that causes the
air spaces between the cells in the plant tissue to decrease. The longer the
duration and the lower the pressure of the vacuum, the less air space there is
within the plant tissue. An increase in the pressure allows the infiltration
medium, including the infective transformation vector, to relocate into the
plant tissue. For plant transformation, vacuum is applied to a plant part in the
presence of Agrobacterium for a certain time period. The length of time
that a plant part or tissue is exposed to vacuum is critical as prolonged
exposure causes hyperhydricity.
Vacuum infiltration-facilitated transformation can be performed in
planta, in which the plant part to be transformed, e.g., flower, is not
excised from the plant, thus eliminating the need for in vitro
regeneration of plants. It also offers several other advantages such as the
generation of many independently transformed plants from a single plant, a
reduction in somaclonal variation because there are no tissue culture steps, and
the possibility of high throughput testing because the process is fast. The
method is also potentially useful for transformation of plants recalcitrant to
plant tissue culture and regeneration.
The use of Agrobacterium-mediated transformation assisted by vacuum
infiltration was first reported in 1993 for transforming Arabidopsis
and since then many improvements have been made. Others plants such as soybeans,
duckweed, wheat, petunia, and rice have also been transformed by this method.
IP aspects
Several organizations have patents and patent applications directed to
Agrobacterium-mediated transformation assisted by vacuum infiltration.
The selected disclosures describe either transformation of any
plant or transformation of monocotyledonous plants.
They also discriminate between any plant part or a
selected plant part or tissue, e.g., flower.
Transformation of any plant
- The Samuel Roberts Foundation Noble Foundation has patent
applications filed in Australia and Europe on methods for direct plant
transformation of any plant with Agrobacterium using vacuum
infiltration. Some limitations of the filed claims lie in the plant part or
plant phase to be transformed: seedlings and plants in
flowering stage. The methods generally entail suspending
Agrobacterium cells containing a vector with a gene of interest in
vacuum infiltration medium, and the plant portions to be transformed are
immersed in the suspension and subjected to vacuum infiltration. Infiltrated
plants subsequently produce transformed seeds from which transformed plants are
obtained. More information about these
applications.
Transformation of monocot plants
-
Paradigm Genetics has a PCT application disclosing the use
of vacuum infiltration to transform monocots
with Agrobacterium. In addition, the disclosure describes the
transformation of rice by applying a vacuum to a rice
panicle immersed in an Agrobacterium suspension. This
disclosure is discussed in detail under the section
Monocots - General transformation
methods. The claims as filed are limited to the use of a monocot
flower as tissue to be transformed with Agrobacterium and subjected to
vacuum. The apparatus to perform the vacuum infiltration is
also part of the filed claims.
Patent applications filed by The Samuel Roberts Noble Foundation
The applications describe methods for direct plant transformation via
Agrobacterium using vacuum. In one of the disclosures,
Agrobacterium containing a vector with a gene of interest contacts the
aerial portions of a plant at flowering stage under vacuum
conditions. The vacuum applied is of sufficient strength to force the
Agrobacterium cells into intimate contact with the plant such that the
T-DNA transfer to the plant takes place.
A plant at flowering stage is defined as a plant form about the beginning of
the first flower bud formation to about the time of the last flower set. The
flowering plants are grown from vernalised seeds. These are seeds subjected to a
period of chilling before germination. The seeds are incubated at 4°C for a
period of time, preferably in the dark, and kept moist. Vernalisation is used to
speed up the formation of flowers.
In the other disclosure, the material selected for transformation is a
seedling.
As part of both disclosures, the plant material is transformed with a mix of
Agrobacterium cells containing different T-DNA to be inserted into the
plants. The transformed plant is allowed to grow into maturity and produce
seeds. Progeny from the seed is selected by the use of selectable markers and
the presence of an additional transferred gene.
Specific PCT Application Information
|
PCT Application Number
|
Title, Independent Claims and Summary of Claims
|
Assignee
|
|
WO
2000/037663 A2
- Earliest priority - 23 December 1998
- Filed - 23 December 1999
- OPI - 29 June 2000
- Expected expiry - N/A
|
Title - Plant transformation process
Claim 1
A method for direct plant transformation using seedlings and
Agrobacterium comprising:
A) contacting at least one seedling with Agrobacterium cells, said
Agrobacterium cells harboring a vector, said vector enabling said
Agrobacterium cells to transfer T-DNA containing at least one gene or
gene fragment to said seedling; B) applying a vacuum to said seedling in
contact with said Agrobacterium cells at a first time, said vacuum of
sufficient strength to force said Agrobacterium cells into intimate
contact with said seedling such that said Agrobacterium cells transfer
said T-DNA to cells of said seedling at a second time, wherein said first and
second time are the same or different.
|
| Claim 9
A method for direct plant transformation using seedlings and
Agrobacterium comprising:
A) contacting at least one seedling with a mixture of Agrobacterium
cells, said mixture comprising cells from a Agrobacterium strain
harboring a vector with a DNA fragment and cells from said
Agrobacterium strain harboring said vector a second DNA fragment, said
vector enabling said Agrobacterium cells to transfer said T-DNA to said
seedling; B) applying a vacuum to said seedling in contact with said
Agrobacterium cells at a first time, said vacuum of sufficient strength
to force said Agrobacterium cells into intimate contact with said
seedling such that said Agrobacterium cells transfer T-DNA to cells of
said seedling at a second time, wherein said first and second time are the same
or different.
|
| Claim 18
A method for direct plant transformation using seedlings and
Agrobacterium comprising:
A) contacting at least one seedling with Agrobacterium cells, said
Agrobacterium cells harboring a vector, said vector enabling said
Agrobacterium cells to transfer T-DNA containing at least one gene or
gene fragment and a selectable marker gene to said seedling; B) applying a
vacuum to said seedling in contact with said Agrobacterium cells at a
first time, said vacuum of sufficient strength to force said
Agrobacterium cells into intimate contact with said seedling such that
said Agrobacterium cells transfer said T-DNA to cells of said seedling
at a second time, wherein said first and second time are the same or
different; C) allowing said transformed seedling to grow to maturity and
set seed; D) germinating said seed to form progeny; E) exposing said
progeny to an agent enabling detection of selectable marker gene
expression; F) selecting for progeny expressing said selectable marker gene
and at least one gene, said expression of said selectable marker gene and at
least one gene indicating gene transfer.
|
The claims as filed of the PCT application WO 2000/037663
recite:
- a method for direct transformation of seedlings with Agrobacterium
by placing the plant material with Agrobacterium having a vector with a
gene of interest or a gene fragment in its T-DNA and applying vacuum to them so
Agrobacterium enters into contact with the seedling and transfers the
T-DNA to the plant cells;
- a method as the one described above but the material is in contact with a
mixture of Agrobacterium cells harboring different DNA fragments
(aren't necessarily gene or gene fragments) in their T-DNAs; and
- a method as the one first mentioned where after the transformation plants
set seed and the progeny from these seeds is selected for the presence of a gene
of interest and a selectable marker.
Status of National phase entries listed on INPADOC:
- Australia (AU25943/00 A) - application lapsed on 28 July
2005
- Canada (CA2352488 A1) - dead application on 23 December
2004 (i.e., the application cannot be reinstated).
- Europe (EP1141356 A2) - application deemed to be withdrawn
on 2 February 2005
- Japan (JP2002533090 T) - application pending
|
The Samuel Roberts Noble Foundation
|
|
WO
2000/063400 A2
- Earliest priority - 21 April 1999
- Filed - 20 April 2000
- OPI - 26 October 2000
- Expected expiry - N/A
|
Title - Plant transformation process
| Claim 1
A method for direct plant transformation using plants and
Agrobacterium comprising:
A) contacting the aerial portions of at least one plant at the time of
flowering with Agrobacterium cells, said Agrobacterium cells
harboring a vector, said vector enabling said Agrobacterium cells to
transfer T-DNA containing at least one gene or gene fragment to said plant; and
B) applying a vacuum to said plant portions in contact with said
Agrobacterium cells at a first time, said vacuum of sufficient strength
to force said Agrobacterium cells into intimate contact with said plant
such that said Agrobacterium cells transfer said T-DNA to cells of said
plant at a second time to form a transformed plant, wherein said first time and
said second time are the same or different.
|
| Claim 9
A method for direct transformation of a plant comprising:
A) vernalizing and germinating initial seed to form said plant contacting the
aerial portions of said plant at the time of flowering with
Agrobacterium cells, said Agrobacterium cells harboring a
vector, said vector enabling said Agrobacterium cells to transfer T-DNA
containing at least one gene or gene fragment to said plant; and B)
applying a vacuum to said plant portions in contact with said
Agrobacterium cells at a first time, said vacuum of sufficient strength
to force said Agrobacterium cells into intimate contact with said plant
such that said Agrobacterium cells transfer said T-DNA to cells of said
plant at a second time to form a transformed plant, wherein said first time and
said second time are the same or different.
|
| Claim 17
A method for direct plant transformation using plants at the time of
flowering and Agrobacterium comprising: A) contacting aerial
portions of at least one plant at the time of flowering with a mixture of
Agrobacterium cells, said mixture comprising cells from a
Agrobacterium strain harboring a vector with a DNA fragment and cells
from said Agrobacterium strain harboring said vector with a second DNA
fragment, said vector enabling said Agrobacterium cells to transfer
said T-DNA to said plant; and B) applying a vacuum to said plant portions
in contact with said Agrobacterium cells at a first time, said vacuum
of sufficient strength to force said Agrobacterium cells into intimate
contact with said plant such that said Agrobacterium cells transfer
T-DNA to cells of said plant at a second time to form a transformed plant,
wherein said first time and said second time are the same or different.
|
| Claim 25
A method for direct transformation of a plant at the time of flowering
comprising:
A) vernalizing and germinating initial seed to form said plant contacting
aerial portions of said plant at the time of flowering with a mixture of
Agrobacterium cells, said mixture comprising cells from a
Agrobacterium strain harboring a vector with a DNA fragment and cells
from said Agrobacterium strain harboring said vector with a second DNA
fragment, said vector enabling said Agrobacterium cells to transfer
said T-DNA to said plant; and B) applying a vacuum to said plant portions
in contact with said Agrobacterium cells at a first time, said vacuum
of sufficient strength to force said Agrobacterium cells into intimate
contact with said plant such that said Agrobacterium cells transfer
T-DNA to cells of said plant at a second time to form a transformed plant,
wherein said first time and said second time are the same or different.
|
Claim 33
A method for direct plant transformation using plants at the time of
flowering and Agrobacterium
comprising:A) contacting aerial portions of at least one plant at the time of
flowering with Agrobacterium cells, said Agrobacterium cells
harboring a vector, said vector enabling said Agrobacterium cells to
transfer T-DNA containing at least one gene or gene fragment and a selectable
marker gene to said plant; B) applying a vacuum to said plant portions in
contact with said Agrobacterium cells at a first time, said vacuum of
sufficient strength to force said Agrobacterium cells into intimate
contact with said plant such that said Agrobacterium cells transfer
said T-DNA to cells of said plant at a second time to form a transformed plant,
wherein said first time and said second time are the same or different; C)
allowing said transformed plant to grow to maturity and set seed; D)
germinating said seed to form progeny; E) exposing said progeny to an agent
enabling detection of selectable marker gene expression; and F) selecting
for progeny expressing said selectable marker gene and at least one gene, said
expression of said selectable marker gene and at least one gene indicating gene
transfer.
|
| Claim 36
A method for direct transformation of a plant at the time of flowering
comprising:
A) vernalizing and germinating initial seed to form said plant; B)
contacting aerial portions of said plant at the time of flowering with
Agrobacterium cells, said Agrobacterium cells harboring a
vector, said vector enabling said Agrobacterium cells to transfer T-DNA
containing at least one gene or gene fragment and a selectable marker gene to
said plant; C) applying a vacuum to said plant portions in contact with
said Agrobacterium cells at a first time, said vacuum of sufficient
strength to force said Agrobacterium cells into intimate contact with
said plant such that said Agrobacterium cells transfer said T-DNA to
cells of said plant at a second time to form a transformed plant, wherein said
first time and said second time are the same or different; D) allowing said
transformed plant to grow to maturity and set seed; germinating said seed to
form progeny; E) exposing said progeny to an agent enabling detection of
selectable marker gene expression; and F) selecting for progeny expressing
said selectable marker gene and at least one gene, said expression of said
selectable marker gene and at least one gene indicating gene transfer.
|
Status of National phase entries listed on INPADOC:
- Australia (AU43652/00 A) - application lapsed on 8 December
2005
- Canada (CA2370638 A1) - dead application on 20 April 2005
(i.e., the application cannot be reinstated).
- Europe (EP1171618 A2) - application deemed to be withdrawn
on 11 May 2005
- New Zealand (NZ513993 A) - application void on 30 January
2004.
|
Note: Patent information on this page was last updated on 8 March 2006.
Vacuum Infiltration of seedling plants
Patent application filed by The Samuel Roberts Noble
Foundation
Actual pending claims
|
EP 1141356 A2
|
| Claim 1
A method for direct plant transformation using seedlings and
Agrobacterium comprising: A) contacting at least one seedling with
Agrobacterium cells, said Agrobacterium cells harboring a
vector, said vector enabling said Agrobacterium cells to transfer T-DNA
containing at least one gene or gene fragment to said seedling; B) applying
a vacuum to said seedling in contact with said Agrobacterium cells at a
first time, said vacuum of sufficient strength to force said
Agrobacterium cells into intimate contact with said seedling such that
said Agrobacterium cells transfer said T-DNA to cells of said seedling
at a second time, wherein said first and second time are the same or different.
|
| Claim 9
A method for direct plant transformation using seedlings and
Agrobacterium comprising: A) contacting at least one seedling with a
mixture of Agrobacterium cells, said mixture comprising cells from a
Agrobacterium strain harboring a vector with a DNA fragment and cells
from said Agrobacterium strain harboring said vector a second DNA
fragment, said vector enabling said Agrobacterium cells to transfer
said T-DNA to said seedling; B) applying a vacuum to said seedling in
contact with said Agrobacterium cells at a first time, said vacuum of
sufficient strength to force said Agrobacterium cells into intimate
contact with said seedling such that said Agrobacterium cells transfer
T-DNA to cells of said seedling at a second time, wherein said first and second
time are the same or different.
|
| Claim 18
A method for direct plant transformation using seedlings and
Agrobacterium comprising: A) contacting at least one seedling with
Agrobacterium cells, said Agrobacterium cells harboring a
vector, said vector enabling said Agrobacterium cells to transfer T-DNA
containing at least one gene or gene fragment and a selectable marker gene to
said seedling; B) applying a vacuum to said seedling in contact with said
Agrobacterium cells at a first time, said vacuum of sufficient strength
to force said Agrobacterium cells into intimate contact with said
seedling such that said Agrobacterium cells transfer said T-DNA to
cells of said seedling at a second time, wherein said first and second time are
the same or different; C) allowing said transformed seedling to grow to
maturity and set seed; D) germinating said seed to form progeny; E)
exposing said progeny to an agent enabling detection of selectable marker gene
expression; F) selecting for progeny expressing said selectable marker gene
and at least one gene, said expression of said selectable marker gene and at
least one gene indicating gene transfer.
|
Vacuum Infiltration of flowering plants
Patent application filed by The Samuel
Roberts Noble Foundation
Actual pending claims
|
EP 1171618 A2
|
| Claim 1
A method for direct plant transformation using plants and
Agrobacterium comprising: A) contacting the aerial portions of at least
one plant at the time of flowering with Agrobacterium cells, said
Agrobacterium cells harboring a vector, said vector enabling said
Agrobacterium cells to transfer T-DNA containing at least one gene or
gene fragment to said plant; and B) applying a vacuum to said plant
portions in contact with said Agrobacterium cells at a first time, said
vacuum of sufficient strength to force said Agrobacterium cells into
intimate contact with said plant such that said Agrobacterium cells
transfer said T-DNA to cells of said plant at a second time to form a
transformed plant, wherein said first time and said second time are the same or
different.
|
| Claim 9
A method for direct transformation of a plant comprising: A) vernalizing and
germinating initial seed to form said plant contacting the aerial portions of
said plant at the time of flowering with Agrobacterium cells, said
Agrobacterium cells harboring a vector, said vector enabling said
Agrobacterium cells to transfer T-DNA containing at least one gene or
gene fragment to said plant; and B) applying a vacuum to said plant
portions in contact with said Agrobacterium cells at a first time, said
vacuum of sufficient strength to force said Agrobacterium cells into
intimate contact with said plant such that said Agrobacterium cells
transfer said T-DNA to cells of said plant at a second time to form a
transformed plant, wherein said first time and said second time are the same or
different.
|
| Claim 17
A method for direct plant transformation using plants at the time of
flowering and Agrobacterium comprising: A) contacting aerial
portions of at least one plant at the time of flowering with a mixture of
Agrobacterium cells, said mixture comprising cells from a
Agrobacterium strain harboring a vector with a DNA fragment and cells
from said Agrobacterium strain harboring said vector with a second DNA
fragment, said vector enabling said Agrobacterium cells to transfer
said T-DNA to said plant; and B) applying a vacuum to said plant portions
in contact with said Agrobacterium cells at a first time, said vacuum
of sufficient strength to force said Agrobacterium cells into intimate
contact with said plant such that said Agrobacterium cells transfer
T-DNA to cells of said plant at a second time to form a transformed plant,
wherein said first time and said second time are the same or different.
|
| Claim 25
A method for direct transformation of a plant at the time of flowering
comprising: A) vernalizing and germinating initial seed to form said plant
contacting aerial portions of said plant at the time of flowering with a mixture
of Agrobacterium cells, said mixture comprising cells from a
Agrobacterium strain harboring a vector with a DNA fragment and cells
from said Agrobacterium strain harboring said vector with a second DNA
fragment, said vector enabling said Agrobacterium cells to transfer
said T-DNA to said plant; and B) applying a vacuum to said plant portions
in contact with said Agrobacterium cells at a first time, said vacuum
of sufficient strength to force said Agrobacterium cells into intimate
contact with said plant such that said Agrobacterium cells transfer
T-DNA to cells of said plant at a second time to form a transformed plant,
wherein said first time and said second time are the same or different.
|
| Claim 33
A method for direct plant transformation using plants at the time of
flowering and Agrobacterium comprising: A) contacting aerial portions
of at least one plant at the time of flowering with Agrobacterium
cells, said Agrobacterium cells harboring a vector, said vector
enabling said Agrobacterium cells to transfer T-DNA containing at least
one gene or gene fragment and a selectable marker gene to said plant; B)
applying a vacuum to said plant portions in contact with said
Agrobacterium cells at a first time, said vacuum of sufficient strength
to force said Agrobacterium cells into intimate contact with said plant
such that said Agrobacterium cells transfer said T-DNA to cells of said
plant at a second time to form a transformed plant, wherein said first time and
said second time are the same or different; C) allowing said transformed
plant to grow to maturity and set seed; D) germinating said seed to form
progeny; E) exposing said progeny to an agent enabling detection of
selectable marker gene expression; and F) selecting for progeny expressing
said selectable marker gene and at least one gene, said expression of said
selectable marker gene and at least one gene indicating gene transfer.
|
| Claim 36
A method for direct transformation of a plant at the time of flowering
comprising: A) vernalizing and germinating initial seed to form said plant;
B) contacting aerial portions of said plant at the time of flowering with
Agrobacterium cells, said Agrobacterium cells harboring a
vector, said vector enabling said Agrobacterium cells to transfer T-DNA
containing at least one gene or gene fragment and a selectable marker gene to
said plant; C) applying a vacuum to said plant portions in contact with
said Agrobacterium cells at a first time, said vacuum of sufficient
strength to force said Agrobacterium cells into intimate contact with
said plant such that said Agrobacterium cells transfer said T-DNA to
cells of said plant at a second time to form a transformed plant, wherein said
first time and said second time are the same or different; D) allowing said
transformed plant to grow to maturity and set seed; germinating said seed to
form progeny; E) exposing said progeny to an agent enabling detection of
selectable marker gene expression; and F) selecting for progeny expressing
said selectable marker gene and at least one gene, said expression of said
selectable marker gene and at least one gene indicating gene transfer.
|
Monocots
Overview
Monocots (Monocotyledonous) comprise one
of the large divisions of Angiosperm plants (flowering plants with seeds
protected within a vessel). They are herbaceous plants with parallel veined
leaves and have an embryo with a single cotyledon, as opposed to dicot plants
(dicotyledonous), which have an embryo with two cotyledons.
Most of the important staple crops of the world, the so-called cereals, such
as wheat, barley, rice, maize, sorghum, oats, rye and millet, are monocots.
Other food crops such as onion, garlic, ginger, banana, plantain, yam and
asparagus are also classified as monocots.
Agrobacterium-mediated transformation of commercially important
monocots was first attained in rice and maize in the mid 90's. Following these
achievements, other monocot crops were successfully transformed and refinements
of techniques led to improved regeneration of transformed monocot tissue.
In this section of the document, the selected patents directed to
Agrobacterium transformation of monocots are categorized as:
-
General transformation
methods, regardless the vector type used for transformation.
-
Monocot plants, which are divided into:
-
Particular plants,
including grains, tropical fruits and flowers. In alphabetical order, patents on
Agrobacterium-mediated transformation of the following monocots are
analyzed individually: banana, barley, duckweed, gladiolus, maize, onions,
pineapple, rice, sorghum, turfgrass and wheat. The inventions cover aspects such
as the initial tissue used for transformation, transformation protocols, media
composition, and in some cases, the insertion of particular genes.
General Monocot Transformation Methods
Summary
Japan Tobacco (in Japan), Rhône-Poulenc
Agro (in France), University of Guelph (in Canada) and
recently, Paradigm Genetics (in the US), the Department
of Primary Industries of Queensland (AU) and the National
Institute of Agrobiological Resources (in Japan) have granted patents
or patent applications directed to methods for Agrobacterium-mediated
transformation of any monocot with a gene of interest. The main difference among
them lies in:
- the initial plant tissue or explant used for the transformation process, and
- the application of additional treatments, such as vacuum infiltration or the
addition of phenolic compounds to facilitate the transformation process.
Japan Tobacco claims
the transformation of a monocot callus during a
dedifferentiation process and the transformation of the scutellum of an
immature embryo prior to dedifferentiation. Thus, these patents granted
in the United States and Australia cover transformation of monocot tissues that
are widely and commonly used. In the United States, the breadth of the claimed
monocot callus transformation method appears limited only by the minimum number
of days in culture before the transformation process takes place. This time
limit is not part of the claims in either the Australian patent or European
patent application.
Rhône-Poulenc Agro (now Bayer
Crop Science) claims the transformation of a monocot
inflorescence via Agrobacterium. The inflorescence can be
dissected and then transformed. Alternatively, callus formation is induced from
an inflorescence in culture, and the derived callus is transformed with
Agrobacterium. A transgenic monocot plant is then regenerated from the
transformed inflorescence-derived callus. The invention is thus limited to
transformation of a monocot inflorescence. Other tissues are not part of the
scope of the claims.
In contrast to the previous two inventions that disclose particular tissue
types for transformation, the Paradigm Genetics application
discloses the use of vacuum infiltration in the
presence of a phenolic compound for monocot transformation with
Agrobacterium. A limitation of the claims as filed in the patent
application is the use of a monocot flower. An
apparatus to perform vacuum infiltration of the monocot plant
is also part of the disclosed invention. It remains to be seen what claim scope
is ultimately granted.
The Department of Primary Industries of Queensland does not
disclose a particular tissue to be transformed in its PCT patent application.
Neither are particular conditions stated for the transformation process. One
limitation of the claimed invention consists of formation of an
organogenic callus by the transformed plant cells.
The University of Guelph has a US application derived from a
PCT application. An Australian application lapsed in 2002. The applications
describe the use of vacuum infiltration in combination with a phenolic compound
for the transformation of a monocot with Agrobacterium.
The National Institute of Agrobiological Resources (Japan)
has PCT and European applications that disclose a method for transforming a
monocot by treatment of intact seed with Agrobacterium containing a
recombinant gene of interest.
Patents and applications assigned to Japan Tobacco
Japan Tobacco has patents and applications relating
to Agrobacterium-transformation of monocots. The granted patents
include.
The patents and patent applications disclose an explant of a monocot in the
process of dedifferentiation or already dedifferentiated used for transformation
with Agrobacterium.
According to the scientific literature, differentiation of a cell is the
process through which a cell becomes specialized to perform a particular
function. A dedifferentiation process is thus the opposite of specialization.
During cell dedifferentiation, more random planes of cell division increase
progressively and there is a loss of organized structures.
Patents granted to Japan Tobacco
Specific Patent Information
|
Patent Number
|
Title, Independent Claims and Summary of Claims
|
Assignee
|
|
US
5591616
- Earliest priority - 7 July 1992
- Filed - 3 May 1994
- Granted - 7 Jan 1997
- Expected expiry - 2 May 2014
|
Title - Method of transforming monocotyledon
| Claim 1
A method for transforming a monocotyledon callus, comprising contacting a
cultured tissue of a monocotyledon during dedifferentiation wherein said
dedifferentiation is obtained by culturing an explant on a
dedifferentiation-inducing medium for not less than 7 days or a
dedifferentiated cultured tissue of a monocotyledon, with a bacterium belonging
to the genus Agrobacterium containing a desired gene.
|
| Claim 17
A method for transforming a monocotyledon with a desired gene, comprising:
A) contacting a cultured tissue of said monocotyledon during
dedifferentiation thereof, or a dedifferentiated cultured tissue of said
monocotyledon, with a suspension of Agrobacterium tumefaciens having a
cell population of 106 to 1011 cells/ml for 3-10 minutes,
and then B) culturing said cultured tissue of said monocotyledon during
dedifferentiation thereof, or said dedifferentiated cultured tissue of said
monocotyledon, on a solid medium for several days together with said
Agrobacterium tumefaciens, or C) adding said Agrobacterium
tumefaciens to culture medium in which said cultured tissue of said
monocotyledon during dedifferentiation thereof or said dedifferentiated cultured
tissue of said monocotyledon is cultured, and continuously culturing said
cultured tissue of said monocotyledon during dedifferentiation or said
dedifferentiated cultured tissue of said monocotyledon together with said
Agrobacterium tumefaciens,
wherein said dedifferentiated cultured tissue of said monocotyledon is
selected from the group consisting of a tissue cultured during the process of
callus formation which is cultured for not less than 7 days after an explant is
placed on a dedifferentiation-inducing medium and a callus, and wherein
said Agrobacterium tumefaciens contains plasmid pTOK162, and said
desired gene is present between border sequences of the T region of said plasmid
pTOK162, or wherein said desired gene is present in another plasmid contained in
said Agrobacterium tumefaciens.
|
The patent discloses that "the term 'dedifferentiated tissue' ...means a
callus or an adventitious embryo-like tissue obtained by culturing an explant in
a medium containing a plant growth regulator such as an auxin or a cytokinin."
|
Japan Tobacco
|
|
US
7060876
- Earliest priority - 7 July 1992
- Filed - 13 Jan 1999
- Granted - 13 Jun 2006
- Expected expiry - 2 May 2014
|
Title - Method for transforming monocotyledons
Claim 1
A method for transforming a monocot plant comprising:
i) culturing an explant of said monocot plant, or a tissue isolated from said
explant, for one to six days in a medium comprising at least one auxin to obtain
a cultured tissue; ii) co-culturing the cultured tissue from step i) with
an Agrobacterium bacterium comprising a polynucleotide of
interest; iii) selecting cultured tissue into which the polynucleotide of
interest has been introduced; and iv) culturing the selected tissue on a
regeneration medium to obtain a transformed monocot plant.
|
Claim 16
A method for transforming a tissue of a monocot plant comprising:
i) culturing an explant of an immature tissue of a monocot plant for one to
six days on a medium comprising at least one auxin and that induces
dedifferentiation of the cells of the explanted tissue to obtain a
dedifferentiating or dedifferentiated cultured immature tissue; ii)
contacting the dedifferentiating or dedifferentiated cultured immature tissue
with cells of Agrobacterium bacteria that comprise a vector comprising
at least one virulence gene of a Ti plasmid, a left T-DNA border, a right T-DNA
border and a polynucleotide of interest located between the left T-DNA border
and the right T-DNA border; thereby obtaining a transformed plant tissue.
|
Claim 20
A method for obtaining a transformed monocot plant comprising
i) culturing an explant of an immature tissue of a monocot plant for one to
six days on a medium comprising at least one auxin and that induces
dedifferentiation of the cells of the explanted tissue to obtain a
dedifferentiating or dedifferentiated cultured immature tissue; ii)
contacting the dedifferentiating or dedifferentiated cultured immature tissue
with cells of Agrobacterium bacteria that comprise a vector comprising
at least one virulence gene of a Ti plasmid, a left T-DNA border, a right T-DNA
border and a polynucleotide of interest located between the left T-DNA border
and the right T-DNA border; thereby obtaining a transformed plant tissue; and
iii) culturing the transformed plant tissue on at least one regeneration
medium, thereby obtaining a transformed monocot plant.
|
Granted US 7060876 is a continuation of US 08/668464 (now abandoned), which
is a continuation-in-part of now granted US 5591616.
The claims are generally drawn towards:
- a method for transforming a monocot plant comprising culturing an explant or
a tissue from an explant for one to six days in a medium
comprising at least one auxin (claim 1)
- a method for transforming a tissue of a monocot plant comprising culturing
an explant of an immature tissue for one to six days on a
medium comprising at least one auxin (claim 16)
- a method for obtaining a transformed monocot plant comprising culturing an
explant of an immature tissue for one to six days on a medium
comprising at least one auxin (claim 20)
Granted US 7060876 and US 5591616 together cover the whole duration of the
dedifferentiation period of monocot plant tissue that can be used as
transformation material by Agrobacterium in the United States.
The term "less than seven days" in the application US 2002/0178463 has been
changed to "one to six days", and there is no limit on the type of plasmid that
is contained in the Agrobacterium that is used to transform the monocot
plant in granted US 7060876.
|
|
US
2002/0178463
- Earliest priority - 7 July 1992
- Filed - 13 Jan 1999
- Pubished - 28 November 2002
- Granted as US 7060876 (see above)
- Expected expiry - N/A
|
Title - Method of transforming monocotyledons
| Claim 1
A method for transforming a monocotyledon, comprising contacting a cultured
tissue of said monocotyledon during dedifferentiation thereof obtained by
culturing an explant on a dedifferentiation-inducing medium for less than 7 days
with a bacterium belonging to the genus Agrobacterium containing a
super binary vector having the virulence region of Ti plasmid pTiBo542 contained
in Agrobacterium tumefaciens A281, left and right border
sequences of T-DNA of a Ti plasmid or an Ri plasmid of a bacterium belonging to
the genus Agrobacterium, and a desired gene located between said left
and right border sequences.
|
Claim 13
A method for transforming a monocotyledon, comprising contacting a cultured
tissue of said monocotyledon during dedifferentiation thereof obtained by
culturing an explant derived from an immature tissue on a
dedifferentiation-inducing medium for less than 7 days with a bacterium
belonging to the genus Agrobacterium containing a desired gene and
containing a vector having the virulence region of Ti plasmid contained in
Agrobacterium tumefaciens.
|
United States patent application US 2002/0178463 is a
continuation-in-part of application US 08/193,058 (now patent US 5,591,616, see
above). The content of this application is very similar to the
parent application. The main difference in the claims is that independent Claim
1 recites the use of a superbinary vector having the virulence region of a
defined Ti plasmid and contained in a specific strain of Agrobacterium
tumefaciens and tissue is cultured in dedifferentiating medium for
less than 7 days.
In claim 13, the explant is derived from an immature tissue. The application
discloses that the "term 'immature' means that the tissue has not reached the
matured state of the tissue and will mature under conditions which allow the
maturation." The description doesn't clarify what physiological or phenotypic
properties an immature tissue has but merely basically restates that "immature"
means not mature.
|
|
AU 667939 B
- Earliest priority - 7 July 1992
- Filed - 6 July 1993
- Granted - 18 April 1996
- Expected expiry - 5 July 2013
|
Title - Method of transforming monocotyledon
The lead claim in the Australian patent AU 667939 B is
broader than in the United States patent.
In the Australian patent, a dedifferentiating or dedifferentiated tissue of a
monocot is also used as the initial tissue for transformation, but there is no
restriction with respect to a minimum number of days of culture in the medium to
induce dedifferentiation.
| Claim 1
A method for transforming a monocotyledon comprising transforming a cultured
tissue during dedifferentiation process or a dedifferentiated cultured tissue of
said monocotyledon with a bacteria belonging to genus Agrobacterium
containing a desired gene.
|
|
EP
604662 A1
- Earliest priority - 7 July 1992
- Filed - 6 July 1993
- Application pending
|
Title - Method of transforming monocotyledon
The claims submitted in the European application EP 604 662
A1 are the same as the claims of the Australian patent.
|
| Remarks |
National phase entry of PCT application WO 94/0977 in Canada (CA 2121545) is
still pending.
|
Note: Patent information on this page was last updated on 3 February 2006.
Patents and application assigned to Japan Tobacco-Patents and application assigned to Japan Tobacco
This family of patents and one application disclose the use of an immature
embryo of a monocot for Agrobacterium-mediated transformation. Within
the embryo, the tissue to be transformed is the scutellum, which is the name
given to the cotyledon of monocot plants. The transformed scutellum can be
induced to become dedifferentiated calli that have the ability to regenerate
normal plants after transformation.
In addition, they disclose an Agrobacterium used for transformation
that contains a Ti or Ri (root-inducing) plasmid with a desired gene and a
plasmid having a virulence region derived from the A. tumefaciens Ti
plasmid pTiBo542.
Specific Patent Information
|
Patent Number
|
Title, Independent Claims and Summary of Claims
|
Assignee
|
|
AU
687863 B
- Earliest priority - 3 September 1993
- Filed - 1 Sept 1994
- Granted - 5 March 1998
- Expected expiry - 31 Aug 2014
|
Title - Method of transforming monocotyledon by using
scutellum of immature embryo
| Claim 1
A method for transforming monocotyledons comprising transforming scutellum of
an immature embryo of a monocotyledon with a bacterium belonging to genus
Agrobacterium containing a desired gene, which immature embryo has not
been subjected to a dedifferentiation treatment, to obtain a transformant.
|
The claims of the Australian patent AU 687863 are directed
to
- a method for transforming a scutellum of an immature embryo of a
monocotyledon with Agrobacterium having a desired gene. The embryo is
not submitted to a dedifferentiation process prior to transformation with
Agrobacterium.
|
Japan Tobacco
|
|
EP
672752 B1
- Earliest priority - 3 September 1993
- Filed - 1 Sept 1994
- Granted - 26 May 2004
- Expected expiry - 31 Aug 2014
|
Title - Method of transforming monocotyledon by using
scutellum of immature embryo
| Claim 1
A method for transforming monocotyledons comprising transforming scutellum of
an immature embryo of a monocotyledon with a bacterium belonging to genus
Agrobacterium containing a desired gene, which immature embryo has not
been subjected to a dedifferentiation treatment, to obtain a transformant.
|
The independent claim is the same as the Australian patent.
Designated contracting States at the time of grant are: Austria, Belgium,
Switzerland, Germany, Denmark, Spain, France, United Kingdom, Greece (reported
on INPADOC as lapsed), Ireland, Italy, Liechtenstein, Luxembourg, Monaco
(reported on INPADOC as lapsed), Netherlands, Portugal, Sweden.
|
|
EP 672752 A1
- Earliest priority - 3 September 1993
- Filed - 1 September 1994
- OPI - 20 September 1995
- Granted as EP 672752 B1 (see above)
|
Title - Method of transforming menocotyledon by using
scutellum of immature embryo
This application has been granted as EP 672752 B1 (see
above).
The independent claim in this application has been granted without
amendments.
|
| Remarks |
- The United States application No. 428238, corresponding to a PCT
application, was filed on 3 May 1995. Specification and claims of the PCT
application WO 956722 are in Japanese.
- National phase entry of the PCT application WO 956722 in Japan (JP 3329819)
has been granted on Sept 30 2002.
- National phase entry of the PCT application WO 956722 in Canada (CA 2148499)
is still pending.
|
Note: Patent information on this page was last updated on 2 February 2006.
Patent assigned to Rhône-Poulenc Agro
The invention disclosed in the following patent is directed to the use of an
inflorescence of a monocot as a target tissue to be transformed with
Agrobacterium. In the method, a dissected inflorescence or a callus
derived from the dissected inflorescence is co-cultivated with
Agrobacterium.
Specific Patent Information
|
Patent Number
|
Title, Independent Claims and Summary of Claims
|
Assignee
|
|
US
6037522
- Earliest priority - 23 June 1998
- Filed - 23 June 1998
- Granted - 14 March 2000
- Expected expiry - 22 June 2018
|
Title- Agrobacterium-mediated transformation of
monocots
| Claim 1
A method of transforming a monocot comprising co-cultivating a monocot
inflorescence with Agrobacterium containing a plasmid comprising a
heterologous nucleic acid.
|
| Claim 5
A method of transforming a monocot comprising:
A) dissecting an inflorescence from a monocot; B) initiating a callus
from the inflorescence to generate an inflorescence-derived callus; and C)
co-cultivating the inflorescence-derived callus with Agrobacterium
containing a plasmid comprising a heterologous nucleic acid.
|
| Claim 13
A method of making a transgenic monocot comprising:
A) dissecting an inflorescence from a monocot; B) initiating a callus
from the inflorescence to generate an inflorescence-derived callus; C)
co-cultivating the inflorescence-derived callus with Agrobacterium
containing a plasmid comprising a heterologous nucleic acid; and D)
regenerating a transgenic monocot from the callus.
|
| Claim 16
A method of making a transgenic monocot comprising:
A) dissecting an inflorescence from a monocot; B) co-cultivating the
inflorescence with Agrobacterium containing a plasmid comprising a
heterologous nucleic acid; C) initiating a callus from the inflorescence;
and D) regenerating a transgenic monocot from the callus.
|
The United States patent US 6037522 claims
- a method of transforming an inflorescence of a monocot with
Agrobacterium having heterologous DNA where:
- the inflorescence to be transformed is first dissected and then
co-cultivated with Agrobacterium; or
- the inflorescence to be transformed is first cultured in a medium to induce
callus formation and then the callus is transformed with
Agrobacterium.
Dependent claims also recite transgenic monocots, seeds or progeny of
transgenic monocots produced by the methods.
The patent describes that "heterologous nucleic acid" is nucleic acid
which is not normally found in Agrobacterium T-DNA or the monocot that is to be
transformed and includes all synthetically engineered and biologically derived
genes which may be introduced into a plant by genetic engineering, including,
but not limited, to nonplant genes, modified genes, synthetic genes, portion of
genes, and genes from monocots and other plant species.
|
Rhône-Poulenc Agro
(now Aventis CropScience, now owned by Bayer)
|
| Remarks |
The related Australian application AU 46163/99 A1 was
abandoned on March 15, 2001.
|
|
Note: Patent information on this page was last updated on 2 February 2006.
Patent application filed by Paradigm Genetics Inc.
The PCT disclosure refers to transformation of monocot plants with
Agrobacterium using vacuum infiltration. The explant
to be transformed is a flower . The monocot flower is in
contact with a solution containing Agrobacterium while the vacuum is
applied. An apparatus to carry out the vacuum infiltration is
also described.
Specific PCT Application Information
|
PCT Number
|
Title, Independent Claims and Summary of Claims
|
Assignee
|
|
WO
0112828 A1
- Earliest priority - 18 August 1999
- Filed - 17 August 2000
- OPI - 22 February 2001
- Expected expiry - N/A
|
Title - Methods and apparatus for transformation of
monocotyledonous plants using Agrobacterium in combination with vacuum
filtration
| Claim 1
An in planta method of transforming a monocotyledonous plant
comprising:
A) contacting at least one flower of the monocotyledonous plant with a
solution or suspension comprising an Agrobacterium clone; and B)
subjecting said plant to a vacuum effective to cause entry of the
Agrobacterium clone into at least one flower of the plant.
|
| Claim 40
An apparatus for the transformation of a monocotyledonous plant, comprising:
- a vacuum chamber of sufficient size to contain at least one monocotyledonous
plant;
- means for generating a vacuum;
- a connector that connects the means for generating a vacuum with the vacuum
chamber; and
- means for affixing the monocotyledonous plant inside the vacuum chamber.
|
The PCT application claims:
- an in planta method of transforming a
monocot flower by contacting at least one flower with
Agrobacterium in suspension or in solution and applying
vacuum to cause the entry of Agrobacterium into the
plant flower.
- an apparatus for transforming a monocot plant comprising a
vacuum chamber of sufficient size to contain the plant, means to generate the
vacuum and affix the plant inside the chamber.
The present application also contains independent claims reciting methods for
transforming rice plants. They are discussed under the section
Particular
monocots - Rice.
|
Paradigm Genetics Inc
|
| Remarks |
A related patent application filed in Australia (AU
67807/00) has lapsed on 2 May 2002.
|
|
Note: Patent information on this page was last updated on 2 February 2006.
Patent application filed by The Department of Primary Industries of Queensland
The present disclosure refers to transformation of monocot cells through
Agrobacterium. The explant to be transformed can be from any
monocotyledonous plant. An advantage of the disclosed method according to the
applicant is that the transformed monocot cells form an organogenic
callus instead of an embryogenic callus. A modified monocot plant is
regenerated from the organogenic callus formed by the selected transformed plant
cells.
The application does not provide a definition for either organogenic or
embryogenic callus. According to commonly accepted definitions in the scientific
literature (which may or may not be used to construe the patent claims), during
the development of an organogenic callus, the shoot or root organ, usually a
shoot, is induced to form first, followed by root or shoot formation from that
shoot or root. In an embryogenic callus type, embryo-like structures develop,
called somatic embryos, that then simultaneously develop shoots and roots. Use
of embryogenic callus, according to the applicant, is time consuming, labor
intensive and not always successful.
Specific Patent Information
|
Patent Number
|
Title, Independent Claims and Summary of Claims
|
Assignee
|
|
WO
01/33943 A1
- Earliest priority - 5 November 1999
- Filed - 3 November 2000
- OPI - 17 May 2001
- Expected expiry - N/A
|
Title - A method of plant transformation
| Claim 1
A method of transforming cells of a monocotyledonous plant with genetic
material, said method comprising:
A) obtaining an explant from said plant; B) co-cultivating the explant
with Agrobacterium species having a T-DNA or T-DNA region comprising
the genetic material to be transformed into the plant cells for a time and under
conditions sufficient for the genetic material to transfer into the plant cells
without said Agrobacterium overgrowing the plant cells; and C)
selecting for the transformed plant cells and permitting the cells to form
organogenic callus.
|
| Claim 21
A method for producing a genetically modified monocotyledonous plant, said
method comprising:
A) obtaining explant from a plant to be genetically modified; B)
co-cultivating the explant with Agrobacterium species having a T-DNA or
T-DNA region comprising genetic material to be transformed into said plant cells
for a time and under conditions sufficient for the genetic material to transfer
to plant cells without said Agrobacterium overgrowing the plant
cells; C) selecting transformed plant cells and permitting the cells to
form organogenic callus; and then D) regenerating a plant from selected
transformed plant cells.
|
| Claim 41
A method for producing a genetically modified monocotyledonous plant, said
method comprising:
A) obtaining an explant from said plant to be genetically modified; B)
co-cultivating the explant with Agrobacterium species having a T-DNA or
T-DNA region comprising the genetic material to be transformed into the plant
cells for a time and under conditions sufficient for the genetic material to
transfer into the plant cells without the Agrobacterium overgrowing the
plant cells; C) selecting for the transformed plant cells and permitting
the cells to form organogenic callus; and D) regenerating a plant from said
transformed organogenic callus.
|
The present PCT application recites:
- method of transforming cells of a monocot plant by co-cultivating an explant
with Agrobacterium having a T-DNA with genetic material to be
transferred into the plant cells. The bacteria do not overgrow
the plant cells and the selected transformed cells form an organogenic
callus.
- a method for producing modified monocot plants by regenerating a plant from
the organogenic callus containing the transformed cells.
The present application also contains independent claims directed to methods
for transforming of pineapple plants (Claims 60 and 77). They are discussed
under the section Particular monocots -
Pineapple.
|
The Department of Primary Industries of Queensland
|
|
AU
779510 B2
- Earliest priority - 5 November 1999
- Filed - 3 Nov 2000
- Granted - 27 Jan 2005
- Expected expiry - 2 Nov 2020
|
Title - A method of plant transformation
|
Claim 1
A method of transforming cells of a pineapple plant with
genetic material, said method comprising:
A) obtaining an explant from said plant; B) co-cultivating the explant
with Agrobacterium species having a T-DNA or T-DNA region comprising
the genetic material to be transformed into the plant cells for a time and under
conditions sufficient for the genetic material to transfer into the plant cells
without said Agrobacterium overgrowing the plant cells; and C)
selecting for the transformed plant cells and permitting the cells to form
organogenic callus.
|
|
Claim 19
A method for producing a genetically modified pineapple
plant, said method comprising:
A) obtaining explant from a plant to be genetically modified; B)
co-cultivating the explant with Agrobacterium species having a T-DNA or
T-DNA region comprising genetic material to be transformed into said plant cells
for a time and under conditions sufficient for the genetic material to transfer
to plant cells without said Agrobacterium overgrowing the plant
cells; C) selecting transformed plant cells and permitting the cells to
form organogenic callus; and then D) regenerating a plant from selected
transformed plant cells.
|
|
Claim 37
A method for producing a genetically modified pineapple
plant, said method comprising:
A) obtaining an explant from said plant to be genetically modified; B)
co-cultivating the explant with Agrobacterium species having a T-DNA or
T-DNA region comprising the genetic material to be transformed into the plant
cells for a time and under conditions sufficient for the genetic material to
transfer into the plant cells without the Agrobacterium overgrowing the
plant cells; C) selecting for the transformed plant cells and permitting
the cells to form organogenic callus; and D) regenerating a plant from said
transformed organogenic callus.
|
This granted patent is a national phase entry of WO 01/33943
(see above).
All three independent claims in the granted patent are limited to a
"pineapple plant" instead of a "monocotyledonous plant".
|
Note: Patent information on this page was last updated on 5 February 2006.
Patent application filed by the University of Guelph (Canada)
The present disclosure is directed to transformation of any explant from
monocot plants using Agrobacterium. According to the applicants, an
advantage of the disclosed method is that vacuum infiltration of the tissue in
the presence of Agrobacterium and a phenolic compound such as
acetosyringone yields better transformation efficiency than by wounding.
According to the inventors, the method is also simpler than previously described
methods. Because the known patent applications have lapsed, the disclosed
methods may be in the public domain. If you'd like to use it and are uncertain
that it is in the public domain in your jurisdiction, it may be best to
contact the
assignee, for which a recent contact address disclosed on the website is
plorenz@uoguelph.ca.
Specific PCT Application Information
|
PCT Number
|
Title, Independent Claims and Summary of Claims
|
Assignee
|
|
WO
00/58484 A2
- Earliest priority - 26 March 1999
- Filed - 26 September 2001
- OPI - 5 October 2000
- Expected expiry - N/A
|
Title - Transformation of monocotyledoneous plants using
Agrobacterium
| Claim 1
A method for the transformation of a monocot plant comprising, i)
exposing explant tissue of said monocot plant to an Agrobacterium
strain under vacuum in the presence of a phenolic compound, said
Agrobacterium strain comprising a heterologous gene of interest within
a vector; ii) removing said Agrobacterium from said explant
tissue; iii) adding an antibiotic against said Agrobacterium;
and iv) selecting explant tissue for occurrence of said heterologous gene
of interest.
|
| Claim 10
A method for the transformation of a monocot plant comprising, i)
placing explant tissue of said monocot plant into media comprising a suspension
of Agrobacterium to obtain a mixture, said Agrobacterium
strain comprising a heterologous gene of interest within a vector; ii)
maintaining said mixture under vacuum in the presence of acetosyringone;
iii) releasing said vacuum and further incubating said explant tissue in the
presence of said Agrobacterium; iv) transferring said explant
tissue to fresh media comprising acetosyringone and incubating said explant
tissue in the dark v) washing said explant tissue with an antibiotic
against said Agrobacterium, vi) transferring said explant tissue
to fresh media and allowing said explant tissue to differentiate, thereby
producing differentiated calli; vii) placing said differentiated calli onto
media containing a selection agent, and maintaining said differentiated calli in
the light; and viii) obtaining calli that grow in the presence of the
selection agent.
|
| Claim 17
A method for the transformation of a monocot plant comprising, i)
placing explant tissue of said monocot plant into media comprising a phenolic
compound, and a suspension of Agrobacterium to obtain a mixture, said
Agrobacterium strain comprising a heterologous gene of interest within
a vector; ii) washing said explant tissue with an antibiotic against said
Agrobacterium and transferring said explant tissue to fresh media
comprising acetosyringone and incubating said explant tissue in the dark;
iii) transferring said explant tissue to fresh media and allowing said explant
tissue to differentiate, thereby producing differentiated calli; iv)
placing said differentiated calli to media containing a selection agent, and
maintaining said differentiated calli in the light; and v) obtaining calli
that grow in the presence of the selection agent.
|
The present PCT application recites:
- method of transforming monocot plant
- by vacuum infiltration of a plant tissue
- with Agrobacterium having a heterologous gene of interest on a
vector
- in the presence of a phenoloic compound, e.g. acetosyringone.
|
University of Guelph
(Canada)
|
| Remarks |
Related applications in Australia (AU 112261/00), Canada (CA 2368841), and US
(US
2002/112261) have lapsed or been withdrawn.
|
Note: Patent information on this page was last updated on 5 February 2006.
Patent application filed by the National Institute of Agrobiological Resources (JP)
The present disclosure is directed to transformation of monocot plants by
infecting intact seed with Agrobacterium. Dependent claims recite that
the seed is pre-germinated. Gramineae and more specifically rice are preferred
embodiments mentioned in dependent claims.
Specific Patent Information
|
Patent Number
|
Title, Independent Claims and Summary of Claims
|
Asignee
|
|
EP 1 198
985 A1
- Earliest priority - 22 July 1999
- Filed - 22 July 1999
- Expected expiry - N/A
- Status -pending
|
Title - Method for super-rapid transformation of
monocotyledon
| Claim 1
A method for transforming a monocotyledon, comprising a step of infecting an
intact seed with an Agrobacterium which contains a desired recombinant
gene.
|
The present EP application recites:
- method of transforming monocot plant by infecting intact seed of a monocot
with Agrobacterium.
Note: because intact seed are mentioned in the broadest claim, transforming
a damaged seed could be outside the scope of the claims.
|
National Institute of Agrobiological Resources (JP)
|
|
AU775233
B2
- Earliest priority - 22 July 1999
- Filed - 22 July 1999
- Granted - 22 July 2004
- Expected expiry - 21 July 2019
|
Title - Method for super-rapid transformation of
monocotyledon
| Claim 1
A method for transforming a monocotyledon, comprising a step of infecting an
intact seed with an Agrobacterium which contains a desired recombinant
gene wherein the seed is a germinated seed which is germinated by preculturing
four to five days after sowing on a medium comprising 2,4-D.
|
The granted independent claim of this patent is limited to transforming an
intact germinated seed that has been precultured for four to five days after
sowing with 2,4-D.
|
| Remarks |
National phase entry of PCT application
WO
01/06844 in Canada (CA 2366104) and China (CN 1352522) are still pending.
|
Note: Patent information on this page was last updated on 5 February 2006.
Gramineae and Cereals
Summary
Gramineae is one of the largest families of monocot plants. Mostly herbaceous
grass-like plants, this family includes several important staple crops (cereals)
such as wheat, rice, maize, sorghum, barley, oats, and millet. It also
encompasses plants such as bamboos, palms, and foraging grasses (e.g.
turfgrass, king grass (Pennisetum purpureum), Brachiaria).
Remember that,
|
patents addressing the Gramineae family embrace cereals,
but patents directed to cereals do not embrace all Gramineae.
|
Gramineae transformation. The United States and Australian
patents granted to the University of Toledo and the United
States patent granted to Goldman and Graves belong to the same
patent family. They all claim a method for transforming seedlings of a Gramineae
with a vir+ Agrobacterium. Furthermore, transformed
pollen grains are obtained from a transformed seedling. Claims of both United
States patents limit the inoculation of the bacterium to a particular area in
the seedling.
Remarkably, the United States patent granted to Goldman and
Graves also contains broad claims to the transformation of Gramineae
with Agrobacterium. This particular claim encompasses any
Gramineae, constituting one of the broadest claims recently issued in
the area of plant transformation technologies. This could mean that any United
States patent claiming Agrobacterium transformation of any tissue of a
Gramineae may be dominated by this patent. The grant of this patent has wreaked
havoc in the scientific community and multiple parties with interest in
Agrobacterium- mediated transformation of Gramineae.
In 1998 the same inventors (Goldman and Graves) filed a related United
States patent application US 2002/0002711 A1 directed to
transformation of Gramineae and corn in particular. One of the independent
claims recites: "A transformed Gramineae". This could be the
broadest claim one could think of, aiming to cover genetic transformation with
any technique of an entire botanical family
of enormous economic interest. If the above United States patent granted to
Goldman and Graves caused outrage in the scientific community,
the eventual granting of a claim as broad as the one filed in the present patent
application could have had a disturbing impact on Gramineae transformation, for
already existing transformants as well as for future transgenic Gramineae.
Luckily, according to the USPTO, the patent application has been abandoned.
Cereal transformation. Plant Genetic
Systems (now part of Bayer Crop Science) has a granted
United States patent and a European application disclosing the transformation of
any cereal with Agrobacterium. The claims require the wounding of a
cereal tissue and the enzymatic disruption of a tissue cell wall before
transformation. The European application additionally recites different
transformation methods besides Agrobacterium. It remains to be seen
what claim scope will be granted in Europe.
Patents granted to The University of Toledo
The invention disclosed in the following patents provides a method for
transforming of Gramineae with a vir+ A.
tumefaciens. A seedling is inoculated with the bacterium in an area of
rapid cell division, which gives rise to germ cell lines. By inoculating this
area, transformation of pollen is attained.
Specific Patent Information
|
Patent Number
|
Title, Independent Claims and Summary of Claims
|
Assignee
|
|
US
5187073
- Earliest priority - 30 June 1986
- Filed - 13 November 1989
- Granted - 16 February 1993
- Expected expiry - 15 February 2010
|
Title - Process for transforming Gramineae and the products
thereof
| Claim 1
A method of producing transformed Gramineae, said method comprising:
A) making a wound in a graminaceous seedling with newly emerging radicle and
stem, said wound being made in an area of the seedling containing rapidly
dividing cells, wherein said area extends from the base of the scutellar node to
slightly beyond the coleoptile node; and B) inoculating the wound with
vir+ A. tumefaciens.
|
The United States patent 5187073 claims
- the transformation of a seedling of a Gramineae plant with
vir+ A. tumefaciens in a wound located between the
scutellar node and the coleoptile node
|
The University of Toledo
|
|
US
6020539
- Earliest priority - 30 June 1986
- Filed - 27 June 1994
- Granted - February 1 2000
- Expected expiry - 15 February 2010
|
Title - Process for transforming Gramineae and the products
thereof
Claim 1
A transformed pollen grain of a Gramineae produced by a plant grown from a
seedling infected with vir+ Agrobacterium tumefaciens containing a
vector comprising genetically-engineered T-DNA.
|
Claim 3
A transformed Gramineae plant derived from a seedling infected with vir+
Agrobacterium tumefaciens which contains a vector comprising
genetically-engineered T-DNA.
|
Claim 6
A transformed Gramineae produced by making a wound in a graminaceous seedling
with newly emerged radicle and stem, the wound being made in an area of the
seedling containing rapidly dividing cells, wherein said area extends from the
base of the scutellar node to slightly beyond the coleoptile node; and
inoculating the wound with vir+ Agrobacterium tumefaciens.
|
Claim 17
A transformed Gramineae produced by making a wound in a graminaceous seedling
with newly emerged radicle and stem, the wound being made in an area of the
seedling containing rapidly dividing cells, wherein said area extends from the
base of the scutellar node to slightly beyond the coleoptile node; and
inoculating the wound with vir+ Agrobacterium tumefaciens; the
transformed Gramineae containing a foreign gene which is an opine synthesis gene
that is a nopaline synthase gene or an octopine synthase gene.
|
Claim 22
An Agrobacterium--mediated transformed Gramineae.
|
Claim 25
A transformed Gramineae plant comprising a genetically-engineered T-DNA
further comprising a heterologous gene and a transcription unit in operable
order.
|
This patent is a continuation of now abandoned US 08/016600, which is a
continuation of now granted US 5187073.
Although assignment of this patent is not stated in the records provided by
the International Patent Documentation Center (INPADOC) and USPTO PAIR, the
patent can be licensed through the University of Toledo
according to the information provided by the Office of Technology Licensing of
the university.
The claims of the United States patent US 6,020,539 embrace the subject
matter claimed in the United States patent US 5,187,073 and the Australian
patent AU 606 874 B2 granted to the University of Toledo. That is the
transformation of a Gramineae seedling in an area of high cellular division with
vir+ A. tumefaciens. Transformed pollen and plants derived from the
seedling inoculated with vir+ A. tumefaciens are also claimed.
United States patent US 6,020,539 further claims
This last, fairly broad claim does not restrict
|
AU 606874 B2
- Earliest priority - 30 June 1986
- Filed - 30 June 1987
- Granted - 21 February 1991
- Expected expiry - 29 June 2007
|
Title - Transformation of Gramineae and products thereof
| Claim 1
A method of producing transformed Gramineae, as hereinbefore defined,
comprising: A) making a wound in a seedling in an area of the seedling
containing rapidly dividing cells that give rise to germ line cells; and
B) inoculating the wound with vir+ A. tumefaciens.
|
The Australian patent 606874 claims the transformation of a
seedling with vir+ A. tumefaciens as well, but it
does not specify the area where the inoculation occurs.
It claims
- wounding of the seedling in an area that gives rise to germ cell lines;
- transformed pollen derived from the transformed seedling having inserted
foreign DNA in its cells;
- transformed Gramineae plant derived from the seedling transformed with
A. tumefaciens having a vector with engineered DNA
|
CA 1341455 A1
- Earliest priority - 30 June 1986
- Filed - 29 June 1987
- Granted - 27 April 2004
- Expected expiry - 26 April 2021
|
Title - Process for transforming Gramineae and the products
thereof
| Claim 1
A method of producing transformed Gramineae comprising: A) making a
wound in a seedling in an area of the seedling containing rapidly dividing
cells; and B) inoculating the wound with vir+ A.
tumefaciens.
|
Claim 10
A transformed pollen grain of a Gramineae.
|
Claim 11
A transformed pollen grain of a Gramineae produced by a plant grown from a
seedling infected with vir+ Agrobacterium tumefaciens.
|
Claim 12
A transformed pollen grain of a Gramineae produced by a plant grown from a
seedling infected with vir+ Agrobacterium tumefaciens which
contains a vector comprising genetically-engineered T-DNA.
|
Claim 13
A transformed pollen grain of a Gramineae produced by a plant grown from a
seedling infected with vir+ Agrobacterium tumefaciens which
contains a vector comprising genetically-engineered T-DNA.
|
This patent claims
- a method of Gramineae transformation by inoculating vir+
Agrobacterium tumefaciens to a seedling that is wounded where the cells are
rapidly dividing
- a transformed Gramineae pollen grain (this claim is broad due to the fact
that there is no limit on the method of transformation)
|
| Remarks |
- A corresponding patent and its divisional patent has been granted in Japan
(JP 2693443 and JP 3234534 respectively).
- A continuation of now granted US 6020539 (US 2002-0002711 A1) has been
abandoned.
|
Note: Patent information on this page was last updated on 14 February 2006.
Patent and application assigned to Plant Genetic Systems (now Bayer Crop Science)
The invention disclosed in the United States patent assigned to
Plant Genetic Systems uses an embryogenic callus of a cereal,
any cereal, as starting material for transformation with
Agrobacterium. The tissue is either wounded or treated with an enzyme
prior to the transformation process.
Plant Genetic Systems is now part of Bayer Crop
Science, for which a recent contact address from their website on
licensing is annette.josten@bayercropscience.com.
Specific Patent Data
|
Patent Number
|
Title, Independent Claims and Summary of Claims
|
Assignee
|
|
US
6074877
- Earliest priority - 23 November 1990
- Filed - 28 May 1998
- Granted - 13 June 2000
- Expected expiry - 27 May 2018
|
Title - Process for transforming monocotyledonous plants
| Claim 1
A process for the stable integration of a DNA, comprising a gene that is
functional in a cell of a cereal plant, wherein said DNA is integrated into the
nuclear genome of said cereal plant, said process comprising the steps of:
A) providing a compact embryogenic callus of said cereal plant; B)
wounding said compact embryogenic callus or treating said compact embryogenic
callus with a cell wall degrading enzyme for a period of time so as not to cause
a complete disruption of tissues, and transferring said DNA into the nuclear
genome of a cell in said compact embryogenic callus by means of
Agrobacterium-mediated transformation to generate a transformed cell;
and C) regenerating a transformed cereal plant from said transformed cell.
|
The United States patent 6074877 claims
-
Agrobacterium-mediated transformation of an embryogenic callus of a
cereal, which is either wounded or treated with an enzyme that degrades cell
walls;
- introduction and stable integration of a gene into the nuclear genome of the
callus cell;
- regeneration of a transformed plant.
|
Plant Genetic Systems
(now Bayer Crop Science)
|
|
EP
955371 A2
- Earliest priority - 23 November 1990
- Filed - 21 November 1991
- Granted as EP 955371 (see below)
|
Title - Process for transforming
monocotyledonous plants
| Claim 1
A method for the stable integration of a DNA comprising a gene that is
functional in a cell of a cereal plant, into the nuclear genome of a cereal
plant, said method comprising:
A) providing a compact embryogenic callus of a corn plant; B) wounding
and/or degrading said compact embryogenic callus and transferring said DNA in
the nuclear genome of a cell in said compact embryogenic callus by means of
electroporation, bombardment with DNA-coated microprojectiles or
Agrobacterium-mediated transformation to generate a transformed cell;
and optionally C) regenerating a transformed cereal plant from said
transformed cell.
|
| Claim 18
The use of compact embryogenic callus of a cereal plant as starting material
for transferring a DNA comprising a gene that is functional in a cell of a
cereal plant, by means of electroporation, bombardment with DNA-coated
microprojectiles or Agrobacterium-mediated transformation, into the
nuclear genome of said cereal plant.
|
The patent application EP 955371 A2 additionally recites the
use of electroporation and microbombardment for the transformation of an
embryogenic callus of a cereal or corn. The claims submitted in the EP
application include:
- the use of an embryogenic callus of a cereal as starting tissue for
transformation;
- transformation of the tissue by either electroporation, microbombardment or
Agrobacterium infection;
- the insertion of a functional gene into the genome of the transformed
cereal; and
- the transformation of an embryogenic callus of corn.
|
|
EP
955371 B1
- Earliest priority - 23 November 1990
- Filed - 21 November 1991
- Granted - February 22 2006
- Expected expiry - 20 November 2011
|
Title - Process for transforming
monocotyledonous plants
Claim 1
A method for the stable integration of a DNA comprising a gene that is
functional in a cell of a cereal plant, into the nuclear genome of a cereal
plant, said method comprising:
a) providing a compact embryogenic callus of a cereal plant; b) wounding
and/or degrading said compact embryogenic callus and transferring said DNA in
the nuclear genome of a cell in said compact embryogenic callus by means of
electroporation, bombardment with DNA-coated microprojectiles or
Agrobacterium-mediated transformation to generate a transformed cell;
and optionally c) regenerating a transformed cereal plant from said
transformed cell.
|
Claim 18
The use of compact embryogenic callus of a cereal plant as starting material
for transferring a DNA comprising a gene that is functional in a cell of a
cereal plant, by means of electroporation, bombardment with DNA-coated
microprojectiles or Agrobacterium-mediated transformation, into the
nuclear genome of said cereal plant.
|
Granted EP 955371 recites a method of cereal transformation
that is not limited to Agrobacterium-mediated DNA
transfer, but also includes electroporation and bombardment with DNA-coated
microprojectiles.
|
| Remarks |
- The European application was assigned to Aventis CropScience
N.V. on 7 June 2000. This may now be assigned to Bayer Crop
Science.
- A corresponding patent application in Canada (CA 2096843) is still pending.
- A corresponding patent in Japan (JP 3234598) has been granted with cereals
limited to those of corn, wheat and rice.
|
Note: Patent information on this page was last updated on 8 March 2006.
Particular monocot plants
Find out more information about patents on particular monocot plants by
following the links shown below.
Banana
Summary
Banana is the first of the particular
monocot plants presented in this section. Some of the patents discussed here
refer to the genus Musa, to which banana and plantain belong.
The inventions assigned to Texas A&M University
disclose transformation of a wounded meristematic tissue from a Musa
plant with A. tumefaciens carrying an engineered T-DNA plasmid.
Embryogenic material of banana transformed with Agrobacterium
containing a gene of interest is disclosed by a United States patent and a
European application assigned to Zeneca & DNA Plant Technology
Corp.
The most limiting factors in the claims of these inventions are:
- the use of a wounded meristematic tissue of a Musa plant
(Texas A & M University),
- the additional application of microbombardment to the already wounded
meristematic Musa tissue (claimed in the Australian and European
patents granted to Texas A & M University) and
- the use of embryogenic material of banana (Australian patent granted to
Syngenta and DNA Plant Technology Corporation) and embryogenic
material from banana inflorescences (United States patent granted to
Zeneca & DNA Plant Technology Corp.).
Banana (Musa) - Specific Patent
Information - part 1
|
Patent Number
|
Title, Independent Claims and Summary of Claims
|
Assignee
|
|
US
5792935
- Earliest priority - 9 December 1993
- Filed - 9 December 1994
- Granted - 11 August 1998
- Expected expiry - 10 August 2015
|
Title - Agrobacterium tumefaciens transformation of
Musa species
| Claim 1
A method for transforming a Musa plant, said method comprising:
A) wounding meristematic tissue from a Musa plant to generate a
wounded Musa plant tissue and to facilitate access of
Agrobacterium tumefaciens to Musa plant cells competent for
transformation and regeneration; and B) applying to said wounded
Musa plant tissue at least one transformation competent
Agrobacterium tumefaciens to transform said Musa plant,
wherein said at least one transformation competent Agrobacterium
tumefaciens harbors at least one Ti plasmid and at least one virulence
gene, wherein said at least one Ti plasmid comprises at least one genetically
engineered T-DNA to effect transformation of said Musa plant.
|
Transformation of an apical or adventitious meristem of a Musa
plant by wounding the tissue and inserting A. tumefaciens carrying a
T-DNA with foreign DNA. The plant can be transformed for the production of
pharmaceutical products or the alteration of phenotypic traits of the fruit.
|
Texas A & M University
|
|
AU
693506 B2
- Earliest priority - 9 December 1993
- Filed - 9 December 1994
- Granted - 2 July 1998
- Expected expiry - 8 December 2014
|
Title - Agrobacterium tumefaciens transformation of
Musa species
| Claim 1
A method for transforming a Musa plant, said method including:
A) wounding meristematic tissue from a Musa plant, followed by
bombarding the said wounded tissue with microparticles, to generate a wounded
Musa plant tissue and to facilitate access of Agrobacterium
tumefaciens to Musa plant cells competent for transformation and
regeneration; and B) applying to said wounded Musa plant tissue at
least one transformation competent Agrobacterium tumefaciens to
transform said Musa plant, wherein said at least one transformation
competent Agr obacterium tumefaciens harbors at least one Ti plasmid
and at least one virulence gene, wherein said at least one Ti plasmid includes
at least one genetically engineered T-DNA to effect transformation of said
Musa plant.
|
Microbombardment of wounded meristematic tissue of a Musa plant to
facilitate A. tumefaciens infection. The transformation method is used
to obtain Musa plants producing pharmaceutical products and fruits with
improved phenotypic traits.
|
|
EP 731632 B1
- Earliest priority - 9 December 1993
- Filed - 9 December 1994
- Granted - 7 November 2001
- Expected expiry - 8 December 2014
|
Title - Agrobacterium tumefaciens transformation of
Musa species
| Claim 1
A method for transforming a Musa plant, said method comprising:
A) pre-wounding the meristematic tissue from a Musa plant prior to
bombarding said plant with microparticles; B) wounding the pre-wounded
meristematic tissue by microparticle bombardment to generate a wounded
Musa plant tissue and to facilitate access of Agrobacterium
tumefaciens to Musa plant cells competent for transformation and
regeneration; and B) applying to said wounded Musa plant tissue at
least one transformation competent Agrobacterium tumefaciens to
transform said Musa plant, wherein said at least one transformation
competent Agrobacterium tumefaciens harbors at least one Ti plasmid and
at least one virulence gene, wherein said at least one Ti plasmid comprises at
least one genetically engineered T-DNA to effect transformation of said
Musa plant.
|
Designated contracting States at the time of grant are: Austria, Belgium,
Germany, Spain, France, United Kingdom, Greece (reported on INPADOC as lapsed),
Ireland, Italy, Netherlands, Portugal, Sweden.
A method for transforming a Musa meristematic tissue similar to the
method disclosed in the related Australian patent. The tissue is wounded prior
to the wounding by microbombardment. Double wounding of the tissue facilitates
access of A. tumefaciens to Musa plant cells. The claims
as filed of the EP application had disclosed a single wounding step by
microbombardment. The granted claims are more limiting as a prior wounding step
is part of the method.
|
CA 2177267 A
- Earliest priority - 9 December 1993
- Filed - 9 December 1994
- Granted - 28 September 2004
- Expected expiry - 8 December 2014
|
Title - Agrobacterium tumefaciens transformation of
Musa species
| Claim 1
A method for transforming a Musa plant, said method comprising:
A) wounding meristematic tissue from a Musa plant by microparticle
bombardment to generate a wounded Musa plant tissue and to facilitate
access of Agrobacterium tumefaciens to Musa plant cells
competent for transformation and regeneration; and B) applying to said
wounded Musa plant tissue at least one transformation competent
Agrobacterium tumefaciens to transform said Musa plant,
wherein said at least one transformation competent Agrobacterium
tumefaciens harbors at least one Ti plasmid and at least one virulence
gene, wherein said at least one Ti plasmid comprises at least one genetically
engineered T-DNA to effect transformation of said Musa plant.
|
Claims as filed are similar to the Australian patent but a single step of
wounding of the Musa tissue by microbombardment prior to the
transformation with A. tumefaciens is disclosed.
|
|
EP
1087016 A2
- Earliest priority - 9 December 1993
- Filed - 9 December 1994
- Deemed to be withdrawn - 10 August 2005
|
Title - Agrobacterium tumefaciens transformation of
Musa species
Claim 1
A method for transforming a Musa plant, said method comprising:
A) wounding meristematic tissue from a Musa plant by microparticle
bombardment to generate a wounded Musa plant tissue and to facilitate
access of Agrobacterium tumefaciens to Musa plant cells
competent for transformation and regeneration; and B) applying to said
wounded Musa plant tissue at least one transformation competent
Agrobacterium tumefaciens to transform said Musa plant,
wherein said at least one transformation competent Agrobacterium
tumefaciens harbors at least one Ti plasmid and at least one virulence
gene, wherein said at least one Ti plasmid comprises at least one genetically
engineered T-DNA to effect transformation of said Musa plant; C)
growing said transformed Musa plant for a sufficient time to identify
the presence of chimeric features; D) producing non-chimeric tissue by
dividing said transformed Musa plant into segments which have at least
one meristem which can regenerate into an intact plant and which have cells that
are uniformily transformed to produce non-chimeric tissue; and E) growing
said non-chimeric tissue into a non-chimeric plant.
|
This application was a divisional application to the application EP 731632
A1. Microbombardment is also used to wound a meristematic tissue of a Musa plant
prior to the transformation with A. tumefaciens. In addition, the
transformed Musa tissue is grown to identify chimeras and regenerate an intact
plant from non-chimeric tissue.
|
|
Remarks
|
Application filed in Japan (JP 9508786 T2) is deemed to be withdrawn.
|
Note: Patent information on this page was last updated on 17 February 2006.
Banana (Musa) - Specific Patent
Information - part 2
|
Patent Number
|
Title, Independent Claims and Summary of Claims
|
Assignee
|
|
US
6133035
- Earliest priority - 16 July 1997
- Filed - 16 July 1997
- Granted - 17 October 2000
- Expected expiry - 15 July 2017
|
Title - Method of Genetically Transforming Banana Plants
| Claim 1
A method of producing a transformed banana plant comprising transforming
banana embryogenic material from inflorescences with Agrobacterium
containing a gene of interest and regenerating a transformed banana plant from
the transformed embryogenic material.
|
| Claim 7
A method of producing a transformed banana plant comprising transforming a
banana somatic embryo from inflorescences with Agrobacterium
containing a gene of interest and regenerating a transformed banana plant from
the transformed somatic embryo.
|
| Claim 11
A method of genetically transforming banana, the method comprising: A)
culturing somatic banana plant tissue from inflorescences in a medium to obtain
at least one somatic embryo structure or pro-embryo structure; B) culturing
the somatic embryo or pro-embryo structure in a medium to obtain embryogenic
material; C) transforming the embryogenic material with
Agrobacterium cells having at least one exogenous DNA sequence to
produce transformed embryogenic material; D) culturing the transformed
embryogenic material in a medium to produce at least one transformed somatic
embryo; and E) germinating the transformed somatic embryo in a medium to
produce a mature plantlet capable of being transferred to soil conditions.
|
| Claim 19
A method of genetically transforming banana, the method comprising: A)
culturing somatic banana plant tissue from inflorescences in a medium to obtain
at least one somatic embryo structure or pro-embryo structure; B) culturing
the somatic embryo or pro-embryo structure in a medium to obtain embryogenic
material; C) culturing the embryogenic material in a medium to produce at
least one somatic embryo; D) transforming the somatic embryo produced in
step (c) with Agrobacterium cells having at least one exogenous DNA
sequence to produce transformed somatic embryos; E) multiplying the
transformed somatic embryo to produce additional transformed somatic embryos;
and F) germinating the transformed somatic embryo to produce a mature
plantlet capable of being transferred to soil conditions.
|
Methods for transformation of embryogenic material from banana inflorescences
with Agrobacterium having a gene of interest. Production of plantlets
capable of being transferred to soil conditions.
|
Zeneca & DNA Plant Technology Corp.
(Zeneca is now Syngenta)
|
|
AU
744496 B2
- Earliest priority - 16 July 1997
- Filed - 13 July 1998
- Granted - 28 February 2002
- Expected expiry - 12 July 2018
|
Title - Method of Genetically Transforming Banana Plants
| Claim 1
A method of producing a transformed banana plant comprising transforming
banana embryogenic material with Agrobacterium containing a gene of
interest and regenerating a transformed banana plant from the transformed
embryogenic material.
|
| Claim 7
A method of producing a transformed banana plant comprising transforming a
banana somatic embryo with Agrobacterium containing a gene of interest
and regenerating a transformed banana plant from the transformed somatic embryo.
|
| Claim 11
A method of genetically transforming banana, the method comprising: A)
culturing somatic banana plant tissue in a medium to obtain at least one somatic
embryo structure or pro-embryo structure; B) culturing the somatic embryo
or pro-embryo structure in a medium to obtain embryogenic material; C)
transforming the embryogenic material with Agrobacterium cells having
at least one exogenous DNA sequence to produce transformed embryogenic
material; D) culturing the transformed embryogenic material in a medium to
produce at least one transformed somatic embryo; and E) germinating the
transformed somatic embryo in a medium to produce a mature plantlet capable of
being transferred to soil conditions.
|
| Claim 19
A method of genetically transforming banana, the method comprising: A)
culturing somatic banana plant tissue in a medium to obtain at least one somatic
embryo structure or pro-embryo structure; B) culturing the somatic embryo
or pro-embryo structure in a medium to obtain embryogenic material; C)
culturing the embryogenic material in a medium to produce at least one somatic
embryo; D) transforming the somatic embryo produced in step (c) with
Agrobacterium cells having at least one exogenous DNA sequence to
produce transformed somatic embryos; E) multiplying the transformed somatic
embryo to produce additional transformed somatic embryos; and F)
germinating the transformed somatic embryo to produce a mature plantlet capable
of being transferred to soil conditions.
|
The invention claimed in Australia is similar to the related United States
patent but the embryogenic material is not from a specific part of a banana
plant.
|
Syngenta Ltd. & DNA Plant Technology Corp.
|
|
EP
996329 A1
- Earliest priority - 16 July 1997
- Filed - 13 July 1998
- Application pending
|
Title - Method of Genetically Transforming Banana Plants
| Claim 1
A method of producing a transformed banana plant comprising transforming
banana embryogenic material with Agrobacterium containing a gene of
interest and regenerating a transformed banana plant from the transformed
embryogenic material.
|
| Claim 7
A method of producing a transformed banana plant comprising transforming a
banana somatic embryo with Agrobacterium containing a gene of interest
and regenerating a transformed banana plant from the transformed somatic embryo.
|
| Claim 11
A method of genetically transforming banana, the method comprising:
A) culturing somatic banana plant tissue in a medium to obtain at least one
somatic embryo structure or pro-embryo structure; B) culturing the somatic
embryo or pro-embryo structure in a medium to obtain embryogenic material;
C) transforming the embryogenic material with Agrobacterium cells
having at least one exogenous DNA sequence to produced transformed embryogenic
material; D) culturing the transformed embryogenic material in a medium to
produce at least one transformed somatic embryo; and E) germinating the
transformed somatic embryo in a medium to produce a mature plantlet capable of
being transferred to soil conditions.
|
| Claim 19
A method of genetically transforming banana, the method comprising:
A) culturing somatic banana plant tissue in a medium to obtain at least one
somatic embryo structure or pro-embryo structure; B) culturing the somatic
embryo or pro-embryo structure in a medium to obtain embryogenic material;
C) culturing the embryogenic material in a medium to produce at least one
somatic embryo; D) transforming the somatic embryo produced in step (C)
with
Agrobacterium cells having at least one exogenous DNA
sequence to produce transformed somatic embryos; E) multiplying the
transformed somatic embryo to produce additional transformed somatic embryos;
and F) germinating the transformed somatic embryo to produce a mature
plantlet capable of being transferred to soil conditions.
|
The claims as filed in the European application recite the same as the claims
granted in the United States patent US 6133035 with the
exception of claim 7, where a banana somatic embryo is
not limited to an embryo derived from an inflorescence.
Transformation of somatic embryos of banana with Agrobacterium
having a gene of interest. Multiplication of transformed somatic embryos and
production of plantlets capable of being transferred to soil conditions.
|
| Remarks |
National phase entry of
WO
1999/03327 in Japan (JP 2001510021 T2) is still pending.
|
Note: Patent information on this page was last updated on 14 February 2006.
Barley - Patent assigned to Sapporo Breweries Ltd (JP)

Barley is one of the major cereal crops worldwide and as such
biotechnological genetic improvement technologies are a desirable avenue for the
introduction of novel traits, like disease resistance or modified starch
production.
This patent discloses a method for transformation of barley using
Agrobacterium in combination with acetosyringone (a phenolic compound
that induces DNA transfer by Agrobacterium) and suspending this mixture
together with callus cells as target tissue for transformation.
Specific Patent Information
|
Patent Number
|
Title, Independent Claims and Summary of Claims
|
Assignee
|
|
US
6291244 B1
- Earliest priority - 25 July 1997
- Filed - 24 Jan 2000
- Granted - 18 Sep 2001
- Expected expiry - 23 Jan 2020
|
Title - Method of producing transformed cells of barley
| Claim 1
1. A method of producing transformed cells of barley, comprising: (a)
suspending, in a suspension medium containing 200 to 1000 mg/l acetosyringone, a
microorganism belonging to the genus Agrobacterium comprising a foreign
gene; (b) culturing, in a co-culture medium containing about 1000 mg/l
acetosyringone, the microorganism belonging to the genus Agrobacterium
and barley callus cells; (c) separating the cultured barley callus cells
from the co-culture medium; and (d) placing the separated barley callus
cells on a selective medium to select the transformed cells into which the
foreign gene has been introduced.
|
The present invention provides variations on existing protocols for the
transformation of cereals and other monocots. In the case of barley the
concentration of the widely used phenolic compound acetosyringone has been
adjusted to the special requirements given for the interaction between
Agrobacterium and the plant cells to achieve optimal transformation
efficiency. If sub-optimal concentrations are used or a different or no phenolic
compound is utilized, thereby possibly sacrificing transformation efficiency,
infringement can likely be avoided.
|
Sapporo Breweries Ltd (JP)
|
| Remarks |
related patents and applications in Japan JP 2002509440 T2 (deemed
withdrawn), Australia AU 79377/98 (lapsed) and
WO
99/04618.
|
Note: Patent information on this page was last updated on 6 February 2006.
Duckweed
Summary
Duckweeds are small, fresh-water plants
with a world-wide distribution. They are exploited for protein production due to
two unusual aspects of their growth: the plants reproduce vegetatively by
budding and under intensive culture they accumulate a very high rate of biomass.
The level of protein production can achieve that obtained with yeast gene
expression systems.
Two entities have patents and patent applications directed to
Agrobacterium-mediated transformation of duckweed:
-
North Carolina State University has been granted a United
States patent directed to transformation of duckweed tissue with
Agrobacterium having a gene of interest. The invention further
comprises a method for mass production of recombinant proteins or peptides from
duckweed cultures.
-
Yeda Research & Development Co. has filed patent
applications in Europe, Australia and Canada directed to a transformed Lemnaceae
plant with Agrobacterium. Lemnaceae is the name of the botanical family
to which duckweed belongs. Duckweeds from the genera Spirodela,
Lemna and Wolffia are used for the production of various
chemical and biological products. The claims as filed recite different methods
for the transformation of Lemnaceae such as in planta transformation,
microinjection of Agrobacterium cells into meristematic plant cells and
incubation of meristematic plant cells with Agrobacterium.
Although the inventions disclosed by both institutes may overlap in terms of
the subject matter, they have been filed in different countries. The claims as
filed by Yeda Research & Development Co. in the European
patent application are broad and may have a different scope if granted.
Duckweed - Specific Patent Information
|
Patent Number
|
Title, Independent Claims and Summary of Claims
|
Assignee
|
|
US
6040498
- Earliest priority - 11 August 1998
- Filed - 11 August 1998
- Granted - 21 March 2000
- Expected expiry - 10 August 2018
|
Title - Genetically Engineered Duckweed
| Claim 1
A method for stably transforming duckweed tissue with a nucleotide sequence
of interest, the method comprising the steps of:
A) inoculating a duckweed plant tissue with
Agrobacterium comprising a vector which comprises a nucleotide sequence
of interest; and B) co-cultivating the tissue with the
Agrobacterium to produce stably transformed tissue.
|
| Claim 20
A stably transformed duckweed plant comprising a heterologous nucleic acid of
interest incorporated in its genome wherein said plant is produced via an
Agrobacterium-mediated method.
|
| Claim 30
A method of producing recombinant proteins or peptides, comprising the steps
of:
A) culturing a stably transformed duckweed plant that expresses at least one
heterologous protein or peptide; and B) collecting the at least one
heterologous protein or peptide from the duckweed cultures.
|
| Claim 48
A method for stably transforming duckweed tissue from the genus
Lemna with a nucleotide sequence of interest, the method comprising the
steps of:
A) inoculating a duckweed plant tissue with Agrobacterium
comprising a vector which comprises a nucleotide sequence of interest, wherein
the duckweed plant tissue is from the genus Lemna; and B)
co-cultivating the tissue with the Agrobacterium to produce stably
transformed tissue.
|
| Claim 59
A stably transformed duckweed plant from the genus Lemna comprising
a heterologous nucleic acid sequence incorporated in its genome wherein said
plant is produced via an Agrobacterium -mediated method.
|
| Claim 62
A method of producing recombinant proteins or peptides, comprising:
A) culturing a stably transformed duckweed plant from the genus
Lemna that expresses at least one heterologous protein or peptide; and
B) collecting the at least one protein or peptide from the duckweed
cultures.
|
A method for transforming a duckweed tissue by co-cultivating the tissue with
Agrobacterium having a sequence of interest. A method for producing
recombinant proteins or peptides by culturing transformed duckweed plants
expressing the proteins or peptides and collecting them form the cultured
plants. The same methods are used to transform a duckweed from the genus
Lemna.
|
North Carolina State University
|
|
AU
775632 B2
- Earliest priority - 12 August 1997
- Filed - 11 August 1998
- Granted - 19 December 2002
- Expected expiry - 10 August 2018
|
Title - Genetically engineered duckweed
Claim 1
A method for producing a stably transformed duckweed plant comprising a
heterologous nucleotide sequence of interest, the method comprising the steps
of:
(a) inoculating a duckweed callus tissue
with an Agrobacterium comprising a vector which is not a super-virulent
vector and which comprises a heterologous nucleotide sequence of interest,
wherein the nucleotide sequence comprises at least one expression cassette
comprising a gene which confers resistance to a selection agent; (b)
co-cultivating the callus tissue with the
Agrobacterium to produce stably transformed callus tissue; and
(c) regenerating a stably transformed duckweed plant from the
stably transformed callus tissue.
|
Claim 40
A method for producing a stably transformed duckweed plant comprising a
chimeric nucleotide sequence of interest, the method comprising the steps of:
(a) inoculating a duckweed callus tissue with an Agrobacterium
comprising a vector which is not a super-virulent vector and which comprises a
chimeric nucleotide sequence of interest, said chimeric nucleotide sequence
comprising a coding sequence operably linked to a transcription initiation
region that is heterologous to said coding sequence; (b) co-cultivating the
callus tissue with the Agrobacterium to produce stably transformed
callus tissue; and (c) regenerating a stably transformed duckweed plant
from the stably transformed callus tissue.
|
Granted AU 775632 recites a method to produce stably
transformed duckweed with duckweed callus tissue with a ('heterologous' or
'chimeric') nucleotide sequence of interest, which comprises
- inoculation of Agrobacterium,
- co-cultivation of Agrobacterium with the callus tissue, and
- regeneration of transformed callus tissue.
|
| Remarks |
- Continuations of the divisional patent application of US 6040498
(US
2004/73968 A1 and
US
2003/115640 A1) are still pending.
- National phase entry of
WO
1999/07210 in Canada (CA 2288895), China (CN 1272762), Europe (EP 1037523),
Japan (JP 2001/513325) are pending.
- Other national phase entry of
WO
1999/07210 includes Israel (IL 132580).
|
|
EP
1021552 A1
- Earliest priority - 10 October 1997
- Filed - 8 October 1998
- Application pending
|
Title - Transgenic Lemnaceae
| Claim 1
A genetically stable, transformed Lemnaceae plant and progeny thereof.
|
| Claim 12*
A method for the stable genetic transformation of Lemnaceae plants which
comprises: incubating Lemnaceae plants and/or tissue with
Agrobacterium cells containing a transforming DNA molecule, whereby
cells in said plant tissue become stably transformed with said DNA.
|
| Claim 19*
A method for the genetic transformation of a plant comprising: A) cutting the
plant into particles of a size such that they still contain undamaged
meristematic tissue capable of developing into full plants; B) incubating
said particles with Agrobacterium cells containing transforming DNA
molecules, whereby said transforming DNA is introduced into meristematic cells
in said particles; and C) producing transformed plants from the transformed
meristematic tissue.
|
| Claim 23*
A method for the stable genetic transformation of a Lemnaceae plant
comprising microinjecting Agrobacterium cells containing a
transforming DNA into the meristematic zone of the plant, whereby the meristemic
tissue becomes stably transformed with said DNA.
|
| Claim 25
A) method for the in planta transformation of Lemnaceae plants
comprising: A) exposing the plant's meristematic zone by removal of the daughter
fronds; B) incubating the plant with Agrobacterium cells capable
of targeting to the meristemic tissue.
|
| Claim 37*
A booster medium for enhancing Agrobacterium cell's virulence
comprising plant tissue culture at a pH below about 5.2.
|
| Claim 43*
A booster medium for enhancing Agrobacterium cell's virulence
comprising an extract from Lemnaceae plants.
|
| Claim 45
A method for maintaining morphogenetic Lemnaceae calli for long-periods of
time comprising culturing the calli in a medium having a low level of sucrose.
|
| Claim 47
A method for the regeneration of plants from calli wherein the plant's growth
medium has sucrose levels below 1.5% and comprises: B5, minerals and organic
compounds.
|
| Claim 48
A method for the production of highly regenerative calli, wherein the calli's
growth medium has sucrose levels below 1.5% and comprises B5, minerals and
organic compounds.
|
| Claim 50
A method for the production of highly regenerative calli, wherein the calli's
growth medium has sucrose levels below 1.5% and comprises B5, minerals, organic
compounds and selection agents.
|
| Claim 52
A method for the production of stable transformed plants, wherein the growth
media has sucrose levels below 1.5% and comprises B5, minerals and organic
compounds.
|
* Claims directly related to Agrobacterium -mediated transformation
of a Lemnaceae plant.
Different methods for stable genetic transformation of a Lemnaceae plant with
Agrobacterium containing a gene of interest. The methods include
incubating the plants with Agrobacterium, incubating meristematic
tissue with the bacterium, injecting the bacterium into the meristematic tissue
and in planta transformation. The invention also includes methods for
enhancing the virulence of Agrobacterium and for regenerating calli and
transformed plants.
|
Yeda Research & Development Co.
|
|
AU
759570 B2
- Earliest priority - 10 October 1997
- Filed - 8 October 1998
- Granted - 17 April 2003
- Expected expiry - 7 October 2018
|
Title - Transgenic Lemnaceae
Claim 1
A stably transformed Lemnaceae plant, tissues, products and progeny thereof
of the genus Spirodela, when produced by Agrobacterium-mediated
transformation.
|
| Claim 2
A method for the stable genetic transformation of Lemnaceae plants,
comprising the step of: Incubating meristematic tissues of Lemnaceae with
Agrobacterium cells containing a transforming DNA molecule, wherein the
Agrobacterium cells are A. tumefaciens strains EHA105, EHA 101
or GVE3103, whereby cells in said tissue become stably transformed with said
DNA, and regenerating Lemnaceae from the meristematic tissue.
|
Claim 3
A method for the stable genetic transformation of Lemnaceae plants,
comprising the step of: microinjecting into a meristematic zone of
Lemnaceae plants and/or tissue Agrobacterium cells containing a
transforming DNA molecule, whereby cells in said plant tissue become stably
transformed with said DNA.
|
Claim 4
A method for the stable genetic transformation of a Lemnaceae plant,
comprising the steps of: a) cutting the plant into particles of a size such
that they still contain undamaged meristematic tissue capable of developing into
full plants; b) incubating said particles with Agrobacterium
cells containing transforming DNA molecules, whereby said transforming DNA is
introduced into meristematic cells in said particles; and c) producing
transformed plants form the meristematic tissue.
|
| Claim 7
A method for the stable genetic transformation of a Lemnaceae plant,
comprising the step of: microinjecting Agrobacterium cells
containing a transforming DNA molecule into the meristematic zone of the plant,
whereby the meristematic tissue becomes stably transformed with said DNA.
|
Claim 8
A method for the in planta transformation of Lemnaceae plants, comprising the
steps of: a) exposing the plant’s meristematic zone by removal of daughter
fronds; and b) incubating the plant with Agrobacterium cells
capable of targeting to the meristematic tissue.
|
This granted patent claims any Lemnaceae plant, part or whole, that is
transformed using Agrobacterium.
It also claims a method of Agrobacterium-mediated transformation
using the meristematic tissue of Lemnaceae plants.
|
| Remarks |
- National phase entry of
WO
1999/19497 in Canada (CA 2312008) is still pending.
- Other national phase entry of
WO
1999/19497 includes Israel (IL 135543).
|
Note: Patent information on this page was last updated on 9 March 2006.
Gladiolus

The present patent claims a method to transform a corm tissue from a
Gladiolus plant with a vir+ A. tumefaciens.
The patent is thus limited to a gladiolus corm (an underground stem modified
into a mass storage tissue) as the tissue to be transformed.
Other types of
gladiolus tissues are not encompassed by the claims.
Specific Patent Information
|
Patent Number
|
Title, Independent Claims and Summary of Claims
|
Assignee
|
|
US
5340730
- Earliest priority - 31 March 1988
- Filed - 17 June 1992
- Granted - 23 August 1994
- Expired - 25 September 2002 (due to non-payment of maintenance fees)
|
Title - Process for Transforming Gladiolus
| Claim 1
A method of producing a transformed Gladiolus plant comprising:
A) removing a piece of tissue from a corm; B) inoculating the tissue
with vir+ Agrobacterium tumefaciens strain;
C) incubating the inoculated tissue until a tumor forms; D) culturing at
least a portion of the tumor in hormone-free medium until a cormel forms;
and E) growing the cormel to produce the transformed plant.
|
|
University of Toledo
|
| Remarks |
This patent has been abandoned according to the USPTO database. While there
don't seem to be any patents with specific claims to Gladiolus
transformation using Agrobacterium, other patents related to general
methods or transformation of monocots still may apply.
|
Note: Patent information on this page was last updated on 7 February 2006.
Maize
Summary
The University of
Toledo (US), Pioneer Hi-Bred (US), and Stine
Biotechnology (US) have been granted United States patents directed to
Agrobacterium-mediated transformation of maize. The main difference
among them is the type of maize tissue used as target for transformation:
- The University of Toledo claims a maize seedling wounded in
a specific area for inoculation of the bacterium.
-
Pioneer Hi Bred claims an immature embryo of maize and a
medium formula for cultivation of a transformed maize embryo
-
Stine Biotechnology also employs immature embryos as target
tissue for transformation with Agrobacterium in their patent. Claims in
their applications disclose a method to improve the production of so-called Type
II callus (a preferred target tissue for the transformation of corn) by
including a monosaccharide like glucose in addition to the usual sucrose in the
medium.
Maize - Specific Patent Information - part 1
|
Patent Number
|
Title, Independent Claims and Summary of Claims
|
Assignee
|
|
US
5177010
- Earliest priority - 30 June 1986
- Filed - 5 September 1990
- Granted - 5 Jan 1993
- Expected expiry - 4 September 2010
|
Title - Process for Transforming Corn and the Products
Thereof
| Claim 1
A method of producing transformed corn, said method comprising:
A) making a wound in a corn seedling with newly emerging radicle and stem,
said wound being made in an area of the seedling containing rapidly dividing
cells, wherein said area extends from the base of the scutellar node to slightly
beyond the coleoptile node; and B) inoculating the wound with
vir+ A. tumefaciens.
|
Transformation of a corn seedling by inoculating vir+
A. tumefaciens in a wounded area located between the scutellar node to
slightly beyond the coleoptile node. This area presents a high rate of cell
division.
|
University of Toledo
|
|
US
2002/0002711 A1
- Earliest priority - 27 June 1994
- Filed - 10 June 1998
- Abandoned - 28 May 2002
|
Title - Process for Transforming Germinae and the Products Thereof
| Claim 1
1. A transformed Gramineae.
|
Claim 7
A fertile transgenic Zea mays plant comprising stably incorporated exogenous
DNA.
|
Claim 10
A transformed corn plant having a transformed gene, the plant produced by an
Agrobacterium-mediated transformation or direct gene transfer
transformation.
|
Claim 11
A transformed corn plant produced by an Agrobacterium or direct cell
transfer whereby the plant or other differentiated organs or tissues provide an
expression of exogenous DNA in the corn product.
|
Claim 12
A transformed corn plant produced by a regenerated protoplast or single cell
cultures.
|
| Claim 13
A transformed corn plant produced by a method equivalent to an
Agrobacterium tumefaciens-mediated transformation.
|
Transformed corn plant having a transformed gene produced by:
Agrobacterium -mediated transformation or an equivalent method, direct
cell transfer, regenerated protoplasts and single cell cultures. Fertile
transgenic Zea mays having an exogenous gene and transformed Gramineae
are also part of the filed claims.
This patent application has been abandoned (failure to respond to a USPTO
action) according to the USPTO.
|
Goldman and Graves
|
| Remarks |
A related patent has been granted in Japan (JP3234534, which is a divisional
of now granted JP 2693443 claiming Agrobacterium-mediated
transformation of Gramineae).
|
|
US
5981840
- Earliest priority - 24 January 1997
- Filed - 24 January 1997
- Granted - 9 Nov 1999
- Expected expiry - 23 January 2017
|
Title - Method for Agrobacterium-Mediated Transformation
| Claim 1
A method for transforming maize using Agrobacterium comprising the
steps of:
A) contacting at least one immature embryo from a maize plant with
Agrobacterium capable of transferring at least one gene to the embryo;
B) co-cultivating the embryo with Agrobacterium; C)
culturing the embryo in a medium comprising N6 salts, an antibiotic at
concentrations capable of inhibiting the growth of Agrobacterium, and a
selective agent to select for embryos expressing the gene; and D)
regenerating plants expressing the gene.
|
| Claim 4
A method for transforming maize using Agrobacterium comprising the
steps of:
A) contacting at least one immature embryo from a maize plant with
Agrobacterium capable of transferring at least one gene to the embryo
in a medium comprising N6 salts; B) co-cultivating the embryo with
Agrobacterium in a medium comprising N6 salts; C) culturing the
embryo in a medium comprising N6 salts, an antibiotic at concentrations capable
of inhibiting the growth of Agrobacterium, and a selective agent to
select for embryos expressing the gene; and D) regenerating plants
expressing the gene in a medium comprising MS salts.
|
| Claim 7
A method for transforming maize using Agrobacterium comprising the
steps of:
A) contacting at least one immature embryo from a maize plant with
Agrobacterium capable of transferring at least one gene to the embryo
in a medium comprising N6 or MS salts; B) co-cultivating the embryo with
Agrobacterium in a medium comprising MS salts; C) culturing the
embryo in a medium comprising N6 salts, an antibiotic at concentrations capable
of inhibiting the growth of Agrobacterium, and a selective agent to
select for embryos expressing the gene; and D) regenerating plants
expressing the gene in a medium comprising MS salts.
|
| Claim 10
A method for optimizing the production of transgenic maize plants of a first
genotype using Agrobacterium-mediated transformation comprising the
steps of:
A) isolating immature embryos from maize; B) separating the embryos into
treatment groups; C) incubating each treatment group separately in a medium
comprising N6 or MS salts and in a suspension of Agrobacterium at
concentrations ranging from about 1×108 cfu/ml to about
1×1010 cfu/ml; D) co-cultivating the embryos with
Agrobacterium on a solid medium; E) culturing the embryos in a
medium comprising N6 salts, an antibiotic at concentrations capable of
inhibiting the growth of Agrobacterium, and a selective agent to select
for embryos transformed by Agrobacterium; F) identifying the
treatment group with the highest transformation frequency; and G) using the
concentration of Agrobacterium generating the highest transformation
frequency to transform other embryos from the first genotype.
|
| Claim 13
A method for transforming maize using Agrobacterium comprising the
steps of:
A) contacting at least one immature embryo from a maize plant with
Agrobacterium capable of transferring at least one gene to the embryo;
B) co-cultivating the embryo with Agrobacterium; C)
culturing the embryo in a medium containing salts other than MS salts, an
antibiotic at concentrations capable of inhibiting the growth of
Agrobacterium, and a selective agent to select for embryos expressing
the gene; and D) regenerating plants expressing the gene.
|
Transformation of an immature embryo of maize by contact and co-cultivation
with Agrobacterium having a gene of interest. The media used for
culturing the embryo contains N6 or MS salts, an antibiotic against
Agrobacterium, and a selective agent for embryos expressing the gene.
Regeneration of plants expressing the gene is also recited in the claims.
|
Pioneer Hi-Bred
|
|
AU
727849 B2
- Earliest priority - 24 January 1997
- Filed - 23 January 1998
- Granted - 4 January 2001
- Expected expiry - 22 January 2018
|
Title - Methods for Agrobacterium-mediated
transformation
| Claim 1
A method for transforming maize using Agrobacterium comprising the
steps of:
A) contacting at least one immature embryo from a maize plant with
Agrobacterium capable of transferring at least one gene to the embryo;
B) co-cultivating the embryo with Agrobacterium; C)
culturing the embryo in a medium comprising N6 salts, an antibiotic at
concentrations capable of inhibiting the growth of Agrobacterium, and a
selective agent to select for embryos expressing the gene; and D)
regenerating plants expressing the gene.
|
Claim 1 states the same method of maize transformation as that of US 5981840.
|
|
EP
971578 A1
- Earliest priority - 24 January 1997
- Filed - 23 January 1998
- Application deemed to be withdrawn - 25 June 2003
|
Title
- Methods for Agrobacterium-mediated Transformation
| Claim 1
A method for transforming maize using Agrobacterium comprising the
steps of:
A) contacting tissue from a maize plant with Agrobacterium capable
of transferring at least one gene to the tissue in a non-LS salt medium;
B) co-cultivating the tissue with Agrobacterium in a non-LS salt
medium; C) culturing the tissue in a non-LS salt medium and a selective
agent to select for tissue expressing the gene; and D) regenerating, in a
non-LS salt medium, plants expressing the gene.
|
The transformation method disclosed in these applications is very similar to
the method claimed in the United States patent US 5981840. The
difference consists in the use of a co-cultivation medium free of LS salts.
|
| Remarks |
- A divisional patent of now granted US 5981840 has been granted in the US
(US
6822144), which claims a stably transformed maize plant (limited to
PHN46 or PHJ90 inbred plants) using Agrobacterium to transform an
immature embryo.
- National phase entry of
WO
1998/32326 in Canada (CA 2278618 AA) is pending.
|
Note: Patent information on this page was last updated on 7 February 2006.
Maize - Specific Patent Information - part 2
|
Patent Number
|
Title, Independent Claims and Summary of Claims
|
Assignee
|
|
US
6420630 B1
- Earliest priority - 1 December 1998
- Filed - 1 December 1998
- Granted - 16 July 2002
- Expected expiry - 30 November 2018
|
Title - Methods for tissue culturing and transforming elite
inbreds of Zea mays L.
| Claim 1
A method for transforming a line of corn using Agrobacterium
comprising the steps of: (a) initiating co-cultivation of an immature
embryo from said line with Agrobacterium capable of transferring at
least one gene to tissue of said line to produce an infected embryo; (b)
applying heat shock treatment during said co-cultivation; (c) culturing the
infected embryo to initiate callus on a medium comprising an antibiotic;
(d) culturing the resulting callus tissue on a medium comprising a selective
agent; (e) selecting transformed callus tissue comprising growing Type II
callus; and (f) regenerating transgenic plants from said Type II callus.
|
A method of transforming maize by co-cultivating Agrobacterium
carrying a gene of interest with immature embryos. Heat shock is applied to
enhance DNA integration.
|
Stine Biotechnology
|
|
US
6919494 B2
- Earliest priority - 1 December 1998
- Filed - 30 July 2001
- Granted - 19 July 2005
- Expected expiry - 29 July 2021
|
Title - Methods for tissue culturing and transforming elite
inbreds of Zea mays L.
| Claim 1
A method for producing a corn plant comprising the steps of:
(a) co-cultivating an immature embryo from said tissue at a temperature of
about 18ËšC. to 20ËšC. with Agrobacterium capable of transferring at
least one DNA sequence of interest to said tissue to produce an infected embryo;
(b) culturing the infected embryo on a medium comprising an antibiotic to
produce a resulting tissue;
(c) culturing said resulting tissue on a medium comprising a selective agent
and an antibiotic;
(d) selecting transformed tissue having Type II callus; and
(e) regenerating transgenic plants from said Type II callus.
|
| Claim 3
A method for transforming a line of corn comprising the steps of:
(a) co-cultivating an immature embryo from said line with
Agrobacterium capable of transferring at least one DNA sequence of
interest to said tissue of said line to produce an infected embryo;
(b) culturing the infected embryo to initiate callus on a medium comprising
an antibiotic and a compound selected from the group consisting of glucose,
maltose, lactose, sorbitol and mannitol, wherein the concentration of said
compound is from 5 g/L to 30 g/L;
(c) culturing the resulting callus tissue on a medium comprising a selective
agent and an antibiotic;
(d) selecting transformed callus tissue comprising growing Type II callus;
and
(e) regenerating transgenic plants from said growing Type II callus.
|
| Claim 4
A method for producing a transformed corn plant using Agrobacterium
comprising the steps of:
(a) initiating co-cultivation of an immature embryo from said tissue with
Agrobacterium capable of transferring at least one DNA sequence of
interest to said tissue to produce an infected embryo;
(b) applying heat shock treatment during said co-cultivation;
(c) culturing the infected embryo to initiate callus on a medium comprising
an antibiotic and glucose;
(d) culturing the resulting callus tissue on a medium comprising a selective
agent and an antibiotic;
(e) selecting transformed callus tissue having Type II callus; and
(f) regenerating transgenic plants from said Type II callus.
|
Granted patent of application
US
2002/0104131 (see below).
Continuation of US Patent Application 09/203,679 (now
US
Patent 6420630 B1)
|
|
US
2002/0104131 A1
- Earliest priority - 1 December 1998
- Filed - 30 July 2001
- Granted as US 6919494 (see above)
|
Title - Methods for tissue culturing and transforming elite
inbreds of Zea mays L.
| Claim 1 (not granted in US 6919494)
A method for stimulating a high frequency production of Type II callus from
immature embryos of elite corn inbreds which comprises culturing said embryos on
a solid medium comprising sucrose and a monosaccharide sugar, wherein the
concentration of said monosaccharide sugar is between about 5 g/L and about 30
g/L.
|
Claim 4
A method for transforming elite lines of corn using Agrobacterium
comprising the steps of:
(a) co-cultivating an immature embryo from said elite line with
Agrobacterium capable of transferring at least one gene to tissue of
said elite line on a solid medium to produce an infected embryo;
(b) culturing the infected embryo on a solid medium comprising an antibiotic;
(c) culturing the resulting tissue on a solid medium comprising a selective
agent to select for transformed tissue;
(d) selecting transformed tissue with growing Type II callus capable of
forming water tower embryo structures; and
(e) regenerating plants from said embryo structures.
|
Claim 22
A method for transforming elite lines of corn using Agrobacterium
comprising the steps of:
(a) co-cultivating an immature embryo from said elite line with
Agrobacterium capable of transferring at least one gene to tissue of
said elite line on a solid medium to produce an infected embryo;
(b) culturing the infected embryo on a solid medium comprising an antibiotic
and a monosaccharide sugar in an amount of from 5 g/L to 30g/L;
(c) culturing the resulting tissue on a solid medium comprising an antibiotic
and a selective agent;
(d) culturing the resulting tissue on a solid medium comprising a selective
agent to select for transformed tissue;
(e) selecting transformed tissue with growing Type II callus capable of
forming water tower embryo structures; and
(f) regenerating plants from said embryo structures.
|
Claim 32
A method for transforming elite lines of corn using Agrobacterium
comprising the steps of:
(a) co-cultivating at a temperature of 19[deg.] C. an immature embryo from
said elite line with Agrobacterium capable of transferring at least one
gene to tissue of said elite line on a solid medium to produce an infected
embryo, said Agrobacterium is selected from Agrobacterium one
to two days after rescue from frozen glycerol stocks;
(b) culturing the infected embryo on a solid medium comprising an antibiotic
at a concentration of 15 mg/L to 75 mg/L and a monosaccharide sugar selected
from the group consisting of glucose, maltose, lactose, sorbitol and mannitol in
an amount of from 5 g/L to 30 g/L;
(c) culturing the resulting tissue on a solid medium comprising an antibiotic
and a selective agent;
(d) culturing the resulting tissue on a solid medium comprising a selective
agent to select for transformed tissue;
(e) selecting transformed tissue with growing Type II callus capable of
forming water tower embryo structures; and
(f) regenerating plants from said embryo structures.
|
A method in which formation of Type II callus (a preferred form of target
tissue for the transformation with Agrobacterium) from immature embryos
is enhanced by adding sucrose and a monosaccharide to the medium.
Continuation of US Patent Application 09/203,679 (now US Patent US
6420630 B1)
|
|
US
2002/0104132 A1
- Earliest priority - 1 December 1998
- Filed - 30 July 2001
- Abandoned - 19 September 2005
|
Title - Methods for tissue culturing and transforming elite
inbreds of Zea mays L.
| Claim 1
A method for stimulating a high frequency production of Type II callus from
immature embryos of elite corn inbreds which comprises
- culturing said embryos on a solid medium comprising sucrose and a
monosaccharide sugar, wherein the concentration of said monosaccharide sugar is
between about 5 g/L and about 30 g/L.
|
| Claim 4
A method for transforming elite lines of corn using Agrobacterium
comprising the steps of:
(a) co-cultivating an immature embryo from said elite line with
Agrobacterium capable of transferring at least one gene to tissue of
said elite line on a solid medium to produce an infected embryo;
(b) culturing the infected embryo on a solid medium comprising an antibiotic;
(c) culturing the resulting tissue on a solid medium comprising a selective
agent to select for transformed tissue;
(d) selecting transformed tissue with growing Type II callus capable of
forming water tower embryo structures; and
(e) regenerating plants from said embryo structures.
|
| Claim 22
A method for transforming elite lines of corn using Agrobacterium
comprising the steps of:
(a) co-cultivating an immature embryo from said elite line with Agrobacterium
capable of transferring at least one gene to tissue of said elite line on a
solid medium to produce an infected embryo;
(b) culturing the infected embryo on a solid medium comprising an antibiotic
and a monosaccharide sugar in an amount of from 5 g/L to 30g/L;
(c) culturing the resulting tissue on a solid medium comprising an antibiotic
and a selective agent;
(d) culturing the resul ting tissue on a solid medium comprising a selective
agent to select for transformed tissue;
(e) selecting transformed tissue with growing Type II callus capable of
forming water tower embryo structures; and
(f) regenerating plants from said embryo structures.
|
| Claim 32
A method for transforming elite lines of corn using Agrobacterium
comprising the steps of:
(a) co-cultivating at a temperature of 19[deg.] C. an immature embryo from
said elite line with Agrobacterium capable of transferring at least one
gene to tissue of said elite line on a solid medium to produce an infected
embryo, said Agrobacterium is selected from Agrobacterium one
to two days after rescue from frozen glycerol stocks.;
(b) culturing the infected embryo on a solid medium comprising an antibiotic
at a concentration of 15 mg/L to 75 mg/L and a monosaccharide sugar selected
from the group consisting of glucose, maltose, lactose, sorbitol and mannitol in
an amount of from 5 g/L to 30 g/L;
(c) culturing the resulting tissue on a solid medium comprising an antibiotic
and a selective agent;
(d) culturing the resulting tissue on a solid medium comprising a selective
agent to select for transformed tissue;
(e) selecting transformed tissue with growing Type II callus capable of
forming water tower embryo structures; and
(f) regenerating plants from said embryo structures.
|
A method as in the application above but specifically designed for elite corn
inbred lines.
Divisional application from US Patent Application 09/203,679 (now US Patent
US 6420630 B1), this application has been abandoned due to
failure to respond to a USPTO action according to the USPTO.
|
|
US
2005/0278802 A1
- Earliest priority - 1 December 1998
- Filed - 18 July 2005
- Application pending
|
Title - Methods for tissue culturing and transforming elite inbreds of
Zea mays L.
| Claim 35
A method for producing a corn plant comprising the steps of:
(a) culturing a corn embryo on a medium comprising a compound selected from
the group consisting of glucose, maltose, lactose, sorbitol, and mannitol,
wherein said compound is in an amount of from about 5 g/L to 30 g/L, to produce
a type II callus; and
(b) regenerating a plant.
|
This is a divisional application of now granted US 6420630.
All of the independent claims preceeding claim 35 has been cancelled.
|
Note: Patent information on this page was last updated on 7 February 2006.
Onions (Allium spp)
Summary
The New Zealand Institute for
Crop & Food Research and Seminis Vegetable Seeds
have filed patent applications directed to the transformation of Allium
spp. (onions) using Agrobacterium.
-
The New Zealand Institute for Crop & Food Research: the
PCT application contains a very broad independent claim reciting a method of
transforming plants of the Allium genus but lacks recitation of any
steps. As such, it is highly unlikely to be granted as filed. If allowed, such a
claim would cover any method used to this end. It is possible that converted
patents will not contain such a claim. New Zealand application NZ 513184, for
example, specifies the target tissue for transformation (embryos or
embryo-derived cell cultures), and that transformation is carried out without
passage through a callus stage. A preferred explant used in the transformation
procedure with Agrobacterium are wounded immature embryos.
-
Seminis Vegetable Seeds discloses a method that uses
embryogenic callus, embryos or flower buds as a target explant for
transformation with Agrobacterium.
Because of their limited subject matter, these applications may be affected
by other patents with granted claims to general transformation methods for
monocots.
Specific Patent Onions - Specific Patent Information
|
Patent Number
|
Title, Independent Claims and Summary of Claims
|
Assignee
|
|
WO
2000/44919 A1
- Earliest priority - 29 January 1999
- Filed - 10 December 1999
- OPI - 3 August 2000
|
Title - Transformation and Regeneration of Allium
plants A preferred embodiment utilizes the alliinase gene, which encodes an
enzyme involved in sulfur metabolism.
| Claim 1
A method of transforming plants of the Allium genus.
|
| Claim 3
A method of transforming plants of the Allium genus comprising
inoculating an embryo culture of an Allium species with an
Agrobacterium tumefaciens strain containing a suitable vector or
plasmid.
|
| Claim 9
A method of transforming Allium using immature embryos as an explant
source, including: (a) isolating immature embryos of the Allium
plant to be transformed; (b) innoculating cultures of the immature embryos
with an Agrobacterium tumefaciens strain containing a binary
vector; (c) wounding embryos and infiltrating embryos with
agrobacteria; (d) transferring embryos to a selective medium; (e)
culturing embryo pieces; (f) selecting putative transgenic cultures;
and (g) regenerating plants.
|
|
New Zealand Institute for Crop & Food Research Ltd.
|
|
AU
763531 C
- Earliest priority - 29 January 1999
- Filed - 10 December 1999
- Granted - 24 July 2003
- Amended - 26 February 2004
- Expected expiry - 9 December 2019
|
Title - Transformation and regeneration of Allium
plants
| Claim 1
A method of transforming plants of the Allium genus comprising the
following steps: (a) delivering previously manipulated DNA into embryo, or
embryo derived culture cell types of the Allium genus via vector or
direct gene transfer; (b) selecting transformed plant material; (c)
culturing and regenerating the transformed plants; wherein the
transformation is carried out without passage through a callus phase.
|
| Claim 7
A method of transforming Allium using immature embryos as an explant
source, including: (a) isolating immature embryos of the Allium
plant to be transformed; (b) innoculating cultures of the immature embryos
with an Agrobacterium tumefaciens strain containing a binary
vector; (c) wounding embryos and infiltrating embryos with
agrobacteria; (d) transferring embryos to a selective medium; (e)
culturing embryo pieces; (f) selecting putative transgenic cultures;
and (g) regenerating plants.
|
|
| Remarks |
- Related patent granted in New Zealand (NZ 513184).
- National phase entries of WO 2000/44919 in Canada (CA 2361143 A1) and Europe
(EP 1144664 A1) are still pending.
|
|
EP
1180927 B1
- Earliest priority - 5 May 1999
- Filed - 5 May 2000
- Granted - 21 December 2005
- Expected expiry - 4 May 2020
|
Title - Transformation of Allium sp with
Agrobacterium using embrogenic callus cultures
A method of transforming Allium species (onions) with
Agrobacterium carrying a heterologous gene. A preferred embodiment
utilizes immature embryos and flower buds as target tissue for transformation.
| Claim 1
A method for transforming an Allium species with a heterologous
gene, the method comprising the step of: contacting embryogenic callus material
from an Allium species with a bacterium belonging to the genus
Agrobacterium which contains a heterologous gene.
|
| Claim 8
A method for transforming an Allium species with a heterologous
gene, the method comprising the steps of: a. culturing immature embryos or
flower buds from an Allium species on an initiation medium for a period
of from about 2 to about 6 months until embryogenic callus material forms on the
embryos or flower buds; b. transferring the embryogenic callus material to
a coculture medium and contacting the embryogenic callus material with a
suspension of Agrobacterium rhizogenes or Agrobacterium
tumefaciens containing a heterologous gene; c. incubating the
embryogenic callus material with the Agrobacterium rhizogenes or
Agrobacterium tumefaciens for a period of from about 2 to about 4 days;
and d. removing the Agrobacterium rhizogenes or Agrobacterium
tumefaciens from the transformed embryogenic callus material.
|
Designated contracting State at the time of grant is Spain.
|
Seminis Vegetable Seeds Inc. (US)
|
|
EP 1180927 A1
- Earliest priority - 5 May 1999
- Filed - 5 May 2000
- Granted as EP 1180927 B1 (see above)
|
Title - Transformation of Allium sp with
Agrobacterium using embrogenic callus cultures
A method of transforming Allium species (onions) with
Agrobacterium carrying a heterologous gene. A preferred embodiment
utilizes immature embryos and flower buds as target tissue for transformation.
| Claim 1 (granted)
A method for transforming an Allium species with a heterologous
gene, the method comprising the step of: contacting embryogenic callus material
from an Allium species with a bacterium belonging to the genus
Agrobacterium which contains a heterologous gene.
|
Claim 9 (granted)
A method for transforming an Allium species with a heterologous
gene, the method comprising the steps of:
a. culturing immature embryos or flower buds from an Allium species
on an initiation medium for a period of from about 2 to about 6 months until
embryogenic callus material forms on the embryos or flower buds; b.
transferring the embryogenic callus material to a coculture medium and
contacting the embryogenic callus material with a suspension of Agrobacterium
rhizogenes or Agrobacterium tumefaciens containing a heterologous gene;
c. incubating the embryogenic callus material with the Agrobacterium
rhizogenes or Agrobacterium tumefaciens for a period of from about
2 to about 4 days; and d. removing the Agrobacterium rhizogenes
or Agrobacterium tumefaciens from the transformed embryogenic callus
material.
|
|
|
AU
780954 B2
- Earliest priority - 5 May 1999
- Filed - 5 May 2000
- Granted - 28 April 2005
- Expected expiry - 4 May 2020
|
Title - Transformation of Allium sp. with
Agrobacterium using embryogenic callus cultures
Claims of this patent are limited to transforming Allium cepa and
A. fistulosum using Agrobacterium.
| Claim 1
A method for transforming an Allium cepa or Allium
fistulosum with a DNA of interest from a heterologous gene, the method
comprising the steps of: contacting embryogenic callus material from an
Allium cepa or Allium fistulosum with a bacterium
belonging to the genus Agrobacterium which contains a DNA of interest
from a heterologous gene and obtaining a transformed Allium cepa or
Allium fistulosum embryogenic callus under selective conditions.
|
| Claim 8
A method for transforming a plant or plant tissue of an Allium
cepa or Allium fistulosum with a DNA of interest from a
heterologous gene, the method comprising the steps of: a. culturing
immature embryos or flower buds from an Allium cepa or
Allium fistulosum on an initiation medium for a period of from about 2
to about 6 months until an embryogenic callus forms on the embryos or flower
buds; b. transferring the embryogenic callus to a coculture medium and
contacting the embryogenic callus with a suspension of Agrobacterium
rhizogenes or Agrobacterium tumefaciens containing a DNA of
interest from a heterologous gene; and c. obtaining a transformed
Allium cepa or Allium fistulosum embryogenic callus under
selective conditions.
|
|
Note: Patent information on this page was last updated on 7 February 2006.
Pineapple
Summary
The invention disclosed by DNA
Plant Technology Corp. in a granted United States patent is directed to
the transformation of embryogenic pineapple cells or pineapple callus with
Agrobacterium having a T-DNA with a heterologous gene.
The recently granted Australian patent also uses an embryogenic cell
or an embryogenic callus cell as a starting material for
transformation.
In a recently filed PCT application, the Department of Primary
Industries of Queensland (Australia) discloses methods for transforming
pineapple cells and genetically modified pineapple by co-cultivating a pineapple
explant with Agrobacterium having a gene of interest. Unlike the method
used by DNA Plant Technology Corp., the transformed pineapple
cells form an organogenic callus, which according to the
applicants is easier and faster to obtain than an embryogenic callus.
Pineapple - Specific Patent Information
|
Patent Number
|
Title, Independent Claims and Summary of Claims
|
Assignee
|
|
US
5952543
- Earliest priority - 25 February 1997
- Filed - 24 February 1998
- Granted - 14 September 1999
- Expected expiry - 23 February 2018
|
Title - Genetically transformed pineapple plants and methods
for their production
| Claim 1
A method for modifying the genotype of a pineapple cell, said method
comprising:
A) contacting said pineapple cell with Agrobacterium comprising a
T-DNA containing a DNA segment, such that said DNA segment is integrated into
the genome of said pineapple cell; and B) selecting a pineapple cell
comprising said integrated DNA segment wherein said pineapple cell is an
embryogenic cell or an embryogenic callus cell.
|
| Claim 11
A method for modifying the genotype of a pineapple cell, said method
comprising:
A) culturing pineapple tissue to produce pineapple embryogenic cells;
B) contacting said pineapple embryogenic cells with Agrobacterium
comprising a T-DNA containing a DNA segment, such that said DNA segment is
integrated into the genome of said pineapple cells; and C) selecting a
pineapple cell comprising said integrated DNA segment.
|
|
DNA Plant Technology Corp.
|
|
AU
740294 B2
- Earliest priority - 25 February 1997
- Filed - 25 February 1998
- Granted - 1 November 2001
- Expected expiry - 24 February 2018
|
Title - Genetically transformed pineapple plants and methods
for their production
| Claim 1
A method for modifying the genotype of a pineapple cell, said method
comprising:
A) contacting said pineapple cell with Agrobacterium comprising a
T-DNA containing a DNA segment, such that said DNA segment is integrated into
the genome of said pineapple cell; and B) selecting a pineapple cell
comprising said integrated DNA segment wherein said pineapple cell is an
embryogenic cell or an embryogenic callus cell.
|
| Claim 11
A method for modifying the genotype of a pineapple cell, said method
comprising:
A) culturing pineapple tissue to produce pineapple embryogenic cells;
B) contacting said pineapple embryogenic cells with Agrobacterium
comprising a T-DNA containing a DNA segment, such that said DNA segment is
integrated into the genome of said pineapple cells; and C) selecting a
pineapple cell comprising said integrated DNA segment.
|
| Claim 39
A method for modifying the genotype of a pineapple cell, said method being
substantially as hereinbefore described with reference to any one of the
examples.
|
| Claim 41
A pineapple plant cell comprising an integrated Agrobacterium T-DNA
sequence comprising a heterologous gene, substantially as hereinbefore described
with reference to any one of the examples.
|
| Claim 51
A pineapple plant comprising an integrated Agrobacterium T-DNA
sequence comprising a heterologous gene, substantially as hereinbefore described
with reference to any one of the examples.
|
* Claims 1 and 11 of the Australian granted patent are the same as those of
the United States patent. The three additional independent claims in this patent
(claims 39, 41, 51) recite methods and transgenic pineapple plants stated in the
examples of the specification.
|
|
WO
2001/33943 A1
- Earliest priority - 5 November 1999
- Filed - 3 November 2000
- OPI - 17 May 2001
|
Title - A method of plant transformation
|
Claim 1 - See below *
|
|
Claim 21 - See below *
|
|
Claim 41 - See below *
|
| Claim 60
A method of transforming cells of a pineapple plant or a related plant with
genetic material, said method comprising: A) obtaining explant from said
pineapple plant or a related species; B) co-cultivating same with
Agrobacterium species having T-DNA or T-DNA region comprising genetic
material to be transformed into said pineapple plant cells for a time and under
conditions sufficient for transfer of the genetic material to occur; C)
selecting for transformed pineapple or related cells and permitting the cells to
form organogenic callus.
|
| Claim 77
A method of genetically modifying a pineapple or related plant, said method
comprising: A) obtaining an explant from a pineapple or related plant to be
genetically modified; B) co-cultivating the explant with
Agrobacterium species having a T-DNA comprising genetic material to be
transferred into the pineapple or related cells for a time and under conditions
sufficient for the genetic material to transfer to said cells; C) selecting
for transformed pineapple or related cells and permitting the cells to form
organogenic callus; and D) regenerating a pineapple or related plant from
said selected transformed cells.
|
Method for transforming pineapple cells by co-cultivating an explant with
Agrobacterium having T-DNA with genetic material to be transformed into
the plant cells.
The selected transformed pineapple cells form an organogenic callus. A
genetically modified pineapple plant is regenerated from the organogenic callus.
* The present application also contains claims (1, 21, 41) directed to
methods for transforming monocot plants in general, which are discussed under
the section
General
transformation methods.
|
Department of Primary Industries of Queensland
|
|
AU
779510 B
- Earliest priority - 5 November 1999
- Filed - 3 November 2000
- Granted - 27 January 2005
- Expected expiry - 2 November 2020
|
Title - A method of plant transformation
|
Claim 1
A method of transforming cells of a pineapple plant with genetic material,
said method comprising:-
(a) obtaining an explant from said plant;
(b) co-cultivating the explant with Agrobacterium species having a
T-DNA or T-DNA region comprising the genetic material to be transformed into the
plant cells for a time and under conditions sufficient for the genetic material
to transfer into the plant cells without said Agrobacterium overgrowing the
plant cells; and
(c) selecting for the tranformed plant cells and permitting the cells to form
organogenic callus.
|
|
Claim 19
A method for producing a genetically modified pineapple plant, said method
comprising:-
(a) obtaining explant from a plant to be genetically modified;
(b) co-cultivating the explant with Agrobacterium species having a
T-DNA or T-DNA region comprising genetic material to be transformed into said
plant cells for a time and under conditions sufficient for the genetic material
to transfer to plant cells without said Agrobacterium overgrowing the plant
cells;
(c) selecting transformed plant cells and permitting the cells to form
organogenic callus; and
(d) then regenerating a plant from selected transformed plant cells.
|
|
Claim 37
A method for producing a genetically modified pineapple plant, said method
comprising:
(a) obtaining an explant from said plant to be genetically modified;
(b) co-cultivating the explant with Agrobacterium species having a
T-DNA or T-DNA region comprising the genetic material to be transformed into the
plant cells for a time and under conditions sufficient for the genetic material
to transfer into the plant cells without the Agrobacterium overgrowing the plant
cells;
(c) selecting for the transformed plant cells and permitting the cells to
form organogenic callus; and
(d) regenerating a plant from said transformed organogenic callus.
|
Granted independent claims in this patent recite the same method of pineapple
transformation as claims 60 and 77 in WO 2001/33943, except
that the plant is limited to pineapple only and not those of "related plants".
|
Note: Patent information on this page was last updated on 7 February 2006.
Rice
Summary
-
United States and Australian patents
were granted to Japan Tobacco on methods for the transformation
of Indica rice. Patents are pending in other jurisdictions. The patent
specification discloses the use of immature embryo cells of
Indica rice for transformation with Agrobacterium
spp. The claims granted recite wide ranges for typical components of media used
in the selection medium. Note that other varieties of rice, such as
Japonica rice, are not covered by the claims
as granted (Update July 2003).
- In 2001, the National Science Council of R.O.C. in Taiwan
was granted a United States patent directed to a method for the transformation
of immature rice embryos with Agrobacterium. The
invention is not limited to any particular rice variety. A
particular feature of the transformation method is that the rice embryos and
Agrobacterium are co-cultivated with a dicot suspension
culture. In one of the preferred embodiments, the dicot suspension
culture is made of potato cells. According to the inventors, such culture is
rich in phenolic compounds, which induce the vir genes of the Ti
plasmid. Thus, the phenolic compounds of the culture assist the transformation
process.
-
Paradigm Genetics filed a PCT application disclosing the
transformation of a rice panicle with Agrobacterium
using vacuum infiltration. This method is carried out
in planta (the transformed plant part is still
attached to the whole plant) and avoids in vitro regeneration steps.
- The Indian company Avestha Gengraine Technologies has filed
a PCT application disclosing a method of transformation of Indica rice using
excised shoot tip tissue as a target for Agrobacterium.
Rice - Specific Patent Information - part 1
|
Patent Number
|
Title, Independent Claims and Summary of Claims
|
Assignee
|
|
US
6329571
- Earliest priority - 22 October 1996
- Filed - 22 October 1997
- Granted - 11 December 2001
- Expected expiry - 21 October 2017
|
Title - Method for Transforming Indica Rice
| Claim 1
A method for transforming rice comprising transforming immature embryo cells
of Indica rice by Agrobacterium method and selecting transformed cells,
characterized in that a medium containing
- 2000 to 4000 mg/l of KNO3,
- 60 to 200 mg/l of MgSO4,
- 200 to 600 mg/l of KH2PO4,
- 100 to 450 mg/l of CaCl2,
- 200 to 600 mg/l of (NH4)2SO4,
- 1 to 7 mg/l of H3BO3,
- 2 to 20 mg/l of MnSO4,
- 20 to 50 mg/l of EDTA or a salt thereof,
- 3 to 8 mg/l of Fe,
- 50 to 200 mg/l of myoinositol,
- 0.5 to 10 mg/l of 2,4-dichlorophenoxyacetic acid,
- 0.01 to 5 mg/l of a cytokinin,
- 5000 to 80,000 mg/l of a sugar, and
- a gelling agent,which medium has a pH of 4.5 to 6.5,
is used as a medium for selecting said transformed cells.
|
A method for transformation of Indica rice using immature embryo cells as
target tissue for Agrobacterium. Ranges for the media components are
disclosed in the independent claim.
|
Japan Tobacco
|
|
AU
736027 B2
- Earliest priority - 22 October 1996
- Filed - 22 October 1997
- Granted - 26 July 2001
- Expected expiry - 21 October 2017
|
Title - Method for Transforming Indica Rice
| Claim 1
A method for transforming rice comprising transforming immature embryo cells
of Indica rice by Agrobacterium method and selecting transformed cells,
characterized in that a medium containing:
- 2000 to 4000 mg/l of KNO3,
- 60 to 200 mg/l of MgSO4,
- 200 to 600 mg/l of KH2PO4,
- 100 to 450 mg/l of CaCl2,
- 200 to 600 mg/l of (NH4)2SO4,
- 1 to 7 mg/l of H3BO3,
- 2 to 20 mg/l of MnSO4,
- 20 to 50 mg/l of EDTA or a salt thereof,
- 3 to 8 mg/l of Fe,
- 50 to 200 mg/l of myoinositol,
- 0.5 to 10 mg/l of 2,4-dichlorophenoxyacetic acid,
- 0.01 to 5 mg/1 of a cytokinin,
- 5000 to 80,000 mg/l of a sugar, and
- a gelling agent, which medium has a pH of 4.5 to 6.5,
is used as a medium for selecting said transformed cells.
|
Transformation of immature embryo cells of Indica rice by
Agrobacterium. The composition of the medium used to select the
transformed cells is disclosed.
|
|
EP 897013
A1
- Earliest priority - 22 October 1996
- Filed - 27 October 1997
- Application deemed withdrawn - 18 December 2003
|
Title - Method for Transforming Indica Rice
| Claim 1
A method for transforming rice comprising transforming immature embryo cells
of Indica rice by Agrobacterium method and selecting transformed cells,
characterized in that a medium containing:
- 2000 to 4000 mg/l of KNO3,
- 60 to 200 mg/l of MgSO4,
- 200 to 600 mg/l of KH2PO4,
- 100 to 450 mg/l of CaCl2,
- 200 to 600 mg/l of (NH4)2SO4,
- 1 to 7 mg/l of H3BO3,
- 2 to 20 mg/l of MnSO4,
- 20 to 50 mg/l of EDTA or a salt thereof,
- 3 to 8 mg/l of Fe,
- 50 to 200 mg/l of myoinositol,
- 0.5 to 10 mg/l of 2,4-dichlorophenoxyacetic acid,
- 0.01 to 5 mg/1 of a cytokinin,
- 5000 to 80,000 mg/l of a sugar, and
- a gelling agent, which medium has a pH of 4.5 to 6.5,
is used as a medium for selecting said transformed cells.
|
|
|
Remarks
|
- National phase entry of
WO
1998/17813 in Canada (CA 2240454) has lapsed according to CIPO.
- National phase entry of
WO
1998/17813 in China (CN 1206435) is deemed withdrawn according to CNPO.
- National phase entry of
WO
1998/17813 in Japan (JP H10-117776) has been rejected by the JPO.
|
Note: Patent information on this page was last updated on 8 February 2006.
Rice - Specific Patent Information - part 2
|
Patent Number
|
Title, Independent Claims and Summary of Claims
|
Assignee
|
|
US
6215051
- Earliest priority - 4 November 1992
- Filed - 4 May 1998
- Granted - 10 April 2001
- Expected expiry - 3 May 2018
|
Title - Aarobacterium-mediated method for
transforming rice (note that Agrobacterium has the incorrect
spelling, as shown above, on the patent)
| Claim 1
A method for the production of a transgenic plant of rice crop comprising the
steps:
A) infecting an immature embryo of rice crop with the genus
Agrobacterium for transformation; B) co-culturing the infected
embryo with a dicot suspension culture during the step of transformation;
C) allowing the transformed embryo in step (B) to grow into a callus in a
selective medium comprising a sufficient amount of a plant growth hormone for
the growth of rice crop; and D) allowing the cultured callus to regenerate
root and shoot in a regeneration medium comprising a pre-determined amount of
nutrients for the growth of rice crop.
|
| Claim 8
A method for the production of a transgenic rice plant comprising the steps
of:
A) transforming an immature rice embryo with a gene encoding a desired gene
product by culturing the embryo in a dicot suspension culture with bacteria from
the genus Agrobacterium, said bacteria comprising said gene; B)
growing the transformed embryo from step (A) into a callus in a selective medium
comprising a rice plant growth hormone; and C) regenerating root and shoot
from said cultured callus in a regeneration medium comprising nutrients for the
growth of rice crop.
|
Method for the production of transgenic rice plants by co-culturing an
immature rice embryo and Agrobacterium with a dicot suspension
culture. The transformed embryo grows into a callus that in turn
regenerates roots and shoots.
|
National Science Council of R.O.C.
|
|
Remarks
|
Related Japanese applications and United States patents are not directed to
transformation of rice with Agrobacterium. They refer to a gene
expression system with a promoter region from the alpha amylase genes.
|
|
WO
2001/12828 A1
- Earliest priority - 18 August 1999
- Filed - 17 August 2000
- OPI - 22 February 2001
|
Title - Methods and Apparatus for transformation of
Monocotyledenous plants using Agrobacterium in combination with vacuum
filtration
|
Claim 1 - See below *
|
| Claim 20
An in planta method of transforming a rice plant comprising: A)
contacting at least one panicle of the rice plant with a solution or suspension
comprising at least one Agrobacterium clone; and B) subjecting the
rice plant to a vacuum effective to cause entry of the Agrobacterium
clone into at least one flower of the panicle.
|
| Claim 38
An in planta method of producing a transgenic rice plant,
comprising: A) contacting at least one panicle of a first rice plant with a
solution comprising at least one Agrobacterium clone wherein the
Agrobacterium clone comprises at least one heterologous gene; B)
subjecting the first rice plant to a vacuum effective to cause entry of the
Agrobacterium clone into at least one flower of the panicle; C)
cultivating the first rice plant to maturity; and D) collecting seeds of
the first rice plant expressing the heterologous gene.
|
|
Claim 40 - See below *
|
An in planta method for transforming rice panicles by contacting the
panicle with Agrobacterium in a suspension containing a heterologous
gene and subjecting the plant to vacuum so Agrobacterium enters the
plant part. After the transformation the plant is cultivated into maturity and
seeds express the heterologous gene.
* Independent claims 1 and 40 recite use of vacuum infiltration to transform
monocotyledonous plants, and are introduced in the
General
Monocot Transformation Methods section.
|
Paradigm Genetics
|
|
Remarks
|
National phase entry of WO 01/12828 in Australia (AU 67807/00 A) has lapsed.
|
|
WO
02/057407 A2
- Earliest priority - 17 January 2001
- Filed - 14 January 2002
- OPI - 25 July 2002
|
Title - Novel Method for Transgenic Plants by Transformation
and Regeneration of Indica Rice Plant Shoot Tips
| Claim 1
A novel method of transforming excised shoot tip tissue of the Indica rice
cultivars by using the Agrobacterium method.
|
A method of transformation of Indica rice using excised shoot tip tissue as a
target for Agrobacterium.
|
Avestha Gengraine Technologies Pty. Ltd.
|
|
Remarks
|
- related application in India IN 2001CH00047
- National phase entry of WO 02/57407 in Europe (EP 1444339) is still pending.
|
Note: Patent information on this page was last updated on 8 February 2006.
Sorghum
Summary
An Australian patent, AU 743 706 B2, was
granted to Pioneer Hi-Bred Inc. in January 2002 and a United
States Patent, US 6 369 298 B1, was granted in April. The subject matter is the
transformation of sorghum via Agrobacterium. A related application was
filed in South Africa.
The granted Australian claims are more
limited than the initially filed claims. The sorghum tissue to be
transformed is now restricted to a certain group of tissues and the
concentration of Agrobacterium cells in suspension is fixed. Another
limiting factor of the granted invention is the number of copies of the sequence
of interest inserted into the genome of a sorghum cell, tissue or plant,
offering another avenue for designing around.
The method disclosed in the US patent utilizes an immature
embryo as target for Agrobacterium. The gene cassette must contain a
gene which confers resistance to a selection agent. Furthermore, during culture
the medium must contain an antibiotic to eliminate the bacteria as well as
contain the selection agent.
The broadest claim in the pending US application recites a
sorghum plant transformed with Agrobacterium. The main restriction is
that fewer than 5 copies of the introduced construct are present in the genome
(multiple copies of integrated foreign DNA are generally undesirable).
Sorghum - Specific Patent Information
|
Patent Number
|
Title, Independent Claims and Summary of Claims
|
Assignee
|
|
AU
743706 B2
- Earliest priority - 30 April 1997
- Filed - 14 April 1998
- Granted - 31 January 2002
- Expected expiry - 13 April 2018
|
Title - Agrobacterium Mediated Transformation of
Sorghum
| Claim 1
A method for transforming sorghum with a nucleotide sequence of interest,
said method comprising the steps of:
A) contacting tissue selected from the group consisting of: an immature
embryo or cells derived from an immature embryo, immature inflorescence, the
basal portion of young leaves and tissue capable of forming callus and/or
secondary embryos from a sorghum plant with an Agrobacterium
comprising a vector which comprises said nucleotide sequence, wherein said
nucleotide sequence comprises at least an expression cassette comprising a gene
which confers resistance to a selection agent; B) co-cultivating the tissue
with said Agrobacterium in a concentration from about 1 x
103 cfu/ml to about 1.5 x 1010 cfu/ml; C) culturing
the tissue in a medium comprising an antibiotic capable of inhibiting the growth
of Agrobacterium and said selection agent; D) regenerating
transformed sorghum plants.
|
Claim 16
A method for transforming sorghum with a nucleotide sequence, said method
comprising the steps of:
A) contacting a tissue selected from the group consisting of: an immature
embryo or cells derived from an immature embryo, immature inflorescence, the
basal portion of young leaves and tissue capable of forming callus and/or
secondary embryos from a sorghum plant with an Agrobacterium
comprising a super-binary vector which comprises said nucleotide sequence,
wherein said nucleotide sequence comprises at least an expression cassette co
mprising a gene which confers resistance to a selection agent; B)
co-cultivating the tissue with said Agrobacterium in a concentration
from about 1 x 103 cfu/ml to about 1.5 x 1010 cfu/ml;
C) culturing the tissue in a medium comprising an antibiotic capable of
inhibiting the growth of Agrobacterium and said selection agent;
D) regenerating transformed sorghum plants.
|
| Claim 31
A Agrobacterium-mediated transformed sorghum plant, said plant
comprising fewer than 5 copies of a nucleic acid of interest flanked by at least
one T-DNA border sequence incorporated in its genome, wherein said plant is
derived from tissue selected from the group consisting of: an immature embryo or
cells derived from an immature embryo, immature inflorescence, the basal portion
of young leaves and tissue capable of forming callus and/or secondary embryos.
|
| Claim 41
A Agrobacterium-mediated transformed plant cell, said cell
comprising fewer than 5 copies of a nucleic acid of interest flanked by at least
one T-DNA border sequence incorporated in its genome, wherein said plant cell is
sorghum and wherein said plant cell is derived from tissue selected from the
group consisting of: an immature embryo or cells derived from an immature
embryo, immature inflorescence, the basal portion of young leaves and tissue
capable of forming callus and/or secondary embryos.
|
| Claim 44
A Agrobacterium-mediated transformed plant tissue, said tissue
comprising fewer than 5 copies of a nucleic acid of interest flanked by at least
one T-DNA border sequence incorporated in its genome of cells of said tissue,
wherein said plant is sorghum and wherein said plant tissue is derived from
tissue selected from the group consisting of: an immature embryo or cells
derived from an immature embryo, immature inflorescence, the basal portion of
young leaves and tissue capable of forming callus and/or secondary embryos.
|
Method for sorghum transformation with Agrobacterium containing a
gene that confers resistance to a selective agent. The tissue to be transformed
is selected from: immature embryo, immature inflorescence, basal portion of
young leaves and tissue capable of forming callus or secondary embryos.
Agrobacterium contains a vector or a super binary vector having the
mentioned gene. The transformed sorghum tissue or cell has less than 5 copies of
the gene of interest flanked by at least one T-border.
|
Pioneer Hi-Bred Inc.
|
|
US
6369298
- Earliest priority - 30 April 1997
- Filed - 7 April 1998
- Granted - 9 April 2002
- Expected expiry - 6 April 2018
|
Title - Agrobacterium Mediated
Transformation of Sorghum
| Claim 1
A method for transforming sorghum with a nucleotide sequence of interest,
said method comprising the steps of: contacting an immature embryo from a
sorghum plant with an Agrobacterium comprising a vector which comprises said
nucleotide sequence, wherein said nucleotide sequence comprises at least an
expression cassette comprising a gene which confers resistance to a selection
agent; co-cultivating said immature embryo with said Agrobacterium; culturing
said immature embryo in a medium comprising an antibiotic capable of inhibiting
the growth of said Agrobacterium and said selection agent; regenerating
transformed sorghum plants.
|
| Claim 15
A method for transforming sorghum with a nucleotide sequence, said method
comprising the steps of: contacting an immature embryo from a sorghum plant with
an Agrobacterium comprising a super-binary vector which comprises said
nucleotide sequence, wherein said nucleotide sequence comprises at least an
expression cassette comprising a gene which confers resistance to a selection
agent; co-cultivating said immature embryo with said Agrobacterium; culturing
said immature embryo in a medium comprising an antibiotic capable of inhibiting
the growth of said Agrobacterium and said selection agent; regenerating
transformed sorghum plants.
|
A method for transformation of sorghum in which an immature embryo is the
target tissue for Agrobacterium. The gene cassette must contain a gene
which confers resistance to a selection agent. During further culture the medium
must contain an antibiotic to eliminate the bacteria as well as contain the
selection agent.
|
|
US
2002/0138879 A1
- Earliest priority - 30 April 1997
- Filed - 19 March 2002
- Application pending
|
Title - Agrobacterium Mediated
Transformation of Sorghum
| Claim 1
An Agrobacterium-transformed sorghum plant wherein said plant comprises fewer
than 5 copies of a nucleic acid of interest flanked by at least one T-DNA border
sequence incorporated in its genome.
|
| Claim 12
A sorghum plant transformed by contacting an immature embryo from a sorghum
plant with an Agrobacterium comprising a nucleic acid of interest;
co-cultivating said immature embryo with said Agrobacterium; culturing said
immature embryo in a medium comprising an antibiotic capable of inhibiting the
growth of said Agrobacterium; and regenerating a transformed sorghum plant, said
plant comprising fewer than 5 copies of said nucleic acid flanked by at least
one T-DNA border sequence incorporated in its genome.
|
| Claim 19
A sorghum plant transformed by contacting an immature embryo from a sorghum
plant with an Agrobacterium comprising a vector which comprises; a nucleic acid
comprising at least one expression cassette comprising a gene of interest; and a
nucleic acid comprising at least one expression cassette comprising a gene which
confers resistance to a selection agent; co-cultivating said immature embryo
with said Agrobacterium; culturing said immature embryo in a medium comprising
an antibiotic capable of inhibiting the growth of said Agrobacterium and a
selection agent; and regenerating a transformed sorghum plant, said plant
comprising fewer than 5 copies of said vector flanked by at least one T-DNA
border sequence incorporated in its genome.
|
This application is a division of now granted US 6369298.
A sorghum plant transformed with Agrobacterium with fewer than 5
copies of the introduced construct integrated in the genome.
|
| Remarks |
National phase entry of
WO
98/49332 has been accepted in South Africa (ZA 98/03603).
|
Note: Patent information on this page was last updated on 8 February 2006.
Turfgrass
Summary
Rutgers University has filed a PCT application directed to
transformation of turfgrass callus with Agrobacterium. The bacterium
contains a vector with a selectable marker gene and an insertion site for any
coding sequence, both of them controlled by promoters isolated from monocot
plants. The promoters, according to the applicants, function efficiently in
turfgrass cells.
Specific Patent Information
|
Patent Number
|
Title, Independent Claims and Summary of Claims
|
Assignee
|
EP
1100876 A1
- Earliest priority - 17 July 1998
- Filed - 13 July 1999
- Application pending
|
Title - Agrobacterium-mediated transformation of
turfgrass
| Claim 1
A method of producing a transgenic turfgrass plant, comprising the steps of:
A) providing regenerable callus tissue from the turfgrass plant; B)
inoculating the tissue with Agrobacterium carrying at least one vector
for transformation, the vector comprising virulence genes that confer strong
infectivity to Agrobacterium, in which vector is inserted a
heterologous DNA construct operably linked to a promoter from a monocotyledonous
species, and a selectable marker gene conferring antibiotic resistance to
transformed cells operably linked to a promoter from a monocotyledonous species;
C) culturing the inoculated tissue under conditions that enable the
Agrobacterium vector to transform cells of the tissue; D)
selectively culturing the inoculated tissue on a selection medium comprising the
antibiotic; and E) regenerating a transformed turfgrass plant from the
selectively cultured tissue.
|
| Claim 11
A superbinary vector system for Agrobacterium-mediated
transformation of turfgrass, which comprises:
A) a virulence region from a Ti plasmid of an A. tumefaciens strain
that confers to the strain as strong a virulence as that displayed by A.
tumefaciens strain 281; B) a selectable marker gene operably linked to
a promoter obtained from a gene of a monocotyledonous plant; and C) a site
for insertion of at least one additional coding sequence, operably linked to a
promoter obtained from a gene of a monocotyledonous plant, the promoter being
the same as or different from the promoter operably linked to the selectable
marker gene.
|
A method of producing a transgenic turfgrass plant by inoculating a
regenerable turfgrass callus with Agrobacterium containing an
antibiotic resistance linked to a monocot promoter. The antibiotic resistance is
used as a selectable marker for the transformed tissue. A transformed turfgrass
plant is regenerated from the selected transformed tissue.
A super-binary vector used for the Agrobacterium-mediated
transformation of turfgrass comprising: a virulence region, a selectable marker
linked to a monocot promoter, and an insertion site for a coding sequence. This
site is linked to the same or a different monocot promoter.
|
Rutgers University
|
| Remarks |
National phase entry of
WO
2000/04133 in Australia (AU 52136/99 A) has lapsed.
|
Note: Patent information on this page was last updated on 9 February 2006.
Wheat
Summary
In 2001 Monsanto was
granted an Australian patent directed to transformation of wheat with
Agrobacterium. Related applications are still pending in Europe and
Canada.
The granted claims of the Australian patent are narrower in their scope than
the claims as filed in the European and Canadian applications. In the Australian
patent the wheat tissues to be transformed are restricted to
certain types of tissues while the applications disclose the transformation of
wheat cells derived from any tissue.
Both the Australian patent and the applications disclose the insertion into
the cells of genes that confer resistance to selective agents such as
gentamycin, kanamycin, and hygromycin. Production of fertile and transgenic
wheat plants is also disclosed.
Note that the claim language may be modified during the prosecution process
and when granted might not encompass the same scope as the filed claims.
Wheat - Specific Patent Information
|
Patent Number
|
Title, Independent Claims and Summary of Claims
|
Assignee
|
|
AU
738153 C
- Earliest priority - 21 June 1996
- Filed - 20 June 1997
- Granted - 13 September 2001
- Amended - 1 July 2004
- Expected expiry - 19 June 2017
|
Title - Methods for the production of stably-transformed,
fertile wheat employing agrobacterium-mediated transformation and
compositions derived therefrom
| Claim 1
A fertile, transgenic wheat plant, the genome of which has been altered
through the genomic introduction of a pre-selected genetic component, said
component comprising an exogenous gene positioned under the control of one or
more pre-selected genetic control elements, the plant prepared by a process
comprising:
A) preparing a DNA composition in vitro, which composition includes
the genetic component one desires to introduce into the genome of a wheat plant;
B) introducing said DNA composition into recipient wheat cells by
Agrobacterium transformation; C) regenerating wheat plants from
said cells which have received said genetic component; and D) identifying a
fertile, transgenic wheat plant whose genome has been altered through the stable
introduction of said genetic component, and wherein said recipient cells
comprise an immature embryo, a callus tissue, or suspension cells.
|
| Claim 7
A fertile, transgenic wheat plant, the genetic complement of which has been
altered through the addition of a DNA composition comprising a pre-selected
functional genetic element that includes a transgene selected from the group
consisting of an nptll gene, a bla gene, a nptI gene,
a dhfr gene, a aphlV gene, a aacC3 gene, a
aacC4 gene and a GUS gene, wherein said functional genetic element
confers on said wheat plant a phenotypic trait that is not found in the
parentage of said plant, wherein said DNA composition was added using
Agrobacterium transformation of recipient cells comprising an immature
embryo, a callus tissue, or suspension cells.
|
| Claim 10
A fertile, transgenic wheat plant, the genome of which has been altered
through the genomic introduction of a pre-selected genetic component, said
component comprising an exogenous gene positioned under the control of one or
more pre-selected genetic control elements, substantially as hereinbefore
described with reference to any one of the examples.
|
Claim 11
A fertile, transgenic wheat plant, the genetic complement of which has been
altered through the addition of a DNA composition comprising a pre-selected
functional genetic element, substantially as hereinbefore described with
reference to any one of the examples.
|
| Claim 14
A method for producing a fertile transgenic wheat plant, comprising the steps
of:
A) establishing a regenerable culture from a wheat plant to be transformed,
wherein said culture comprises an immature embryo, a callus tissue, or
suspension cells; B) introducing a DNA composition comprising a genetic
component one desires to introduce into the genome of said wheat plant, by
Agrobacterium transformation; C) identifying or selecting a
transformed cell line; and D) regenerating a fertile transgenic wheat plant
therefrom, wherein said DNA is transmitted through a complete sexual cycle of
said transgenic plant to its progeny, wherein said progeny comprises a
selectable or screenable marker gene, and wherein said marker gene is
chromosomally integrated.
|
| Claim 18
A method for producing a fertile transgenic wheat plant, substantially as
hereinbefore described with reference to any one of the examples.
|
| Claim 19
A method for producing a transgenic wheat plant, comprising the steps of:
A) establishing a culture from a wheat plant to be transformed, wherein said
culture comprises an immature embryo, a callus tissue, or suspension cells;
B) transforming said culture with an Agrobacterium comprising a
DNA composition comprising a genetic component one desires to introduce into the
genome of said wheat plant; C) identifying or selecting a transformed cell
line; and D) regenerating a transgenic wheat plant therefrom.
|
| Claim 21
A method for producing a transgenic wheat plant, substantially as
hereinbefore described with reference to any one of the examples.
|
Process for the production of a fertile, transgenic wheat plant by
transforming an immature embryo, a callus tissue or suspension cells of wheat
with Agrobacterium having an exogenous gene. The transgene can be
selected from: an nptII gene, bla gene, nptI gene, dhfr gene, aphIV gene, aacC3,
aacC4 and a GUS gene. The fertile transgenic wheat plant produces progeny
comprising a selectable or screenable marker integrated into the chromosomes.
|
Monsanto
|
|
EP
856060 A1
- Earliest priority - 21 June 1996
- Filed - 20 June 1997
- Application pending
|
Title - Methods for the Production of Stably-transformed,
Fertile Wheat employing Agrobacterium-mediated transformation and
compositions derived therefrom
| Claim 1
A fertile, transgenic wheat plant, the genome of which has been altered
through the genomic introduction of a pre-selected genetic component, said
component comprising an exogenous gene positioned under the control of one or
more pre-selected genetic control elements, the plant prepared by a process
comprising:
A) preparing a DNA composition in vitro, which composition includes
the genetic component one desires to introduce into the genome of a wheat plant;
B) introducing said DNA composition into recipient wheat cells by
Agrobacterium transformation; C) regenerating wheat plants from
said cells which have received said genetic component; and D) identifying a
fertile, transgenic wheat plant whose genome has been altered through the stable
introduction of said genetic component.
|
| Claim 8
A fertile, transgenic wheat plant, the genetic complement of which has been
altered through the addition of a DNA composition comprising a pre-selected
functional genetic element that includes a transgene selected from the group
consisting of an nptll gene, a bla gene, a nptI gene, a dhfr gene, a aphlV gene,
a aacC3 gene, a aacC4 gene and a GUS gene, wherein said functional genetic
element confers on said wheat plant a phenotypic trait that is not found in the
parentage of said plant.
|
| Claim 14
A method for producing a fertile transgenic wheat plant, comprising the steps
of:
A) establishing a regenerable culture from a wheat plant to be transformed;
B) introducing a DNA composition comprising a genetic component one
desires to introduce into the genome of said wheat plant, by
Agrobacterium transformation; C) identifying or selecting a
transformed cell line; and D) regenerating a fertile transgenic wheat plant
therefrom, wherein said DNA is transmitted through a complete sexual cycle of
said transgenic plant to its progeny, wherein said progeny comprises a
selectable or screenable marker gene, and wherein said marker gene is
chromosomally integrated.
|
| Claim 18
A method for producing a transgenic wheat plant, comprising the steps of:
A) establishing a culture from a wheat plant to be transformed; B)
transforming said culture with an Agrobacterium comprising a DNA
composition comprising a genetic component one desires to introduce into the
genome of said wheat plant; C) identifying or selecting a transformed cell
line; and D) regenerating a transgenic wheat plant therefrom.
|
National phase entry of WO 97/48814, this application is still pending.
Insertion of a foreign gene into a wheat plant via Agrobacterium .
The foreign gene is selected from a group of genes conferring resistance to
different antibiotics, i.e. kanamycin, hygromycin, and also the GUS gene.
Regenerating and obtaining fertile transformed wheat plants is also covered by
the claims.
|
| Remarks |
- National phase entry of
WO
97/48814 in Canada (CA 2230216) is still pending.
- National phase entry of
WO
97/48814 in China (CN 1208437) is deemed to be withdrawn on 26 January 2005.
-
WO
97/48814 has also entered national phase in Czech Republic (CZ 9800867),
Hungary (HU 9902123), and Turkey (TR 9800294).
- A related patent application in the US
(US
2003/24014 A1) is still pending.
|
Note: Patent information on this page was last updated on 9 February 2006.
Dicots
Overview
Dicotyledonous plants (dicots) are the
second major group of plants within the Angiospermae division
(flowering plants with seeds protected in vessels). The other major group is the
monocots.
In contrast to monocots, dicots have an embryo with two cotyledons, which
give rise to two seed leaves. The mature leaves have veins in a net-like
pattern, and the flowers have four or five parts.
Apart from cereals and grasses that belong to the monocot group, most of the
fruits, vegetables, spices, roots and tubers, which constitute a very important
part of our daily diet, are classified as dicots. In addition, all legumes,
beverages such as coffee and cocoa, and a great variety of flowers, oil seeds,
fibers, and woody plants belong to the dicot group.
Several patents encompass transformation of dicots, although they are mainly
directed to the use of co-integrated vectors and binary vectors for the
incorporation of foreign DNA into plants. A broad patent directed to
transformation of dicots using an Agrobacterium strain lacking
functional tumor genes was granted to Washington
University. The invention teaches transformed dicot cells,
regenerated plants and their progeny.
Only patents with broad claims reciting methods for
Agrobacterium-mediated transformation of dicot plants are presented
here. Inventions directed to insertion of specific genes and generation of
transformed plants exhibiting determined traits are beyond the scope and goal of
this white paper.
The cited patents disclose inventions directed to general methods to obtain
transgenic plants through Agrobacterium-mediated transformation from
plant groups as diverse as pulses, vegetables, fiber crops, oil-producing crops
and ornamental trees. The inventions cover aspects such as the initial tissue
used for transformation, transformation protocols, media composition, and in
some cases the insertion of particular genes into plants.
General transformation methods
Summary
A patent with broad claims to transformation of dicots in general with a
non-oncogenic Agrobacterium was issued to Washington
University.
Although issued in 2000 in the United States, this patent has an initial
priority date of 1983. Thus, the prosecution process took approximately 17 years
until the patent was finally granted by the United States Patent and Trademark
Office (USPTO). The patent could be considered one of the broadest in scope
granted in the area of Agrobacterium transformation. The patent rights
under this patent may overlap with the rights already granted in previous
patents related to transformation of dicots with Agrobacterium.
One of the distinctive factors of that patent is the knocking out of the
cytokinin function in the Ti plasmid in order to get a non-tumorigenic
Agrobacterium strain. As a general practice in
Agrobacterium-mediated transformation, "disarmed" strains lacking
functional tumorigenic genes are used. The present patent thus may constitute a
blow for a widely used and standard procedure carried out to regenerate complete
transformed dicot plants.
With respect to enablement of the invention, the examples referred to
transformation of tobacco only, a model plant at the time the invention was
initially filed and one of the easiest dicot plants to be transformed with
Agrobacterium. No other plant examples are provided in the disclosure.
Most other patents analyzed here claim transformation of dicots in
conjunction with the use of co-integrated or binary vectors, the vectors being
the main subject matter of the claimed inventions. This group of patents are
reviewed under the section of "Binary vectors and co-integrated vectors". In the
following table, you will find a reference to those patents and links to more
information on them.
| Assigned to |
Patent No. |
Title |
|
|
Washington University
|
US
6051757
|
Regeneration of plants containing genetically engineered T-DNA
|
More information on this patent |
| Schilperoort & Hille |
US
4693976
|
Process for the incorporation of foreign DNA into the genome of
dicotyledonous plants using stable co-integrated plasmids.
|
More information on these patents
|
|
EP
120515 B1
|
A process for the incorporation of foreign DNA into the genome of
dicotyledonous plants; a process for the production of Agrobacterium
tumefaciens bacteria.
|
| Syngenta Mogen B.V. |
US
4940838
|
Process for the incorporation of foreign DNA into the genome of
dicotyledonous plants.
|
More information on these patents
|
|
US
5464763
|
|
EP
120516 B1
|
A process for the incorporation of foreign DNA into the genome of
dicotyledonous plants; Agrobacterium tumefaciens bacteria and a process
for the production thereof.
|
| Leiden University & Schilperoort |
US
5149645
|
A process for introducing foreign DNA into the genome of plants
|
More information on this patent |
Patent granted to Washington University
The present United States patent granted to Washington
University discloses the transformation of dicot plants with an
Agrobacterium vector having the cytokinin gene of the T-DNA region
inactivated. According to the USPTO assignments database, this patent was
exclusively licensed to
Syngenta.
In a wildtype T-DNA of a Ti plasmid, the genes encoding phytohormones are
responsible for the tumorous state of a transformed tissue. Cytokinin, one of
those phytohormones, induces the formation of shoots in a tumor.
In the disclosed invention, regeneration of a transformed dicot plant is
achieved by inactivating the cytokinin gene. Additionally, the cytokinin gene is
replaced by foreign DNA. The plasmid containing the mutant T-DNA, with foreign
DNA replacing the cytokinin gene, is accomplished by homologous recombination
within Agrobacterium.
Specific Patent Information
|
Patent Number
|
Title, Independent Claims and Summary of Claims
|
Assignee
|
|
US
6051757
- Earliest priority - 4 November 1983
- Filed - 5 June 1995
- Granted - 18 April 2000
- Expected expiry - 17 April 2017
|
Title - Regeneration of plants containing genetically
engineered T-DNA
| Claim 1
A method of transforming a dicotyledonous plant susceptible to transformation
by Agrobacterium, comprising:
contacting the plant with an Agrobacterium tumefaciens bacterium
comprising a gene vector, the vector comprising (i) DNA foreign to the
Agrobacterium, and (ii) the vector not comprising a functional
cytokinin autonomy gene.
|
| Claim 2
A method for producing a morphologically and developmentally normal
dicotyledonous plant comprising non-Agrobacterium foreign DNA stably
integrated in the plant's genome, said method comprising the following steps:
A) transforming a dicotyledonous plant cell susceptible to transformation by
Agrobacterium with an Agrobacterium -derived gene vector, said
vector comprising (i) non-Agrobacterium foreign DNA and (ii)
the vector not comprising a functional cytokinin autonomy gene; and
B) regenerating said transformed plant cell to produce a morphologically and
developmentally normal transformed plant with said foreign DNA stably integrated
in the plant's genome.
|
| Claim 5
A method for producing a transgenic dicotyledonous plant comprising a stably
integrated non-Agrobacterium foreign DNA, the method comprising:
A) sexually propagating a dicotyledonous plant comprising
non-Agrobacterium foreign DNA stably integrated into its genome, said
foreign DNA having been introduced into the genome by an
Agrobacterium-derived gene vector not comprising a functional
cytokinin-autonomy gene; and B) selecting for progeny plants which comprise
the non-Agrobacterium foreign DNA stably integrated into the genome of
said progeny plants.
|
| Claim 6
A method for producing a transgenic dicotyledonous plant comprising stably
integrated non-Agrobacterium foreign DNA, the method comprising:
A) sexually propagating a dicotyledonous plant comprising
non-Agrobacterium foreign DNA stably integrated into its genome, said
plant derived from a dicotyledonous plant which was transformed by
Agrobacterium-mediated transformation with a gene vector comprising
(i) said non-Agrobacterium foreign DNA and (ii) not
comprising a functional cytokinin autonomy gene; and
B) obtaining a progeny plant which comprises the non-Agrobacterium
foreign DNA stably integrated into its genome.
|
| Claim 7
A method for producing a transgenic dicotyledonous plant comprising stably
integrated non-Agrobacterium foreign DNA, the method comprising:
A) propagating a dicotyledonous plant comprising non-Agrobacterium
foreign DNA stably integrated into its genome, said plant derived from a
dicotyledonous plant which was transformed by Agrobacterium-mediated
transformation with a gene vector comprising (i) said
non-Agrobacterium foreign DNA and (ii) not comprising a functional
cytokinin autonomy gene; and
B) obtaining a plant which comprises the non-Agrobacterium foreign
DNA stably integrated into its genome.
|
| Claim 8
A method for producing a transgenic dicotyledonous plant comprising stably
integrated non-Agrobacterium foreign DNA, the method comprising:
growing a seed of a dicotyledonous plant comprising
non-Agrobacterium foreign DNA stably integrated into its genome, said
plant derived from a dicotyledonous plant which was transformed by
Agrobacterium-mediated transformation with a gene vector comprising
(i) said non-Agrobacterium foreign DNA and (ii) not
comprising a functional cytokinin autonomy gene.
|
| Claim 9
A method for producing seed of a transgenic dicotyledonous plant comprising
stably integrated non-Agrobacterium foreign DNA, the method comprising:
A) propagating a dicotyledonous plant comprising non-Agrobacterium
foreign DNA stably integrated into its genome, said plant derived from a
dicotyledonous plant which was transformed by Agrobacterium-mediated
transformation with a gene vector comprising (i) said
non-Agrobacterium foreign DNA and (ii) not comprising a functional
cytokinin autonomy gene; and
B) harvesting seed from said propagated plant.
|
| Claim 10
A method of transforming a dicotyledonous plant of a species that is a
naturally susceptible host for Agrobacterium, comprising:
contacting the plant with an Agrobacterium bacterium comprising a
gene vector, the vector comprising (i) DNA foreign to the
Agrobacterium and (ii) the vector not comprising a functional
cytokinin autonomy gene.
|
| Claim 11
A method for producing a transgenic dicotyledonous plant comprising
non-Agrobacterium foreign DNA stably integrated in the plant's genome,
said method comprising the following steps:
A) transforming a cell of a dicotyledonous plant species that is a naturally
susceptible host for Agrobacterium by Agrobacterium -mediated
transformation with a gene vector comprising (i) non-Agrobacterium
foreign DNA and (ii) not comprising a functional cytokinin autonomy gene;
and
B) regenerating said transformed plant cell to produce a normal transformed
dicotyledonous plant with said foreign DNA stably integrated in the plant's
genome.
|
| Claim 14
A method for producing a transgenic dicotyledonous plant comprising a stably
integrated non-Agrobacterium foreign DNA, the method comprising:
A) sexually propagating a dicotyledonous plant comprising
non-Agrobacterium foreign DNA stably integrated into its genome, said
plant derived from a dicotyledonous plant which is of a species that is a
naturally susceptible host for Agrobacterium and which was transformed
by Agrobacterium-mediated transformation with a gene vector comprising
(i) said non-Agrobacterium foreign DNA and (ii) not
comprising a functional cytokinin autonomy gene; and
B) obtaining a progeny plant which comprises the non-Agrobacterium
foreign DNA stably integrated into its genome.
|
| Claim 15
A method for producing a transgenic dicotyledonous plant comprising a stably
integrated non-Agrobacterium foreign DNA, the method comprising:
A) propagating a dicotyledonous plant comprising non-Agrobacterium
foreign DNA stably integrated into its genome, said plant derived from a
dicotyledonous plant which is of a species that is a naturally susceptible host
for Agrobacterium and which was transformed by
Agrobacterium-mediated transformation with a gene vector comprising
(i) said non-Agrobacterium foreign DNA and (ii) not
comprising a functional cytokinin autonomy gene; and
B) obtaining a plant which comprises the non-Agrobacterium foreign
DNA stably integrated into its genome.
|
| Claim 16
A method for producing a transgenic dicotyledonous plant comprising stably
integrated non-Agrobacterium foreign DNA, the method comprising:
growing a seed of a dicotyledonous plant comprising
non-Agrobacterium foreign DNA stably integrated into its genome, said
plant derived from a dicotyledonous plant which is of a species that is a
naturally susceptible host for Agrobacterium and which was transformed
by Agrobacterium-mediated transformation with a gene vector comprising
(i) said non-Agrobacterium foreign DNA and (ii) not
comprising a functional cytokinin autonomy gene.
|
| Claim 17
A method for producing seed of a transgenic dicotyledonous plant comprising
stably integrated non-Agrobacterium foreign DNA, the method comprising:
A) propagating a dicotyledonous plant comprising non-Agrobacterium
foreign DNA stably integrated into its genome, said plant derived from a
dicotyledonous plant which is of a species that is a naturally susceptible host
for Agrobacterium and which was transformed by
Agrobacterium-mediated transformation with a gene vector comprising
(i) said non-Agrobacterium foreign DNA and (ii) not
comprising a functional cytokinin autonomy gene; and
B) harvesting seed from said propagated plant.
|
| Claim 18
An Agrobacterium-mediated method for genetically engineering a
dicotyledonous plant comprising:
A) producing a transgenic plant cell by transforming a cell of dicotyledonous
plant species that is a naturally susceptible host for Agrobacterium
with a gene vector comprising non-Agrobacterium foreign DNA and not
comprising a functional cytokinin autonomy gene by Agrobacterium
tumefaciens-mediated transformation; and B) regenerating a whole
normal plant from the transgenic plant cell which contains said foreign DNA
stably integrated into its genome.
|
| Claim 20
A method for producing a transgenic dicotyledonous plant comprising intact
T-DNA comprising non-Agrobacterium foreign DNA stably integrated into
the genome of said plant, the method comprising:
A) propagating a dicotyledonous plant comprising non-Agrobacterium
foreign DNA stably integrated into its genome, said plant derived from a
dicotyledonous plant which is of a species that is a naturally susceptible host
for Agrobacterium and which was transformed by
Agrobacterium-mediated transformation with a disarmed T-DNA gene vector
comprising (i) said non-Agrobacterium foreign DNA and (ii)
not comprising a functional cytokinin autonomy gene; and
B) obtaining a plant which comprises the intact T-DNA stably integrated into
its genome.
|
The United States patent
US
6051757 claims
- transformation of a dicot plant, which is either susceptible to
transformation (claim 1) or a naturally susceptible host (claim 10) with A.
tumefaciens (claim 1) or an Agrobacterium (claim 10) having a
vector that lacks the cytokinin function and contains foreign DNA instead;
- regeneration of a transformed dicot cell and production of a morphologically
normal plant;
- sexual or non-sexual propagation of the transformed dicot plant and
generation of a progeny bearing the foreign gene;
- seed production and harvesting from a propagated transformed dicot plant.
|
Washington University, exclusively licensed to
Syngenta
|
| Remarks |
A related United States application (US 07/155092) was in
interference, the process by which the United States Patent Office determines
who was the earliest inventor when there are competing claims (in this case,
from Monsanto).
According to the USPTO status database PAIR, Syngenta lost the interference case
in 2004.
|
Note: Patent information on this page was last updated on 10 March 2006.
Particular dicot plants
Find out more information about patents on particular dicot plants by
following the links shown below.
Acacia
Summary
The genus Acacia is composed of as many as 8000 species native to
the tropics and subtropics. The commercially valuable species Acacia
mangium is variously known as "Mangium", "Black Wattle" and "Hickory
Wattle", and is traded as brown salwood. Its distribution covers the northern
part of Queensland in Australia, Papua New Guinea and the Molucca Islands of
Indonesia. Mangium is a fast-growing tree, relatively short-lived (30-50 years)
and adapted to a wide range of acidic soils in most tropical lowlands. It is a
pioneer species that colonize disturbed sites. Major plantations of A.
mangium are grown in Southeast Asia for paper pulp. Wood from this species
is used in furniture, handles of sporting goods, door frames and light
construction. Plantations of A. mangium are also used for erosion
control, shade and shelter. This species is playing an important role in efforts
to sustain commercial supply of tree products while reducing pressure on natural
forest ecosystems.
The Institute of Molecular Agrobiology, located at the
National University of Singapore, has filed applications related to the genetic
transformation of A. mangium with Agrobacterium and to the
regeneration of the species. The PCT applications disclose methods for
transforming A. mangium with a gene of interest using A.
tumefaciens. One of the recited methods uses stems as initial tissue to be
transformed with the bacterium.
For patent documents in the United States, Australia and New Zealand, the
ownership has changed to Temasek Life Sciences Laboratory Ltd.
Specific Patent Information
|
Patent Number
|
Title, Independent Claims and Summary of Claims
|
Assignee
|
|
US
6846971
- Earliest priority - 19 January 2000
- Filed - 2 January 2002
- Granted - 25 January 2005
- Expected expiry - 18 January 2000
|
Title - Regeneration and genetic transformation of
Acacia mangium
Claim 1
A method of transforming Acacia mangium with a gene of interest
comprising the steps of:
a) activating Agrobacterium tumefaciens comprising said gene of
interest by culturing said Agrobacterium in induction medium comprising
acetosyringone; b) preculturing an explant of Acacia mangium
selected from the group comprising a stem, a leaflet, a petiole and a bud in
medium comprising supplemented basic MS medium, wherein said explant is soaked
in 0.5 M mannitol prior to the co-cultivation; c) co-cultivating said
activated Agrobacterium tumefaciens and said precultured explant in
medium comprising supplemented basic MS medium to produce infected
explants; d) culturing said infected explants in medium comprising
supplemented basic MS to induce callus and adventitious buds; and e)
culturing said callus or adventitious buds on a selective medium comprising
supplemented basic MS medium; wherein in said supplemented basic MS medium
comprises a) thidiazuron, b) indole-3-acetic acid, c) casein enzymatic
hydrolysate, d) L-ascorbic acid, e) L-glutamine, f) L-asparagine, g) L-proline,
h) sucrose and l) phytagel or agar.
|
Claim 7
A method of preparing transgenic Acacia mangium cells comprising the
steps of a) preculturing stem pieces of Acacia mangium in culture
medium comprising supplemented basic MS medium, wherein said stem pieces are
soaked in 0.5M mannitol prior to co-cultivating with Agrobacterium
tumefaciens wherein said supplemented basic MS medium comprises a)
thidiazuron, b) indole-3-acetic acid, c) casein enzymatic hydrolysate, d)
L-ascorbic acid, e) L-glutamine, f) L-asparagine, g) L-proline, h) sucrose and
i) phytagel or agar; and b) co-cultivating said stem pieces of step (a)
with Agrobacterium tumefaciens in culture medium AM-265, wherein said
Agrobacterium was activated by culturing the Agrobacterium in
induction medium comprising acetosyringone prior to said co-cultivation.
|
Granted US 6846971 recites a method of
Agrobacterium-mediated transformation of Acacia mangium.
|
Temasek Life Sciences Laboratory Ltd
|
|
AU
784180 B2
- Earliest priority - 19 January 2000
- Filed - 19 January 2000
- Granted - 12 February 2006
- Expected expiry - 18 January 2020
|
Title - Regeneration and genetic transformation of
Acacia mangium
|
Caim 1 A method for regenerating Acacia mangium
comprising: a) inducing callus formation from an explant; b) culturing
said callus to produce adventitious buds; c) culturing said adventitious
buds to elongate and produce pinnate leaves; and d) culturing elongated
buds of step (c) such that they produce roots and become plantlets.
|
|
Claim 11 A method for regenerating Acacia mangium
comprising: a) culturing auxiliary buds from an Acacia mangium
tree to produce adventitious buds comprising hyllodes; b) subculturing said
adventitious buds comprising phyllodes to produce advantitious shoots; c)
culturing said adventitious shoots.
|
|
Claim 14
A method of tranforming Acacia
mangium with a gene of interest comprising the steps of: a)
activating Agrobacterium tumefaciens comprising said
gene of interest to form activated Agrobacterium tumefaciens; b)
preculturing an explant of Acacia mangium to yield a precultured
explant; c) co-cultivating said activated Agrobacterium
tumefaciens and said precultured explant to produce infected
explants; d) culturing said infected explants to induce callus and
adventitious buds; and e) culturing said callus or adventitious buds on a
selective medium.
|
|
Claim 25
A method for promoting root formation from
transformed adventitious buds comprising
- culturing transformed adventitious buds on a medium comprising 1/2 MS basic
medium supplemented with a) alpha-naphthaleneacetic acid, b) kinetin, c) casein
enzymatic hydrolysate, d) L-ascorbic acid, e) L-glutamine, f) L-asparagine, g)
L-proline, h) sucrose and i) phytagel.
|
|
Claim 28
A method of preparing transgenic Acacia
mangium cells comprising the steps of a) preculturing stem pieces of
Acacia mangium in a culture medium; and b) cocultivating said
stem pieces of step (a) with activated Agrobacterium tumefaciens.
|
|
Claim 41
A transgenic Acacia mangium cell.
|
|
Claim 42
A transgenic Acacia mangium plant.
|
The applicant of granted AU 784180 is stated in the patent
document as Temasek Life Sciences Laboratory.
|
|
US
2005/155116 A1
- Earliest priority - 19 January 2000
- Filed - 9 December 2004
- Application pending
|
Title - Regeneration and genetic transformation of acacia
mangium
|
Claim 1 A method for regenerating Acacia mangium
comprising: a) inducing callus formation from an explant; b) culturing
the callus on a medium comprising thidiazuron to produce adventitious
buds; c) culturing the adventitious buds to elongate the buds and produce
pinnate leaves; and d) culturing elongated buds of step (c) to produce
plantlets with roots.
|
|
Claim 11 A method for regenerating Acacia mangium
comprising: a) culturing auxiliary buds from an Acacia mangium
tree to produce adventitious buds comprising phyllodes; b) subculturing the
adventitious buds comprising phyllodes to produce adventitious shoots; c)
culturing the adventitious shoots.
|
|
Claim 14
A method of making transgenic Acacia
mangium plants comprising; a) preparing transgenic Acacia
mangium cells by preculturing stem pieces in culture medium comprising
thidiazuron; b) co-cultivating the stem pieces of step (a) with
Agrobacterium in medium comprising thidiazuron to form adventitious
buds; c) culturing the adventitious buds in a selective medium comprising
an antibiotic and gibberellic acid; and d) rooting the plantlets which
develop from the adventitious buds of step c).
|
This application is a divisional of now granted US 6846971
(see above).
|
|
WO
2001/53452 A2
- Earliest priority - 19 January 2000
- Filed - 19 January 2000
- OPI - 7 November 2002
|
Title - Regeneration and genetic transformation of acacia
mangium
|
Claim 1
A method for regenerating Acacia mangium comprising:
A) inducing callus formation from an explant; B) culturing said callus
to produce adventitious buds; C) culturing said adventitious buds to
elongate and produce pinnate leaves; and D) culturing elongated buds of
step (c) such that they produce roots and become plantlets.
|
|
Claim 11
A method for regenerating Acacia mangium comprising:
A) culturing auxiliary buds from an Acacia mangium tree to produce
adventitious buds comprising phyllodes; B) subculturing said adventitious
buds comprising phyllodes to produce adventitious shoots; and C) culturing
said adventitious shoots.
|
|
Claim 14*
A method of transforming Acacia mangium with a gene of interest
comprising the steps of:
A) activating Agrobacterium tumefaciens comprising said gene of
interest to form activated Agrobacterium tumefaciens; B)
preculturing an explant of Acacia mangium to yield a precultured
explant; C) co-cultivating said activated Agrobacterium
tumefaciens and said precultured explant to produce infected
explants; D) culturing said infected explants to induce callus and
adventitious buds; and E) culturing said callus or adventitious buds on a
selective medium.
|
|
Claim 25
A method for promoting root formation from transformed adventitious buds
comprising culturing transformed adventitious buds on a medium comprising 1/2 MS
basic medium supplemented with:
A) cx-naphthaleneacetic acid, B) kinetin, C) casein enzymatic
hydrolysate, D) L-ascorbic acid, E) L-glutamine, F)
L-asparagine, G) L-proline, H) sucrose and I) phytagel.
|
| Claim 28*
A method of preparing transgenic Acacia mangium cells comprising the
steps of:
a) preculturing stem pieces of Acacia mangium in a culture medium;
and b) co-cultivating said stem pieces of step (a) with activated
Agrobacterium tumefaciens.
|
| Claim 41
A transgenic Acacia mangium cell.
|
| Claim 42
A transgenic Acacia mangium plant.
|
Methods for transforming explants of A. mangium with a gene of
interest by co-cultivating A. tumefaciens having the gene of interest
with pre-cultured explants of the tree species. In one of the methods the tissue
selected for transformation is stems. Transgenic cells and plants of A.
mangium are also part of the recited invention.
Additional claims recite methods for the regeneration of non-transformed
A. mangium from different tissues.
|
Institute of Molecular Agrobiology
|
| Remarks |
- National phase entries of WO 2001/53452 in Canada (CA 2362767) and China (CN
1378599) are pending.
- National phase entry of WO 2001/53452 in Europe (EP 1272608) is deemed to be
withdrawn on 9 March 2005.
- National phase entry of WO 2001/53452 in New Zealand (NZ 514910) has been
granted on 27 February 2004.
- Other national phase entry of WO 2001/53452 include: Norway (NO 20014331;
application rejected according to INPADOC), Brazil (BR 200009112).
|
|
Note: Patent information on this page was last updated on 10 March 2006.
Summary
The University of
Toledo has been granted three patents in the United States, Australia
and Europe directed to the transformation of Phaseolus vulgaris
(common beans) with Agrobacterium.
One of the distinctive features of the claimed intentions is a lack of
regeneration of transformed bean plants in a tissue culture media. Mesocotyl
cells of beans seedlings are inoculated with Agrobacterium and then the
plant is allowed to grow normally. Note that the European patent claims
transformation of Phaseolus vulgaris (common beans) as well as
Glycine max (soybeans).
Specific Patent Information
|
Patent Number
|
Title, Independent Claims and Summary of Claims
|
Assignee
|
|
US
5169770
- Earliest priority - 16 December 1988
- Filed - 21 June 1990
- Granted - 8 December 1992
- Patent expired - 5 January 2005
|
Title - Agrobacterium mediated transformation of
germinating plant seeds
Claim 1
A non-tissue culture process for producing a transgenic plant, which process
comprises: (a) germinating a seed of a Phaseolus vulgaris plant
for about 24 to 48 hours; (b) inoculating the meristematic or mesocotyl
cells produced by the germinating seed of step (a), prior to differentiation of
said cells, with an armed or disarmed Agrobacterium strain containing
an Agrobacterium-derived vector, said vector containing a transferable
gene; and (c) allowing the cells to differentiate into a mature plant.
|
Granted patent US 5169770 has expired due to non-payment of
maintenance fees according to the USPTO.
|
University of Toledo
|
|
EP
397687 B1
- Earliest priority - 21 December 1987
- Filed - 16 December 1988
- Granted - 11 May 1994
- Expected expiry - 15 December 2008
|
Title - Agrobacterium mediated transformation of
germinating plant seeds
Claim 1
A non-tissue culture process for producing a transgenic plant, which
comprises:
(a) germinating a seed of a Phaseolus vulgaris or Glycine
max plant, for 24 to 48 hours; (b) inoculating the meristematic or
mesocotyl cells produced during germination, prior to differentiation of the
seed, with a virulent or non-virulent Agrobacterium strain containing a
transferable gene in an Agrobacterium-derived vector; and (c) allowing the
cells to differentiate into a mature plant.
|
Designated contracting States at the time of grant are: Austria (patent
lapsed as reported by INPADOC), Belgium (patent lapsed as reported by INPADOC),
Switzerland (patent lapsed as reported by INPADOC), Germany (patent lapsed as
reported by INPADOC), France (patent lapsed as reported by INPADOC), United
Kingdom (patent lapsed as reported by INPADOC), Italy, Liechtenstein,
Luxembourg, Netherlands (patent lapsed as reported by INPADOC), Sweden (patent
lapsed as reported by INPADOC)
|
| Remarks |
- National phase entries of
WO
1989/05859 in Australia (AU 633248 B2 and AU 648951
B2) have both ceased according to IP Australia.
- National phase entry of
WO
1989/05859 in Japan (JP H04/501201) is deemed to be withdrawn.
- Other national phase entries of
WO
1989/05859 include Denmark (DK 126690) and Kuwait (KR 154872).
|
Note: Patent information on this page was last updated on 10 March 2006.
Summary
The genus Brassica encompasses
crops such as broccoli, brussel sprouts, cabbage and cauliflower. In addition
turnips and choy sum, an Asian vegetable, belong to the Brassica
genus. Finally mustards, canola or rapeseed and rutabaga are species of
Brassica as well.
The patents granted to Calgene in the United States and in
Europe are directed to transgenic Brassica cells containing expression
cassettes inserted in their genome through co-cultivation with a disarmed
Agrobacterium tumefaciens. Brassica explants, such as leaf and
hypocotyl tissue, and protocols to achieve transformation are claimed as well as
the component elements of the expression cassettes.
One the most limiting aspects of the claimed inventions is the sequences of
the expression cassette or construct inserted into the genome of
Brassica plants. In this regard the expression cassette must contain
the following elements in 5' to 3' order:
- a transcription initiation region;
- an open reading frame (ORF) or a sequence complementary to an endogenous
sequence of a plant;
- a right T-DNA border; and
- a structural gene.
AgrEvo (now Bayer Crop Science) has a granted United States
patent that is directed to a method to produce a transgenic Brassica
microspore using Agrobacterium . The microspore is treated first with a
mucolytic enzyme to kill the bacteria and then develops into a haploid or
doubled haploid embryo and ultimately a homozygous transgenic plant (Update July
2003).
The University of Helsinki has granted Australian and United
States patents and a European application directed to the transformation of
turnip rape (Brassica rapa ) with A.
tumefaciens. The claims as granted in Australia and in the US and claims as
filed in Europe are fairly narrow in scope; the methods comprise very detailed
steps, e.g. type of tissue to be transformed and specific, pre-cultivation and
co-cultivation conditions.
Brassica - Patents granted to Calgene
Specific Patent Information
|
Patent Number
|
Title, Independent Claims and Summary of Claims
|
Assignee
|
|
US
5188958
- Earliest priority - 29 May 1986
- Filed - 14 August 1989
- Granted - 23 February 1993
- Expected expiry - 22 February 2010
|
Title - Transformation and foreign gene expression in
Brassica species
Claim 1
Transgenic Brassica species cells and progeny thereof comprising an
expression cassette, wherein said cells are characterized as oncogene-free and
capable of regeneration to morphologically normal whole plants, and wherein said
expression cassette comprises, in the 5' to 3' direction of transcription:
(i) a transcription initiation region functional in Brassica
species cells; (ii) a DNA sequence comprising an open reading frame having
an initiation codon at its 5' terminus or a nucleic acid sequence complementary
to an endogenous transcription product which when expressed will alter the
phenotype of said transgenic cells; (iii) a transcription termination
region functional in Brassica species cells; (iv) a right border
of T-DNA; and (v) a structural gene capable of expression in said Brassica
providing for selection of transgenic Brassica species cells;
wherein said expression cassette is capable of altering the phenotype of said
Brassica species cells when said cells are grown under conditions
whereby said DNA sequence or said nucleic acid sequence is expressed.
|
| Claim 8
A transformed Brassica plant produced according to the method
comprising:
A) co-cultivating Brassica cells with disarmed A.
tumefaciens comprising a plasmid containing an insertion sequence resulting
from joining in vitro of a transcription cassette to at least the right T-DNA
border of a Ti or Ri plasmid whereby said Brassica cells are
transformed with said insertion sequence which becomes integrated into the plant
cell genome to provide transformed oncogene-free cells; B) transferring
said transformed oncogene-free cells to callus inducing medium, wherein said
callus inducing medium contains at least one auxin and a means for selecting for
transformed cells as a result of a marker carried on said plasmid whereby callus
comprising transformed cells is produced; C) transferring said callus to
regeneration medium containing less than about 2% sucrose or an organic caloric
equivalent thereto to produce shoots; and D) transferring said shoots to a
growing medium to produce plants capable of having an altered phenotype when
grown under condition whereby a DNA sequence in said insertion sequence is
expressed.
|
Transformation of Brassica with a disarmed A. tumefaciens
having a cassette with a right T-DNA border from a Ti or a Ri-plasmid that is
free of oncogenic genes. Induction of callus and shoot formation are key steps
in the method to regenerate plants having an altered phenotype. The elements of
the expression cassette are also recited in the claims.
|
Calgene
|
|
US
5463174
- Earliest priority - 29 May 1986
- Filed - 11 September 1992
- Granted - 31 October 1995
- Expected expiry - 22 February 2010
|
Title - Transformation and foreign gene expression in
Brassica species
| Claim 1
Transgenic Brassica species cells and progeny thereof comprising an
expression cassette, wherein said cells are characterized as oncogene-free and
capable of regeneration to morphologically normal whole plants, and wherein said
expression cassette comprises, in the 5' to 3' direction of transcription:
(i) a transcription initiation region functional in Brassica species
cells; (ii) a DNA sequence comprising an open reading frame having an
initiation codon at its 5' terminus or a nucleic acid sequence complementary to
an endogenous transcription product; and (iii) a transcription termination
region functional in Brassica species cells; wherein at least one
of said transcription initiation region and transcription termination region is
not naturally associated with said DNA sequence or said nucleic acid sequence;
and wherein said expression cassette imparts a detectable trait when said
Brassica species cells are grown under conditions whereby said DNA
sequence or said nucleic acid sequence is expressed.
|
| Claim 8
A method for transforming Brassica species cells to produce
morphologically normal whole Brassica plants capable of having an
altered phenotype as a result of said transformation, said method comprising:
A) co-cultivating a Brassica leaf explant with disarmed A.
tumefaciens comprising a plasmid containing an expression cassette joined
to at least a right T-DNA border, whereby said expression cassette becomes
integrated into the genome of cells in said Brassica explant to provide
transformed oncogene-free cells; B) transferring said explant to callus
inducing medium comprising approximately 1 mg/l of one or more growth regulators
selected from the group consisting of 2,4-D, kinetin and zeatin to allow callus
to form on said explant; C) transferring said callus to regeneration medium
containing less than about 2% sucrose, or an organic caloric equivalent thereto,
and comprising at least one milligram per liter of a cytokinin, and a means for
selecting for transformed cells as a result of a marker carried on said plasmid,
whereby shoots comprising transformed cells are produced from said callus;
and D) transferring said shoots to a growing medium to produce plants
capable of having an altered phenotype when grown under conditions whereby a DNA
sequence in said expression cassette is expressed.
|
| Claim 11
A transformed Brassica plant produced according to the method
comprising:
A) co-cultivating a Brassica leaf or hypocotyl explant with disarmed
A. tumefaciens comprising a plasmid containing an expression cassette
joined to at least a right T-DNA border, whereby said expression cassette
becomes integrated into the genome of cells in said Brassica explant to
provide transformed oncogene-free cells, and wherein said expression cassette
comprises a neomycin phosphotransferase II gene conferring kanamycin resistance;
B) transferring said explant to callus inducing medium comprising at least
one auxin to allow callus to form on said explant; C) transferring said
callus to regeneration medium containing less than about 2% sucrose, or an
organic caloric equivalent thereto, and comprising at least one milligram per
liter of a cytokinin, and a means for selecting for transformed cells as a
result of expression of said neomycin phosphotransferase II gene, whereby shoots
comprising transformed cells are produced from said callus; and D)
transferring said shoots to a growing medium to produce plants.
|
| Claim 19
A cell culture of stably transformed Brassica species cells, wherein
said cells are capable of regeneration into morphologically normal whole
Brassica plants capable of having an altered phenotype as a result of
said transformation and regeneration, and wherein said cells are produced
according to a method comprising:
A) co-cultivating a Brassica leaf or hypocotyl explant with disarmed
A. tumefaciens comprising a plasmid containing an expression cassette
joined to at least a right T-DNA border, whereby said expression cassette
becomes integrated into the genome of cells in said Brassica tissue
explant to provide transformed oncogene-free cells; B) transferring said
tissue explant to callus inducing medium to produce callus comprising stably
transformed cells, wherein said callus inducing medium contains at least one
auxin and a means for selecting for transformed cells as a result of a marker
carried on said plasmid.
|
| Claim 20
Transgenic Brassica species cells and progeny thereof comprising an
expression cassette, wherein said cells are characterized as oncogene-free and
capable of regeneration to morphologically normal whole plants, and wherein said
expression cassette comprises, in the 5' to 3' direction of transcription:
(i) a transcription initiation region functional in Brassica species
cells; (ii) a DNA sequence comprising a gene of interest encoding a protein
product or a nucleic acid sequence complementary to an endogenous transcription
product which when expressed will alter the phenotype of said transgenic cells;
and (iii) a transcription termination region functional in
Brassica species cells; wherein said expression cassette further
comprises a structural gene capable of expression in said Brassica
species cells and providing for selection of Brassica species cells
comprising said structural gene, and a right border region of T-DNA capable of
providing for integration of said expression cassette into the genome of said
Brassica species cells; and wherein said gene of interest or said
nucleic acid sequence is expressed and imparts a detectable trait to said
Brassica species cells.
|
Granted US 5463174 is a continuation of now
granted US 5188958.
Method to transform Brassica leaf and hypocotyl explants with a
disarmed A. tumefaciens having a cassette with a right T-DNA border.
Media composition for callus and shoot regeneration are claimed. A claimed
expression cassette contains npt II gene for conferring resistance to
kanamycin; other elements of the cassette are also recited in the claims.
|
|
US
5750871
- Earliest priority - 29 May 1986
- Filed - 30 March 1995
- Granted - 12 May 1998
- Expected expiry - 22 February 2010
|
Title - Transformation and foreign gene expression in
Brassica species
| Claim 1
Transgenic Brassica species cells and progeny thereof comprising an
expression cassette, wherein said cells are characterized as oncogene-free and
capable of regeneration to morphologically normal whole plants, and wherein said
expression cassette comprises, in the 5' to 3' direction of transcription:
(i) a transcription initiation region functional in Brassica species
cells; (ii) a DNA sequence comprising an open reading frame having an
initiation codon at its 5' terminus or a nucleic acid sequence complementary to
an endogenous transcription product; and (iii) a transcription termination
region functional in Brassica species cells; wherein at least one
of said transcription initiation region and transcription termination region is
not naturally associated with said DNA sequence or said nucleic acid sequence;
and wherein said expression cassette is integrated into the genome of said
Brassica species cells and imparts a detectable trait when said
Brassica species cells are grown under conditions whereby said DNA
sequence or said nucleic acid sequence is expressed.
|
| Claim 15
A method for transforming Brassica species cells to produce
morphologically normal whole Brassica plants having an altered
phenotype as a result of said transformation, said method comprising:
A) co-cultivating a Brassica hypocotyl or leaf explant with disarmed
A. tumefaciens comprising a plasmid containing an expression cassette
joined to at least a right T-DNA border, whereby said expression cassette
becomes integrated into the genome of cells in said Brassica explant to
provide transformed oncogene-free cells; B) transferring said explant to
callus inducing medium to allow callus to form on said explant, wherein said
callus inducing medium comprises about 1 mg/l of an auxin and from about 0 to 1
mg/l of a cytokinin; C) transferring said callus to regeneration medium
containing less than about 2% sucrose, or an organic caloric equivalent thereto,
and comprising at least one milligram per liter of a cytokinin, and a means for
selecting for transformed cells as a result of a marker carried on said plasmid,
whereby shoots comprising transformed cells are produced from said callus;
and D) transferring said shoots to a growing medium to produce plants
having an altered phenotype when grown under conditions whereby a DNA sequence
in said expression cassette is expressed.
|
Granted US 5750871 is a continuation of now
granted US 5463174.
The inventors claim elements of an expression cassette that is integrated
into the genome of Brassica cells. Hypocotyl and leaf explants are used
for transformation. Medium components for callus and shoot regeneration are also
claimed.
|
|
EP
270615 B1
- Earliest priority - 29 May 1986
- Filed - 26 May 1987
- Granted - 4 August 1993
- Revoked (appeal of proprietor rejected) - 28 July 2000
|
Title - Transformation and foreign gene expression in
Brassica species
| Claim 1
Transgenic Brassica species cells having a DNA construct resulting
from in vitro joining of at least two fragments, wherein said fragments
comprise: (i) a transcription initiation region functional in said
Brassica; (ii) a DNA sequence comprising an open reading frame
having an initiation codon at its 5' terminus or a sequence complementary to an
endogenous transcription product; (iii) a transcription termination region
functional in said Brassica; (iv) a right border of T-DNA;
and (v) a structural gene capable of expression in said Brassica
providing for selection of transformed Brassica cells; wherein
said fragments provide an expression cassette capable of expression in said
Brassica cells.
|
| Claim 7
A method for transforming Brassica cells to produce
Brassica plants said method comprising:
A) co-cultivating Brassica cells with A. tumefaciens
comprising a plasmid comprising an insertion sequence resulting from the in
vitro joining of a transcription cassette to at least the right T-DNA
border and a marker which provides for selection of cells containing said
marker, whereby said Brassica cells are transformed with said insertion
sequence which becomes integrated into the plant cell genome; B)
transferring said transformed Brassica cells to callus inducing media
containing at least one auxin and selecting for cells comprising said marker to
produce callus from said transformed cells; C) transferring said callus to
regeneration media containing less than about 2% sucrose or an organic caloric
equivalent to produce shoots; and D) transferring said shoots to a growing
medium to produce plants.
|
Designated contracting States at the time of grant are: Austria, Belgium,
Switzerland (patent lapsed as reported by INPADOC), Germany, France, United
Kingdom, Italy, Liechtenstein, Luxembourg, Netherlands, Sweden (patent lapsed as
reported by INPADOC)
Transgenic Brassica cells and progeny having an expression cassette
that confers an altered phenotype. A method to transform those cells with a
disarmed A. tumefaciens is also claimed. The method is the same as the
one claimed in US 5188958.
|
CA 1341167 A1
- Earliest priority - 29 May 1986
- Filed - 28 May 1987
- Granted - 16 January 2001
- Expected expiry - 15 January 2018
|
Title - Transformation and foreign gene expression in
Brassica species
|
Claim 1
Transgenic Brassica species cells and
cellular progeny thereof comprising an expression cassette, wherein said cells
are characterized as oncogene-free and capable of regeneration to
morphologically normal whole plants, and wherein said expression cassette
comprises, in the 5'- 3' direction of transcription: (1) a transcription
initiation region functional in Brassica species cells; (2) a DNA
sequence comprising an open reading frame having an initiation codon at its 5'
terminus or a nucleic acid sequence complementary to an endogenous transcription
product; and (3) a transcription termination region functional in
Brassica species cells; wherein at least one of said transcription
initiation region and transcription termination region is not naturally
associated with said DNA sequence or said nucleic acid sequence; and wherein
said expression cassette imparts a detectable trait when said Brassica
species cells are grown under conditions whereby said DNA sequence or said
nucleic acid sequence is expressed.
|
|
Claim 2
Transgenic Brassica species cells and
cellular progeny thereof comprising an expression cassette, wherein said cells
are characterized as oncogene-free and capable of regeneration to
morphologically normal whole plants, and wherein said expression cassette
comprises in the 5' - 3' direction of transcription: (1) a transcription
initiation region functional in Brassica species cells; (2) a DNA
sequence comprising an open reading frame having an initiation codon at its 5'
terminus or a nucleic acid sequence complementary to an endogenous transcription
product which when expressed will alter the phenotype of said transgenic cells;
(3) a transcription termination region functional in Brassica
species cells; wherein said expression cassette further comprises a structural
gene capable of expression in said Brassica species cells and providing for
selection of transgenic Brassica species cells comprising said
structural gene, and a right border region of T-DNA capable of providing for
integration of said expression cassette into the genome of said
Brassica species cells; and wherein said expression cassette is capable
of altering the phenotype of said Brassica species cells when said
cells are grown under conditions whereby said DNA sequence or said nucleic acid
sequence is expressed.
|
|
Claim 6
A method for transforming Brassica
species cells to produce morphologically normal whole Brassica plants
capable of having an altered phenotype as a result of said transformation, said
method comprising:
- co-cultivating Brassica cells with A.tumefaciens
comprising an oncogene-free plasmid containing an insertion sequence resulting
from joining in vitro of a transcription cassette to at least the right T-DNA
border of a Ti- or Ri-plasmid whereby said Brassica cells are
transformed with said insertion sequence which becomes integrated into the plant
cell genome to provide transformed oncogene-free cells;
- transferring said transformed oncogene-free cells to callus inducing medium,
wherein said callus inducing medium contains at least one auxin and a means for
selecting for transformed cells as a result of a marker carried on said plasmid
whereby callus comprising transformed cells is produced;
- transferring said callus to regeneration medium containing less than about
2% sucrose or an organic caloric equivalent thereto to produce shoots; and
- transferring said shoots to a growing medium to produce plants capable of
having an altered phenotype when grown under conditions whereby a DNA sequence
in said insertion sequence is expressed.
|
|
Claim 16
Transgenic Brassica species cells and
cellular progeny thereof comprising an expression cassette, wherein said cells
are derived from tissue explants and are characterized as oncogene-free, and
wherein said expression cassette comprises, in the 5'- 3' direction of
transcription: (1) a transcription initiation region functional in
Brassica species cells; (2) a DNA sequence comprising an open
reading frame having an initiation codon at its 5' terminus or a nucleic acid
sequence complementary to an endogenous transcription product; and (3) a
transcription termination region functional in Brassica species cells;
wherein at least one of said transcription initiation region and transcription
termination region is not naturally associated with said DNA sequence or said
nucleic acid sequence; and wherein said expression cassette imparts a detectable
trait when said Brassica species cells are grown under conditions
whereby said DNA sequence or said nucleic acid sequence is expressed.
|
|
Claim 17
Transgenic Brassica species cells and
cellular progeny thereof comprising an expression cassette, wherein said cells
are derived from tissue explants and are characterized as oncogene-free, and
wherein said expression cassette comprises in the 5' - 3' direction of
transcription: (1) a transcription initiation region functional in
Brassica species cells; (2) a DNA sequence comprising an open
reading frame having an initiation codon at its 5' terminus or a nucleic acid
sequence complementary to an endogenous transcription product which when
expressed will alter the phenotype of said transgenic cells; (3) a
transcription termination region functional in Brassica species cells;
wherein said expression cassette further comprises a structural gene capable of
expression in said Brassica species cells and providing for selection of
transgenic Brassica species cells comprising said structural gene, and
a right border region of T-DNA capable of providing for integration of said
expression cassette into the genome of said Brassica species cells; and
wherein said expression cassette is capable of altering the phenotype of said
Brassica species cells when said cells are grown under conditions
whereby said DNA sequence or said nucleic acid sequence is expressed.
|
|
Claim 18
A method for transforming Brassica
species cells to produce morphologically normal whole Brassica plants
capable of having an altered phenotype as a result of said transformation, said
method comprising: transforming Brassica cells with a transcription
cassette comprising, in the 5'-3' direction of transcription: (1) a
transcription initiation region functional in Brassica species cells;
(2) a DNA sequence comprising an open reading frame having an initiation
codon at its 5' terminus or a nucleic acid sequence complementary to an
endogenous transcription product; and (3) a transcription termination
region functional in Brassica species cells; wherein at least one of
said transcription initiation region and said transcription termination region
is not naturally associated with said DNA sequence or said nucleic acid
sequence; whereby said cassette becomes integrated into the plant cell genome to
provide transformed cells which are not tumor cells; transferring said
transformed cells to callus inducing medium, wherein said callus inducing medium
contains at least one auxin and a means for selecting for transformed cells as a
result of a marker carried on said plasmid whereby callus comprising transformed
cells is produced; transferring said callus to regeneration medium; and
transferring said shoots to a growing medium to produce plants capable of having
an altered phenotype when grown under conditions whereby a DNA sequence in said
insertion sequence is expressed.
|
|
CA 1341481 A1
- Earliest priority - 29 May 1986
- Filed - 28 May 1987
- Granted - 26 April 2005
- Expected expiry - 25 April 2025
|
Title - Transformation and foreign gene expression in
Brassica species
|
Claim 1 An expression or transcription cassette comprising in the 5' -
3' direction of transcription: (1) a transcription initiation region
functional in Brassica species cells; (2) a nucleic acid sequence
comprising an open reading frame having an initiation codon at its 5' terminus
or a nucleic acid sequence complementary to an endogenous transcription product
which when expressed will alter the phenotype of Brassica species
cells; (3) a transcription termination region functional in
Brassica species cells; (4) a structural gene capable of
expression in Brassica species cells and providing for selection of
transgenic Brassica species cells comprising said structural gene;
and (5) a right border region of T-DNA capable of providing for integration
of said expression or transcription cassette into the genome of
Brassica species cells; and wherein said expression or transcription
cassette is capable of altering the phenotype of said transgenic
Brassica species cells when said cells are grown under conditions
whereby said nucleic acid sequence is expressed.
|
|
Claim 11
Transgenic Brassica species tissue
consisting of a uniform cell type comprising an expression cassette, wherein
said tissue is characterized as oncogene-free, and wherein said expression
cassette comprises, in the 5' - 3' direction of transcription: (1) a
transcription initiation region functional in Brassica species tissue;
(2) a DNA sequence comprising an open reading frame having an initiation
codon at its 5' terminus or a nucleic acid sequence complementary to an
endogenous transcription product; and (3) a transcription termination
region functional in Brassica species tissue; wherein at least one of
said transcription initiation region and transcription termination region is not
naturally associated with said DNA sequence or said nucleic acid sequence; and
wherein said expression cassette imparts a detectable trait when said
Brassica species tissue is grown under conditions whereby said DNA
sequence or said nucleic acid sequence is expressed.
|
|
Claim 12
Transgenic Brassica species tissue
consisting of a uniform cell type comprising an expression cassette, wherein
said tissue is characterized as oncogene-free, and wherein said expression
cassette comprises in the 5' - 3' direction of transcription: (1) a
transcription initiation region functional in Brassica species tissue;
(2) a DNA sequence comprising an open reading frame having an initiation
codon at its 5' terminus or a nucleic acid sequence complementary to an
endogenous transcription product which when expressed will alter the phenotype
of said transgenic tissue; and (3) a transcription termination region
functional in Brassica species tissue; wherein said expression cassette
further comprises a structural gene capable of expression in said
Brassica species tissue and providing for selection of transgenic
Brassica species tissue comprising said structural gene, and a right
border region of T-DNA capable of providing for integration of said expression
cassette into the genome of said Brassica species tissue; and wherein
said expression cassette is capable of altering the phenotype of said
Brassica species tissue when said tissue is grown under conditions
whereby said DNA sequence or said nucleic acid sequence is expressed.
|
|
Claim 13
A transgenic Brassica species cell
comprising an expression cassette, wherein said expression cassette comprises,
in the 5' - 3' direction of transcription: (1) a transcription initiation
region functional in the Brassica species cell; (2) a DNA
sequence comprising an open reading frame having an initiation codon at its 5'
terminus or a nucleic acid sequence complementary to an endogenous transcription
product; and (3) a transcription termination region functional in the
Brassica species cell; wherein at least one of said transcription
initiation region and transcription termination region is not naturally
associated with said DNA sequence or said nucleic acid sequence; and wherein
said expression cassette imparts a detectable trait when said Brassica
species cell is grown under conditions whereby said DNA sequence or said nucleic
acid sequence is expressed.
|
|
Claim 14
A transgenic Brassica species cell
comprising an expression cassette, wherein said expression cassette comprises in
the 5' - 3' direction of transcription: (1) a transcription initiation
region functional in the Brassica species cell; (2) a DNA
sequence comprising an open reading frame having an initiation codon at its 5'
terminus or a nucleic acid sequence complementary to an endogenous transcription
product which when expressed will alter the phenotype of said transgenic cell;
and (3) a transcription termination region functional in the
Brassica species cell; wherein said expression cassette further
comprises a structural gene capable of expression in said Brassica
species cell and providing for selection of the transgenic Brassica
species cell comprising said structural gene, and a right border region of T-DNA
capable of providing for integration of said expression cassette into the genome
of said Brassica species cell: and wherein said expression cassette is
capable of altering the phenotype of said Brassica species cell when
said cell is grown under conditions whereby said DNA sequence or said nucleic
acid sequence is expressed.
|
|
|
WO
1987/07299 A1
- Earliest priority - 29 May 1986
- Filed - 26 May 1987
- OPI - 3 December 1987
|
Title - Transformation and foreign gene expression in
Brassica species
Claim 1
Transformed Brassica species cells having a DNA construct resulting
from in vitro joining of at least two fragments, wherein said fragments
comprise:
(1) a transcription initiation region functional in said Brassica;
(2) a DNA sequence comprising an open reading frame having an initiation
codon at its 5' terminus or a sequence complementary to an endogenous
transcription product; (3) a transcription termination region func tional
in said Brassica; (4) a right border of T-DNA; (5) a
structural gene capable of expression in said Brassica providing for
selection of transformed Brassica cells; wherein said fragments provide
an expression cassette capable of expression in said Brassica cells.
|
Claim 7
A method for transforming Brassica cells to produce
Brassica plants, said method comprising:
- co-cultivating Brassica cells with A. tumefaciens
comprising a plasmid comprising an insertion sequence resulting from the in
vitro joining of a transcription cassette to at least the right T-DNA
border and a marker which provides for selection of cells containing said
marker, whereby said Brassica cells are transformed with said insertion
sequence which becomes integrated into the plant cell genome;
- transferring said transformed Brassica cells to callus inducing
media containing at least one auxin and selective for cells comprising said
marker to produce callus from said transformed cells;
- transferring said callus to regenerate media containing less than about 2%
sucrose or organic caloric equivalent to produce shoots; and
- transferring said shoots to a growing medium to produce plants.
|
|
| Remarks |
- Other national phase entries of WO 1987/07299 include: Finland (FI 880383;
patent lapsed), Japan (JP H01/500718; appeal against rejection of application
withdrawn by applicant).
|
Note: Patent information on this page was last updated on 13 March 2006.
Brassica - Patent Assigned to AgrEvo
Canada Inc. (now Bayer Crop Science)
Specific Patent Information
|
Patent Number
|
Title, Independent Claims and Summary of Claims
|
Assignee
|
|
US
6316694
- Earliest priority - 17 March 1995
- Filed - 14 November 1997
- Granted - 13 November 2001
- Expected expiry - 14 March 2016
|
Title - Transformed embryogenic microspores for the
generation of fertile homozygous plants
| Claim 1
A method for producing a stably transformed Brassica embryogenic
microspore, capable of leading to a non-chimeric transformed haploid or doubled
haploid embryo which develops into a fertile homozygous Brassica plant
within one generation, said process comprising the following steps: a.
infecting an embryogenic microspore with Agrobacteria, which contain a
plasmid carrying a gene of interest under regulatory control of initiation and
termination signals bordered by at least one T-DNA border, and b. washing
out and killing the Agrobacteria after co-cultivation using mucolytic
enzymes, thereby producing a stably transformed Brassica embryogenic
microspore.
|
| Claim 2
A method for producing a non-chimeric Brassica plant, containing a
foreign DNA stably incorporated into its genome, said method comprising:
a. co-cultivating a Brassica embryogenic microspore with
Agrobacteria which contains a plasmid carrying a gene of interest under
regulatory control of initiation and termination signals; b. washing out
and killing the Agrobacteria after co-cultivation using mucolytic
enzymes; and c. regenerating a non-chimeric haploid or doubled haploid
Brassica embryo from said microspore, wherein the embryo contains said
gene of interest stably integrated into its genome, thereby producing a
non-chimeric Brassica plant.
|
This patent discloses a method to generate transgenic plants from the
Brassica family by using microspores as a target tissue for
Agrobacterium carrying a gene of interest. After infection bacteria are
eliminated by treatment with mucolytic enzymes. Microspores are further
cultivated to produce haploid or doubled haploid embryos from which fully
regenerated transgenic plants are obtained.
|
AgrEvo Canada Inc. (now Bayer Crop Science)
|
| Remarks |
- Claims of other granted national phase entries of the corresponding PCT
application for US 6316694
(WO
1996/29419) in Australia (AU 710201) and China (CN 1110562) are not limited
to plants from the Brassica family.
- National phase entry of
WO
1996/29419 in Canada (CA 2215763) is pending.
- Nationall phase entry of
WO
1996/29419 n Europe (EP 737748) is deemed to be withdrawn on 6 September
2000.
|
Note: Patent information on this page was last updated on 13 March 2006.
Turnip rape (Brassica rapa) - Granted
patents assigned to the University of Helsinki
Specific Patent Information
|
Patent Number
|
Title, Independent Claims and Summary of Claims
|
Assignee
|
|
US
6455761
- Earliest priority - 18 September 1997
- Filed - 10 March 2000
- Granted - 24 September 2002
- Expected expiry - 15 September 2018
|
Title - Agrobacterium-mediated transformation of
turnip rape
Claim 1
A method for transforming mature plants of turnip rape, comprising
(i) excising an internode section of the inflorescence-carrying stem of a
mature turnip rape plant, (ii) sterilizing said internode section, and
cutting it in 4-8 mm segments to obtain an internode segment, (iii) placing
an internode segment in a horizontal position on an agar pre-cultivation medium
supplemented with 15-90 μM of silver nitrate and 2,4-dichlorophenoxyacetic acid
(2,4-D) hormone, (iv) pre-cultivating the internode segment on said medium
for 1 day, (v) immersing the internode segment in a MS solution inoculated
with Agrobacterium tumefaciens bacteria carrying at least one gene
heterologous to said turnip rape, (vi) placing the immersed internode
segment in a horizontal position on an agar MS co-cultivation medium,
(vii) co-cultivating the internode segment with Agrobacteria for 2
days, (viii) washing the internode segment to remove the
Agrobacteria, (ix) placing the internode segment in a vertical
position with the basal side down on MS agar medium for selection with an
antibiotic, the medium being supplemented with cytokinine hormones and silver
nitrate, to obtain an internode segment with regenerated primordia or embryonic
green nodules, (x) placing the internode segment with regenerated primordia
or embryogenic green nodules on a hormone-free regeneration medium, and
(xi) recovering the transgenic shoots regenerated.
|
The independent claim of United Stated patent US 6455761
discloses a quite detailed protocol of how to obtain transgenic turnip rape
(Brassica rapa). This offers a number of opportunities to develop
similar methods and avoid infringement with respect to this specific patent at
the same time. Other patents have more general claims that cover the use of
Agrobacterium to produce transgenic dicots for example.
|
University of Helsinki
|
|
AU
732372 B2
- Earliest priority - 18 September 1997
- Filed - 16 September 1998
- Granted - 26 April 2001
- Patent ceased - 22 April 2004
|
Title - Agrobacterium-mediated transformation of
turnip rape
Claim 1
A method for transformation of mature plants of turnip rape, comprising
- excising an internode section of the inflorescence carrying stem of a
mature turnip rape plant, - sterilizing said internode section, and cutting
it in 4-8 mm segments, - placing a segment in a horizontal position on an
agar pre-cultivation medium supplemented with silver nitrate and 2,
4-dichlorophenoxyacetic acid (2, 4-D) hormone, - pre-cultivating the
segment on said medium for 1 day, - immersing the segment in a MS solution
inoculated with Agrobacterium tumefaciens bacteria carrying at least
one gene heterologous to said turnip rape, - placing the immersed segment
in a horizontal position on an agar MS co-cultivation medium,
-co-cultivating the segment with Agrobacteria for 2 days, -
washing the segment from the Agrobacteria, -placing the segment in
a vertical position with the basal side down on MS agar medium for selection
with an antibiotic, the medium being supplemented with cytokinine hormones and
silver nitrate, and -placing the segment with regenerated primordia or
embryogenic green nodules on a hormone free regeneration medium, and -
recovering the transgenic shoots regenerated.
|
|
| Remarks |
- National phase entry of
WO
1999/14349 in Canada (CA 2302835) is deemed dead on 16 September 2004.
- National phase entry of
WO
1999/14349 in Europe (EP 1009845) is deemed to be withdrawn on 6 October
2004.
- Other national phase entry of
WO
1999/14349 includes Finland (FI 973720).
|
Note: Patent information on this page was last updated on 13 March 2006.
Cacao
Summary
The Penn State Research
Foundation has filed patent applications in Europe and Australia (both
now abandoned) and has been granted a United States patent related to
transformation of cacao floral tissue or a cacao cell with
Agrobacterium.
The invention sets out different steps for a method to transform cacao
tissue. The steps include
- induction of primary callus growth in a specified culture medium;
- induction of secondary callus growth in a medium with specific requirements;
and
- embryo development in a specific hormone-free medium.
Specific Patent Information
|
Patent Number
|
Title, Independent Claims and Summary of Claims
|
Assignee
|
|
US
6150587
- Earliest priority - 27 June 1997
- Filed - 26 June 1998
- Granted - 21 November 2000
- Expected expiry - 25 June 2018
|
Title - Method and tissue culture media for inducing somatic
embryogenesis, Agrobacterium-mediated transformation and efficient
regeneration of cacao plants
| Claim 1
A method of inducing Agrobacterium -mediated transformation of
cacao, which method comprises:
A) co-culturing a cacao floral tissue explant or cell with a
non-tumorigenic Agrobacterium to produce a transformed embryogenic
callus, wherein the cacao tissue explant or cell is cultured on a primary callus
growth medium, said primary callus growth medium comprising DKW basal salts, a
carbon source, and at least two growth regulators; B) culturing the
embryogenic callus produced in step (A) on a secondary callus growth medium
having the property of inducing homeostatic growth and bipolar callus
development, wherein the secondary callus growth medium is comprised of a low
salt WPM basal medium, at least one growth regulator and a carbon source;
and C) culturing the callus produced in step (B) on a hormone-free embryo
development medium having the property of inducing embryo differentiation,
wherein the embryo development medium is comprised of a DKW basal medium and a
carbon source.
|
Transformation of cacao floral tissue or cacao cells with a non-tumorigenic
Agrobacterium. Media for cultivation of embryogenic callus and
induction of embryo differentiation are also claimed.
Another granted patent
US
6197587 and patent application
US
2001/047524 A1 share the same priority documents
as US 6150587, however the claims do not concern transformation
of cacao plants. US 6197587 B1 recites a method of inducing
somatic embryogenesis in a cacao tissue, and US
2001/047524 A1 recites a method of inducing somatic
embryogenesis in a cacao tissue as well as regenerating cacao plantlets, and
medium compositions for callus growth, embryo development, and regeneration.
|
Penn State Research Foundation
|
|
WO
1999/00008 A1
- Earliest priority - 27 June 1997
- Filed - 26 June 1998
- OPI - 7 January 1999
|
Title - Method and tissue culture media for inducing somatic
embryogenesis, Agrobacterium-mediated transformation and efficient
regeneration of cacao plants
Claim 1
A method of inducing Agrobacterium-mediated transformation of cacao
comprising the steps of:
(a) coculturing a cacao tissue explant or cell with a non-tumorigenic
Agrobacterium to produce a transformed embryogenic callus; (b)
culturing the embryogenic callus produced in step (a) on an embryo development
medium, said medium having the property of inducing embryo differentiation to
obtain mature transformed somatic embryos.
|
|
Claim 16 A method of regenerating transformed cacao plantlets comprising
the steps of: (a) providing a transformed cacao somatic embryo; (b)
germinating said somatic embryo on a primary embryo conversion medium; and
(c) regenerating a transformed cacao plantlet on a secondary embryo
conversion medium from a germinated embryo produced in step (b).
|
|
Claim 24 A method of regenerating transformed cacao plantlets comprising
the steps of: (a) providing a transformed cacao somatic embryo; (b)
culturing said somatic embryo on a plant regeneration medium.
|
PCT application WO 1999/00008 recite an
Agrobacterium-mediated transformation method of cacao that is not
limited to cacao floral tissue explant or cell as granted US
6150587 (see above), but of any cacao tissue explant or cell.
Methods of regenerating transformed cacao plantlets are also recited.
Related PCT application
WO
1999/00487 recites a method of inducing somatic embryogenesis in a
cacao tissue as well as regenerating cacao plantlets, and medium compositions
for callus growth, embryo development, and regeneration.
|
| Remarks |
- National phase entry of WO 1999/00008 in Australia (AU 81743/98) has lapsed
on 9 March 2000.
- National phase entry of WO 1999/00008 in Europe (EP 999737) is deemed to be
withdrawn on 12 March 2003.
|
Note: Patent information on this page was last updated on 13 March 2006.
Camelina sativa belongs to the family Brassicaceae. This plant is
native to Eastern Europe and Southwest Asia, where there are also wild weedy
forms. The developed crop form was widely grown across Europe until the 1950s.
The seeds yield an oil of excellent nutritional quality which in the past was
used as an illuminant and for cosmetic purposes, while the stems were utilized
for making brushes, packaging, and thatching temporary buildings. There were
additional uses of the green crop as fodder and of the seed for fattening
poultry, while the protein-rich press cake was a valued livestock food. Small
areas have been grown in recent years for use in the soap and cosmetic
industries and as a constituent of birdseed. Experiments are being conducted to
assess its future potential.
Summary of the invention
The present invention discloses a general method for transformation of
Camelina sativa using Agrobacterium. Independent Claim 1 is
not limited in the sort of explant used for transformation. The only limitation
seems to be that an explant is used as starting material, which could mean that
full plants are excluded from protection.
Independent Claims 27-30 recite broad claims on various industrial
application of the genetically modified plant, which is seen as having potential
for the production of a number of metabolites and products.
Naturally, this patent application must be viewed in the light of the many
other patents on Agrobacterium-mediated transformation, including general
methods, methods for dicots and vectors.
Specific Patent Information
|
Patent Number
|
Title, Independent Claims and Summary of Claims
|
Assigne
|
|
WO
2002/38779 A1
- Earliest priority - 13 November 2000
- Filed - 12 November 2001
- OPI - 16 May 2002
|
Title - A transformation system in Camelina sativa
Claim 1
A method for Agrobacterium-mediated genetic transformation,
characterized in that the method is Agrobacterium-mediated genetic
transformation of Camelina sativa comprising the steps of:
(a) providing explants from Camelina sativa; (b) contacting the
explants of Camelina sativa with Agrobacterium containing at
least one recombinant DNA construct; (c) allowing the transformation to
take place on culture medium optionally supplemented with at least one
hormone; (d) inducing formation (regeneration) of one or
more shoots and roots from the transformed explants on a cell culture medium
optionally containing at least one hormone; and (e) growing the shoots into
a whole Camelina sativa plant.
|
|
Claim 27 The use of Camelina sativa as an alternative model
plant in Agrobacterium-mediated transformation.
|
|
Claim 28 The use of transgenic Camelina sativa for producing
heterologous or homologous products.
|
|
Claim 29 The use of transgenic Camelina sativa for producing
proteins.
|
|
Claim 30 The use of transgenic Camelina sativa for producing
metabolites.
|
Agrobacterium-mediated transformation of Camelina sativa
explants and the subsequent regeneration of the transformed cells into whole
Camelina sativa plants. The use of transgenic Camelina sativa for the
production of homologous or heterologous recombinant products are also claimed.
According to the specification, the term "hormone" in claim 1 'means
organic compounds or molecules originating in certain parts or organs of a
plant, which compounds when transported to another tissue elicit a certain
response. Plant hormones are active preferably in small concentrations and can
be used in different combinations. The major classes of plant hormones are
auxin, gibberellins, cytokinins, ethylene, and abscisic acid, each of which has
many effects. Also a variety of other compounds including oligosaccharmns,
batasins and brassino steroids function as hormones in plants.'
|
Unicorp Ltd
|
| Remarks |
- National phase entry of WO 2002/38779 in Canada (CA 2427117), United States
(US 2004/0031076) and Europe (EP1334199) are pending.
- National phase entry of WO 2002/38779 in Australia (AU 1407802) has lapsed
as advertised on 29 January 2004 according to IP Australia.
- National phase entry of WO 2002/38779 in Finland (FI 110009B B1) has been
granted on 15 November 2002.
|
Note: Patent information on this page was last updated on 14 March 2006.
Carnations
Summary
In a European application and a United
States granted patent, the invention claimed by Florigene
Europe is directed to
- a method for transforming carnation plant material with A.
tumefaciens or A. rhizogenes. The material to be transformed
encompasses any explant of a carnation plant and in certain methods specifically
leaves from shoots grown in culture.
- methods for producing genetically altered carnation plants. A method for
micropropagating shoots from initially propagated vitrified shoots is also
covered.
- methods to alter the normal phenotype of carnation plants. The
characteristics included are prolonged vase life, resistance to a herbicide and
modification of color.
Carnations - Patent application filed by Florigene Europe B.V.
Specific Patent Information
Patent Number
|
Title, Independent Claims and Summary of Claims
|
Assignee
|
|
WO
1992/017056 A1
- Earliest priority - 1 April 1991
- Filed - 31 March 1992
- OPI - 15 October 1992
|
Title - Carnation plants and methods for their
transformation and propagation
Claim 1
A method for genetically transforming carnation plant material, said method
comprising:
A) co-cultivating carnation plant material with Agrobacterium cells
carrying an exogenous DNA sequence; B) initiating callus formation in the
plant material; and C) selecting transformed plant cells.
|
Claim 5
A method for producing genetically altered carnation plants, said method
comprising:
A) co-cultivation of carnation plant material with Agrobacterium
cells carrying an exogenous DNA sequence including a selectable marker gene in a
co-cultivation medium containing nutrients, an energy source, and an induction
compound under conditions which allow the Agrobacterium cells to infect
the plant material and transfer the exogenous DNA to the carnation chromosomes;
B) culturing plant material from step (A) in a callus initiation medium
containing nutrients, an energy source, an auxin, a cytokinin, an
anti-Agrobacterium antibiotic, and a plant selection agent which
inhibits callus and shoot formation from plant material which does not express
the selectable marker gene to produce transformed callus material; and C)
culturing transformed callus material in a regeneration medium containing
nutrients, an energy source, an auxin, a cytokinin, an
anti-Agrobacterium antibiotic, and the plant selection agent, present
in amounts effective to produce transformed shoots.
|
|
Claim 23
A method for micropropagating shoots from carnation plant material, said
method comprising:
A) culturing carnation plant material to produce a plurality of shoots; and
B) placing vitrified shoots from step (A) in a normalizing medium
containing nutrients and an energy source but being substantially free from
growth regulators, whereby new shoots are produced which are free from
vitrification.
|
|
Claim 26
A method for micropropagating shoots from previously established carnation
shoots, said method comprising:
A) separating individual shoots; and B) culturing individual shoots in a
multiplication medium comprising nutrients, an energy source, growth regulators
and a solidifying agent for a time sufficient to produce at least about 50
shoots for each individual shoot cultured.
|
|
Claim 27
A method for regenerating carnation plants, said method comprising: culturing
carnation plant material on a regeneration medium containing nutrients, an
energy source, a solidifying agent, indole butyric acid at a concentration in
the range from about 1 to 5 M, and thidiazuron at a concentration in the range
from about 0.5 to 2 M, whereby shoots are produced at a regeneration frequency
above about 20 percent.
|
| Claim 28
Carnation callus material which expresses an exogenous DNA sequence.
|
Claim 30
A carnation plant having cells which express an exogenous DNA sequence.
|
The claims of the PCT application recite transformation of carnation plant
material with Agrobacterium. There is no mention of the plant material
used for transformation. Methods for shoot formation and rooting as well as a
method for whole plant regeneration are recited in the claims.
|
Florigene Europe B.V.
|
| Remarks |
National phase entry of WO 1992/017056 in Europe (EP
582603) is deemed to be withdrawn on 16 April 2003.
|
Note: Patent information on this page was last updated on 14 March 2006.
Carnations - Patent granted to Florigene Europe B.V.
Specific Patent Information
|
Patent Number
|
Title, Independent Claims and Summary of Claims
|
Assignee
|
|
US
5589613 A
- Earliest priority - 1 April 1991
- Filed - 10 November 1993
- Granted - 31 December 1996
- Expected expiry - 30 December 2016
|
Title - Carnation plants and methods for their
transformation and propagation
Claim 1
A method for genetically transforming carnation plant material, said method
comprising:
A) co-cultivating carnation plant material with Agrobacterium
tumefaciens or rhizogenes cells carrying an exogenous DNA
sequence; B) initiating callus formation in the plant material; and
C) selecting transformed plant cells.
|
| Claim 5
A method for producing genetically altered carnation plants, said method
comprising:
A) co-cultivation of carnation plant material with Agrobacterium
tumefaciens or rhizogenes cells carrying an exogenous DNA sequence
including a selectable marker gene in a co-cultivation medium containing
nutrients, an energy source, and an induction compound under conditions which
allow the Agrobacterium cells to infect the plant material and transfer
the exogenous DNA to the carnation chromosomes, wherein the carnation plant
material is leaf obtained from shoots grown in culture; B) culturing plant
material from step (A) in a callus initiation medium containing nutrients, an
energy source, an auxin, a cytokinin, an anti-Agrobacterium
antibiotic, and a plant selection agent which inhibits callus and shoot
formation from plant material which does not express the selectable marker gene
to produce transformed callus material; and C) culturing transformed callus
material in a regeneration medium containing nutrients, an energy source, an
auxin, a cytokinin, an anti-Agrobacterium antibiotic, and the plant
selection agent, present in amounts effective to produce transformed shoots.
|
|
Claim 22
A method for micropropagating shoots from transformed carnation plant
material, said method comprising:
A) culturing transformed carnation plant material obtained from callus to
produce a plurality of vitrified shoots; and B) placing vitrified shoots
from step (A) in a medium containing nutrients and an energy source but being
substantially free from growth regulators for a period of at least about one
month, whereby new shoots are produced which are free from vitrification.
|
| Claim 24
Carnation callus material derived from an explant material which has been
transformed with an exogenous DNA sequence, wherein said DNA sequence comprises
a functional gene capable of imparting a phenotype not possessed by the explant
material and wherein said DNA sequence has been integrated into the carnation
genome.
|
Claim 26
A carnation plant having cells derived from an explant material which have
been transformed with an exogenous DNA sequence, wherein said DNA sequence
comprises a functional gene capable of imparting a phenotype not possessed by
the explant material and wherein said DNA sequence has been integrated into the
carnation genome.
|
Claim 28
A carnation plant having cells derived from an explant material which have
been transformed with an exogenous DNA sequence so that flowers of the plant
display a phenotype characterized by controlled senescence resulting in
prolonged vase life relative to the vase life of flowers from plants propagated
from non-transformed cells of the explant material.
|
| Claim 29
A transgenic carnation plant derived from an explant material comprising an
exogenous DNA sequence so that flowers of the plant display a phenotype charac
terized by controlled senescence resulting in prolonged vase life relative to
the vase life of flowers from plants propagated from non-transformed cells of
the explant material.
|
| Claim 31
A carnation plant having cells derived from an explant material which have
been transformed with an exogenous DNA sequence to display a phenotype
characterized by resistance to a herbicide.
|
| Claim 32
A transgenic carnation plant derived from an explant material comprising an
exogenous DNA sequence to display a phenotype characterized by resistance to a
herbicide.
|
| Claim 34
A carnation plant having cells derived from an explant material which have
been transformed with an exogenous DNA sequence so that flowers of the plant
display a phenotype characterized by a color conferred by said exogenous DNA
sequence which color is modified relative to a flower color of the explant
material.
|
| Claim 35
A transgenic carnation plant derived from an explant material comprising an
exogenous DNA sequence so that flowers of the plant display a phenotype
characterized by a modified color conferred by said exogenous DNA sequence which
color is modified relative to a flower color of the explant material.
|
| Claim 37
A carnation plant derived from an explant material having cells which have
been transformed with an exogenous DNA sequence to display a phenotype
characterized by enhanced resistance to disease relative to the disease
resistance of plants propagated from non-transformed cells of the explant
material.
|
| Claim 38
A transgenic carnation plant derived from an explant material comprising an
exogenous DNA sequence to display a phenotype characterized by enhanced
resistance to disease relative to the disease resistance of plants propagated
from non-transformed cells of the explant material.
|
| Claim 40
A carnation plant having cells which have been transformed with the ACC
synthase gene.
|
Claim 41
A carnation plant having cells which have been transformed with a
chlorsulfuron resistance gene.
|
Transformation of carnation plant material with A. tumefaciens or
A. rhizogenes carrying a gene of interest. Carnation leaves are
transformed to alter the phenotype of the plants. A controlled senescence,
resistance to a herbicide, resistance to diseases, and alteration of color are
part of the desirable characters introduced into the plants via
Agrobacterium transformation.
|
Florigene Europe B.V.
|
Note: Patent information on this page was last updated on 14 March 2006.
Chrysanthemums
Summary
A transformed chrysanthemum plant
capable of expressing a gene of interest is the subject of the invention granted
to Florigene Europe in the United States. In this patent, the
explants or plant material transformed with Agrobacterium are limited
to stem, leaf, peduncle, petiole, meristem and shoot apex. The invention
discloses a method to regenerate a chrysanthemum shoot and a chrysanthemum plant
expressing an exogenous gene.
Specific Patent Information
|
Patent Number
|
Title, Independent Claims and Summary of Claims
|
Assignee
|
|
US
5567599
- Earliest priority - 21 August 1990
- Filed - 26 January 1994
- Granted - 22 October 1996
- Expected expiry - 25 January 2014
|
Title - Method for producing transformed chrysanthemum
plants
| Claim 1
A method for producing a chrysanthemum plant comprising an exogenous DNA
fragment, which chrysanthemum plant is capable of expressing a gene within the
exogenous DNA fragment, comprising the steps of: A) isolating an explant from
source material from a chrysanthemum plant, wherein said source material is
selected from the group consisting of leaf, stem, peduncle, petiole, meristem,
and shoot apex; B) inoculating the explant from source material from the
chrysanthemum plant with a culture of Agrobacterium, which
Agrobacterium comprises an exogenous DNA fragment comprising a gene
under the control of a promoter capable of promoting the transcription of the
gene within the exogenous fragment, to obtain an inoculated explant; C)
incubating the inoculated explant of step (B) on an incubation medium; D)
culturing the incubated explant of step (C) on a regeneration medium to obtain
regenerated shoots of the chrysanthemum plant; and E) culturing the
regenerated shoots of step (D) on a rooting medium to obtain a chrysanthemum
plant comprising the exogenous DNA fragment, in which the chrysanthemum plant is
capable of expressing the gene within the exogenous DNA fragment.
|
Claim 60
A method for producing a chrysanthemum plant comprising an exogenous DNA
fragment using Agrobacterium as a vector, comprising the steps of:
A) incubating chrysanthemum plant source material on a pretreatment medium;
B) isolating a leaf explant from source material from the chrysanthemum
plant; C) inoculating the explant from source material from the
chrysanthemum plant with a culture of Agrobacterium, which
Agrobacterium comprises an exogenous DNA fragment comprising a gene
under the control of a promoter capable of promoting the transcription of the
gene within the exogenous fragment, to obtain an inoculated explant; D)
incubating the inoculated explant of step (C) on an incubation medium; E)
culturing the incubated mixture of step (D) on a regeneration medium to obtain
regenerated shoots of the chrysanthemum plant; and F) culturing the
regenerated shoots of step (E) on a rooting medium to obtain a chrysanthemum
plant comprising the exogenous DNA fragment.
|
Production of a transformed chrysanthemum plant expressing a gene of interest
by transforming different explants with Agrobacterium carrying the
exogenous gene. The group of explants transformed include leaf, stem, peduncle,
petiole, meristem and shoot apex. To obtain a chrysanthemum plant, shoot
formation and rooting are induced.
|
Florigene Europe B.V.
|
|
Remarks
|
National phase entry of
WO
1992/03041 in Australia (AU 84330/91) has
lapsed on 13 May 1993.
|
Note: Patent information on this page was last updated on 14 March 2006.
Chrysanthemum - Patent granted to Florigene Europe B.V.
Actual granted claims
|
US 5 567 599
|
| Claim 1
A method for producing a chrysanthemum plant comprising an exogenous DNA
fragment, which chrysanthemum plant is capable of expressing a gene within the
exogenous DNA fragment, comprising the steps of: A) isolating an explant from
source material from a chrysanthemum plant, wherein said source material is
selected from the group consisting of leaf, stem, peduncle, petiole, meristem,
and shoot apex; B) inoculating the explant from source material from the
chrysanthemum plant with a culture of Agrobacterium, which
Agrobacterium comprises an exogenous DNA fragment comprising a gene
under the control of a promoter capable of promoting the transcription of the
gene within the exogenous fragment, to obtain an inoculated explant; C)
incubating the inoculated explant of step (B) on an incubation medium; D)
culturing the incubated explant of step (C) on a regeneration medium to obtain
regenerated shoots of the chrysanthemum plant; and E) culturing the
regenerated shoots of step (D) on a rooting medium to obtain a chrysanthemum
plant comprising the exogenous DNA fragment, in which the chrysanthemum plant is
capable of expressing the gene within the exogenous DNA fragment.
|
Claim 60
A method for producing a chrysanthemum plant comprising an exogenous DNA
fragment using Agrobacterium as a vector, comprising the steps of:
A) incubating chrysanthemum plant source material on a pretreatment medium;
B) isolating a leaf explant from source material from the chrysanthemum
plant; C) inoculating the explant from source material from the
chrysanthemum plant with a culture of Agrobacterium, which
Agrobacterium comprises an exogenous DNA fragment comprising a gene
under the control of a promoter capable of promoting the transcription of the
gene within the exogenous fragment, to obtain an inoculated explant; D)
incubating the inoculated explant of step (C) on an incubation medium; E)
culturing the incubated mixture of step (D) on a regeneration medium to obtain
regenerated shoots of the chrysanthemum plant; and F) culturing the
regenerated shoots of step (E) on a rooting medium to obtain a chrysanthemum
plant comprising the exogenous DNA fragment.
|
Citrus
Summary
The INIA1
and the IVIA2 from Spain have a granted United
States patent directed to a method for transforming adult citrus plants with
A. tumefaciens having a gene of interest.
The invention discloses in vitro micrografting of transformed shoots
onto stocks, at least twice, in order to generate complete adult plants. The
second in vitro micrografting can be skipped by planting the first
micrografted plants directly into soil.
The related European application EP 870 838 A3, which is not
presented here, does not refer to a transformation method in particular, and
instead inoculation of a vector carrying a gene of interest into a citrus plant
can be performed by any method, including Agrobacterium as disclosed in
dependent Claim 2. Furthermore, independent Claim 1 covers any woody species,
therefore this application is mentioned in the section 'Woody Tree Species'.
1 Instituto Nacional de Investigacion y Tecnologia Agraria
y Alimentaria (INIA), Spain
2 Instituto Valenciano de Investigaciones Agrarias
(IVIA), Spain
Specific Patent Information
|
Patent Number
|
Title, Independent Claims and Summary of Claims
|
Assignee
|
US
6103955
- Earliest priority - 5 March 1997
- Filed - 5 March 1998
- Granted - 15 August 2000
- Expected expiry - 4 March 2018
|
Title - Procedure for the genetic transformation of adult
plants of woody species
Claim 1
A procedure for the genetic transformation of citrus adult plants consisting
of:
(a) co-culturing explants of adult tissue from citrus plant species, from the
first flushes of the grafts of buds of citrus adult plants onto stocks, with a
non-oncogenic strain of Agrobacterium tumefaciens, optionally modified
to further contain genes which encode the characteristics of interest to be
inserted into the citrus plant, in feeder plates, and subsequently, in a culture
medium which favors the induction of transgenic shoots and permits the selection
thereof; (b) in vitro micrografting said transgenic shoots, their buds or
apices, onto stocks cultivated in vitro; and (c) grafting the resulting in
vitro micrografted plants, their buds and apices, onto other stocks which give
vigor and allowing the successful grafts to grow to generate complete adult
plants, or directly transplanting the in vitro micrografted plants into the soil
to generate complete adult plants.
|
Method for transforming explants of adult citrus plants with a non-oncogenic
A. tumefaciens having a gene of interest. The transformed shoots are
micrografted onto other stocks to allow regeneration of complete adult plants.
|
INIA & IVIA
|
| Remarks |
- Related application in Europe (EP 870838) is pending.
- Related patent granted in Spain (ES 2151338), however, claim 1 recites a
procedure for the genetic transformation of adult plants of woody species, and
is not limited to those of citrus species.
|
Note: Patent information on this page was last updated on 14 March 2006.
Coffee
Summary
Coffee belongs to the botanical family
Rubiaceae. There are at least 25 species of the genus Coffea, all
indigenous to Africa, and some islands in the Indian Ocean. Today coffee is
cultivated in some eighty countries in South and Central America, the Caribbean,
Africa and Asia, generally in areas lying between the Tropics of Cancer and
Capricorn. The two biggest producers by far are Brazil and Colombia, followed by
Indonesia, Vietnam and Mexico.
The coffee tree is a tropical evergreen shrub with two beans per fruit, which
when ripe resemble a red cherry. The two most commercially important species
grown are Coffea canephora (robustas) and Coffea arabica
(arabicas). The latter, which accounts for 70% of the world production, grows at
higher altitudes, requires less rain, and its beans have a lower caffeine
content than that of robustas. Arabica coffee is highly susceptible to pests and
diseases; therefore resistance is a major goal of plant breeding programs. It is
grown throughout Latin America, in Central and East Africa, in India and to some
extent in Indonesia. Robusta coffee is grown in West and Central Africa,
throughout Southeast Asia and in Brazil. Two other species, which are grown on a
much smaller scale are Coffea liberica (Liberica coffee), grown in
Malaysia and in West Africa, and Coffea dewevrei (Excelsa coffee).
After oil, coffee is the most important traded commodity in the world, and is
the primary export of many developing countries. More than two thirds of current
world coffee production is exported from Latin America and the Caribbean, with
much of the rest coming from African and Asian producers. However, most coffee
is consumed in the developed world; the United States and the European Community
together import two out of every three bags of coffee produced in the world.
Coffee - Independent claim
IP aspects
The Nara Institute of Science and Technology has granted
patents in Australia, United States, and
Japan related to genetic transformation of coffee with A.
tumefaciens. In the Australian granted patent there is no
limitation on the species of Coffea to be transformed or on the gene to
be introduced into the plants. The major limitation of the granted invention
lies in the strain of A. tumefaciens used for the transformation
process.
Furthermore, the patent application has only been filed in countries where
coffee is not a major agricultural product, at least not at the same scale as
the well-known coffee producing countries. For instance, in Australia there are
only two places with commercial production. One is located in north of
Queensland and the other one is in the Northern Rivers region of New South
Wales. The production of coffee in Australia was around US$800,000 dollars worth
in 1998/1999, while the world coffee trade is estimated at around US$13 billion
dollars per year. Thus, the patents on the present invention will likely have
very little impact for the most important coffee producers' countries.
Specific Patent Information
Patent Number
|
Title, Independent Claims and Summary of Claims
|
Assignee
|
|
US
6392125
- Earliest priority - 28 December 1998
- Filed - 22 December 1999
- Granted - 21 May 2002
- Expected expiry - 21 December 2019
|
Title - Method for producing the transformants of coffee
plants and transgenic coffee plants
Claim 1
A method for producing a transformant of Coffea arabica, the method
comprising the steps of:
(a) infecting an embryogenic callus of Coffea arabica with
Agrobacterium tumefaciens EHA101 strain that comprises a vector
containing an exogenous gene and a gene available for the selection of
transformed embryonic callus to produce a transformed embryogenic callus in a
medium containing N6 -[2-isopentenyl]-adenosine,
(b) selecting said transformed embryonic callus,
(c) forming a somatic embryo from said transformed embryogenic callus and
(d) regenerating a transformed Coffea arabica from said somatic
embryo.
|
Granted patent US 6392125 recites an
Agrobacterium-mediated method to produce a transformant of Coffee
arabica. The A. tumefaciens strain is limited to EHA101.
|
Nara Institute of Science and Technology
|
|
AU
729635 B2
- Earliest priority - 28 December 1998
- Filed - 23 December 1999
- Granted - 8 February 2001
- Expected expiry - 22 December 2019
|
Title - Method for producing the transformants of coffee
plants and transgenic coffee plants
|
Claim 1 A method for producing a transformant of a coffee plant, the
method comprising the steps of: (a) infecting an embryogenic callus of a
coffee plant with Agrobacterium tumefaciens EHA101 strain comprising a
vector comprising an exogenous gene to produce a transformed embryogenic
callus; (b) forming a somatic embryo from said transformed embryogenic
callus; and (c) regenerating a transformed coffee plant from said somatic
embryo.
|
Granted patent AU 729635 does not limit the type of coffee
plant to be transformed with A. tumefaciens EHA101, and there is no
statement on the components of the medium used for infecting the coffee plant
callus.
|
| Remarks |
- Related application in Canada (CA 2291932) is pending.
- Related patent has been granted in Japan (JP 3286733) on 27 May 2002.
- Other related patent document published in Switzerland (CH 694207).
|
Note: Patent information on this page was last updated on 14 March 2006.
Cotton
Summary
Five different entities have patents and
patent applications related to methods for transforming cotton with
Agrobacterium.
Agracetus (now owned by Monsanto) has been
granted two patents in the United States and one in Europe, directed to
transformation of immature cotton plants with A. tumefaciens. The
Agracetus patents have the earliest priority date in the group of cotton
transformation patents, dating back to 1986. The major aspects of the inventions
are:
-
hypocotyl cotton tissue is selected for transformation;
- at least two sequences including a foreign chimeric gene and a resistance
gene are introduced into plants. The product of the foreign gene is, in one of
the United States patents, either a foreign protein or a negative RNA stand; and
- completely transformed plants are regenerated.
Calgene (also owned by Monsanto) has one
United States patent related to this topic and recently a European and an
Australian patent have also been granted. In both Agracetus' and
Calgene's inventions hypocotyl cotton tissue is transformed with
Agrobacterium. However, in contrast to Agracetus'
inventions, Calgene claims any exogenous gene
and Agrobacterium species. Other distinctive features of the invention
by Calgene include the use of a cotton seedling grown
in the dark as source material for the tissue to be transformed and the
induction of embryogenic callus formation in a hormone-free medium.
Differing from those discussed above, Cotton Inc. and
The Institute of Molecular Agrobiology (SG) disclose in their
patent applications the use of meristematic cells of apical shoot
tips of cotton, and cotton petiole and root
callus, respectively, as tissues to be transformed with
Agrobacterium.
Aventis CropScience (now Bayer Crop Science) and Bayer
BioScience patents and applications disclose the use of cotton
embryogenic callus as target tissue for transformation with
Agrobacterium. The addition of a plant phenolic
compound prior or during the transformation of the cotton tissue for
vir gene induction constitutes a disclosed improvement of cotton
transformation methodology. This group has the most recent priority date (19 May
1999) among the cotton transformation patents.
Cotton - Patents granted to Agracetus
Specific Patent Information
|
Patent Number
|
Title, Independent Claims and Summary of Claims
|
Assignee
|
|
US
5004863
- Earliest priority - 3 December 1986
- Filed - 3 December 1986
- Granted - 2 April 1991
- First reexamination (B1) - 8 December 1992
- Second reexammination (B2) - 17 October 2000
- Expected expiry - 1 April 2008
|
Title - Genetic engineering of cotton plants and lines
| Claim 1
A method of introducing genes into cotton plants and plant lines comprising
the steps of:
A) exposing hypocotyl tissue of immature cotton plants to a culture of
transformation competent non-oncogenic Agrobacterium tumefaciens
harboring a Ti plasmid having a T-DNA region including both a foreign chimeric
gene and a selection agent resistance gene, both genes including appropriate
regulatory sequences so as to be expressed in the cells of cotton plants;
B) culturing the exposed tissue in the presence of a selection agent for which
the resistance gene encodes for resistance so as to select for plant cells
transformed with the T-DNA region; C) inducing somatic embryo formation in
the exposed tissue in culture; and D) regenerating the somatic embryos into
whole cotton plants.
|
| Claim 16
A method for introducing genes into cotton plants and plant lines, comprising
the following steps in sequence:
A) surface sterilizing cotton seeds; B) allowing said cotton seeds to
germinate thus forming immature cotton plants, said immature cotton plants
including hypocotyl tissue; C) exposing said hypocotyl tissue to a culture
of transformation competent non-oncogenic Agrobacterium tumefaciens
harboring a Ti plasmid having a T-DNA region including both a foreign chimeric
gene and a selection agent resistance gene; D) culturing said hypocotyl
tissue on a medium containing at least one antibiotic toxic to said
Agrobacterium tumefaciens but not toxic to cotton cells; E)
culturing said tissue of step (D) in the presence of a selection agent for which
the resistance gene encodes for resistance so as to select for plant cells
transformed with the T-DNA region; F) inducing somatic embryo formation in
the exposed tissue in culture; and G) regenerating the somatic embryos into
whole cotton plants.
|
Transformation of hypocotyl tissue of immature cotton plants with A.
tumefaciens having a T-DNA with a chimeric gene and a resistance gene.
Cotton plants are regenerated from somatic embryos induced from the transformed
tissue. A protocol for the introduction of foreign T-DNA into cotton plants is
also claimed.
|
Agracetus (now owned by Monsanto)
|
|
US
5159135
- Earliest priority - 3 December 1986
- Filed - 30 August 1990
- Granted - 27 October 1992
- First reexamination (B1) - 24 October 2000
- Expected expiry -1 April 2008
|
Title - Genetic engineering of cotton plants and lines
| Claim 1
Cotton seed capable of germination into a cotton plant comprising in its
genome a chimeric recombinant gene construction including:
(i) a foreign gene, and (ii) promoter and control sequences operable in
cotton cells,
- the chimeric gene construction being effective in the cells of the cotton
plant to express a cellular product coded by the foreign gene;
- the cellular product imbuing the plant with a detectable trait;
- the cellular product selected from the group consisting of a foreign protein
and a negative strand RNA.
|
| Claim 5
A cotton plant comprising in the genome of at least some of its cells a
foreign gene construction including promoter and control sequences effective in
cotton cells,
- said gene construction further including a heterologous coding sequence;
- the foreign gene construction effective to cause expression of a detectable
cellular product coded by the heterologous coding sequence in the plant cells;
- the cellular product selected from the group consisting of a foreign protein
and a negative strand RNA.
|
| Claim 6
A cotton plant comprising in its genome at least two foreign gene
constructions each including promoter and control sequences effective in cotton
cells,
- both gene constructions further including heterologous coding sequences;
- both foreign gene constructions effective to cause the expression of a
detectable cellular product coded by the heterologous coding sequence in the
plant cells;
- the cellular product of one of the foreign gene constructions selected from
the group consisting of a foreign protein and a negative strand RNA;
- the other foreign gene construction being a selectable marker gene which
imbues the cotton cells with the trait of resistance to a selection agent.
|
| Claim 7
A cotton plant comprising in its genome at least two foreign gene
constructions each including promoter and control sequences effective in cotton
cells,
- both gene constructions further including heterologous coding sequences;
- both foreign gene constructions effective to cause the expression of a
detectable cellular product coded by the heterologous coding sequence in the
plant cells;
- the cellular product of one of the foreign gene constructions selected from
the group consisting of a foreign protein and a negative strand RNA;
- the other foreign gene construction being a selectable marker gene which
imbues the cotton cells with the trait of resistance to a selection agent;
- the foreign gene constructions having been transformed into the cotton plant
or the progenitors of the cotton plant by Agrobacterium-mediated plant
transformation.
|
Granted US 5159135 is a continuation of now
granted US 5004863 (see above).
Transformation of cotton plants with two different foreign gene constructions
via Agrobacterium. The first one contains either a foreign protein or a
negative strand of RNA, and the second construction contains a resistance gene
that acts as a selectable marker. Cotton plants containing both constructions
are claimed.
|
|
EP
270355 B1
- Earliest priority - 3 December 1986
- Filed - 2 December 1987
- Granted - 16 March 1994
- Expected expiry - 1 December 2007
|
Title - Genetic engineering of cotton plants and lines
| Claim 1
A method of introducing genes into cotton plants and plant lines comprising
the steps of:
- exposing hypocotyl tissue of immature cotton plants to a culture of
transformation competent non-oncogenic Agrobacterium tumefaciens
harboring a Ti plasmid having a T-DNA region including both
(i) a foreign chimeric gene, and (ii) a selection agent resistance gene.
|
| Claim 16
Cotton seeds capable of germination into cotton plants comprising in their
genome:
- a chimeric gene construction including:
(i) a foreign gene, and
(ii) promoter and control sequences operable in plant cells, the chimeric
gene construction being effective in the cells of the cotton plant to express a
cellular product coded by the foreign gene.
|
Designated contracting States at the time of grant are: Austria (patent
lapsed as reported by INPADOC), Belgium (patent lapsed as reported by INPADOC),
Switzerland (patent lapsed as reported by INPADOC), Germany, Spain, France,
United Kingdom, Greece (patent lapsed as reported by INPADOC), Italy,
Liechtenstein (patent lapsed as reported by INPADOC), Luxembourg, Netherlands,
Sweden (patent lapsed as reported by EPO)
As in US 5,004,863, hypocotyl tissue of immature cotton
plants is transformed with A. tumefaciens having a T-DNA containing a
chimeric gene and a resistance gene. Cotton seeds that give rise to transformed
cotton plants expressing the product of foreign gene are also claimed.
|
|
Remarks
|
- Related patent application filed in Brazil (BR 8706530; application lapsed
as reported by INPADOC), China (CN 87107233; application deemed to be withdrawn
as reported by CNPO), India (IN 168950), and Australia (AU 28100/89; application
lapsed as reported by IP Australia).
|
Note: Patent information on this page was last updated on 15 March 2006.
Cotton - Patents granted to Calgene
Specific Patent Information
|
Patent Number
|
Title, Indpendent Claims and Summary of Claims
|
Assignee
|
|
US
5846797
- Earliest priority - 4 October 1995
- Filed - 4 October 1995
- Granted - 8 December 1998
- Expected expiry - 3 October 2015
|
Title - Cotton transformation
| Claim 1
In a method for regenerating transformed cotton plants from explant tissue,
the improvement whereby embryogenic callus is generated from a transformed
cotton tissue explant which is cultivated on cotton callus initiation media
which is not supplied with exogenous plant hormones, wherein said explant tissue
is hypocotyl tissue cut from a seedling which has been grown in the dark.
|
| Claim 8
A method for the transformation of cotton plants, said method comprising the
steps of:
A) cutting cotton hypocotyl tissue to form an explant, wherein said hypocotyl
tissue is cut from seedling which has been grown in the dark; B)
co-cultivating said cotton explant tissue with Agrobacterium
comprising a DNA sequence of interest; and C) culturing said co-cultivated
explant on cotton callus initiation media comprising a selective agent and no
exogenous plant hormones, whereby transformed cells are induced to produce
embryogenic callus on said hormone-free selective media.
|
Transformation of hypocotyl cotton tissue grown in the dark with
Agrobacterium having a gene of interest. Embryogenic callus induced
from the transformed tissue in a hormone-free medium regenerates into
transformed cotton plants.
|
Calgene (now owned by Monsanto)
|
|
EP
910239 B1
- Earliest priority - 4 October 1995
- Filed - 4 October 1996
- Granted - 5 December 2001
- Expected expiry - 3 october 2016
|
Title - Transformation of cotton plants
| Claim 1
A method of regenerating cotton plants from explant tissue comprising
generating embryogenic callus from a cotton tissue explant cultivated on cotton
initiation media not supplied with exogenous plant hormones.
|
| Claim 12
A method for the transformation of cotton plants, said method comprising:
A) cutting cotton tissue to form an explant; B) co-cultivating said
cotton explant tissue with Agrobacterium comprising a DNA sequence of
interst; and C) culturing said co-cultivated explant on cotton initiation
media comprising a selective agent and no exogenous plant hormones,
whereby transformed cells are induced to produce embryogenic callus on said
hormone-free selective media.
|
Designated contracting States at the time of grant are: Austria (patent
lapsed as reported by INPADOC), Belgium, Switzerland (patent lapsed as reported
by INPADOC), Germany, Denmark (patent lapsed as reported by INPADOC), Spain,
Finland, France, United Kingdom, Greece, Ireland, Italy, Liechtenstein,
Luxembourg, Monaco, Netherlands (patent lapsed as reported by INPADOC), Portugal
(patent lapsed as reported by INPADOC), Sweden (patent lapsed as reported by
INPADOC)
Unlike the related United States patent, the cotton explant to be transformed
with Agrobacterium is not defined. Any transformed cotton tissue is
induced to produce embryogenic callus on a hormone-free medium.
|
|
AU
727910 B2
- Earliest priority - 4 October 1995
- Filed - 4 October 1996
- Granted - 4 January 2001
- Expected expiry - 3 October 2016
|
Title - Transformation of cotton plants
| Claim 1
A method for regenerating transformed cotton plants from explant tissue,
characterized by an improvement whereby embryogenic callus is generated from a
transformed cotton tissue explant which is cultivated on cotton callus
initiation media not supplied which is not supplied with exogenous plant
hormones, wherein said explant tissue is hypocotyl tissue cut from a seedling
which has been grown in the dark.
|
| Claim 8
A method for regenerating cotton plants from explant tissue, the method being
substantially as hereinbefore described with reference to any one of the
examples.
|
| Claim 9
A method for regenerating cotton plants from explant tissue, the method being
substantially as hereinbefore described with reference to the 'New' Regime in
Figure 1.
|
| Claim 11
A method for the transformation of cotton plants, the method comprising the
steps of:
A) cutting cotton hypocotyl tissue to form an explant, wherein said hypocotyl
tissue cut from a seedling which has been grown in the dark; B)
co-cultivating said cotton explant tissue with Agrobacterium
comprising a DNA sequence of interest; and C) culturing said co-cultivated
explant on cotton callus initiation media comprising a selective agent and no
exogenous plant hormones, whereby transformed cells are induced to produce
embryogenic callus on said hormone-free selective media.
|
| Claim 14
A method for the transformation of cotton plants, the method being
substantially as hereinbefore described with reference to any one of the
examples.
|
The claims of the Australian patent are substantially the same as the claims
of the United States patent. In addition, the Australian patent refers to
methods for regenerating cotton plants.
|
|
WO
1997/12512 A2
- Earliest priority - 4 October 1995
- Filed - 4 October 1996
- OPI - 22 May 1997
|
Title - Transformation of cotton plants
Claim 1
In a method for regenerating cotton plants from explant tissue, the
improvement whereby embryogenic callus is generated from a cotton tissue explant
which is not cultivated on cotton initiation media supplied with exogenous plant
hormones.
|
Claim 12
A method for the transformation of cotton plants, said method comprising the
steps of
(a) cutting cotton tissue to form an explant, (b) co-cultivating said
cotton explant tissue with Agrobacterium comprising a DNA sequence of
interest, and (c) culturing said co-cultivated explant on cotton initiation
media comprising a selective agent and no exogenous plant hormones, whereby
transformed cells are induced to produce embryogenic callus on said hormone-free
selective media.
|
|
| Remarks |
Related patent application filed in China (CN 1198655; application deemed to
be withdrawn as reported by CNPO) and Turkey (TR 9800654; national phase entry
of WO 1997/12512).
|
Note: Patent information on this page was last updated
on 15 March 2006.
Cotton - Patent applications filed by Cotton Inc.
Specific Patent Information
|
Patent Number
|
Title, Indpendent Claims and Summary of Claims
|
Assignee
|
|
AU
747514 B2
- Earliest priority - 19 February 1998
- Filed - 18 February 1999
- Granted - 16 May 2002
- Expected expiry - 17 February 2019
|
Title - A method for the production of transgenic plants
using apical shoot tips
|
Claim 1
A method for producing a transformed plant comprising,
1) isolating apical shoot tips from three day old seedlings;
2) chilling the isolated apical shoot tips for a sufficient period of time to
slow the metabolic activity of cells and to accumulate the cells at a single
stage of cell division or mitosis;
3) dissecting the apical shoot tips to expose meristematic cells;
4) introducing a transforming agent into the dissected apical shoot tips,
wherein said transforming agent is a DNA molecule comprising a gene conferring a
desired phenotypic trait to the plant; and
5) regenerating a transgenic plant from shoots which form on the meristematic
cells.
|
|
Claim 19
A method for producing a transformed cotton plant comprising,
1) isolating apical shoot tips from three-day-old seedlings; 2) chilling
the isolated apical shoot tips for a sufficient period of time to slow the
metabolic activity of cells and to accumulate the cells at a single stage of
cell division or mitosis; 3) dissecting the apical shoot tips to expose
meristematic cells; 4) introducing a transforming agent into the dissected
apical shoot tips, wherein said transforming agent is a DNA molecule comprising
a gene conferring a desired phenotypic trait to the plant; and 5)
regenerating a transgenic plant from shoots which form on the meristematic
cells.
|
|
Claim 22
A transformed cotton plant produced by:
a) isolating aan apical shoot tip from a three day old cotton seedling;
b) chilling the isolated apical shoot tip for a sufficient period of time to
slow the metabolic activity of cells and to accumulate the cells at a single
stage of cell division or mitosis; c) dissecting the apical shoot tip to
expose meristematic cells; d) exposing the dissected meristematic cells to
a recombinant Agrobacterium comprising a gene conferring a desired
phenotypic trait to a plant; and e) regenerating a transgenic cotton plant
from the shoot which form from the meristematic cells.
|
|
Claim 25
A method for producing a transformed cotton plant as is herein described in
the detailed description.
|
|
Cotton Inc.
|
|
EP
1056334 B1
- Earliest priority - 19 February 1998
- Filed - 18 February 1999
- Granted - 8 September 2004
- Expected expiry - 17 February 2019
|
Title - A method for the production of
transgenic plants using apical shoot tips
|
Claim 1
A method for producing a transformed plant comprising,
a) isolating apical shoot tips from three-day-old-seedlings; b) chilling
the isolated apical shoot tips for a sufficient period of time to slow the
metabolic activity of cells and to accumulate the cells at a single stage of
cell division or mitosis; c) dissecting the apical shoot tips to expose
meristematic cells; d) introducing a transforming agent into the dissected
apical shoot tips, wherein said transforming agent is a DNA molecule comprising
a gene conferring a desired phenotypic trait to the plant; and e)
regenerating a transgenic plant from shoots which form on the meristematic
cells.
|
Claim 7
A method for producing a transformed cotton plant comprising,
a) isolating apical shoot tips from three-day-old seedlings; b) chilling
the isolated apical shoot tips for a sufficient period of time to slow the
metabolic activity of cells and to accumulate the cells at a single stage of
cell division or mitosis; c) dissecting the apical shoot tips to expose
meristematic cells; d) introducing a transforming agent into the dissected
apical shoot tips, wherein said transforming agent is a DNA molecule comprising
a gene conferring a desired phenotypic trait to the plant; and e)
regenerating a transgenic plant from shoots which form on the meristematic
cells.
|
Designated contracting States at the time of grant are: Austria (patent
lapsed as reported by INPADOC), Belgium, Switzerland (patent lapsed as reported
by INPADOC), Cyprus, Germany (patent lapsed as reported by INPADOC), Denmark
(patent lapsed as reported by INPADOC), Spain (patent lapsed as reported by
EPO), Finland (patent lapsed as reported by EPO), France, United Kingdom, Greece
(patent lapsed as reported by EPO), Ireland (patent lapsed as reported by
INPADOC), Italy, Liechtenstein (patent lapsed as reported by EPO), Luxembourg,
Monaco (patent lapsed as reported by EPO), Netherlands (patent lapsed as
reported by INPADOC), Portugal, Sweden (patent lapsed as reported by INPADOC)
Granted EP 1056334 recites a method of
producing a transformed cotton plant, the "transforming agent" of which is not
limited to Agrobacterium.
|
|
WO
1999/041975 A1
- Earliest priority - 19 February 1998
- Filed - 18 February 1999
- OPI - 26 August 1999
|
Title - A method for the production of
transgenic plants using apical shoot tips
|
Claim 1
A method for producing a transformed plant comprising,
1) isolating apical shoot tips from three day old seedlings; 2) chilling
the isolated apical shoot tips; 3) dissecting the apical shoot tips to
expose meristematic cells; 4) introducing a transforming agent into the
dissected apical shoot tips; and 5) regenerating a plant from shoots which
form on the meristematic cells.
|
Claim 23
A method for producing a transformed cotton plant comprising,
1) isolating apical shoot tips from three day old seedlings; 2) chilling
the isolated apical shoot tips; 3) dissecting the apical shoot tips to
expose meristematic cells; 4) introducing a transforming agent into the
dissected apical shoot tips; and 5) regenerating a plant from shoots which
form on the meristematic cells.
|
Claim 27
A transformed cotton plant produced by:
a) isolating an apical shoot tip from a three day old cotton seedling;
b) chilling the isolated apical shoot tip; c) dissecting the apical shoot
tip to expose meristematic cells; d) exposing the dissected meristematic
cells to a recombinant Agrobacterium comprising a gene conferring a
desired phenotypic trait to a plant; and e) regenerating a transgenic
cotton plant from the shoots which form from the meristematic cells.
|
|
| Remarks |
- National phase entries of WO 1999/041975 in Canada (CA 2321044) and Japan
(JP 2002/503487) are pending.
- Other national phase entry of WO 1999/041975 includes Israel (IL 137410).
|
Note: Patent information on this page was last updated on 15 March 2006.
Cotton - Patents owned and patent applications filed by The Institute of Molecular Agrobiology (now owned by Temasek Life Sciences Laboratory Ltd)
Specific Patent Information
|
Patent Number
|
Title, Independent Claims and Summary of Claims
|
Assignee
|
|
AU
782198 B2
- Earliest priority - 11 June 1999
- Filed - 11 June 1999
- Granted - 7 July 2005
- Expected expiry - 10 June 2019
|
Title - High-efficiency Agrobacterium-mediated
transformation of cotton using petiole explants
Claim 1
A method for producing a transgenic cotton plant comprising the steps of:
(a) obtaining cotton petiole explants, (b) exposing the petiole
explants to a culture of Agrobacterium tumefaciens that harbors a
vector comprising an exogenous gene and a selectable marker, the
Agrobacterium being capable of effecting the stable transfer of the
exogenous gene and selection agent resistance gene to the genome of the cells of
the petiole explant, (c) culturing the petiole explants in medium
containing plant hormones to induce callus formation, (d) selecting
transformed callus that expresses the exogenous gene, (e) culturing the
selected callus in suspension culture to induce formation of embryoids,
(f) regenerating the embryoids into whole transgenic cotton plants.
|
Granted AU 782198 recites an A.
tumefaciens-mediated transformation method to produce transgenic cotton
plants using the petiole explant. Induction of callus formation requires "plant
hormones", the definition of which is unclear in the description. Dependent
claim 17 recites use of 2,4-dichlorophenoxacetic acid (2,4-D) and kinetin as
these plant hormones.
|
Institute of Molecular Agrobiology (now owned by Temasek Life
Sciences Laboratory Ltd)
|
|
WO
2000/77230 A1
- Earliest priority - 11 June 1999
- Filed - 11 June 1999
- OPI - 21 December 2000
|
Title - High-efficiency
Agrobacterium-mediated transformation of cotton using petiole explants
Claim 1
A method for producing a transgenic cotton plant comprising the steps of:
(a) obtaining cotton petiole explants, (b) exposing the petiole explants
to a culture of Agrobacterium tumefaciens that harbors a vector
comprising an exogenous gene and a selectable marker, the Agrobacterium
being capable of effecting the stable transfer of the exogenous gene and
selection agent resistance gene to the genome of the cells of the petiole
explant, (c) culturing the petiole explants to induce callus
formation, (d) selecting transformed callus that expresses the exogenous
gene, (e) culturing the selected callus in suspension culture to induce
formation of embryoids, (f) regenerating the embryoids into whole
transgenic cotton plants.
|
Method for producing a transgenic cotton plant by exposing petiole explants
to A. tumefaciens carrying a vector having a gene of interest. This is
followed by induction of callus and embryoid formation and regeneration of a
whole plant.
|
|
AU
777365 B2
- Earliest priority - 10 March 1999
- Filed - 10 March 1999
- Granted - 14 October 2004
- Expected expiry - 9 March 2019
|
Title - Agrobacterium-mediated transformation of
cotton with novel explants
Claim 1
A method for producing a transgenic cotton plant comprising the steps of:
(a) obtaining cotton fibrous root explants, (b) culturing the fibrous
root explants to induce callus formation, (c) exposing root callus to a
culture of Agrobacterium tumefaciens that harbors a vector comprising
an exogenous gene and a selectable marker, the Agrobacterium being
capable of effecting the stable transfer of the exogenous gene and selection
agent resistance gene to the genome of the cells of the callus, (d)
culturing the callus in the presence of the selection agent to which the
selection agent resistance gene confers resistance so as to select for
transformed cells, (e) inducing somatic embryo formation in the selected
callus culture, and (f) regenerating the induced somatic embryos into whole
transgenic cotton plants, wherein the cotton fibrous root explants in step
(a) are obtained by growing cotton seedlings in the presence of multi-effect
triazole.
|
Granted AU 777365 recites an A.
tumefaciens-mediated transformation method for producing a transgenic
cotton plant, where "multi-effect triazole" must be added in the growth medium
of the cotton seedlings to obtain fibrous root explants.
|
|
WO
2000/53783 A1
- Earliest priority - 10 March 1999
- Filed - 10 March 1999
- OPI - 14 September 2000
|
Title - Agrobacterium-mediated transformation of
cotton with novel explants
Claim 1
A method for producing a transgenic cotton plant comprising the steps of:
(a) obtaining cotton fibrous root explants, (b) culturing the fibrous
root explants to induce callus formation, (c) exposing root callus to a
culture of Agrobacterium tumefaciens that harbors a vector comprising an
exogenous gene and a selectable marker, the Agrobacterium being capable of
effecting the stable transfer of the exogenous gene and selection agent
resistance gene to the genome of the cells of the callus, (d) culturing the
callus in the presence of the selection agent to which the selection agent
resistance gene confers resistance so as to select for transformed cells,
(e) inducing somatic embryo formation in the selected callus culture, and
(f) regenerating the induced somatic embryos into whole transgenic cotton
plants.
|
|
| Remarks |
- National phase entries of WO 2000/77230 in China (CN1352692 A), Europe
(EP1194579 A1) and Japan (JP2003502050T) are pending.
- Other national phase entries of WO 2000/77230 include Brazil (BR9917361 A)
and Mexico (MXPA01012750 A).
- National phase entry of WO 2000/53783 in China (CN1240841) has been granted
on 8 February 2006.
- National phase entry of WO 2000/53783 in Europe (EP1159436 A1) is pending.
|
Note: Patent information on this page was last updated on 15 March 2006.
Cotton - Patent application filed by Aventis CropScience (now Bayer BioScience NV)
Specific Patent Information
|
Patent Number
|
Title, Independent Claims and Summary of Claims
|
Assignee
|
|
AU
772686 B2
- Earliest priority - 19 May 1999
- Filed - 18 May 2000
- Granted - 6 May 2004
- Expected expiry - 17 May 2020
|
Title - Improved method for Agrobacterium-mediated
transformation of cotton
Claim 1
A method for producing a transgenic cotton plant, comprising the step of
- incubating Agrobacterium cells comprising a DNA fragment of
interest operably linked to at least one T-DNA border with a plant phenolic
compound capable of inducing increased vir gene expression in said
Agrobacterium cells prior to or during the cocultivation of solid
cotton embryogenic callus cultivated on solid media with said
Agrobacterium cells.
|
Claim 2
A method for producing a transgenic cotton plant, said method comprising:
a) cocultivating cotton embryogenic callus with Agrobacterium
cells, said Agrobacterium cells comprising a DNA fragment of interest
operably linked to at least one T-DNA border, in the presence of a plant
phenolic compound capable of inducing increased vir gene expression in
said Agrobacterium cells for a time sufficient to generate embryogenic
callus comprising a transformed cotton cell; and b) regenerating a
transgenic cotton plant from said transformed cell.
|
Claim 10
A method for producing a transgenic cotton plant by
Agrobacterium-mediated transformation, characterised in that
-
Agrobacterium cells comprising a DNA fragment of interest operably
linked to at least one T-DNA border are co-cultivated with solid cotton
embryogenic callus cultivated on solid media in the presence of a plant phenolic
compound capable of inducing vir gene expression in said
Agrobacterium cells.
|
Claim 11
Use of a plant phenolic compound capable of inducing increased vir
gene expression in said Agrobacterium cells for
Agrobacterium-mediated transformation of solid cotton embryogenic
callus cultivated on solid media.
|
Granted AU 772686 recites an
Agrobacterium-mediated method of producing a transgenic cotton plant,
where "solid embryogenic callus" is cultured with a "plant phenolic compund"
before or during Agrobacterium infection. According to the
specification, "plant phenolic compounds ... suitable for the invention are
those substituted phenolic molecules which are capable to induce a positive
chemotactic response, particularly those who are capable to induce increased
vir gene expression in a Ti-plasmid containing Agrobacterium
sp., particularly a Ti-plasmid containing Agrobacterium
tumefaciens."
|
Aventis CropScience (now Bayer BioScience NV)
|
|
US
6483013
- Earliest priority - 19 May 1999
- Filed - 19 May 2000
- Granted - 19 November 2002
- Expected expiry - 19 May 2020
|
Title - Method for Agrobacterium mediated
transformation of cotton
Claim 1
A method for producing a transgenic cotton plant comprising the steps of:
(A) incubating Agrobacterium cells comprising a DNA fragment of
interest operably linked to at least one T-DNA border, with a plant phenolic
compound capable of inducing increased vir gene expression in said
Agrobacterium cells; (B) co-cultivating solid cotton embryogenic
callus cultivated on solid media with said Agrobacterium cells to
generate embryogenic callus comprising a transformed cotton cell; and (C)
regenerating a transgenic cotton plant from said transformed cell; wherein said
incubating step occurs prior to or during said co-cultivation step.
|
Claim 2
A method for producing a transgenic cotton plant comprising the steps of:
(A) co-cultivating solid cotton embryogenic callus cultivated on solid media
with Agrobacterium cells, said Agrobacterium cells comprising
a DNA fragment of interest operably linked to at least one T-DNA border, in the
presence of a plant phenolic compound capable of inducing increased vir
gene expression in said Agrobacterium cells, for a time sufficient to
generate embryogenic callus comprising a transformed cotton cell; and (B)
regenerating a transgenic cotton plant from said transformed cell.
|
Claim 10
A process for producing a transgenic cotton plant comprising:
(A) co-cultivating solid cotton embryogenic callus cultivated on solid media,
wherein said cotton embryogenic callus has not been generated from a cotton
explant comprising transformed cells, with Agrobacterium cells in the
presence of a plant phenolic compound capable of inducing increased vir gene
expression in said Agrobacterium cells; said Agrobacterium
cells comprising a DNA fragment of interest operably linked to at least one
T-DNA border; wherein said Agrobacterium cells are cocultivated with
said cotton embryogenic callus for a time sufficient to generate embryogenic
callus comprising a transformed cotton cell; and (B) regenerating a
transgenic cotton plant from said transformed cell.
|
|
|
WO
2000/71733 A1
- Earliest priority - 19 May 1999
- Filed - 18 May 2000
- OPI - 30 November 2000
|
Title - Improved method for
Agrobacterium-mediated transformation of cotton
Claim 1
A method for producing a transgenic cotton plant, comprising the step of:
- incubating Agrobacterium cells comprising a DNA fragment of
interest operably linked to at least one T-DNA border with a plant phenolic
compound prior to or during the cocultivation of cotton embryogenic callus with
said Agrobacterium cells.
|
| Claim 2
A method for producing a transgenic cotton plant, said method comprising:
- cocultivating cotton embryogenic callus with Agrobacterium cells,
said Agrobacterium cells comprising a DNA fragment of interest operably
linked to at least one T-DNA border, in the presence of a plant phenolic
compound, for a time sufficient to generate embryogenic callus comprising a
transformed cotton cell; and
- regenerating a transgenic cotton plant from said transformed cell.
|
| Claim 10
A method for producing a transgenic cotton plant by
Agrobacterium-mediated transformation comprising
- co-cultivating Agrobacterium cells comprising a DNA fragment of
interest operably linked to at least one T-DNA border with cotton embryogenic
callus, characterized in that said cocultivating occurs in the presence of a
plant phenolic compound.
|
| Claim 11
Use of a plant phenolic compound for Agrobacterium-mediated
transformation of cotton embryogenic callus.
|
| Claim 13
A method for producing a transgenic cotton plant by
Agrobacterium-mediated transformation characterized in that
Agrobacterium cells comprising a DNA fragment of interest operably
linked to at least one T-DNA border are cocultivated with cotton embryogenic
callus in the presence of a plant phenolic compound.
|
Methods for transformation of cotton embryogenic callus with
Agrobacterium by incubating Agrobacterium cells with a plant
phenolic compound. The incubation with the phenolic compound can be prior or
during co-cultivation of the bacterium cells with the cotton tissue.
|
| Remarks |
- National phase entry of WO 2000/71733 in China (CN1234869C C) has been
granted on 4 January 2006.
- National phase entry of WO 2000/71733 in Europe (EP 1183377 A1) is pending.
- Other national phase entries of WO 2000/71733 include Brazil (BR 0010749 A),
Mexico (MXPA01011871 A), Turkey (TR200103311T T2), and South Africa (ZA
200109521 A).
|
Note: Patent information on this page was last updated on 16 March 2006.
Eucalyptus
Because of the long generation time of
woody species and the presence of lignified tissues, a main problem in
transformation of these species is the rapid generation of tissues amenable to
DNA introduction by various methods. This is reflected in the methods described
in the patents and applications described below.
Summary
Patent applications on Agrobacterium-mediate transformation of
Eucalyptus have been filed mainly by four private companies:
-
Shell International Research Maatschappij has a granted
Australian patent related to the production of genetically modified
Eucalyptus by transforming Eucalyptus tissue or cells with
Agrobacterium having gene(s) of interest. As part of the invention,
phenylurea is used to induce shoot formation from the transformed
Eucalyptus cells. This patent has expired, so the technology described
in it is now in the public domain.
-
Oji Paper Co., from Japan, has granted patents in Australia
and the United States related to the transformation of adventitious shoots from
a mature Eucalyptus tree, using A. tumefaciens; and
-
Genesis Research & Development Corp. and Fletcher Challenge
Forests Ltd (both based in NZ), had a granted patent in the United
States on a method used to produce material amenable to
Agrobacterium-mediated transformation. The method is described for
eucalypt and pine trees. However this patent and other patent applications in
this patent family have been abandoned. Genesis filed an unrelated patent
application published in 2005.
-
ArborGen, now the assignee for related patent applications
by Westvaco, has patent applications pending in the USA and
Brazil on methods used for Agrobacterium-mediated transformation.
Notice that the claims in pending applications may vary in scope if granted.
Eucalyptus - Patent granted to Shell Internationale Research Maatschappij B.V.
This page provides specific information on patents that were granted: Shell,
Oji Paper, Genesis/Fletcher (several pending applications recently published
will be shown on a new page). Note that the patents of Shell and
Genesis/Fletcher shown below are no longer in force. This means that the
technology described in them is now in the public domain.
|
Patent Number
|
Title, Independent Claims and Summary of Claims
|
Assignee
|
|
AU
706650 B2
- Earliest priority - 17 February 1995
- Filed - 16 February 1996
- Granted - 17 June 1999
- Patent ceased - 20 September 2001
|
Title - Genetic modification of plants
Claim 1
A process for producing genetically modified Eucalyptus plant
material comprising one or more stably incorporated DNA sequences of interest,
which process comprises
(a) subjecting Eucalyptus cells or tissue to Agrobacterium
mediated transfer of the DNA sequence(s) of interest, inducing shoot formation
in transformed cells or tissue, and
(b) selecting
transformed material, the induction of shoot formation being carried out in the
presence of N-(2-chloro-4-pyridyl)-N'-phenylurea or another phenylurea.
|
Process for the production of genetically modified Eucalyptus with
stable DNA incorporated in its genome by transforming Eucalyptus
tissue or cells with Agrobacterium having gene(s) of interest. The
induction of shoot formation must have been carried out in presence of
phenylurea for the process to be covered by this claim.
|
Shell International Research Maatschappij
|
|
WO
1996/25504 A1
- Earliest priority - 17 February 1995
- Filed - 16 February 1996
- OPI - 22 August 1996
|
Title - Genetic modification of plants
Claims identical to the granted Australian patent AU 706650
B2
Remarks:
- National phase entries of WO 1996/25504 in Europe (EP 808372) deemed to be
withdrawn on 14 February 2001.
- National phase entry of WO 1996/25504 in New Zealand (NZ 303170) was granted
on 16 February 1996 and lapsed on 16 September 2003 as reported by IPONZ.
- Parent application of WO 1996/25504 in the United Kingdom (GB 2298205 A1)
deemed to be withdrawn as reported by INPADOC on 11 June 1997.
- Other national phase entries of WO 1996/25504 include Brazil (BR 9607723;
application refused as reported by INPADOC on 18 November 2003), Israel (IL
117023), African Intellectual Property Organization (OA 10503), South Africa (ZA
9601200).
|
|
AU
772053 B2
- Earliest priority - 7 May 1999
- Filed - 2 May 2000
- Granted - 8 April 2004
- Expected expiry - 2 May 2020
|
Title - Process for transformation of mature trees of
Eucalyptus plants
Claim 1
A process for production of transgenic Eucalyptus plants from a
mature tree of Eucalyptus plant, comprising the steps of: (1)
preparing a shoot tip explant from a mature tree of Eucalyptus
plant; (2) inducing the shoot tip explant to form adventitious
shoots; (3) pre-culturing the adventitious shoots to prepare infection in
an infection induction medium; (4) infecting segments of explant cut out
from the pre-cultured adventitious shoots, with Agrobacterium
tumefaciens in an infection medium; (5) rotary-culturing the segments
of the explant from the step (4) in a medium for sterilization containing
antibiotics so as to sterilize the Agrobacterium tumefaciens attached
to the segments of the explant, to form calli and to select transformed
calli; (6) forming shoot primordia from the transformed calli; (7)
regenerating transgenic plants from the transformed shoot primordia.
|
Granted AU 772053 recites a process to produce transgenic
Eucalyptus plants using A. tumefaciens to transform
"adventitious shoots" induced to form from "shoot tips" of a "mature"
Eucalyptus tree. Note that all the steps above must be used in order
for the claim to cover the process; additional steps may be added and the claim
would still cover the process if all the steps above are used.
|
Oji Paper Co.
|
|
US
6563024
- Earliest priority - 7 May 1999
- Filed - 5 May 2000
- Granted - 13 May 2003
- Expected expiry - 5 May 2020
|
Title - Process for transformation of mature trees of
Eucalyptus plants
Independent claim 1 of granted US 6563024
recites the same process of producing transgenic Eucalyptus plants as
that of AU 772053.
|
|
EP 1050209 A2
- Earliest priority - 7 May 1999
- Filed - 4 May 2000
- Application pending
|
Title - Process for transformation of mature trees of
Eucalyptus plants
Independent claim 1 of this patent application recites the same process of
producing transgenic Eucalyptus plants as that of AU
772053. Note that any granted claims may be different in scope.
|
|
Remarks
|
Parent application in Japan (JP 2000/316403) is pending.
|
|
US
6255559
- Earliest priority - 15 September 1998
- Filed - 15 September 1998
- Granted - 3 July 2001
- Patent expired - 3 August 2005
|
Title - Methods for producing genetically modified plants,
genetically modified plants, plant materials and plant products produced thereby
Claim 1
A method for producing genetically modified plant material comprising:
(1) preparing an in vitro shoot culture of a target plant, the target plant
being of the Eucalyptus or Pinus species; (2) maintaining
and growing the shoot culture until it has produced multiple modes and stem
segments; (3) selecting and excising the stem segments from one or more
nodes of a shoot; (4) transforming a stem segment by stably incorporating
a genetic contruct comprising a selection marker and a polynucleotide of
interest into the stem segment to form a putatively transformed stem
segment; (5) exposing a putatively transformed stem segment to a selection
medium comprising a selection agent that permits survival of transformed stem
segments and is lethal to stem bud on the that were not successfully
transformed; (6) selectively inducing the formation of an adventitious bud
on the putatively transformed stem segment to form a putatively transformed
adventitious bud; (7) selectively regenerating the putatively transformed
adventitious bud by excising the putatively transformed adventitious bud and
exposing the putatively transformed adventitious bud to a selection medium
comprising a selection agent that permits survival of transformed adventitious
buds and is lethal to adventitious buds that were not successfully transformed
to identify a transformed adventitious bud; and (8) elongating the
transformed adventitious bud to form a transformed shoot.
|
This patent expired due to non-payment of maintenance fees according to
USPTO.
Granted US 6255559 recites a method for transformation of
Eucalyptus or Pinus species based on introducing a desired
gene into an in vitro shoot culture and using excised stems with multiple nodes
grown from that culture as targets for transformation. Transgenic adventitious
buds are induced in a medium containing a selection agent and regenerated into
plants. The mode of transformation is not limited to that using A.
tumefaciens.
|
Genesis Research & Development Corp.; Fletcher Challenge Forest Ltd
|
|
US
2002/016981 A1
- Earliest priority - 15 September 1998
- Filed - 20 March 2001
- Application abandoned - 6 October 2003
|
Title - Methods for producing genetically modified plants,
genetically modified plants, plant materials and plant products produced thereby
Claim 1
A method for producing genetically modified plant material of the
Eucalyptus or Pinus species, comprising:
(1) culturing nodal stem segments of a target plant selected from the
Eucalyptus and Pinus species; (2) transforming the stem
segments with a genetic construct by incubating the nodal stem segments with an
Agrobacterium culture transformed with the genetic construct; (3)
promoting regeneration of adventitious shoot buds from the transformed stem
segments; (4) selecting transformed adventitious shoot buds; and (5)
regenerating transformed plant material from the transformed adventitious shoot
buds.
|
Patent application US 2002/016981 has been abandoned due to
failure to respond to an office action, according to the USPTO.
|
|
Remarks
|
Related PCT application
WO
2000/15813 recites a method to produce genetically modified plant material
that is not limited to Eucalyptus species, nor via
Agrobacterium-mediated transformation.
|
Note: Patent information on this page was last updated on 17 March 2006.
(Update July 2003)
Guar, also called "cluster bean", and formerly referred to as Cyamopsis
psoralioides, is a native plant of India where it is grown principally for
its green fodder and for the pods that are used for food and feed. As a legume
it is capable of fixing nitrogen through symbiotic rhizobia. Its seed gum
(galactomannan gum) has a wide variety of food and other commercial uses.
Patents owned and applications filed by Danisco A/S (DK)
Specific Patent Information
|
Patent Number
|
Title, Independent Claims and Summary of Claims
|
Assignee
|
|
US
6307127
- Earliest priority - 10 June 1994
- Filed - 4 April 1997
- Granted - 23 October 2001
- Expired - 23 November 2005
|
Title - Transformation of guar
Claim 1
A method for producing a genetically modified plant or part thereof of the
genus Cyamopsis, comprising the steps of
(1) introducing a recombinant DNA sequence into at least one cell or
protoplast by means of a β-lactamase producing Agrobacterium and
(2) generating genetically modified explants using at least one selection or
shoot growth medium comprising (a) at least one β-lactamase inhibitor
and (b) at least one auxin inhibitor or ethylene inhibitor, so as to
obtain a genetically modified plant or part thereof containing in its
genome at least one recombinant DNA sequence.
|
Claim 22
A method for producing a genetically modified plant or part thereof of the
genus Cyamopsis, comprising the steps of
(1) introducing a recombinant DNA sequence into at least one cell or
protoplast by means of a β-lactamase producing Agrobacterium and
(2) generating genetically modified explants using at least one selection or
shoot growth medium comprising a nickel salt, so as to obtain a genetically
modified plant or part thereof containing in its genome at least one recombinant
DNA sequence.
|
Claim 28
A method for producing a genetically modified plant or part thereof of the
genus Cyamopsis, comprising the steps of
(1) introducing a recombinant DNA sequence into at least one cell or
protoplast by means of a β-lactamase producing Agrobacterium and
(2) generating genetically modified explants using at least one selection or
shoot growth medium comprising at least one β-lactamase inhibitor.
|
US 6307127 has expired due to non-payment of maintenance
fees as reported by the USPTO.
This granted patent discloses a method to transform the leguminous plant guar
using Agrobacterium .
- An auxin or ethylene inhibitor is added during selection to inhibit callus
formation and induce shoot formation.
- A beta-lactamase inhibitor is added to inhibit the formation of auxin-like
substances produced by degradation of carbenicillin added to kill the bacteria
after co-cultivation. This is an additional means of preventing callus
proliferation.
|
Danisco A/S
|
|
US
2001/034887 A1
- Earliest priority - 10 June 1994
- Filed - 22 May 2001
- Application abandoned - 1 June 2003
|
Title - Transformation of guar
Claim 1
A genetically modified plant of the genus Cyamopsis or part thereof,
said plant or plant part comprising in its genome at least one recombinant DNA
sequence.
|
Claim 4
A method for producing a genetically modified plant of the genus
Cyamopsis or part thereof, comprising the steps of
(i) introducing a recombinant DNA sequence carrying a selectable marker into
at least one cell or protoplast derived from said genus to obtain a transformed
cell or protoplast, and (ii) generating from said transformed cell or
protoplast genetically modified explants using at least one selection medium
and/or at least one shoot growth medium comprising at least one beta-lactamase
inhibitor so as to obtain a genetically modified plant or part thereof
containing in its genome at least one recombinant DNA sequence.
|
Claim 25
A method for producing a genetically modified plant of the genus
Cyamopsis or part thereof, comprising the steps of
(i) introducing a recombinant DNA sequence carrying a selectable marker into
at least one cell or protoplast derived from said genus to obtain a transformed
cell or protoplast, and (ii) generating from said transformed cell or
protoplast genetically modified explants using at least one selection medium
and/or at least one shoot growth medium comprising a nickel salt, so as to
obtain a genetically modified plant or part thereof containing in its genome at
least one recombinant DNA sequence.
|
Claim 29
A method for producing a genetically modified plant or part thereof of a
plant species, comprising the steps of (i) introducing a recombinant DNA
sequence carrying a selectable marker into at least one cell or protoplast
derived from said genus to obtain a transformed cell or protoplast, and
(ii) generating from said transformed cell or protoplast genetically modified
explants using at least one selection medium an/or at least one shoot growth
medium comprising at least one penicillin-like antibiotic and at least one
beta-lactamase inhibitor so as to obtain a genetically modified plant or part
thereof containing in its genome at least one recombinant DNA sequence.
|
US 2001/034887 is a continuation of now
granted US 6307127.
This application recites a method of producing a genetically modified plant
of the genus Cyamopsis that is not limited to
Agrobacterium-mediated trasnformation.
|
|
AU
690999 B2
- Earliest priority - 10 June 1994
- Filed - 6 June 1995
- Granted - 7 May 1998
- Expected expiry - 6 June 2015
|
Title - Transformation of guar
|
|
WO
1995/34667 A2
- Earliest priority - 10 June 1994
- Filed - 6 June 1995
- OPI - 21 December 1995
|
Title - Transformation of guar
Claim 1
A genetically modified plant or part thereof of the genus
Cyamopsis, said plant or plant part comprising in its genome at least
one recombinant DNA sequence.
|
Claim 4
A method for producing a genetically modified plant or part thereof of the
genus Cyamopsis, comprising the steps of
- introducing a recombinant DNA sequence into at least one cell or protoplast
and
- generating genetically modified explants using at least one selection or
shoot growth medium comprising at least one compound selected from an auxin
inhibitor, a beta-lactamase inhibitor and an ethylene inhibitor, so as to obtain
a genetically modified plant or part thereof containing in its genome at least
one recombinant DNA sequence.
|
Claim 23
A method for producing a genetically modified plant in which at least one
medium used for selection or growth of cells, protoplasts, callus or plant parts
comprises at least one substance that inhibits bacterial growth or that
increases the effect of a bacterial growth inhibitor without having any
substantial plant growth regulating or plant toxic effect.
|
Claim 30
Chimeric plants capable of producing transgenic seeds and obtained by
grafting a genetically modified shoot cultivated in vitro onto a non-in vitro
cultivated plant.
|
|
|
Remarks
|
- National phase entry of WO 1995/34667 in Australia (AU 690999 B2) has been
granted on 7 May 1998 and expired on 29 January 2004.
- National phase entry of WO 1995/34667 in Europe (EP 766743) is deemed to be
withdrawn on 13 August 2003 as reported by INPADOC.
- National phase entry of WO 1995/34667 in Japan (JP H10/501139) is pending.
- National phase entry of WO 1995/34667 in New Zealand (NZ 287848) has been
granted on 26 June 1998 and expired on 13 December 2005 as reported by IPONZ.
- National phase entry of WO 1995/34667 in Canada (CA 2192552) is deemed dead
on 7 June 2004 as reported by CIPO.
- Other national phase entries of WO 1995/34667 include Brazil (BR 9507970;
application refused as reported by INPADOC), Poland (PL 317578), and Russia (RU
2173345).
|
Note: Patent information on this page was last updated on 17 March 2006.
Summary
Impatiens is the genus of
popular ornamental bedding plants. Ball Horticultural Co. has a
granted United States patent related to a method for the production of
transgenic Impatiens plants by transforming an Impatiens
tissue with Agrobacterium having either a vector with a selectable
marker gene and a foreign gene or two expression vectors where one of them has a
selectable marker gene and the other one a foreign gene.
Specific Patent Information
|
Patent Number
|
Title, Independent Claims and Summary of Claims
|
Assignee
|
|
US
6121511
- Earliest priority - 12 September 1997
- Filed - 11 September 1998
- Granted - 19 September 2000
- Expected expiry - 11 September 2018
|
Title - Production of transgenic Impatiens
Claim 1
A method for producing transgenic Impatiens plants, comprising the
steps of:
(a) introducing an expression vector into a plant tissue explant via
Agrobacterium to produce a transformed explant, wherein said expression
vector comprises a selectable marker gene and a second foreign gene, or
(a') introducing two expression vectors into said plant tissue explant via
Agrobacterium to produce a transformed explant, wherein one of said
expression vectors comprises a selectable marker gene, and wherein the second of
said expression vectors comprises a second foreign gene; (b) culturing said
transformed explant on a selection medium; (c) culturing said transformed
explant on regeneration medium; and (d) recovering fertile transgenic
plants from said transgenic explants capable of transmitting said foreign gene
to progeny.
|
Claim 36
A fertile transgenic Impatiens plant having stably integrated in the
plant genome a foreign gene, wherein said transgenic Impatiens plant is capable
of transmitting said foreign gene to progeny.
|
Granted US 6121511 recites a method to produce transgenic
Impatiens plants by introducing into an Impatiens tissue
either one expression vector having a selectable marker and a second foreign
gene or two expression vectors where one of them contains a selectable marker
and the other one contains a second foreign gene. The introduction of one or two
vectors into the tissue is via Agrobacterium. The transformed tissue is
regenerated into fertile transgenic plants with the foreign gene stably
integrated in the genome. The progeny of these plants also contain the foreign
gene.
|
Ball Horticultural Company
|
|
US
6528703
- Earliest priority - 11 September 1998
- Filed - 18 May 2000
- Granted - 4 March 2003
- Expected expiry - 11 September 2018
|
Title - Production of transgenic Impatiens
Claim 1
A method for producing transgenic Impatiens plants, comprising the
steps of:
(a) introducing an expression vector into an Impatiens plant tissue
explant to produce a transformed explant, wherein said expression vector
comprises a selectable marker gene and a second foreign gene and said plant
tissue explant is selected from the group consisting of Impatiens
shoot tips, Impatiens hypocotyl tips, and Impatiens node
regions, or (a) introducing two expression vectors into said plant tissue
explant to produce a transformed explant, wherein one expression vector
comprises a selectable marker gene, and wherein the other expression vector
comprises a second foreign gene; (b) culturing said transformed explant on
a selection medium; (c) culturing said transformed explant on a
regeneration medium; and (d) recovering fertile transgenic plants from said
transgenic explants capable of transmitting said second foreign gene to progeny.
|
This granted patent is a divisional of now granted
US 6121511 (see above).
Granted US 6528703 recites a method for producing transgenic
Impatiens plants that is not limited to
Agrobacterium-mediated transformation, and the Impatiens
plant tissue explant that can be used is limited to shoot tips, hypocotyl tips
and node regions.
|
Note: Patent information on this page was last updated on 17 March 2006.
Summary
The patents granted to
Biosem (assignments changed to Groupe Limagrain
Holding) in the United States and in Europe claim
- the production of transgenic diploid melon (C. melo) plants having
a DNA molecule introduced by A. tumefaciens;
- a method to transform cotyledons of C. melo by contacting with
A. tumefaciens;
- the insertion of a sequence conferring resistance to cucumber mosaic virus;
and
- media for inducing shoot formation from transformed cotyledons and for
regeneration of transformed plantlets.
Specific Patent Information
|
Patent Number
|
Title, Independent Claims and Summary of Claims
|
Assignee
|
|
US
5422259
- Earliest priority - 11 August 1989
- Filed - 5 March 1993
- Granted - 6 June 1995
- Expected expiry - 6 June 2012
|
Title - Transgenic plants belonging to the species
Cucumis melo
Claim 1
Process for the production of transgenic plantlets having diploid phenotype
from genetically transformed explants, said plantlets belonging to the species
Cucumis melo and containing at least one gene introduced by the
intermediary of Agrobacterium tumefaciens , comprising the following
steps: A) inducing genetically transformed shoot buds from cotyledons of
Cucumis melo in a shoot bud induction medium without forming calli,
wherein the cotyledons are obtained from embryos which have germinated from 0 to
4 days before being contacted with A. tumefaciens, wherein the
induction medium comprises about 440 to about 2,200 mg/L of calcium chloride
calculated as CaCl2R2H2 O, and about 0.3 to
about 1.13 mg/L 6-benzyl aminopurine (BAP); and B) forming genetically
transformed plantlets from genetically transformed shoot buds, wherein the step
of forming comprises: (i) culturing the genetically transformed shoot buds in a
medium having 6-benzyl aminopurine (BAP) until the shoot buds have reached a
height of at least 3 mm; and (ii) transferring and incubating the shoot
buds in a suitable macro-element plant cell culture medium sufficiently to form
the genetically transformed plantlets.
|
Claim 2
Process for production of transgenic plantlets with a diploid phenotype, from
genetically transformed explants, said plantlets belonging to the species
Cucumis melo and containing at least one gene introduced by the
intermediary of A. tumefaciens comprising the following steps: A)
inducing genetically transformed shoot buds from cotyledons of Cucumis
melo in a shoot bud induction medium without forming calli, wherein the
cotyledons are obtained from embryos which have germinated from 0 to 4 days
before being contacted with A. tumefaciens, and wherein the induction
medium comprises about 440 to about 2,200 mg/L of calcium chloride calculated as
CaCl2R2H2 O, about 0.3 to about 1.13 mg/L of
6-benzyl aminopurine (BAP), and about 0 to about 1.3 mg/L indole-3-acetic acid
(IAA); and B) forming genetically transformed plantlets from the
genetically transformed shoot buds, wherein the step of forming comprises: (i)
culturing the shoot buds in a medium having 6-benzyl aminopurine (BAP) until the
shoot buds have reached a height of at least 3 mm; and (ii) transferring
and incubating the shoot buds in a suitable macro-elements plant cell culture
medium comprising:
- KH2PO4 from about 50 to about 100 mg/L;
- MgSO4from about 75 to about 300 mg/L;
- CaCl2R2H2O from about 500 to about 2500
mg/L;
- KNO3 from about 750 to about 1200 mg/L; and
- NH4NO3 from about 150 to about 200 mg/L sufficiently
to form the genetically transformed plantlets.
|
Process for the production of transgenic diploid melon plantlets by
transforming cotyledons of C. melo having a gene of interest introduced
via A. tumefaciens. The process includes media components and protocols
for inducing formation of transformed shoot buds and formation of plantlets.
|
Biosem (now owned by Groupe Limagrain Holding)
|
|
US
5789656
- Earliest priority - 11 August 1989
- Filed - 2 March 1995
- Granted - 4 August 1998
- Expected expiry - 6 June 2012
|
Title - Transgenic plants belonging to the species
Cucumis melo
Claim 1
Transgenic plants having a diploid phenotype belonging to the species
Cucumis melo comprising at least one DNA sequence introduced by the
intermediary of Agrobacterium tumefaciens.
|
Claim 2
Transgenic plant tissue having a diploid phenotype belonging to the species
Cucumis melo comprising at least one DNA sequence that confers
resistance to cucumber mosaic virus.
|
Claim 9
Transgenic plants having a diploid phenotype and belonging to the species
Cucumis melo comprising at least one DNA sequence that confers
resistance to Cucumber mosaic virus.
|
Claim 15
Transgenic plants having diploid phenotype, belonging to the species
Cucumis melo, and containing at least one gene introduced by the
intermediary of Agrobacterium tumefaciens, wherein the plant tissue is
produced from genetically transformed explants by a process comprising the
following step: A) inducing genetically transformed shoot buds from cotyledons
of Cucumis melo in a shoot bud induction medium without forming calli,
wherein the cotyledons are obtained from embryos which have germinated from 0 to
4 days before being contacted with A. tumefaciens, wherein the
induction medium comprises about 440 to about 2,200 mg/L of calcium chloride
calculated as CaCl2R2H2 O, and about 0.3 to
about 1.3 mg/L 6-benzyl aminopurine (BAP); and B) forming genetically
transformed plantlets from genetically transformed shoot buds, wherein the step
of forming comprises: (i) culturing the genetically transformed shoot buds in a
medium having 6-benzyl aminopurine (BAP) until the shoot buds have reached a
height of at least 3 mm; and (ii) transferring and incubating the shoot
buds in a suitable macro-element plant cell culture medium sufficiently to form
the genetically transformed plantlets.
|
Granted US 5789656 is a divisional of now
granted US 5422259.
Process for the production of transgenic diploid melon plantlets by
transforming cotyledons of C. melo having a gene of interest introduced
via A. tumefaciens. Transgenic diploid melon having the gene of
interest, i.e. gene for cucumber mosaic virus, are also claimed.
|
|
US
6198022
- Earliest priority - 11 August 1989
- Filed - 3 August 1998
- Granted - 6 March 2001
- Expected expiry - 6 June 2012
|
Title - Transgenic plants belonging to the species
Cucumis melo
Claim 1
A process for the production of transgenic plants resistant to cucumber
mosaic virus, said plants belonging to the species Cucumis melo, said
process comprising the following steps:
i) introduction, via Agrobacterium tumefaciens, of a gene coding for
the capsid protein of the cucumber mosaic virus, into explants of plants
belonging to the species Cucumis melo, said explants being cotyledons
of embryos isolated from seeds, the said cotyledons having germinated for 0 to 4
days; ii) induction of genetically transformed shoot buds from transformed
explants obtained in step (i); iii) development of transgenic plantlets
from genetically transformed shoot buds obtained in step (ii); iv)
development of transgenic plants from the transgenic plantlets obtained in step
(iii).
|
Claim 5
An isolated nucleotide sequence coding for the capsid protein of the cucumber
mosaic virus, comprising the coding region of the following sequence (SEQ ID:1):
gttattgtct actgactata tagagagtgt ttgtgctgtg ttttctcttt tgtgtcgtag
60 aattgagtcg agtc atg gac aaa tct gaa tca acc agt gct ggt cgt aac
110 Met Asp Lys Ser Glu Ser Thr Ser Ala Gly Arg Asn
1 5 10 cgt cga cgt cgt ccg
cgt cgt ggt tcc cgc tcc gcc ccc tcc tcc gcg 158 Arg Arg Arg Arg Pro
Arg Arg Gly Ser Arg Ser Ala Pro Ser Ser Ala 15
20 25 gat gct aac ttt aga gtc ttg tcg cag cag ctt tcg cga
ctt aat aag 206 Asp Ala Asn Phe Arg Val Leu Ser Gln Gln Leu Ser Arg
Leu Asn Lys 30 35 40 acg tta gca
gct ggt cgt cca act att aac cac cca acc ttt gta ggg 254 Thr Leu Ala
Ala Gly Arg Pro Thr Ile Asn His Pro Thr Phe Val Gly 45
50 55 60 agt gaa cgc tgt aga cct ggg tac
acg ttc aca tct att acc cta aag 302 Ser Glu Arg Cys Arg Pro Gly Tyr
Thr Phe Thr Ser Ile Thr Leu Lys 65
70 75 cca cca aaa ata gac cgt ggg tct tat tac ggt aaa agg
ttg tta cta 350 Pro Pro Lys Ile Asp Arg Gly Ser Tyr Tyr Gly Lya Arg
Leu Leu Leu 80 85 90
cct gat tca gtc acg gaa tat gat aag aag ctt gtt tcg cgc att caa 398
Pro Asp Ser Val Thr Glu Tyr Asp Lys Lys Leu Val Ser Arg Ile Gln
95 100 105 att cga gtt aat cct ttg ccg aaa
ttt gat tct acc gtg tgg gtg aca 446 Ile Arg Val Asn Pro Leu Pro Lys
Phe Asp Ser Thr Val Trp Val Thr 110 115
120 gtc cgt aaa gtt cct gcc tcc tcg gac tta tcc gtt gcc gcc atc tct
494 Val Arg Lys Val Pro Ala Ser Ser Asp Leu Ser Val Ala Ala Ile Ser
125 130 135 140 gct atg ttc
gcg gac gga gcc tca ccg gta ctg gtt tat cag tat gcc 542 Ala Met Phe
Ala Asp Gly Ala Ser Pro Val Leu Val Tyr Gln Tyr Ala
145 150 155 gca tct gga gtc caa gcc aac aac
aaa ctg ttg tat gat ctt tcg gcg 590 Ala Ser Gly Val Gln Ala Asn Asn
Lys Leu Leu Tyr Asp Leu Ser Ala 160
165 170 atg cgc gct gat ata ggt gac atg aga aag tac gcc gtc
ctc gtg tat 638 Met Arg Ala Asp Ile Gly Asp Met Arg Lys Tyr Ala Val
Leu Val Tyr 175 180 185 tca
aaa gac gat gcg ctc gag acg gac gag cta gta ctt cat gtt gac 686 Ser
Lys Asp Asp Ala Leu Glu Thr Asp Glu Leu Val Leu His Val Asp
190 195 200 atc gag cac caa cgc att ccc aca
tct gga gtg ctc cca gtc 728 Ile Glu His Gln Arg Ile Pro Thr Ser Gly
Val Leu Pro Val 205 210 215
tgattccgtg ttcccagaat cctccctccg atctctgtgg cgggagctga gttggcagtt
788 ctgctataaa ctgtctgaag tcactaaacg ttttttacgg tgaacgggtt
gtccatccag 848 cttacggcta aaatggtcag tcgtggagaa atccacgcca gcagatttac
aaatctctga 908 ggcgcctttg aaaccatctc ctaggtttct tcggaaggac ttcggtccgt
gtacctctag 968 cacaacgt 976.
|
|
Claim 6
An isolated nucleotide sequence coding for the capsid protein of the cucumber
mosaic virus, comprising the coding region of the following sequence (SEQ ID:3):
agagagtgtg tgtgctgtgt tttctctttt gtgtcgtaga attgagtcga gtc atg
56
Met
1 gac aaa tct
gaa tca acc agt gct ggt cgt aac cgt cga cgt cgt ccg 104 Asp Lys Ser
Glu Ser Thr Ser Ala Gly Arg Asn Arg Arg Arg Arg Pro
5 10 15 cgt cgt ggt tcc cgc tcc gcc ccc
tcc tcc gcg gat gct aac ttt aga 152 Arg Arg Gly Ser Arg Ser Ala Pro
Ser Ser Ala Asp Ala Asn Phe Arg 20
25 30 gtc ttg tcg cag cag ctt tcg cga ctt aat aag acg tta
gca gct ggt 200 Val Leu Ser Gln Gln Leu Ser Arg Leu Asn Lys Thr Leu
Ala Ala Gly 35 40 45 cgt cca
act att aac cac cca acc ttt gta ggg agt gaa cgc tgt aga 248 Arg Pro
Thr Ile Asn His Pro Thr Phe Val Gly Ser Glu Arg Cys Arg
50 55 60 65 cct ggg tac
acg ttc aca tct att acc cta aag cca cca aaa ata gac 296 Pro Gly Tyr
Thr Phe Thr Ser Ile Thr Leu Lys Pro Pro Lys Ile Asp
70 75 80 cgt ggg tct tat tac ggt aaa agg
ttg tta cta cct gat tca gtc acg 344 Arg Gly Ser Tyr Tyr Gly Lys Arg
Leu Leu Leu Pro Asp Ser Val Thr 85
90 95 gaa tat gat aag aag ctt gtt tcg cgc att caa att cga
gtt aat cct 392 Glu Tyr Asp Lys Lys Leu Val Ser Arg Ile Gln Ile Arg
Val Asn Pro 100 105 110 ttg
ccg aaa ttt gat tct acc gtg tgg gtg aca gtc cgt aaa gtt cct 440 Leu
Pro Lys Phe Asp Ser Thr Val Trp Val Thr Val Arg Lys Val Pro
115 120 125 gcc tcc tcg gac tta tcc gtt gcc
gcc atc tct gct atg ttc gcg gac 488 Ala Ser Ser Asp Leu Ser Val Ala
Ala Ile Ser Ala Met Phe Ala Asp 130 135
140 145 gga gcc tca ccg gta ctg gtt tat cag tat gcc gca tct
gga gtc caa 536 Gly Ala Ser Pro Val Leu Val Tyr Gln Tyr Ala Ala Ser
Gly Val Gln 150 155
160 gcc aac aac aaa ctg ttg tat gat ctt tcg gcg atg cgc gct gat ata
584 Ala Asn Asn Lys Leu Leu Tyr Asp Leu Ser Ala Met Arg Ala Asp Ile
165 170 175 ggt gac atg aga aag
tac gcc gtc ctc gtg tat tca aaa gac gat gcg 632 Gly Asp Met Arg Lys
Tyr Ala Val Leu Val Tyr Ser Lys Asp Asp Ala 180
185 190 cta gag acg gac gag cta gta ctt cat gtt gac atc gag
cac caa cgc 680 Leu Glu Thr Asp Glu Leu Val Leu His Val Asp Ile Glu
His Gln Arg 195 200 205 att ccc
acg tct gga gtg ctc cca gtc tgattcgtgt tcccagaatc 727 Ile Pro Thr Ser
Gly Val Leu Pro Val 210 215 ctccctccga tctctgtggc
gggagctgag ttggcagttc tgctataaac tgtctgaagt 787 cactaaacgt ttttacggtg
aacgggttgt ccatccagct tacggctaaa atggtcagtc 847 gtggagaaat ccacgccagt
agatttacaa atctctgagg cgcctttgaa accatctcct 907 aggtttcttc ggaaggactt
cggtccgtgt acctctagca caacgtgcta gtttcagggt 967 acgggtgccc ccccactttc
gtgggggcct ccaaaaggag 1007.
|
Granted US 6198022 is a divisional of now
granted US 5789656 (see above), which is a
divisional of now granted US 5422259 (see
above).
The process described above applied to the production of cucumber mosaic
virus-resistant plants by expression of the viral capsid protein (this is a
divisional application of the patent listed immediately above).
|
|
EP
412912 B1
- Earliest priority - 11 August 1989
- Filed - 9 August 1990
- Granted - 16 March 1994
- Expected expiry - 9 August 2010
|
Title - Transgenic plants of the species Cucumis
melo
| Claim 1
Process for production of transgenic, phenotypically normal plantlets from
genetically transformed explants, said plantlets belonging to the species
Cucumis melo and containing at least one gene, which has been
introduced through Agrobacterium tumefaciens, characterized by the
following steps: A) induction of genetically transformed shoot buds from
cotyledons of Cucumis melo which have germinated for 0 to 4 days and,
after this period, have been brought into contact with A. tumefaciens,
the induction being carried out on an induction medium for genetically
transformed shoot buds which comprises all of the minerals, salts and vitamins
normally required for the induction of shoot buds from genetically
non-transformed explants and containing, amongst the mineral salts,
approximately 440 to approximately 2,200 mg/L of calcium chloride calculated as
CaCl2R2H2O, and approximately 0.8 to
approximately 1.2% of bacto-agar or agar-agar, said induction medium being
supplemented with approximately 0.3 to about 1.13 mg/L of 6-benzyl aminopurine
(BAP); and approximately 0 to approximately 1.3 mg/L indole-3-acetic acid (IAA);
B) culturing the resulting genetically transformed shoot buds in two
successive stages, the first of these culture stages taking place on a plant
cell culture medium containing a cytokinin and, more particularly, 6-benzyl
aminopurine (BAP), and the second stage, which is carried out when the shoot
buds have reached a length of at least 3 mm, taking place on a plant cell
culture medium containing, as macroelements:
- KH2 PO4 approximately 50 to approximately 100 mg/L
- MgSO4 approximately 75 to approximately 300 mg/L
- CaCl2R2H2O approximately 500 to
approximately 2500 mg/L
- KNO3 approximately 750 to approximately 1200 mg/L
- NH4NO3 approximately 150 to approximately 200 mg/L
|
| Claim 15
Cell culture medium suitable for the development of shoot buds into plantlets
in the course of the regeneration of a plant, characterized in that it contains,
as macro-elements:
- KH2 PO4 approximately 50 to approximately 100 mg/L
- MgSO4R2H2O approximately 75 to approximately 300 mg/L
- CaCl2R2H2O approximately 1000 to
approximately 2500 mg/L
- KNO3 approximately 750 to approximately 1200 mg/L
- NH4NO3 approximately 150 to approximately 200 mg/L.
|
Claim 18
Shoot bud induction medium composed of a plant cell culture medium, which
comprises all the minerals, salts and vitamins normally required for inducing
shoot buds from non-genetically transformed explants and containing, amongst its
mineral salts, calcium chloride, and bacto-agar or agar-agar, characterized in
that the CaCl2 content of this medium is 1000 to 2200 mg/L calculated
as CaCl2 R2H2O, and the bacto-agar or agar-agar
content is 0.8 to 1.2%, said medium being supplemented with 0.3 to about 2.0
mg/L of BAP and 0 to 1.3 mg/L of IAA.
|
Designated contracting States at the time of grant are: Belgium (patent
lapsed as reported by INPADOC), Germany (patent lapsed as reported by INPADOC),
Spain, France (patent lapsed as reported by INPADOC), United Kingdom (patent
lapsed as reported by INPADOC), Greece, Italy, Luxembourg (patent lapsed as
reported by INPADOC), Netherlands
The process for the production of transgenic diploid melon plantlets is very
similar to the process claimed in the related United States patents. Media
components for shoot buds induction and plantlet development are also part of
the claims.
|
|
Remarks
|
- Related patent in Japan (JP 3174048 B2) was granted on 11 June 2001. A
divisional application of now granted JP 3174048 was filed (JP H11/320981),
which was rejected on 13 November 2002.
- Other related patent documents include Israel (IL 95334) and Portugal (PT
94967).
|
Note: Patent information on this page was last updated on 21 March 2006.
Summary
FreshWorld has a granted patent in the United States related
to a method for transforming plumule material or cotyledons of a pea seed,
either from a garden pea plant or an edible pod, with A. tumefaciens
or A. rhizogenes carrying a gene of interest. A related Australian
application was abandoned.
Specific Patent Information
|
Patent Number
|
Title, Independent Claims and Summary of Claims
|
Assignee
|
|
US
5286635
- Earliest priority - 24 September 1991
- Filed - 24 September 1991
- Granted - 15 February 1994
- Expired - 15 March 2006
|
Title - Genetically transformed pea plants and methods for
their production
| Claim 1
A method for genetically transforming a pea plant, said method comprising:
A) culturing explant material from the seed plumule of the pea plant with
Agrobacterium tumefaciens or rhizogenes cells
carrying an exogenous DNA sequence, wherein the strain of Agrobacterium
is selected to be capable of infecting and transferring DNA to the explant
material; B) regenerating shoots from the explant material from step (A),
wherein said shoots are obtained from non-callus material; C) selecting
regenerated shoots from step (B) which express the exogenous DNA sequence,
and D) rooting said regenerated shoots to produce viable pea plants
expressing the exogenous DNA sequence.
|
| Claim 7
A method for genetically transforming a pea plant, said method comprising:
A) obtaining plumule material from a pea plant seed; B) culturing the
plumule material with Agrobacterium tumefaciens or rhizogenes
cells carrying an exogenous DNA sequence in a co-cultivation medium for a time
and under conditions selected to effect transfer of the exogenous DNA sequence
to cells of the plumule material, wherein the strain of Agrobacterium
is selected to be capable of infecting and transferring DNA to the explant
material; C) separating the Agrobacterium cells form the plumule
material; D) regenerating shoots from the plumule material from step (C) in
a regeneration medium for a time and under conditions selected to produce shoots
from non-callus regions of the plumule; (E) selecting regenerated shoots
from step (D) which express the exogenous DNA sequence; and (F) rooting the
selected regenerated shoots from step (E) in a rooting medium to produce plants
which express the exogenous DNA sequence.
|
| Claim 19
A method for genetically transforming a pea plant, said method comprising:
A) preparing an explant by removing the seed coat from a sterilized seed of
the pea plant and cutting off the cotyledons where they are attached to the
embryo; B) culturing explant material from sterilized seed of the pea plant
with Agrobacterium tumefaciens or rhizogenes cells
carrying an exogenous DNA sequence, wherein the strain of Agrobacterium
is selected to be capable of infecting and transferring DNA to the explant
material; C) regenerating shoots from the explant material from step (A),
wherein said shoots are obtained from non-callus material; D) selecting
regenerating shoots from step (B) which express the exogenous DNA sequence,
and E) rooting said regenerated shoots to produce viable pea plants
expressing the exogenous DNA sequence.
|
Granted US 5286635 has expired due to
non-payment of maintenance fees according to the USPTO.
Method for transforming the plumule of a pea seed and cotyledons with A.
tumefaciens or A. rhizogenes having an exogenous gene. Shoot
regeneration and production of viable pea plants expressing the gene of interest
are also claimed.
|
FreshWorld
|
|
WO
1993/06209 A1
- Earliest priority - 24 September 1991
- Filed - 9 September 1992
- OPI - 1 April 1993
|
Title - Genetically transformed pea plants and methods for
their production
|
Claim 1
A method for genetically transforming a pea plant, said method comprising:
(a) culturing explant material from the pea plant with
Agrobacterium cells carrying an exogenous DNA sequence; (b)
regenerating shoots from the explant material from step (a), wherein said shoots
are obtained from non-callus material; and (c) selecting regenerated shoots
from step (b) which express the exogenous DNA sequence.
|
|
Claim 8
A method for genetically transforming a pea plant, said method comprising:
(a) culturing explant material from the seed plumule of the pea plant with
Agrobacterium cells carrying an exogenous DNA sequence; (b)
regenerating shoots from the explant material from step (a); and (c)
selecting regenerated shoots from step (b) which express the exogenous DNA
sequence.
|
Claim 15
A method for genetically transforming a pea plant, said method comprising:
(a) obtaining a plumule material from pea plant seed; (b) culturing the
plumule material with Agrobacterium cells carrying an exogenous DNA
sequence in a cocultivation medium for a time and under conditions selected to
effect transfer of the exogenous DNA sequence to cells of the plumule
material; (c) separating the Agrobacterium cells from the plumule
material; (d) regenerating shoots from the plumule material from step (c)
in a regeneration medium for a time and under conditions selected to produce
shoots from non-callus regions of the plumule; (e) selecting regenerated
shoots from step (d) which express the exogenous DNA sequence; and (f)
rooting the selected regenerated shoots from step (e) in a rooting medium.
|
|
Claim 33
A pea plant which expresses a heterologous gene.
|
|
|
Remarks
|
National phase entry of WO 1993/06209 in Australia (AU
26441/92) has lapsed on 16 June 1994.
|
Note: Patent information on this page was last updated on 21 March 2006.
Summary
The present United States patent granted to Institut National de la
Recherche Agronomique discloses a method for modifying a
Pelargonium spp. via transformation with A. rhizogenes. A
pelargonium plant or tissue is transformed in vivo . Flower scent is
one of the specific characteristics to be modified by the transformation
process.
Specific Patent Information
|
Patent Number
|
Title, Independent Claims and Sumamry of Claims
|
Assignee
|
|
US
5648598
- Earliest priority - 20 December 1994
- Filed - 20 December 1994
- Granted - 15 July 1997
- Expected expiry - 20 December 2014
|
Title - Ornamental character of scented geraniums by genetic
transformation
| Claim 1
A method of genetically modifying a plant of the genus Pelargonium
to modify at least one ornamental characteristic of said plant, the method
comprising the steps of, transforming a live Pelargonium plant or live
tissue thereof with the T-DNA of the Ri plasmid of Agrobacterium
rhizogenes, and propagating the resulting transformant to obtain a plant
for ornamental use.
|
| Claim 5
A method of genetically modifying a Pelargonium species or variety
having a unique scent comprising transforming live plants or live tissues of
said species or variety with the T-DNA of the Ri plasmid of Agrobacterium
rhizogenes, and propagating the resultant transformants to obtain plants
characterized by improved ornamental characteristics.
|
Method for the transformation of a live Pelargonium plant or live
tissue with T-DNA of A. rhizogenes. The transformation is aimed at
modifying an ornamental characteristic or the scent of a geranium plant.
|
Institut National de la Recherche Agronomique
|
Note: Patent information on this page was last updated on 21 March 2006.
Summary
DNA Plant Technology
has been granted a United States patent directed to the transformation of a
pepper explant (young cotyledon) with A. tumefaciens or A.
rhizogenes. Shoot formation is then induced from the transformed cells.
Gibberellin and an inhibitor of ethylene are used as components of an
elongation/selection culture medium for shoots.
Specific Patent Information
|
Patent Number
|
Title, Independent Claims and Summary of Claims
|
Assignee
|
|
US
5262316
- Earliest priority - 22 November 1991
- Filed - 22 November 1991
- Granted - 16 November 1993
- Expected expiry - 22 November 2011
|
Title - Genetically transformed pepper plants and methods
for their production
| Claim 1
A method for genetically transforming a pepper plant, said method comprising:
A) co-cultivating explant material from the pepper plant with
Agrobacterium tumefaciens or rhizogenes cells carrying an
exogenous DNA sequence wherein the explant material is selected from the group
consisting of young embryonic cotyledons and young expanded cotyledons; B)
selecting and inducing shoots from the explant material from step (A), wherein
said shoots are obtained from non-callus material and express the exogenous DNA
sequence; and C) elongating and further selecting the shoots from step (B)
|
Claim 11
A method for genetically transforming a pepper plant, said method comprising:
A) obtaining the explant material from the pepper plant seed; B)
co-cultivating the explant material obtained in step (A) with Agrobacterium
tumefaciens or rhizogenes cells carrying an exogenous DNA sequence
in a co-cultivation medium for a time and under conditions selected to effect
transfer of the exogenous DNA sequence to cells of the explant material obtained
in step (A), wherein the explant material is selected from the group consisting
of young embryonic cotyledons and young expanded cotyledons; C) removing
the Agrobacterium cells from the explant material obtained in step
(A); D) selecting and inducing shoots from the explant material from step
(C) in a selection/induction medium for a time and under conditions chosen to
produce shoots from non-callus regions of the explant material and select shoots
which express the exogenous DNA sequence, wherein the elongation/selection
medium contains a gibberellin in the amount of about 0.1 to 50 mg/l and an
inhibitor of ethylene action; E) elongating and further selecting the
shoots from step (D) in an elongation/selection medium; and F) rooting the
selecting regenerated shoots from step (E) in a rooting medium.
|
Claim 25
A method for generating a pepper plant, said method comprising:
A) obtaining young explant material from the pepper plant, wherein the young
explant material is selected from the group consisting of embryonic cotyledons
and young expanded cotyledons; B) inducing shoots from the explant material
from step (A) in an induction medium containing BA for a time and under
conditions chosen to induce about regeneration from non-callus regions of the
explant material; and C) elongating the shoots from step (B) in an
elongation medium containing a gibberellin and an inhibitor of ethylene action.
|
Claim 31
A method for regenerating a pepper plant, said method comprising:
A) obtaining young explant material from a pepper plant seed; B)
inducing shoots from the young explant material from step (A) in an induction
medium containing BA for a time and under conditions chosen to induce shoot
regeneration from non-callus regions of the explant material, wherein the young
explant material is selected from the group consisting of embryonic cotyledons
and young expanded cotyledons; C) elongating the shoots from step (B) in an
elongation medium containing a gibberellin and an inhibitor of ethylene action;
and rooting the shoots from step (C) in a rooting medium.
|
|
DNA Plant Technology
|
|
WO
1993/09665 A1
- Earliest priority - 22 November 1991
- Filed - 10 November 1992
- OPI - 27 May 1993
|
Title - Genetically transformed pepper plants and methods
for their production
Claim 1
A method for genetically transforming a pepper plant, said method comprising:
(a) cocultivating explant material from the pepper plant with
Agrobacterium cells carrying an exogenous DNA sequence; (b)
selecting and inducing shoots from the explant material from step (a), wherein
said shoots are obtained from non-callus material and express the exogenous DNA
sequence; and (c) elongating and further selecting the shoots from step
(b).
|
Claim 12
A method for genetically transforming a pepper plant, said method comprising:
(a) obtaining the explant material from the pepper plant seed; (b)
cocultivating the explant material obtained in step (a) with
Agrobacterium cells carrying an exogenous DNA sequence in a
cocultivation medium for a time and under conditions selected to effect transfer
of the exogenous DNA sequence to cells of the explant material obtained in step
(a); (c) removing the Agrobacterium cells from the explant
material obtained in step (a); (d) selecting and inducing shoots from the
explant material from step (c) in a selection/induction medium for a time and
under conditions chosen to produce shoots from non-callus regions of the explant
material and select shoots which express the exogenous DNA sequence; (e)
elongating and further selecting the shoots from step (d) in an
elongation/selection medium; and (f) rooting the selected regenerated
shoots from step (e) in a rooting medium.
|
Claim 31
A pepper plant which expresses a heterologous gene.
|
Claim 32
A method for regenerating a pepper plant, said method comprising:
(a) obtaining young explant material from the pepper plant; (b) inducing
shoots from the explant material from step (a), wherein said shoots are obtained
from non-callus material; and (c) elongating the shoots from step (b).
|
Claim 41
A method for regenerating a pepper plant, said method comprising:
(a) obtaining young explant material from a pepper plant seed; (b)
inducing shoots from the young explant material from step (a) in an induction
medium for a time and under conditions chosen to produce shoots from non-callus
regions of the explant material; (c) elongating the shoots from step (b) in
an elongation medium containing gibberelin; and (d) rooting the shoots from
step (C) in a rooting medium.
|
|
|
Remarks
|
National phase entry of WO 1993/09665 in Australia (AU
30743/92) has lapsed on 11 August 1994.
|
Note: Patent information on this page was last updated on 21 March 2006.
Summary
The invention disclosed by Fillatti & Comai (owned by
Calgene Inc.) in patents granted in the United States and Australia is directed
to the transformation of poplar leaves with an armed (tumor-causing genes)
A. tumefaciens having a gene of interest.
The construct inserted into a transformed poplar comprises a transcription
initiation region, an open reading frame (ORF) expressing a peptide and a
transcription termination region.
Specific Patent Information
|
Patent Number
|
Title, Independent Claims and Summary of Claims
|
Assignee
|
|
US
4795855
- Earliest priority - 14 November 1985
- Filed - 24 February 1986
- Granted - 3 January 1989
- Expected expiry - 3 January 2006
|
Title - Transformation and foreign gene expression with
woody species
|
Claim 1
A transformed poplar plant comprising
transformed cells, said cells comprising a DNA construct as a result of
transforming of poplar cells with said DNA construct, which construct comprises
in the 5'-3' direction
(1) a transcription-initiation region;
(2) an open reading frame other than T-DNA expressing a peptide downstream
from said transcription-initiation region, and under the transciptional
regulation of said transcription-initiation region; and
(3) a transcription-termination region to provide an expression cassette
capable of expression in said cells, wherein
- at least one of said open reading frame, transcription initiation region,
and transcription termination region is from a plant other than poplar, and
wherein
- said expression cassette is bordered by at least the right T-DNA border, and
wherein
- said construct is a result of joining in vitro at least two of (1),
(2), and (3) and said right T-DNA border.
|
|
Claim 7
Stably transformed poplar seedlings comprising
cells comprising a DNA construct as a result of transformation of poplar cells
with said DNA construct, which construct comprises in the 5'-3' direction:
(1) a transcription initiation region,
(2) an open reading frame, other than T-DNA, encoding a peptide, said open
reading frame downstream from said transcription initiation region and under the
transcriptional regulation of said transcription initiation region, and
(3) a transcription termination region, to provide an expression cassette
capable of expression in said poplar cells, wherein
- at least one of said open reading frame, transcription initiation region,
and transcription termination region is from a plant other than poplar, and
wherein
- said construct is as a result of joining in vitro at least two of
(1), (2), and (3).
|
|
Claim 9
A method for transforming a poplar plant which
comprises:
(a) preincubating poplar leaf explants from shoot cultures with a medium
conditioned with plant cells;
(b) cocultivating said leaf explants with Agrobacterium tumefaciens
comprising an armed Ti-plasmid containing vir genes and an expression
construct comprising transcriptional initiation and termination regulatory
regions functional in said poplar and a gene other than the wild-type gene of
one or both of the initiation and termination regions and under their regulatory
control, bordered by at least the right T-DNA border, whereby said expression
construct becomes integrated into the genome of cells of said leaf explant;
(c) transferring said leaf explants after cocultivation to a regeneration
medium comprising plant hormones and phytohormones produced by a Ti-plasmid
comprising A. tumefaciens strain, whereby callus is formed and shoots
develop; and
(d) transferring shoots to growing medium to produce a poplar plant.
|
Granted US 4795855 is a
continuation-in-part of abandoned US 06/798050.
Method to transform poplar leaf explants with A. tumefaciens having
a construct with a gene of interest flanked by a right T-DNA border.
Regeneration of transformed poplar plants from the explants, and elements of the
construct are also claimed.
|
Calgene Inc.
|
|
AU 597916 B2
- Earliest priority - 14 November 1985
- Filed - 13 November 1986
- Granted - 14 June 1990
- Expired - 9 September 1993
|
Title - Transformation and foreign gene expression with
woody species e.g. Poplar
|
Claim 1
A transformed poplar plant comprising
transformed cells, said cells comprising a DNA construct as a result of
transforming of poplar cells with said DNA construct, which construct comprises
in the 5'-3' direction
(1) a transcription-initiation region;
(2) an open reading frame other than T-DNA expressing a peptide downstream
from said transcription-initiation region, and under the transciptional
regulation of said transcription-initiation region; and
(3) a transcription-termination region to provide an expression cassette
capable of expression in said cells, wherein
- at least one of said open reading frame, transcription initiation region,
and transcription termination region is from a plant other than poplar, and
wherein
- said expression cassette is bordered by at least the right T-DNA border, and
wherein
- said construct is a result of joining in vitro at least two of (1),
(2), and (3) and said right T-DNA border.
|
Claim 8
Stably transformed poplar seedlings comprising cells comprising a DNA
construct as a result of transformation of poplar cells with said DNA construct,
which construct comprises in the 5'-3' direction:
(1) a transcription initiation region,
(2) an open reading frame, other than T-DNA, encoding a peptide, said open
reading frame downstream from said transcription initiation region and under the
transcriptional regulation of said transcription initiation region, and
(3) a transcription termination region, to provide an expression cassette
capable of expression in said poplar cells, wherein
- at least one of said open reading frame, transcription initiation region,
and transcription termination region is from a plant other than poplar, and
wherein
- said construct is as a result of joining in vitro at least two of
(1), (2), and (3).
|
Claim 10
A method for transforming a poplar plant which comprises:
(a) preincubating poplar leaf explants from shoot cultures with a medium
conditioned with plant cells;
(b) cocultivating said leaf explants with Agrobacterium tumefaciens
comprising an armed Ti-plasmid containing vir genes and an expression
construct comprising transcriptional initiation and termination regulatory
regions functional in said poplar and a gene other than the wild-type gene of
one or both of the initiation and termination regions and under their regulatory
control, bordered by at least the right T-DNA border, whereby said expression
construct becomes integrated into the genome of cells of said leaf explant;
(c) transferring said leaf explants after cocultivation to a regeneration
medium comprising plant hormones and phytohormones produced by a Ti-plasmid
comprising A. tumefaciens strain, whereby callus is formed and shoots
develop; and
(d) transferring shoots to growing medium to produce a poplar plant.
|
Granted AU 597916 contains the same three independent claims as those of US
4795855 (see above).
|
|
Remarks
|
- Related application in Europe (EP 227264) is deemed to be withdrawn on 12
May 1993 as reported on INPADOC.
- Related patent granted in New Zealand (NZ 217915), which has lapsed on 14
January 1994 as reported by IPONZ.
- Other jurisdiction in which a related patent was filed includes Finland (FI
864331; application lapsed as reported by INPADOC).
|
Note: Patent information on this page was last updated on 22 March 2006.
Summary
Florigene's inventions
disclosed in two granted United States patents, a PCT application and their
national phase entries are directed to:
- a method for producing a transformed somatic rose embryo, which expresses an
exogenous gene,
- a method for transforming embryogenic, friable, granular rose callus cells
with Agrobacterium,
- a method for transforming a rose plant and producing transformed rose
plantlets, and
- culture media for callus cultivation and somatic embryo maintenance.
An additional protocol is disclosed to obtain somatic embryos out of a mature
somatic tissue, a stamen filament and a leaf explant. These protocols are not
limited to transformed tissues.
A new United States patent application has been filed by
Florigene. Unlike the granted United States patents, the
application describes Agrobacterium-mediated transformation of rose
callus cells, without specifying the origin of the callus.
Florigene was founded as a joint venture between DNA Plant Technology Co.
(now called S&G Seeds) and Rabobank Biotech Venture Fund, the former also
listed as an assignee in the PCT application.
Roses - Patents granted to Florigene Europe B.V.
Specific Patent Information
|
Patent Number
|
Title, Independent Claims and Summary of Claims
|
Assignee
|
|
US
5480789
- Earliest priority - 1 April 1991
- Filed - 18 November 1993
- Granted - 2 January 1996
- Expected expiry - 2 January 2013
|
Title - Genetically transformed rose plants and methods for
their production
Claim 1
A method for producing a somatic rose embryo, which expresses an exogenous
DNA sequence including a selectable marker gene, said method comprising:
A) culturing tissue from a rose plant on a callus induction medium containing
nutrients, an energy source, an auxin, and a cytokinin in amounts effective to
induce formation of embryogenic callus, wherein the tissue is cultured until a
friable, granular embryogenic callus is produced; B) combining cells from
the embryogenic callus of step (A) with Agrobacterium cells carrying
the exogenous DNA sequence in a co-cultivation medium containing nutrients, an
energy source, and an induction compound under conditions which allow the
Agrobacterium cells to infect the embryogenic callus cells and transfer
the exogenous DNA sequence to the embryogenic callus cell chromosomes; C)
culturing embryogenic callus cells from step (B) in a selection medium
containing nutrients, an energy source, an auxin, a cytokinin, and an agent
which inhibits the growth of embryogenic callus cells which do not express the
selectable marker gene; and D) culturing the cells selected in step (C) in
a maintenance medium containing nutrients, an energy source, an antibacterial
agent, and a growth regulator, other than an auxin or a cytokinin, present in
amounts effective to produce viable somatic embryos capable of being regenerated
into transformed plantlets.
|
Granted US 5480789 is a continuation of
abandoned US 07/678846.
Method for the production of a transformed somatic rose embryo expressing a
gene of interest by transforming an embryogenic callus with
Agrobacterium carrying the exogenous gene.
|
Florigene Europe B.V.
|
|
US
5792927
- Earliest priority - 1 April 1991
- Filed - 5 June 1995
- Granted - 11 August 1998
- Expected expiry - 2 January 2013
|
Title - Genetically transformed rose plants and methods for
their production
Claim 1
A method for genetically transforming callus cells from a rose plant, said
method comprising: A) incubating friable, granular callus cells with
Agrobacterium cells carrying an exogenous DNA sequence; and B)
selecting callus cells which express at least a portion of the exogenous DNA
sequence.
|
Claim 5
A method for genetically transforming a rose plant, said method comprising:
A) culturing tissue from the rose plant under conditions selected to produce a
friable, granular callus; B) incubating cells from the callus of step (A)
with Agrobacterium cells carrying an exogenous DNA sequence; C)
selecting callus cells from step (B) which express at least a portion of the DNA
sequence; and D) producing transformed plantlets from the selected callus
cells of step (C).
|
| Claim 15
A somatic rose embryo produced by the method comprising: A) culturing tissue
from a rose plant on a callus induction medium containing nutrients, an energy
source, an auxin, and a cytokinin in amounts effective to induce callus
formation; B) combining cells from the callus of step (A) with
Agrobacterium cells carrying the exogenous DNA sequence in a
co-cultivation medium containing nutrients, an energy source, and an induction
compound under conditions which allow the Agrobacterium cells to infect
the callus cells and transfer the exogenous DNA sequence to the callus cell
chromosomes; C) culturing callus cells from step (B) in a selection medium
containing nutrients, an energy source, an auxin, a cytokinin, and an agent
which inhibits the growth of callus cells which do not express the selectable
marker gene; and D) culturing the cells selected in step (C) in a
maintenance medium containing nutrients, an energy source, an antibacterial
agent, and a growth regulator, other than an auxin or a cytokinin, present in
amounts effective to produce somatic embryos.
|
Granted US 5792927 is a divisional of now
granted US 5480789 (see above).
Method for transforming rose callus cells with Agrobacterium
carrying an exogenous gene and selecting callus cells containing that exogenous
gene. Production of a transformed somatic rose embryo and a method for
transforming a rose plant starting from a transformed granular callus are part
of the claimed invention.
|
Note: Patent information on this page was last updated on 22 March 2006.
Roses - Patent application filed by Florigene
B.V.
Specific Patent Information
|
Patent Number
|
Title, Independent Claims and Summary of Claims
|
Assignee
|
|
WO
1992/00371 A1
- Earliest priority - 1 April 1991
- Filed - 21 June 1991
- OPI - 9 January 1992
|
Title - Rose plants and methods for their production and
transformation
|
Claim 1
A method for controlled regeneration of a rose plantlet from a somatic embryo
which comprises:
(a) providing a somatic embryo; (b) culturing the somatic embryo on a
maturation medium capable of inducing differentiation of the embryo to yield a
differentiated embryo; (c) germinating the differentiated embryo on
germination medium to yield a germinated embryo; and (d) propagating the
germinated embryo on propagation medium to produce a mature plantlet capable of
being transferred to soil conditions.
|
|
Claim 8
A method for obtaining at least one somatic embryo from mature somatic tissue
of rose plant which comprises:
(a) culturing mature somatic tissue on callus induction medium comprising
effective amounts of a nutrient medium, an energy source, an auxin and a
cytokinin to obtain at least one induced callus; and (b) culturing the
induced callus in a regeneration media capable of inducing completion of the
development of somatic embryos comprising effective amounts of a nutrient
medium, an energy source, an auxin and a cytokinin in which the source of the
auxin and cytokinin in the regeneration media differs from the source of the
auxin and cytokinin in the callus induction medium to obtain at least one
somatic embryo.
|
|
Claim 17
A method for obtaining a somatic embryo from a stamen filament of rose plant
which comprises:
(a) culturing the stamen filament on callus induction medium comprising
effective amounts of a nutrient medium, an energy source, an auxin and a
cytokinin to obtain at least one induced callus; and (b) culturing the
induced callus in a regeneration media capable of inducing completion of the
development of somatic embryos comprising effective amounts of a nutrient
medium, an energy source, an auxin and a cytokinin in which the ratio of auxin
to cytokinin is decreased by a factor of two to about 15 relative to the ratio
of auxin to cytokinin in the callus induction medium to obtain a somatic embryo.
|
|
Claim 20
A method for obtaining a somatic embryo from a leaf explant of rose plant
which comprises:
(a) culturing the leaf explant on a callus induction medium comprising
effective amounts of a nutrient medium, an energy source, an auxin and a
cytokinin to obtain at least one induced callus; and (b) culturing the
induced callus in a regeneration media capable of inducing completion of the
development of somatic embryos comprising effective amounts of a nutrient
medium, an energy source, an auxin and a cytokinin to which the source of the
auxin and cytokinin in the regeneration media differs from the source of the
auxin and cytokinin in the callus induction medium to obtain a somatic embryo.
|
Claim 26
A method for genetically transforming callus cells from a rose plant, said
method comprising:
- incubating the callus cells with Agrobacterium cells carrying an
exogenous DNA sequence; and
- selecting callus cells which express at least a portion of the exogenous DNA
sequence.
|
Claim 29
A method for genetically transforming a rose plant, said method comprising:
(a) culturing tissue from the rose plant under conditions selected to produce
a callus; (b) incubating cells from the callus of step (a) with
Agrobacterium cells carrying an exogenous DNA sequence; (c)
selecting callus cells from step (b) which express at least a portion of the DNA
sequence; and (d) producing transformed plantlets from the selected callus
cells of step (c).
|
Claim 34
A method for producing a somatic rose embryo which expresses an exogenous DNA
sequence, said method comprising:
(a) culturing tissue from a rose plant on a callus induction medium
containing nutrients, an energy source, an auxin, and growth regulator, a
cytokinin in amounts effective to induce callus formation wherein the tissue is
derived from a plant part selected from the group consisting of stamen
filaments, leaf explants, stem sections, shoot tips, petal, sepal, petiole, and
peduncle; (b) combining cells from the callus of step (a) with
Agrobacterium cells carrying the exogenous DNA sequence in a
cocultivation medium containing nutrients, an energy source, and an induction
compound under conditions which allow the Agrobacterium cells to infect
the callus cells and transfer the exogenous DNA sequence to the callus cell
chromosomes;; (c) culturing callus cells from step (b) in a selection
medium containing nutrients, an energy source, an auxin, a cytokinin, and an
agent which inhibits the growth of callus cells which do not express the
selectable marker gene; and (d) culturing the cells selected in step (c)
in a regeneration medium containing nutrients, an energy source, an
antibacterial agent, and a growth regulator selected from abscisic acid and
giberellic acid, other than an auxin or a cytokinin, present in amounts
effective to produce somatic embryos.
|
Claim 50
A rose callus cell which expresses an exogenous DNA sequence.
|
Claim 51
A rose plant having cells which express an exogenous DNA sequence.
|
Claim 52
A somatic rose embryo which expresses an exogenous DNA sequence.
|
The PCT application has DNA Plant Technology Co. as a
co-assignee listed with Florigene B.V..
The claims of the PCT application recite methods to regenerate a rose
plantlet from a somatic embryo and to obtain a somatic embryo from somatic rose
tissue, i.e. stamen filament, and leaf. Similar to its related United States
patent, methods are also claimed to transform a rose callus with
Agrobacterium having an exogenous gene, to produce a transformed
somatic embryo and transformed rose plantlets.
|
Florigene B.V.
|
|
US
2001/007157 A1
- Earliest priority - 18 November 1993
- Filed - 10 August 1998
- Abandoned - 15 July 2002
|
Title - Genetically transformed rose plants and methods for
their production
Claim 1
A method for genetically transforming callus cells from a rose plant, said
method comprising:
- incubating the callus cells with Agrobacterium cells carrying an
exogenous DNA sequence; and
- selecting callus cells which express at least a portion of the exogenous DNA
sequence.
|
Claim 6
A method for genetically transforming a rose plant, said method comprising:
(a) culturing tissue from the rose plant under conditions selected to produce
a callus; (b) incubating cells from the callus of step (a) with
Agrobacterium cells carrying an exogenous DNA sequence; (c)
selecting callus cells from step (b) which express at least a portion of the DNA
sequence; and (d) producing transformed plantlets from the selected callus
cells of step (c).
|
Claim 13
A method for producing a somatic rose embryo which expresses an exogenous DNA
sequence including a selectable marker gene, said method comprising:
(a) culturing tissue from a rose plant on a callus induction medium
containing nutrients, an energy source, an auxin, and a cytokinin in amounts
effective to induce callus formation; (b) combining cells from the callus
of step (a) with Agrobacterium cells carrying the exogenous DNA
sequence in a cocultivation medium containing nutrients, an energy source, and
an induction compound under conditions which allow the Agrobacterium
cells to infect the callus cells and transfer the exogenous DNA sequence to the
callus cell chromosomes; (c) culturing callus cells from step (b) in a
selection medium containing nutrients, an energy source, an auxin, a cytokinin,
and an agent which inhibits the growth of callus cells which do not express the
selectable marker gene; and (d) culturing the cells selected in step (c)
in a maintenance medium containing nutrients, an energy source, an antibacterial
agent, and a growth regulator, other than an auxin or a cytokinin, present in
amounts effective to produce somatic embryos.
|
Claim 38
A rose callus cell which expresses an exogenous DNA sequence.
|
Claim 39
A rose plant having cells which express an exogenous DNA sequence.
|
Claim 40
A somatic rose embryo which expresses an exogenous DNA sequence.
|
Abandoned application US 2001/007157 is a
continuation of now granted US 5792927, which
is a divisional of now granted US 5480789
(see above).
Methods for transforming a rose callus with Agrobacterium cells
carrying an exogenous DNA. Unlike the granted patent US
5792927, the type of callus to be transformed is not specified. A
method for producing a somatic rose embryo expressing an exogenous sequence is
also described. Rose callus, somatic embryo and plant expressing an exogenous
gene are recited in the filed claims.
|
|
Remarks
|
- National phase entry of WO 1992/00371 in Europe (EP 536327) is deemed to be
withdrawn on 2 July 2003.
- National phase entries of WO 1992/00371 in Japan (JP H05/507415 T2 and its
divisional JP 2001/190169 A2) are deemed to be withdrawn (JP H05/507415 T2 was
rejected and an appeal was filed, which was later withdrawn on 13 July 2001; JP
2001/190169 A2 was rejected without any further appeal, notice of rejection sent
to applicant on 8 April 2003).
|
Note: Patent information on this page was last updated on 22 March 2006.
Summary
The University of
Toledo, Monsanto, Pioneer Hi-Bred
and University of Mississippi collectively have several patents
granted in the United States, Canada, Australia and Europe which are directed to
Agrobacterium transformation of soybean (Glycine max).
The University of Toledo has both an Australian and a United
States patent which claim a non-tissue culture process to transform meristematic
or mesocotyl cells of a soybean seed. An Agrobacterium strain of any
species is used for the transformation and can contain either an armed (with
tumor-causing genes) or a disarmed vector. A related European patent
additionally claims a method for transforming beans (Phaseolus
vulgaris).
In the United States patents granted to Monsanto, a
cotyledon from a soybean seedling or an embryonic axis are used for
transformation with Agrobacterium containing a disarmed vector.
Additionally they claim the insertion of a gene encoding for neomycin
phosphotransferase II (nptII) and a gene encoding EPSPS. The first gene
confers resistance to kanamycin and neomycin among other antibiotics, and the
later confers resistance to the herbicide glyphosate.
A United States patent
(US
6384301 B1) and published application
(US
2002/0157139 A1) disclose a method for soybean transformation using
a wounded embryonic axis isolated from germinating seed as target for
Agrobacterium-mediated transformation. The explant is cultured in a
medium containing a selection agent. The difference between the granted patent
and the application is that in the patent application the wounding step is
omitted, thereby providing an alternative protocol to obtain transgenic soybean
plants.
In the European and Australian applications, Monsanto
discloses a method to prepare a transformed germline of soybean starting with an
embryonic axis of a soybean seed for transformation process.
The inventions disclosed by Pioneer Hi-Bred in patents
granted in the United States (2), Australia (1) and Canada (1) use a hypocotyl
or a cotyledonary node of a soybean seed transformed with any species of
Agrobacterium. Detailed protocols for co-cultivation of a soybean
explant with the bacterium are also claimed.
University of Mississippi owns a United States patent
(US
5968830) on an Agrobacterium-mediated transformation
method of a hypocotyl soybean explant, which also recites a method of
regenerating soybean via organogenesis.
Soybean - Patents granted to The University of
Toledo
Specific Patent Information
|
Patent Number
|
Title, Independent Claims and Summary of Claims
|
Assignee
|
|
US
5376543
- Earliest priority - 21 December 1987
- Filed - 7 December 1992
- Granted - 27 December 1994
- Expired - 29 January 2003
|
Title - Agrobacterium mediated transformation of
germinating plant seeds
| Claim 1
A non-tissue culture process for producing a transgenic soybean plant, which
process comprises:
A) germinating a seed of a Glycine max plant for about 24 to 48
hours; B) inoculating the meristematic or mesocotyl cells produced by the
germinating seed of step (A), prior to differentiation of said cells, with an
armed or disarmed Agrobacterium strain containing an
Agrobacterium-derived vector, said vector containing a transferable
gene; and C) allowing the cells to differentiate into a mature plant.
|
Granted US 5376543 has expired due to
non-payment of maintenance fees as reported by USPTO.
Production of a transgenic soybean plant through a non-tissue culture
process. Meristematic or mesocotyl cells are inoculated with an armed or
disarmed Agrobacterium vector having a gene of interest. The cells
differentiate into a mature plant.
|
University of Toledo
|
|
AU 648951 B2
- Earliest priority - 21 December 1987
- Filed - 27 April 1993
- Granted - 5 May 1994
- Expired - 18 July 2002
|
Title - Agrobacterium mediated transformation of
germinating plant seeds
| Claim 1
A non-tissue culture process for producing a transgenic plant, which process
comprises:
A) germinating a seed of a Glycine max plant for about 24 to 48
hours; B) inoculating the meristematic or mesocotyl cells produced by the
germinating seed of step (A), prior to differentiation of said cells, with an
armed or disarmed Agrobacterium strain containing an
Agrobacterium-derived vector, said vector containing a transferable
gene; and C) allowing the cells to differentiate into a mature plant.
|
Granted AU 648951 recites the same process of producing a transgenic soybean
plant in claim 1 as that of US 5376543 (see above).
|
|
EP
397687 B1
- Earliest priority - 21 December 1987
- Filed - 16 December 1988
- Granted - 11 May 1994
- Expected expiry - 16 December 2008
|
Title - Agrobacterium mediated transformation of
germinating plant seeds
| Claim 1
A non-tissue culture process for producing a transgenic plant, which
comprises:
A) germinating a seed of a Phaseolus vulgaris or a Glycine
max plant for 24 to 48 hours; B) inoculating the meristematic or
mesocotyl cells produced during germination, prior to differentiation of the
seed, with a virulent or non-virulent Agrobacterium strain containing a
transferable gene in an Agrobacterium -derived vector; and C)
allowing the cells to differentiate into a mature plant.
|
Granted EP 397687 is a national phase entry of
WO
1989/05859.
Designated contracting States at the time of grant are: Austria (patent
lapsed as reported by INPADOC), Belgium (patent lapsed as reported by INPADOC),
Switzerland (patent lapsed as reported by INPADOC), Germany (patent lapsed as
reported by INPADOC), France (patent lapsed as reported by INPADOC), United
Kingdom (patent lapsed as reported by INPADOC), Italy, Liechtenstein,
Luxembourg, Netherlands (patent lapsed as reported by INPADOC), Sweden (patent
lapsed as reported by INPADOC).
The method for producing a transgenic soybean plant is the same as the one
disclosed in the related United States and Australian patents (above mentioned),
but transformation of beans (Phaseolus vulgaris) is also included in
the claims (see section on
beans).
|
|
Remarks
|
- National phase entry of WO 1989/05859 in Japan (JP H04/501201) is deemed to
be withdrawn.
- Other national phase entries of WO 1989/05859 include Denmark (DK 126690)
and Kuwait (KR 154872).
|
Note: Patent informaion on this page was last updated on 23 March 2006.
Soybean - Patents granted to and patent
applications filed by Monsanto
Specific Patent Information
|
Patent Number
|
Title, Independent Claims and Summary of Claims
|
Assignee
|
|
US
5416011
- Earliest priority - 22 July 1988
- Filed - 23 November 1993
- Granted - 16 May 1995
- Expected expiry - 16 May 2012
|
Title - Method for soybean transformation and regeneration
| Claim 1
A method for transforming soybeans which comprises:
A) preparing a cotyledon explant from a soybean seedling by: (i)
removing the hypocotyl region by cutting just below the cotyledonary node,
(ii) separating the two cotyledons at the cotyledonary node by tearing the
cotyledons apart, and (iii) removing the epicotyl from the cotyledon to
which it remains attached, B) inserting a chimeric gene into the explant of part
(A) by inoculation of at least the region adjacent to the axillary bud of the
explant with a disarmed Agrobacterium tumefaciens vector containing
said chimeric gene; C) selecting transformed explant tissue, and D)
regenerating a differentiated transformed plant from the transformed explant
tissue of part (C).
|
| Claim 10
A method for transforming soybeans which comprises:
A) preparing a cotyledon explant from a soybean seedling by: (i)
removing the hypocotyl region by cutting just below the cotyledonary node,
(ii) separating the two cotyledons at the cotyledonary node by tearing the
cotyledons apart, and (iii) removing the epicotyl from the cotyledon to
which it is attached, and (iv) wounding the explant by making at least one
cut in the axillary bud region of the explant, B) inserting a chimeric gene into
the explant of part (A) which gene encodes for neomycin phosphotransferase II by
inoculation and co-cultivation of the explant with a disarmed Agrobacterium
tumefaciens vector containing said chimeric gene; C) selecting
transformed explant tissue by growing the explant in the presence of kanamycin,
and D) regenerating a differentiated transformed plant from the transformed
explant tissue of part (C).
|
| Claim 12
A method for transforming soybeans which comprises:
A) preparing a cotyledon explant from a soybean seedling by: (i)
removing the hypocotyl region by cutting just below the cotyledonary node,
(ii) separating the two cotyledons at the cotyledonary node, and
(iii) removing the epicotyl from the cotyledon to which it remains attached, B)
inserting a chimeric gene into the explant of part (A) by inoculation of at
least the region adjacent to the axillary bud of the explant with a disarmed
Agrobacterium tumefaciens vector containing said chimeric gene;
C) selecting transformed explant tissue, and D) regenerating a
differentiated transformed plant from the transformed explant tissue of part
(C).
|
Transformation of a cotyledon of a soybean seedling by inoculation with a
disarmed A. tumefaciens vector having a chimeric gene. As part of the
invention, the chimeric gene encodes for npt II.
|
Monsanto
|
|
US
5569834
- Earliest priority - 22 July 1988
- Filed - 14 February 1995
- Granted - 29 October 1996
- Expected expiry - 16 May 2012
|
Title - Method for soybean transformation and regeneration
| Claim 1
A soybean plant comprising a chimeric gene and associated DNA resulting from
an Agrobacterium tumefaciens -mediated transformation, said chimeric
gene capable of conferring kanamycin resistance to said soybean plant, produced
by the method which comprises:
A) preparing a cotyledon explant from a soybean seedling by: (i)
removing the hypocotyl region by cutting just below the cotyledonary node,
(ii) separating the two cotyledons at the cotyledonary node by tearing the
cotyledons apart, and (iii) removing the epicotyl from the cotyledon to
which it remains attached, B) inserting a chimeric gene into the explant of part
(A) by inoculation and co-cultivation of the explant with a disarmed
Agrobacterium tumefaciens vector containing said chimeric gene;
C) selecting transformed explant tissue, and D) regenerating a
differentiated transformed plant from the transformed explant tissue of part
(C).
|
United States granted patent US 5569834 is a
divisional of now granted US 5416011 (see
above).
Method to obtain a soybean plant resistant to kanamycin via A.
tumefaciens transformation. The explant for transformation is a cotyledon
isolated from a soybean seedling.
|
|
US
5824877
- Earliest priority - 22 July 1988
- Filed - 25 October 1996
- Granted - 20 October 1998
- Expected expiry -
- 16 May 2012
|
Title - Method for soybean transformation and regeneration
| Claim 1
A method for transforming soybean which comprises:
A) preparing a cotyledon explant from a soybean seedling by: (i)
removing the hypocotyl region by cutting just below the cotyledonary node,
(ii) separating the two cotyledons at the cotyledonary node by tearing the
cotyledons apart, and (iii) removing the epicotyl from the cotyledon to
which it remains attached, B) inserting a chimeric gene into the explant of part
(A) by inoculation and co-cultivation of the explant with a disarmed
Agrobacterium tumefaciens vector containing said chimeric gene;
C) selecting transformed explant tissue, and D) regenerating a
differentiated transformed plant from the transformed explant tissue of part
(C).
|
| Claim 10
A method for transforming soybean which comprises:
A) preparing a cotyledon explant from a soybean seedling by: (i)
removing the hypocotyl region by cutting just below the cotyledonary node,
(ii) separating the two cotyledons at the cotyledonary node by tearing the
cotyledons apart, and (iii) removing the epicotyl from the cotyledon to
which it is attached, and (iv) wounding the explant by making at least one
cut in the axillary bud region of the explant, B) inserting a chimeric gene into
the explant of part (A) which gene encodes for 5-enolpyruvylshikimatephosphate
synthase by inoculation and co-cultivation of the explant with a disarmed
Agrobacterium tumefaciens vector containing said chimeric gene;
C) selecting transformed explant tissue by growing the explant in the presence
of glyphosate, and D) regenerating a differentiated transformed plant from
the transformed explant tissue of part (C).
|
United States granted patent US 5824877 is a
divisional of now granted US 5569834 (see
above).
As in the previous United States patents, a cotyledon explant is transformed
by inoculation and co-cultivation with A. tumefaciens containing a gene
encoding glyphosate resistance.
|
|
US
5959179
- Earliest priority - 13 March 1996
- Filed - 13 March 1996
- Granted - 28 September 1999
- Expected expiry - 13 March 2016
|
Title - Method for transforming soybeans
| Claim 1
A method for transforming soybean, comprising:
A) preparing a cotyledon explant from a soybean seedling by: (i)
incubating said seedling at about 0ºC to about 10ºC for at least 24 hours;
(ii) removing the hypocotyl region by cutting in the region of from about
0.2 to about 1.5 cm below the cotyledonary node; (iii) splitting and
completely separating the remaining attached hypocotyl segment, also thereby
separating the two cotyledons; (iv) removing the epicotyl from the
cotyledon to which it remains attached; and (v) wounding the cotyledon in
the region of the axillary bud; B) inserting DNA to be introduced into said
explant of step (a) by inoculating at least the region adjacent to the axillary
bud of the explant with a disarmed Agrobacterium tumefaciens vector
containing said DNA; C) selecting transformed explant tissue; and D)
regenerating a differentiated transformed plant from said transformed explant
tissue of step (c).
|
A method for transforming a soybean cotyledon by inoculating into the
axillary bud region a disarmed A. tumefaciens vector containing DNA of
interest.
|
|
WO
1998/00557 A2
- Earliest priority - 28 June 1996
- Filed - 28 May 1997
- OPI - 8 January 1998
|
Title - Methods of optimizing substrate pools and
biosynthesis of poly-'beta'-hydroxybutyrate-co-poly-'beta'-hydroxyvalerate in
bacteria and plants
Claim 37
A method for transforming soybean, comprising: (a) preparing a cotyledon
explant from a soybean seedling by: (i) incubating said seedling at about
0ËšC to about 10ËšC for at least 24 hours; (ii) removing the hypocotyl
region by cutting in the region of from about 0.2 to about 1.5 cm below the
cotyledonary node; (ii) splitting and completely separating the remaining
attached hypocotyl segment, also thereby separating the two cotyledons;
(iii) removing the epicotyl from the cotyledon to which it remains attached; and
(iv) wounding the cotyledon in the region of said axillary bud; (b)
inserting DNA to be introduced into said explant of step (a) by inoculating at
least the region adjacent to the axillary bud of the explant with a disarmed
Agrobacterium tumefaciens vector containing said DNA; (c)
selecting transformed explant tissue; and (d) regenerating a differentiated
transformed plant from said transformed explant tissue of step (c).
|
PCT application WO 1998/00557 recites genes and methods for
optimizing levels of substrates employed in the biosynthesis of copolymers of
3-hydroxybutyrate (3HB) and 3-hydroxyvalerate (3HV) in plants and bacteria using
recombinant DNA technology. Claim 37 is one of the independent claims that
recite a method to transform soybean using a disarmed A. tumefaciens
containing DNA that is to be introduced.
|
US
6384301
- Earliest priority - 14 January 1999
- Filed - 20 December 2001
- Granted - 24 October 2002
- Expected expiry - 20 December 2021
|
Title - Soybean Agrobacterium transformation method
Claim 1
A method of making germline-transformed soybean plants using
Agrobacterium mediation, the method comprising:
(a) initiating the germination of a soybean seed; (b) isolating the
embryonic axis including the embryonic meristem from the soybean seed to prepare
an explant; (c) wounding the explant; (d) exposing the explant to a
disarmed Agrobacterium vector comprising a heterologous genetic
construct comprising a selectable marker gene wherein the heterologous genetic
construct is transferred into at least one cell in the explant; (e)
culturing the explant in the presence of a selection agent in a manner allowing
identification of soybean cells of the explant to which the heterologous genetic
construct has been transferred; (f) inducing formation of one or more
shoots from the explant, the shoot comprising germline transformed cells;
(g) cultivating the shoot into a whole fertile mature soybean plant.
|
A method for soybean transformation using a wounded embryonic axis isolated
from germinating seed as a target for Agrobacterium-mediated
transformation. The explant is cultured in a medium containing a selection
agent.
|
|
US
7002058
- Earliest priority - 14 January 1999
- Filed - 20 December 2001
- Granted - 21 February 2006
- Expected expiry - 20 December 2021
|
Title - Soybean transformation method
Claim 1
A method of making germline-transformed soybean plants using
Agrobacterium mediation, the method comprising:
(a) initiating the germination of a soybean seed; (b) isolating the
embryonic axis including the embryonic meristem from the soybean seed to prepare
an explant; (c) exposing the explant to a disarmed Agrobacterium
vector comprising a heterologous genetic construct comprising a selectable
marker gene wherein the heterologous genetic construct is transferred into at
least one cell in the explant; (d) culturing the explant in the presence
of a selection agent in a manner allowing identification of soybean cells of the
explant to which the heterologous genetic construct has been transferred;
(e) inducing formation of one or more shoots from the explant, the shoot
comprising germline transformed cells; (f) cultivating the shoot into a
whole fertile mature soybean plant.
|
Claim 11
A method of transforming a soybean cell using Agrobacterium
comprising:
(a) initiating the germination of a soybean seed; (b) isolating the
embryonic axis including the embryonic meristem from the soybean seed to prepare
an explant; (c) exposing the explant to a disarmed Agrobacterium
vector comprising a heterologous genetic construct comprising a selectable
marker gene wherein the heterologous genetic construct is transferred into at
least one cell in the explant; (d) culturing the explant in the presence
of a selection agent in a manner allowing identification of soybean cells of the
explant to which the heterologous genetic construct has been transferred.
|
United States granted patent US 7002058 is a
continuation of now granted US 6384301.
An Agrobacterium-mediated transformation method of soybean, where
the embryonic axis does not require wounding before it is exposed to a disarmed
Agrobacterium in comparison to claim 1 of US 6384301
(see above), where wounding of the embryogenic axis is included in the
transformation step.
|
|
US
2006/0059589 A1
- Earliest priority - 14 January 1999
- Filed - 4 November 2005
- Application pending
|
Title - Soybean transformation method
Claim 11
A method of producing a transformed soybean cell comprising:
(a) initiating the germination of a soybean seed; (b) substantially
removing at least one cotyledon from the germinating seed; (c) exposing at
least a portion of the meristematic region in the germinating seed; (d)
exposing one or more cells in the meristematic region to a disarmed
Agrobacterium vector comprising a heterologous genetic construct,
wherein said genetic construct comprises a selectable marker gene, and said
genetic construct is transferred into at least one cell in the meristematic
region; (e) culturing the cells of the meristematic region in the presence
of a selection agent to identify a transformed soybean cell that contains the
genetic construct.
|
Claim 25
A method of producing a fertile transgenic soybean plant comprising:
(a) initiating the germination of a soybean seed; (b) substantially
removing at least one cotyledon from the germinating seed; (c) exposing at
least a portion of the meristematic region in the germinating seed; (d)
exposing one or more cells in the meristematic region to a disarmed
Agrobacterium vector comprising a heterologous genetic construct,
wherein said genetic construct comprises a selectable marker gene, and said
genetic construct is transferred into at least one cell in the meristematic
region; (e) culturing the cells of the meristematic region in the presence
of a selection agent in a manner that identifies a transformed soybean cell that
contains the genetic construct; (f) inducing formation of one or more
shoots from the meristematic region, wherein said shoot comprises at least one
transformed cell, to produce a transgenic soybean shoot; (g) cultivating
the transgenic soybean shoot into a fertile transgenic soybean plant.
|
United States patent application US 2006/0059589 is a
divisional of now granted US 7002058 (see
above).
Claims 1-10 in this application have been cancelled according to the
publication.
This application recites an Agrobacterium-mediated transformation
method of soybean, where cells in the meristematic tissue are exposed to a
disarmed Agrobacterium.
|
|
WO
2000/42207 A2
- Earliest priority - 4 November 1999
- Filed - 12 January 2000
- OPI - 20 July 2000
|
Title - Soybean transformation method
Claim 1
A method of preparing a germline-transformed soybean plant using
Agrobacterium mediation, the method comprising: (a) initiating
the germination of a soybean seed; (b) isolating the embryonic axis from
the soybean seed to prepare an explant; (c) wounding the explant;
(d) exposing the explant to a disarmed Agrobacterium vector
comprising a heterologous genetic construct including a selectable marker gene
under conditions in which the heterologous genetic construct is transferred into
at least one cell in the explant; (e) culturing the explant in the
presence of a selection agent in a manner capable of identifying soybean cells
of the explant to which the heterologous genetic construct has been
transferred; (f) inducing formation of one or more shoots from the
explant, the shoot comprising germline transformed cells; (g) cultivating
the shoot into a whole fertile mature soybean plant.
|
PCT application WO 2000/42207 recites an
Agrobacterium-mediated transformation method of soybean, where a
wounded embryonic axis is exposed to a disarmed Agrobacterium.
|
| Remarks |
- National phase entry of WO 1998/00557 in Australia (AU 31443/97) has lapsed
on 25 March 1999.
- National phase entry of WO 1998/00557 in Canada (CA 2259251) is pending.
- National phase entry of WO 2000/42207 in Australia (AU 2000/28488) has
lapsed on 18 August 2005.
- National phase entry of WO 2000/42207 in Canada (CA 2359868) has lapsed on
12 January 2004.
- National phase entry of WO 2000/42207 in Europe (EP 1141346) is deemed to be
withdrawn on 3 March 2004.
- National phase entry of WO 2000/42207 in Japan (JP 2002534129) is pending.
|
Note: Patent information on this page was last updated on 24 March 2006.
Soybean - Patent applications filed by Monsanto
Actual pending claims
|
EP 1 141 346 A1* & AU 28488/00
|
| Claim 1
A method of preparing a germline-transformed soybean plant using
Agrobacterium mediation, the method comprising: A) initiating the
germination of a soybean seed; B) isolating the embryonic axis from the
soybean seed to prepare an explant; C) wounding the explant; D)
exposing the explant to a disarmed Agrobacterium vector comprising a
heterologous genetic construct including a selectable marker gene under
conditions in which the heterologous genetic construct is transferred into at
least one cell in the explant; E) culturing the explant in the presence of
a selection agent in a manner capable of identifying soybean cells of the
explant to which the heterologous genetic construct has been transferred;
F) inducing formation of one or more shoots from the explant, the shoot
comprising germline transformed cells; G) cultivating the shoot into a
whole fertile mature soybean plant.
|
* The PCT application WO 0042207 A2 was
converted into the present European application.
Soybean - Patents granted to and patent
applications filed by Pioneer Hi-Bred
Specific Patent Information
|
Patent Number
|
Title, Independent Claims and Summary of Claims
|
Assignee
|
|
US
5563055
- Earliest priority - 27 July 1992
- Filed - 28 March 1994
- Granted - 8 October 1996
- Expired - 11 November 2004
|
Title - Method of Agrobacterium-mediated
transformation of cultured soybean cells
Claim 1
A method for transforming soybean cells, comprising the steps of
(A) providing a complete plant medium that supports rapid division of plant
cells, said medium comprising (i) a virulence-inducing amount of a signal
molecule, (ii) a growth promoting amount of an auxin, and (iii)
Agrobacterium tumefaciens bacteria in log growth phase, such that said
bacteria are present in said medium in a concentration of about 108 viable cells
per ml, wherein said bacteria contain a chimeric gene and said medium is
buffered at a pH below 6.0; (B) introducing into a first portion of said
medium a plurality of germinated soybean seeds, from each of which seeds seed
coat and radicle have been removed, and separating the cotyledons of each seed
so as to expose the cotyledonary node of each seed, whereby a plurality of
explants is produced; then (C) macerating said cotyledonary node, without
cutting entirely through each of said explants to the abaxial side thereof, and
thereafter maintaining said explants in said first portion, at room temperature,
for at least about 30 minutes; then (D) transferring said explants to a
second portion of said medium in solidified form, such that said explants are
embedded in said medium, adaxial side up and level with the surface of said
medium, and culturing said explants for about 3 days at about 22° C.; (E)
treating said explants in counterselection medium; (F) cultivating said
explants in agarose-solidified selection medium, wherein said explants are
embedded adaxial side down in said selection medium, whereby transformed cells
in said explants are favored; and then (G) selecting transformed cells from
said explants.
|
Transformation of cotyledonary nodes of soybean seeds in a medium containing
A. tumefaciens, an auxin, and a signal molecule that induces virulence.
Transformed tissue is subsequently selected.
|
Pioneer Hi-Bred
|
|
AU 670316 B2
- Earliest priority - 27 July 1992
- Filed - 26 July 1993
- Granted - 11 July 1996
- Expired - 24 February 2005
|
Title - An improved method of
Agrobacterium-mediated transformation of cultured soybean cells
| Claim 1
A genotype-independent method for producing a transgenic soybean plant which
comprises:
A) co-cultivating an explant derived from a hypocotyl or cultured
cotyledonary nodes of a germinated soybean seed with cells of an
Agrobacterium species containing a chimeric gene at a concentration of
108 to 3 x 108 cells/ml and in the presence of a signal
compound selected from the group consisting of acetosyringone,
alfa-hydroxyacetosyringone, acetovanillone, syringaldehyde, syringic acid,
sinapinic acid and mixtures thereof; B) maintaining a temperature for
co-cultivation of from 18 to 28°C; and C) inducing
virulence of the Agrobacterium by decreasing the pH of the plant
culture media below pH 6.0.
|
Transformation of a hypocotyl or a cotyledonary node of a soybean seed by
co-cultivation with Agrobacterium in a medium having specific signal
compounds that induce Agrobacterium virulence, in order to regenerate transgenic
soybean plants.
A divisional patent of now granted AU
670316 has also been granted (AU 691423 B2,
expired 24 February 2005), however the claims do not recite an
Agrobacterium-mediated transformation method of soybean, but a method
to regenerate soybean plants from cotyledonary nodes.
|
|
CA 2140910 C
- Earliest priority - 27 July 1992
- Filed - 26 July 1993
- Granted - 23 March 1999
- Lapsed - 26 July 2005
|
Title - An improved method of
Agrobacterium-mediated transformation of cultured soybean cells
| Claim 1
A genotype-independent method for producing a transgenic soybean plant which
comprises:
A) co-cultivating an explant derived from a hypocotyl or cultured
cotyledonary node of a germinated soybean seed with cells of an
Agrobacterium species containing a chimeric gene at a concentration of
108 to 3 x 108 cells/ml and in the presence of a signal
compound selected from the group consisting of acetosyringone,
alpha-hydroxyacetosyringone, acetovanillone, syringaldehyde, syringic acid,
sinapinic acid and mixtures thereof; B) maintaining a temperature for
co-cultivation of from about 22 to about 25°C; C) inducing virulence of
the Agrobacterium by decreasing the pH of the plant culture media below
pH 6.0; and D) regenerating a transgenic soybean plant.
|
Claims are the same as for the Australian patent AU 670316.
|
|
WO
1994/02620 A2
- Earliest priority - 27 July 1992
- Filed - 26 July 1993
- OPI - 3 February 1994
|
Title - An improved method of
Agrobacterium-mediated transformation of cultured soybean cells
Claim 1
A genotype-independent method for producing a transgenic soybean plant which
comprises:
a. cocultivating an explant derived from a hypocotyl or cultured cotyledonary
nodes of a germinated soybean seed with Agrobacterium species
containing a chimeric gene in the presence of a signal compound selected from
the group consisting of acetosyringone, a-hydroxyacetosyringone, acetovanillone,
syringaldehyde, syringic acid, and sinapinic acid and mixtures thereof; b.
maintaining a temperature for cocultivation of from 18 to 28°C; and c.
inducing virulence of the Agrobacterium by decreasing the pH of the
plant culture media below pH 6.0.
|
PCT application WO 1994/02620 recites a method to produce a transgenic
soybean plant.
|
| Remarks |
- National phase entry of WO 1994/02620 in Europe (EP 652965) is deemed to be
withdrawn on 12 march 2003.
- National phase entry of WO 1994/02620 in Japan (JP 2952041) has been granted
on 20 September 1999, which has lapsed on 9 July 2004. A divisional of now
granted JP 2952041 (JP H10/014425) has been rejected by the JPO, the notice of
which was sent to the applicant on 20 April 2000.
- Other national phase entries of WO 1994/02620 include Argentina (AR 247920),
Brazil (BR 9306802), Hungary (HU 70467).
|
Note: Patent information on this page was last updated on 24 March 2006.
Soybean - Patent assigned to University of
Mississipppi
Specific Patent Information
|
Patent Number
|
Title, Independent Claims and Summary of Claims
|
Assignee
|
|
US
5968830
- Earliest priority - 28 March 1997
- Filed - 28 March 1997
- Granted - 19 October 1999
- Expected expiry - 28 March 2017
|
Title - Soybean transformation and regeneration methods
| Claim 1
A method of regenerating soybeans (G. max) via organogenesis,
comprising:
A) obtaining hypocotyl explants from germinated seedlings of soybean plants
whose regeneration is desired, B) maintaining said hypocotyl explants on a
shoot induction medium comprising a cytokinin until shoots form at the acropetal
end of said hypocotyl explant, C) excising shoots from said hypocotyl
explant and maintaining said shoots on a shoot elongation medium until said
shoots are competent on a rooting medium, and maintaining said shoots on a
rooting medium until rooted plantlets are formed, and D) transplanting said
plantlets to soil.
|
| Claim 7
A method for transforming soybean plants to express exogenous DNA,
comprising:
A) obtaining a hypocotyl explant from germinated seedlings of a soybean
plant, B) maintaining said explant on a shoot induction medium comprising a
cytokinin for 16-32 hours, C) bombarding said explant, with the acropetal
end facing up, with microparticles of an inert metal coated with exogenous DNA
comprising a plasmid which comprises an expression gene, said expression gene
encoding the expression of a protein exogenous to said soybean plant, D)
maintaining said bombarded hypocotyl explant on a medium selective for growth of
transformed tissues, followed by maintenance on a shoot elongation medium and
preparing plantlets from shoots so obtained.
|
| Claim 10
A method of transforming soybeans, comprising:
A) obtaining a hypocotyl soybean explant from germinated seedlings, and
B) maintaining on its side or upright on a shoot induction medium comprising a
cytokinin with a basipetal end thereof submerged in said medium, C)
pre-culturing and/or co-culturing an Agrobacterium strain with a
virulence enhancing substance, and D) adding said pre- or co-cultured
bacteria to the acropetal end of said upright hypocotyl explant or by complete
submersion, E) co-incubating said hypocotyl explant for a time sufficient
to permit transfection of said hypocotyl explant by said bacteria, F)
disinfecting said hypocotyl explant, maintaining said hypocotyl explant on a
shoot induction medium and assaying said explant for expression of introduced
foreign DNA, and regenerating hypocotyl explants positive for expression of said
DNA.
|
Transformation of a hypocotyl soybean explant by cultivation with
Agrobacterium in a medium having a virulence-inducing signal and
cytokinin. A method for regeneration of soybeans (G. max) via
organogenesis is also disclosed. Additionally, the explant can be transformed by
microbombardment.
|
University of Mississippi
|
Note: Patent information on this page was last updated on 27 March 2006.
Summary
The United States patent granted to Asgrow Seeds refers to
- a method for transforming squash embryogenic calli with
Agrobacterium,
- regeneration of transformed squash plants, and
- components of an induction medium for regeneration of the transformed calli.
Asgrow Seeds was previously a subsidiary of the Upjohn Company, which was
sold to Empresas La Moderna (ELM; Mexico) in 1994, and soon after became Seminis
Inc.. Seminis is now owned by Monsanto Co. (acquisition signed in 2005).
Specific Patent Information
|
Patent Number
|
Title, Independent Claims and Summary of Claims
|
Assignee
|
|
US
5677157
- Earliest priority - 20 September 1989
- Filed - 5 December 1994
- Granted - 14 October 1997
- Expired - 16 November 2005
|
Title - Somatic embryogenesis and transformation of squash
|
Claim 1
A method of transforming and regenerating squash plants, which comprises:
A) excising shoot tips from germinating squash; B) transforming
embryogenic calli by inoculating the excised squash tissue with
Agrobacterium comprising a DNA construct having a beneficial gene and a
plant expressible selection marker gene and culturing the resulting explant on
an induction media comprising MS media, 2,4,5-T, BAP, and Kn; C)
selectively growing the transformed embryogenic calli on media containing a
selection agent for the plant expressible selection marker gene; and D)
subjecting the transformed embryogenic calli to an embryogenic regeneration
procedure from which whole transformed squash plants can be obtained.
|
|
Claim 4
A method of transforming and regenerating squash plants, which comprises:
A) excising tissue from mature squash seeds; B) transforming embryogenic
calli by inoculating said excised squash tissue with Agrobacterium
comprising a DNA construct having a beneficial gene and a plant expressible
selection marker gene and culturing on an induction media comprising MS media,
2,4-D or 2,4,5-T, BAP, and Kn; C) selectively growing the transformed
embryogenic calli on media containing a selection agent for the plant
expressible selection marker gene; and D) subjecting the transformed
embryogenic calli to an embryogenic regeneration procedure from which whole
transformed squash plants can be obtained.
|
Granted US 5677157 has expired due to
non-payment of maintenance fees.
Methods to transform embryogenic calli derived from squash shoot tips and
squash seeds with Agrobacterium having a gene of interest. Media for
culturing the transformed explant and embryogenic regeneration procedure are
claimed.
Additionally, transformation of the same explants by microprojectile
bombardment is also claimed. The claims referring to this transformation method
are not shown here.
|
Asgrow Seed Company
|
|
WO
1991/04332 A1
- Earliest priority - 20 September 1989
- Filed - 22 August 1990
- OPI - 4 April 1991
|
Title - Somatic embryogenesis of squash
|
Claim 1
A method of regenerating and transforming Cucurbita pepo L. (squash)
plants, which belong to the family Cucurbitaceae, which comprises
(1) excising squash tissue selected from the group consisting of shoot tips
from germinating squash seeds and squash tissue from mature seeds, (3)
producing embryogenic calli from said tissues, being either non-transformed or
transformed, (4) selectively growing the transformed embryogenic call on
media containing kanamycin, and (5) subjecting the transformed embryogenic
calli to an embryogenic regeneration procedure from which whole transformed
squash plants can be obtained.
|
PCT application WO 1991/04332 recites a transformation and
regeneration method of Cucurbita pepo. Note that the steps in the
published document have skipped number 2. Agrobacterium-mediated
transformation of C. pepo is recited in dependent claim 7.
|
The Upjohn Company
|
|
Remarks
|
- National phase entry of WO 1991/04332 in Australia (AU 62840/90) has lapsed
on 11 June 1992.
- National phase entry of WO 1991/04332 in Europe (EP 62840) has been granted
on 30 November 1994. Independent claim 1 does not limit the method of
transformation to that of Agrobacterium.
- National phase entry of WO 1991/04332 in Japan (JP H 05/500308) has been
deemed to be withdrawn on 25 November 1997.
|
|
Note: Patent information on this page was last updated on 27 March 2006.
Summary
Update July 2003
A United States patent was issued to
(VPP Corp) DNA Plant Technology Corp. with granted claims
disclosing a method to produce transgenic strawberry plants by co-cultivating
Agrobacterium carrying a gene of interest with explants in the presence
of glucose or fructose.
The US patent is broad with respect to the target tissue used in
transformation. The main limitation of the patent is with additives to the
culture medium. If the procedure is carried out in medium containing a
carbohydrate that is not glucose or fructose or no carbohydrate, it is unlikely
there would be infringement.
Specific Patent Information
|
Patent Number
|
Title, Independent Claims and Summary of Claims
|
Assignee
|
|
US
6274791
- Earliest priority - 19 January 1998
- Filed - 15 January 1999
- Granted - 14 August 2001
- Expected expiry - 15 January 2019
|
Title - Methods for strawberry transformation using
Agrobacterium tumefaciens
Claim 1
A method of preparing transgenic strawberry shoots, the method comprising:
(a) contacting strawberry explants with Agrobacterium tumefaciens
in a co-cultivation medium prepared using glucose or fructose, thereby producing
transformed strawberry explants; and (b) culturing the transformed
strawberry explants in a selection medium prepared using glucose or fructose,
thereby producing transformed strawberry shoots.
|
Granted United States patent US 6274791 recites an
Agrobacterium tumefaciens-mediated transformation method of strawberry,
where the co-cultivation and selection medium includes glucose or fructose.
|
DNA Plant Technology Corp.
|
|
WO
1999/35903 A1
- Earliest priority - 19 January 1998
- Filed - 15 January 1999
- OPI - 22 July 1999
|
Title - Methods for strawberry transformation using
Agrobacterium tumefaciens
Claim 1
A method for the preparation of transgenic strawberry explants comprising
contacting strawberry explants with Agrobacterium tumefaciens in a
co-cultivation medium containing glucose or fructose.
|
Claim 27
A method for the preparation of transgenic strawberry shoots comprising
culturing transformed strawberry explants in selection medium containing glucose
or fructose.
|
Claim 35
A method for the preparation of transgenic strawberry plants comprising
culturing transformed strawberry shoots in rooting medium containing glucose or
fructose.
|
PCT application WO 1999/35903 recites use of glucose or fructose in the
medium that is used for transforming strawberry with Agrobacterium.
|
|
Remarks
|
National phase entry of WO 1999/35903 in Australia
(AU 23231/99) has lapsed on 5 October 2000.
|
Note: Patent information on this page was last updated on 27 March 2006.
Summary
The invention claimed by
Biosem in a granted European patent is directed to the
transformation of callus of sugar beet by contacting the calli
with Agrobacterium having a vector with a gene of interest. The
transformation process takes place in a liquid culture medium.
A transgenic sugar beet plant resistant to the sugar beet necrotic yellow
vein virus is also part of the disclosed invention. A cDNA or genomic fragment
conferring resistance to this virus is specifically limited to a certain
nucleotide sequence that encodes at least part of the protein responsible for
the resistance.
Monsanto has recently filed applications in Australia,
United States and a PCT application related to a method for transforming a sugar
beet leaf with Agrobacterium. The transformed leaf is
initially derived from a selected region of a sugar beet seedling.
The following table presents basic bibliographic data and a summary of the
inventions. Full text of the granted European patent and the PCT application can
be accessed as PDF.
| Sugar beet |
| Assigned to Biosem |
| Issued patents |
| Patent No. |
Issue date |
Summary of the claims |
|
EP
517833 B1
Full patent text
|
November 2, 1995
|
Method for transforming calli of sugar beet by contacting a suspension of
them with Agrobacterium having a vector with a gene to be introduced
into the plant cells. The gene of interest confers resistance to the infection
caused by the sugar beet necrotic yellow vein virus.
View Claims
|
|
Remarks: Granted French patent FR 2658987 B1 is not
analyzed.
|
|
Assigned to Monsanto
|
| Applications |
| Application No. |
Publication date |
Summary of the claims |
|
WO
01/42480 A2*
Full patent application
text
(1,181 kb)
|
June 14, 2001
|
A method for preparing transgenic sugar beet cells by selecting part of the
cotyledon and hypocotyl region of a sugar beet seedling and micropropagating
this part to form a shoot, from which a leaf is selected and put in contact with
Agrobacterium cells. The Agrobacterium cells contain a vector
with an exogenous gene. Transgenic sugar beet plants capable of expressing the
exogenous gene are also recited in the claims.
View Claims
|
|
US
2001/42257 A1*
Full patent application
text
(880 kb)
|
November 15, 2001
|
The filed claims are worded the same as the claims of the related PCT patent
application. View Claims
|
|
Remarks: A related application was also filed in Australia (AU 200125757 A5).
|
*It is important to remember that applications are
not issued patents and the claims as filed have not been
approved by any country. Thus, they are non-binding.
Sugar beet - Patent granted to Biosem
Specific Patent Information
|
Patent Number
|
Title, Independent Claims and Summary of Claims
|
Assignee
|
|
EP
517833 B1
- Earliest priority - 2 March 1990
- Filed - 1 March 1991
- Granted - 2 November 1995
- Expected expiry - 1 March 2011
|
Title - Regeneration and genetic transformation of sugarbeet
| Claim 1
Method for transforming plant cells belonging to species Beta
vulgaris, characterized in that it comprises the bringing into contact of
the dispersion of friable white calluses in a liquid plant cell culture medium
containing 0 to about 3.0 mg/liter of the cytokinin, or of a suspension of
friable white calluses in a liquid plant cell culture medium containing about
0.1 to about 3.0 mg/liter of the cytokinin, with Agrobacterium
containing a vector carrying a gene intending to be introduced into the plant
cells, following by co-culturing the plant cells and the bacteria in order to
give rise to transformed friable calluses.
|
| Claim 21
Transgenic plant belonging to the Beta vulgaris species and
resistance to infection by the sugar beet necrotic yellow vein virus (BNYVV),
the said plant being transformed in a stable manner by a nucleic acid fragment
whose expression product is capable of conferring the said resistance, the said
fragment being derived from the 5' end of genomic or subgenomic RNA2 of BNYVV,
or from the corresponding cDNA, this fragment encoding at least a portion of the
proteins encoded by nucleotides 145 to 3285 of the wild type sequence of RNA2,
and being under the control of a promoter allowing the expression of the
fragment in the plant cells and being in this sense or antisense orientation.
|
Granted European patent EP 517833 is a national
phase entry of
WO
1991/13159 (publication in French).
Designated contracting States at the time of grant are: Austria, Belgium,
Switzerland, Germany, Denmark, Spain, France, United Kingdom, Greece (patent
lapsed as reported by INPADOC), Italy, Liechtenstein, Luxembourg, Netherlands,
Sweden
Method for transforming calli of sugar beet by contacting a suspension of
them with Agrobacterium having a vector with a gene to be introduced
into the plant cells. The gene of interest confers resistance to the infection
caused by the sugar beet necrotic yellow vein virus.
|
Biosem
|
| Remarks |
Related patent granted in France (FR 2658987) on 14 April
1995.
|
Note: Patent information on this page was last updated on 27 March 2006.
Sugar beet - Patent applications filed by
Monsanto
|
Patent Number
|
Title, Independent Claims and Summary of Claims
|
Assignee
|
|
WO
2001/42480 A2
- Earliest priority - 7 December 1999
- Filed - 6 December 2000
- OPI - 14 June 2001
|
Title - Sugarbeet regeneration and transformation
| Claim 1
A method for the preparation of transgenic sugarbeet cells, the method
comprising:
A) selecting a sugarbeet seedling, the seedling comprising a cotyledon region
and a hypocotyl region; B) removing the cotyledon region and upper half of
the hypocotyl region from the seedling; C) contacting the cotyledon region
and upper half of the hypocotyl region with micropropagation media to form a
micropropagated shoot, the micropropagated shoot comprising at least one leaf or
portion thereof comprising a leaf base; D) removing a leaf from the
micropropagated shoot at the leaf base; and E) contacting the leaf at the
leaf base with Agrobacteria in a manner forming a tissue comprising a transgenic
sugarbeet cell, capable of expressing an exogenous structural nucleic acid
sequence wherein: the Agrobacteria comprises a vector; and the vector
comprises operatively linked in the 5' to 3' orientation:
- a promoter that directs transcription of an exogenous structural nucleic
acid sequence;
- an exogenous structural nucleic acid sequence; and
- a 3' transcription terminator.
|
| Claim 7
A method for the preparation of a transgenic sugarbeet plant, the method
comprising:
A) selecting a sugarbeet seedling, the seedling comprising a cotyledon region
and a hypocotyl region; B) removing the cotyledon region and upper half of
the hypocotyl region from the seedling; C) contacting the cotyledon region
and upper half of the hypocotyl region with micropropagation media to form a
micropropagated shoot, the micropropagated shoot comprising at least one leaf or
portion thereof comprising a leaf base; D) removing a leaf from the
micropropagated shoot at the leaf base; E) contacting the leaf base with
Agrobacteria in a manner forming a tissue comprising a transgenic sugarbeet
cell; F) culturing said tissue to form a transgenic shoot; G)
culturing the transgenic shoot to form a transgenic rooted shoot; and H)
growing the transgenic rooted shoot to form a transgenic sugarbeet plant capable
of expressing an exogenous structural nucleic acid sequence, wherein:
the Agrobacteria comprise a vector; and the vector comprises operatively
linked in the 5' to 3' orientation:
- a promoter that directs transcription of an exogenous structural nucleic
acid sequence;
- an exogenous structural nucleic acid sequence; and
- a 3' transcription terminator.
|
A method for preparing transgenic sugar beet cells by selecting part of the
cotyledon and hypocotyl region of a sugar beet seedling and micropropagating
this part to form a shoot, from which a leaf is selected and put in contact with
Agrobacterium cells. The Agrobacterium cells contain a vector
with an exogenous gene. Transgenic sugar beet plants capable of expressing the
exogenous gene are also recited in the claims.
|
Monsanto
|
|
US
2001/42257 A1
- Earliest priority - 7 December 1999
- Filed - 6 December 2000
- Abandoned - 18 March 2004
|
Title - Sugarbeet regeneration and transformation
| Claim 1
A method for the preparation of transgenic sugarbeet cells, the method
comprising:
A) selecting a sugarbeet seedling, the seedling comprising a cotyledon region
and a hypocotyl region; B) removing the cotyledon region and upper half of
the hypocotyl region from the seedling; C) contacting the cotyledon region
and upper half of the hypocotyl region with micropropagation media to form a
micropropagated shoot, the micropropagated shoot comprising at least one leaf or
portion thereof comprising a leaf base; D) removing a leaf from the
micropropagated shoot at the leaf base; and E) contacting the leaf at the
leaf base with Agrobacteria in a manner forming a tissue comprising a transgenic
sugarbeet cell, capable of expressing an exogenous structural nucleic acid
sequence wherein: the Agrobacteria comprises a vector; and the vector
comprises operatively linked in the 5' to 3' orientation:
- a promoter that directs transcription of an exogenous structural nucleic
acid sequence;
- an exogenous structural nucleic acid sequence; and
- a 3' transcription terminator.
|
| Claim 7
A method for the preparation of a transgenic sugarbeet plant, the method
comprising:
A) selecting a sugarbeet seedling, the seedling comprising a cotyledon region
and a hypocotyl region; B) removing the cotyledon region and upper half of
the hypocotyl region from the seedling; C) contacting the cotyledon region
and upper half of the hypocotyl region with micropropagation media to form a
micropropagated shoot, the micropropagated shoot comprising at least one leaf or
portion thereof comprising a leaf base; D) removing a leaf from the
micropropagated shoot at the leaf base; E) contacting the leaf base with
Agrobacteria in a manner forming a tissue comprising a transgenic sugarbeet
cell; F) culturing said tissue to form a transgenic shoot; G)
culturing the transgenic shoot to form a transgenic rooted shoot; and H)
growing the transgenic rooted shoot to form a transgenic sugarbeet plant capable
of expressing an exogenous structural nucleic acid sequence, wherein:
the Agrobacteria comprise a vector; and the vector comprises operatively
linked in the 5' to 3' orientation:
- a promoter that directs transcription of an exogenous structural nucleic
acid sequence;
- an exogenous structural nucleic acid sequence; and
- a 3' transcription terminator.
|
According to the USPTO, this application has been abandoned due to failure of
the applicant to respond to an office action. There are no continuity data
reported as yet.
The filed claims are worded the same as the claims of the related PCT patent
application.
|
| Remarks |
- National phase entry of WO 2001/42480 in Australia (AU
2001/25757) and Canada (CA 2395365) have both
lapsed (AU 2001/25757 lapsed on 15 August 2002; CA 2395365
lapsed on 6 December 2004).
- Other national phase entries of WO 2001/42480 include Czech Republic
(CZ 20022139), Poland (PL 356025), Slovakia
(SK 200200804),
|
Note: Patent information on this page was last updated on 28 March 2006.
Summary
In a United States granted patent
Calgene discloses methods to transform tomato cotyledons with
A. tumefaciens having a gene of interest. The construct to be
integrated into the tomato cells contains transcription initiation and
termination regulatory regions, a gene of interest and at least a right T-DNA
border. In one of the claimed methods, the bacterium carries binary vectors.
Tomato cells resistant to the herbicide glyphosate are also part of the
invention.
Specific Patent Information
|
Patent Number
|
Title, Independent Claims and Summary of Claims
|
Assignee
|
|
US
5565347
- Earliest priority - 10 June 1986
- Filed - 30 August 1993
- Granted - 15 October 1996
- Expected expiry - 15 October 2013
|
Title - Transformation and foreign gene expression with
plant species
| Claim 1
A transformed Lycopersicon esculentum cotyledon cell, wherein said
cell is present in an in vitro cell culture.
|
| Claim 2
A method for transforming tomato species cells, said method comprising:
A) pre-incubating tomato cotyledon sections with medium conditioned by a
plant cell feeder culture; B) co-cultivating said cotyledon sections with
Agrobacterium tumefaciens cells comprising vir genes, wherein
said Agrobacterium cells further comprise DNA construct
comprising: (i) transcriptional initiation and termination regulatory
regions functional in tomato plant cells and (ii) a gene other than the
wild-type gene associated with at least one of said transcriptional initiation
and termination regions, and (iii) at least a right T-DNA border, whereby
said construct becomes integrated into the genome of cells in said cotyledon
section to provide transformed tomato plant cells; C) incubating said
transformed tomato plant cells in a regeneration medium comprising a
bacteriocide and a means for selection of said transformed tomato plant cells as
the result of a marker on said DNA construct, whereby transformed tomato shoots
develop; and D) transferring said transformed shoots to a rooting medium to
produce transformed tomato plants.
|
| Claim 9
A method for modifying the genotype of tomato plant cells, said method
comprising:
A) pre-incubating tomato cotyledon sections with medium conditioned by a
plant cell feeder culture, B) contacting said cotyledon sections with a
culture of a disarmed Agrobacterium tumefaciens strain comprising
vir genes and a binary vector plasmid comprising at least the right
T-DNA border and a gene of interest, wherein said gene of interest is under
regulatory control of transcriptional initiation and termination regions
functional in tomato plant cells, and wherein said gene of interest is
integrated into the genome of cells in said tomato cotyledon sections, and
C) isolating said tomato cells comprising said integrated gene of interest.
|
| Claim 16
A method for transforming tomato species cells, said method comprising:
A) co-cultivating tomato cotyledon sections with Agrobacterium
tumefaciens cells comprising vir genes, wherein said
Agrobacterium cells further comprise a DNA construct comprising
transcriptional initiation and termination regulatory regions functional in
tomato plant cells and a gene other than the wild-type gene associated with at
least one of said transcriptional initiation and termination regions, and at
least a right T-DNA border, whereby said construct becomes integrated into the
genome of cells in said cotyledon section to provide transformed tomato plant
cells; B) incubating said transformed tomato plant cells in a regeneration
medium comprising a bacteriocide and a means for selection of said transformed
tomato plant cells as the result of a marker on said DNA construct, whereby
transformed tomato shoots develop; and C) transferring said transformed
shoots to a rooting medium to produce transformed tomato plants.
|
| Claim 19
A method for modifying the genotype of tomato plant cells, said method
comprising:
A) contacting tomato cotyledon sections with a culture of a disarmed
Agrobacterium tumefaciens strain comprising vir genes and a
binary vector plasmid comprising at least the right T-DNA border and a gene of
interest, wherein said gene of interest is under regulatory control of
transcriptional initiation and termination regions functional in tomato plant
cells, and wherein said gene of interest is integrated into the genome of cells
in said tomato cotyledon sections, and B) isolating said tomato cells
comprising said integrated gene of interest.
|
Transformation of tomato cotyledon sections with A. tumefaciens
carrying a construct with a foreign gene. Transformed tissues are regenerated
into tomato plants. Disarmed A. tumefaciens having a binary vector with
a foreign gene is used to transform tomato cells.
|
Calgene Inc.
|
| Remarks |
- Related application in Australia (AU 73351/87) has lapsed on 17 January
1991.
- Related application in China (CN 87104202) has been withdrawn on 12 December
1990.
- Related application in Europe (EP 249432) has been deemed to be withdrawn on
20 March 1991.
- Related application in New Zealand (NZ 220642) has been granted and
registered on 26 April 1996 and has expired.
- Other related patent documents in Israel (IL 82704) and Japan (JP
S63/068088).
|
Note: Patent information on this page was last updated on 28 March 2006.
The
forestry industry --which relies on woody tree species-- is a major economical
factor for several countries. Tree species like Eucalyptus and
Pinus are very important in the paper and cellulose industry. Because
of their long generation times, novel breeding methodologies are sought to
introduce disease resistance genes, influence lignin production or modulate
flowering time for example. Patents covering transformation technologies could
be of commercially strategic relevance.
Summary
- The European application assigned to the Instituto Nacional de
Investigacion y Tecnologia Agraria y Alimentaria (INIA) and the
Instituto Valenciano de Investigaciones Agrarias (IVIA), both
in Spain, is related to a United States patent analyzed in the 'Citrus' section.
The present application discloses a procedure for the transformation of
any woody species using adult plant material as primary
explant. The explant is grafted on a stock to generate shoots which are then
used as target tissue for Agrobacterium-mediated transformation.
Treated shoots are then re-grafted in vitro to select for transformed shoots,
which are then regenerated into full transgenic plants. This method addresses
the problem of how to obtain improved clones from elite woody trees from which
it is usually hard to obtain totipotent, regenerable material.
- The PCT application assigned to the Companhia Suzano de Papel e
Celulose and the University of Sao Paulo in Brazil
discloses a method to transform woody tree species starting from pre-germinated
seed material. The method disclosed was developed for transformation of
Eucalyptus spp but the claims have been worded to encompass any woody
tree species, which could include conifers. The method disclosed in the
independent claims is rather detailed in terms of timing of the multiple steps.
This timing could be very different for other tree species than
Eucalyptus, which would allow ways to design around the claim in this
patent (if granted) and thus avoid infringement.
Specific Patent Information
|
Patent Number
|
Tite, Independent Claims and Summary of Claims
|
Assignee
|
|
WO
2002/14463 A2
- Earliest priority - 18 August 2000
- Filed - 16 August 2001
- OPI - 21 February 2002
- International search report (A3) - 6 May 2004
- Modified first page (C1) - 1 July 2004
|
Title - Method for genetic transformation of woody trees
| Claim 1
METHOD FOR GENETIC TRANSFORMATION OF WOODY TREES, which comprises the
following steps: -sterilization and washing of seeds of woody trees;
-transference of said seeds to an appropriate medium of culture;
-germination for a period between about 2 and 17 days; -collection of
germinated material; -inoculation with Agrobacterium, containing
one or more genes of interest and optionally one or more marker genes, under
concentration between about 10E+7 and 10E+9 cells per ml; -await
inoculation between about 20 and 30 hours in a liquid medium;
-transference of the material to a solid medium for a period between about 38
and 50 hours in the dark, under temperature between about 25 and 31 C and
ambient humidity; -transference of the material to start plantlet growth in
the light; -withdrawal of a plantlet leaf obtained between about 5 and 17
days during growth in the light; -transference of the plantlet leaf to the
MS medium containing auxins derived from urea; -await germination of the
plant tissue for approximately 20 days; and -identification and selection
of the transformed plantlets.
|
| Claim 2
METHOD FOR GENETIC TRANSFORMATION OF WOODY TREES, which comprises the
following steps: -sterilization and washing of seeds of woody trees;
-transference of said seeds to an appropriate medium of culture;
-germination for a period between about 2 and 17 days; -collection of
germinated material; -sonication of the material as collected ; inoculation
with Agrobacterium, containing one or more genes of interest and
optionally one or various marker genes, under concentration between about 107
and 109 cells per ml; -await inoculation between about 20 and 30 hours in a
liquid medium; -transference of the material to a solid medium for a period
between about 38 and 50 hours in the dark, under temperature between about 25
and 31 C and ambient humidity; -transference of the material to start the
plantlet growth in the light; -withdrawal of a plantlet leaf obtained
between about 5 and 17 days during growth in the light; -transference of
the plantlet leaf to the MS medium containing auxins derived from urea;
-await germination of the plant tissue for approximately 20 days and
-identification and selection of transformed plantlets.
|
| Claim 9
METHOD TO OBTAIN TRANSGENIC WOODY TREE PLANTS, which comprises the following
steps: -sterilization and washing of seeds of woody trees;
-transference of said seeds to an appropriate medium of culture;
-germination for a period between about 2 and 17 days; -collection of
germinated material; -inoculation with Agrobacterium, containing
one or more genes of interest and optionally one or more marker genes, under
concentration between about 107 and 109 cells per ml; -await inoculation
between about 20 and 30 hours in a liquid medium ; -transference of the
material to a solid medium for a period between about 38 and 50 hours in the
dark, under temperature between about 25 and 31 C and ambient humidity;
-transference of the material to start the plantlet growth step in the light;
-withdrawal of a plantlet leaf obtained between about 5 and 17 days during
growth in the light; -transference of plantlet leaf to the MS medium
containing auxins derived from urea; -await germination of the plant tissue
for approximately 20 days; -identification and selection of transformed
plantlets; -maintaining transforming plantlets in a multiplication and
elongation medium for about 20 days; -regeneration of the final transformed
plant from one of the following regions hypocotyl; cotyledon; primary leaves and
col.
|
A method for transformation of woody trees using pre-germinated seed as
target tissue for Agrobacterium-mediated transformation.
|
Companhia Suzano de Papel e Celulose and Universidade De Sao Paulo
|
|
Remarks
|
- National phase entry of WO 2002/14463 in Australia (AU 2001/279510) is
pending.
- National phase entry of WO 2002/14463 in China (CN 1630723) is pending.
- National phase entry of WO 2002/14463 in Europe (EP 1448777) is pending.
- National phase entry of WO 2002/14463 in the United States
(US
2004/055041) is pending.
- Other national phase entries of WO 2002/14463 include Brazil (BR 200113455),
South Africa (ZA 200301299).
|
|
EP
0870838 A2
- Earliest priority - 5 March 1997
- Filed - 4 March 1998
- Application pending
|
Title - Procedure for the genetic transformation of adult
plants of woody species
| Claim 1
A genetic transformation procedure for adult plants of woody species which
consists of:
- inoculating explants of adult tissue of woody species, from the first shoots
of the grafts of buds of adult plants of woody species on stocks, with
appropriate vectors which carry the genes which encode the characteristics of
interest, under conditions which permit the development of transgenic shoots;
and
- micrografting in vitro said transgenic shoots, their buds or apices, on
stock cultivated in vitro and,
- subsequently, grafting the resulting micrografted plants onto other stocks
which give vigor and let the taken shoots grow to generate complete adult
transgenic plants, or directly transplanting the in vitro micrografted plants
into the soil, to give complete adult transgenic plants.
|
A procedure for transformation of adult woody species with appropriate
vectors, which is not limited to Agrobacterium. Adult tissue is grafted
on stocks to generate new buds or apices that are used as target tissue for
transformation followed by in vitro micrografting of transgenic shoots.
|
|
|
Remarks
|
- Related United States patent
US
6103955 recites an Agrobacterium-mediated transformation method of
citrus (see section on
citrus).
- Other related patent application filed in Spain (ES 2151338).
|
Note: Patent information on this page was last updated on 28 March 2006.
Conifers
Summary
Botanical aspects
Conifers is a major group within the Gymnosperms plants (plants with naked
seeds that appear in a cone). They usually have needle-shaped or scale-like
leaves, and nearly all are evergreen. The trees have a conical shape and have
cones for pollen and seed production.
Within Conifers, Pinus is the largest genus with about 120 species.
It is also the most widespread genus of trees in the Northern Hemisphere. The
natural distribution of pines ranges from arctic and subarctic regions of
Eurasia and North America to subtropical and tropical (usually montane) regions
of Central America and Asia. Pines are also extensively planted in temperate
regions of the Southern Hemisphere. Many pines are fast growing species tolerant
of poor soils and relatively arid conditions, making them popular in
reforestation. Due to their occurrence in some very cold and dry environments
where disease and stand-destroying disturbance are rare, pines are collectively
the most long-lived of conifers. Ages of over 1000 years are common for some
pine species.
Important pine products include wood, turpentine, and edible seeds. The wood
of several Pinus species (e.g. P. elliottii) is widely used
for construction. Synthetic products derived from turpentine (e.g. terpin,
anethole, camphor, and dl-menthol) are used in pharmaceutical preparations (e.g.
expectorant in humans), in perfumery, in the elaboration of cigarettes,
cosmetics, toilet products, and to impart flavor in different products.
IP aspects
There are a couple of patents directed to transformation of conifers by
microprojectile bombardment, but very few related to transformation through
Agrobacterium.
A United States patent on transformation of pine tissue
with Agrobacterium was granted to North Carolina State
University in 1989. The patent claims a method for the transformation
of a differentiated tissue of pine with A. tumefaciens. The strain of
A. tumefaciens used for transformation can be selected from: a strain
capable of causing crown gall, a strain with a co-integrated Ti-plasmid and a
strain with a binary vector system.
Recently, Genesis Research and Development Corporation has
filed a United States patent application directed to transformation of nodal
stem segments of a plant from the genus Pinus with
Agrobacterium.
Conifers - Specific Patent Information
|
Patent Number
|
Title, Independent Claims and Summary of Claims
|
Assignee
|
|
US
4886937
- Earliest priority - 20 May 1985
- Filed - 22 June 1988
- Granted - 12 December 1989
- Expected expiry - 20 May 2005
|
Title - Method for Transforming Pine
Claim 1
A method for transforming pine, comprising inoculating differentiated pine
tissue with a strain of Agrobacterium tumefaciens selected from the
group consisting of (i) a strain containing a Ti plasmid which is capable of
causing crown gall in said pine, (ii) a strain containing a plasmid comprising
the vir region of said Ti plasmid and TDNA borders, and (iii) a strain
containing a first plasmid comprising the vir region of said Ti plasmid and a
second plasmid comprising TDNA borders.
|
Claim 5
A transformed pine comprising differentiated pine tissue, said differentiated
pine tissue comprising cells transformed by a strain of Agrobacterium
tumefaciens selected from the group consisting of (i) a strain containing a Ti
plasmid which is capable of causing crown gall in said pine, (ii) a strain
containing a plasmid comprising the vir region of said Ti plasmid and TDNA
borders, and (iii) a strain containing a first plasmid comprising the vir region
of said Ti plasmid and a second plasmid comprising TDNA borders.
|
A method for transforming a differentiated pine tissue with a strain of
A. tumefaciens selected from: a strain capable of causing crown gall in
pines, a strain with a Ti-plasmid having both the vir genes and the
T-borders and a strain having two plasmids, one with the vir genes and
the other with the T-borders. A transformed pine attained with the mentioned
method is also claimed.
|
North Carolina State University
|
|
US
2002/16981 A1
- Earliest priority - 15 September 1998
- Filed - 20 March 2001
- Abandoned - 6 October 2003 (failure to respond to an office action)
|
Title - Methods for Producing Genetically Modified Plants,
Plant Materials and Plant Products Produced Thereby
Claim 1
A method for producing genetically modified plant material of the
Eucalyptus or Pinus species, comprising:
(a) culturing nodal stem segments of a target plant selected from the
Eucalyptus and Pinus species;
(b) transforming the stem segments with a genetic construct by incubating the
nodal stem segments with an Agrobacterium culture transformed with the genetic
construct;
(c) promoting regeneration of adventitious shoot buds from the transformed
stem segments;
(d) selecting transformed adventitious shoot buds; and
(e) regenerating transformed plant material from the transformed adventitious
shoot buds.
|
A method for producing genetically modified material of Pinus by
incubating nodal stem segments with an Agrobacterium culture
transformed with a genetic construct. Transformed plant material is regenerated
from transformed adventitious shoot buds. The invention also includes
transformation of Eucalyptus species. This part is discussed under
Particular dicots - Eucalyptus.
|
Genesis Research and Development Corporation
|
|
Remarks
|
- US 2002/0016981 was a continuation-in-part of now granted
US
6255559, which is the priority document of WO 2000/15813. Claim 1 of
WO
2000/15813 does not limit the type of plant to be transformed.
- Related applications also filed in Brazil (BR 9913740 A), Indonesia (ID
29949) and South Africa (ZA 200101818). Granted United States patent US 6 255
559 is also related to this application, but Agrobacterium -mediated
transformation of Pinus is not the subject matter of the invention.
- National phase entry of
WO
2000/15813 in Australia (AU 61270/99), Canada (CA 2341781), China (CN
1326510), Europe (EP 1114169), New Zealand (NZ 510474) are deemed
lapsed/withdrawn.
|
|
WO
2002/031112 A2
- Earliest priority - 10 October 2000
- Filed - 10 October 2001
- OPI - 18 April 2002
|
Title - Enhanced transformation and regeneration of
transformed embryogenic pine tissue
Claim 1
A method for regenerating transgenic plants of pine of the genus
Pinus subgenus Pinus which comprises:
(A) subjecting pine cells to Agrobacterium infection for
Agrobacterium transformation; (B) minimizing damage to cells
subsequent to Agrobacterium infection; (C) rapidly selecting
transformed cells; (D) culturing said transformed cells to produce
transgenic somatic embryos; and (E) germinating said transgenic somatic
embryos to produce transgenic plants.
|
Claim 25
A method for regenerating transgenic plants of pine of the genus
Pinus subgenus Pinus which comprises:
(A) subjecting pine cells to Agrobacterium infection for
Agrobacterium transformation; (B) eradicating
Agrobacterium; (C) minimizing damage to cells during and
subsequent to Agrobacterium eradication; (D) rapidly selecting
transformed cells; (E) culturing said transformed cells to produce
transgenic somatic embryos; and (F) germinating said transgenic somatic
embryos to produce transgenic plants.
|
Claim 39
A method for minimizing damage to transformed cells of pine of the genus
Pinus subgenus Pinus following infection by
Agrobacterium for Agrobacterium transformation which
comprises:
(a) washing transformed cells in a liquid wash medium; (b) plating said
cells on a support membrane; (c) resuspending said cells in a liquid wash
medium; and (d) recovering washed, transformed cells with minimal physical
damage.
|
Claim 46
A method for pine cell tissue culture which comprises culturing pine cells on
a support membrane placed over a gel medium.
|
Claim 52
A method for selecting transformed cells of pine of the genus Pinus
subgenus Pinus which comprises:
(A) culturing cells which have been subjected to transformation on a support
membrane placed over a gel medium; (B) contacting said cells with a
selection agent; and (C) selecting transformed cells.
|
Claim 58
A method for eradicating Agrobacterium from cells of pine of the
genus Pinus subgenus Pinus which comprises:
(A) culturing cells on a support membrane over a layer containing an
eradicant, said layer positioned in or over a gel medium; and (B)
recovering cells from which said Agrobacterium contaminant has been
eradicated.
|
This patent document was retrieved on the BIOS Patent Lens using the terms
"((conifer or pine or pinus) in the title or abstract) and (transform* in the
title or abstract)".
Claims in this application recite a method of
Agrobacterium-mediated transformation of pine cells, where physical
damage of cells after Agrobacterium infection is kept to a minimum
(e.g. by use of vessels or support membranes).
|
Westvaco Corporation
|
| Remarks |
- National phase entry of WO 2002/031112 in Australia (AU 1308102 A), Canada
(CA 2424313 A1), and United States (US 2002100083 A1) are pending.
- Related patent applications also filed in Brazil (BR 0114563 A) and South
Africa (ZA 200303570 A).
- National phase entry of WO 2002/031112 in New Zealand (NZ 525632) has been
published as granted on 24 September 2004.
|
Note: Patent information on this page was last updated on 21 February 2006.
Marine algae
Summary
Algal aspects
Algae are relatively undifferentiated organisms which, unlike plants, have no
true roots, leaves, flowers or seeds. They are found in marine, freshwater and
terrestrial habitats. Their size varies from tiny microscopic unicellular forms
of 3-10 µm (microns) to large macroscopic multicellular forms up to 70 meters
long and growing at up to 50 cm per day. Algae do not have water-conducting
tissues, as they are, at some stage, surrounded by water, which is also
important for reproduction by spores. The spores may be motile or non-motile.
Most of the algae are photosynthetic organisms that have chlorophyll. Apart from
chlorophyll, they contain additional pigments, which are the basis of
classification.
Phytoplankton, seaweeds and symbiotic dinoflagellates (unicellular,
biflagellate organisms) in corals and sea anemones are marine algae. Seaweeds
are classified as Green algae (Chlorophyta), Brown algae (Phaeophyta), Red algae
(Rhodophyta) and some filamentous Blue-green algae (Cyanobacteria). Most of the
seaweeds are red (6000 species) and the rest known are brown (2000 species) or
green (1200 species). Seaweeds are used in many maritime countries as a source
of food, for industrial applications and as a fertilizer. Nori (Porphyra
spp.), a Japanese red seaweed, is very popular in the Japanese diet, has a
high protein content (25-35% of dry weight), vitamins (e.g. vitamin C) and
mineral salts, especially iodine. Industrial utilization is at present largely
confined to extraction for phycocolloids, industrial gums classified as agars,
carrageenans and alginates. Agars, extracted from red seaweeds such as
Gracilaria , are used in the food industry and in laboratory media
culture. Carrageenans, extracted from red seaweeds such as Chondrus,
Gymnogongrus, and Eucheuma among others, are used to provide
particular gel qualities. Alginates are derivatives of alginic acid extracted
from large brown algae such as Laminaria. They are used in printers'
inks, paints, cosmetics, insecticides, and pharmaceutical preparations. In the
USA, alginates are used as stabilizers in ice cream and also as a suspending
agent in milk shakes. In 1995, the estimated value of international seaweed gums
market was $560 million dollars.
IP aspects
Northeastern University, in the United States, has filed a
PCT application related to transformation of multicellular marine algae via
Agrobacterium. Marine algae are defined by the applicants as
non-angiosperm photosynthetic eukaryotic organisms that live in the ocean or in
saline water. According to the disclosure, marine algae could serve as a source
of valuable pharmaceutical compounds through genetic engineering. They naturally
have a very high protein content and are easy to grow for biomass.
With respect to genetic transformation, the applicants claim to provide a
stable method for genetic transformation of multicellular marine algae. The
method comprises wounding the outer cell wall layer of an alga in order to
facilitate the access of Agrobacterium T-DNA with a gene of interest.
The transformation of algal cells takes place in an environment containing
seawater to ensure the survival of the transformed algae. To exemplify their
invention, the applicants describe the transformation of the red alga
Porphyra, known as nori, for which worldwide production is estimated at
$1.5 billion dollars annually.
Algae transformation - Specific Patent
Information
|
Patent Number
|
Title, Independent Claims and Summary of Claims
|
Assignee
|
|
WO
2000/62601 A1
- Earliest priority - 15 April 1999
- Filed - 14 April 2000
- OPI - 26 October 2000
|
Title - Agrobacterium-mediated genetic
transformation of multicellular marine algae, resultant strains and their
products
| Claim 1
A method for causing genetic transformation of multicellular marine algae,
said method comprising:
A) culturing cells of a transformation-competent Agrobacterium
species, said cells containing a Ti plasmid that contains a gene of interest;
B) wounding a multicellular marine algae to be transformed in a manner
that is sufficient to penetrate at least the cuticle, or outer cell wall layer
of said alga; C) applying cells of said transformation-competent
Agrobacterium species to wounded cells of said alga; and D)
co-culturing said applied cells of said Agrobacterium species with said
wounded algal cells for a time sufficient to effect transformation of some of
said algal cells.
|
| Claim 20
A stable transgenic multicellular marine algae, said alga comprising a DNA
sequence coding for a gene foreign to said alga, wherein said alga is further
capable of expressing said DNA sequence and of transferring said expressible DNA
sequence to progeny of said alga.
|
| Claim 22
A transgenic strain of marine algae comprising and capable of expressing a
DNA sequence coding for an antigen of a pathogenic microorganism or an antigenic
determinant thereof, wherein said antigen or antigenic determinant thereof is
capable of eliciting a secretory immune response in a human or other animal upon
oral administration of cellular material from said algae.
|
| Claim 23
A transgenic strain of marine algae with enhanced disease resistance to
marine fungi compared to a non-transformed said strain.
|
Claim 24
A transgenic strain of marine algae capable of producing a compound having an
enhanced health benefit compared to a non-transformed said strain.
|
| Claim 26
A method for eliciting a secretory immune response in a human or other
animal, said method comprising:
- orally administering an effective amount of a composition comprising
transgenic marine algae, or tissue thereof,
wherein said transgenic algae,
or algal tissue, comprise and are capable of expressing a DNA sequence coding
for an antigen of a pathogenic microorganism or an antigenic determinant
thereof, wherein said antigen or antigenic determinant thereof is capable
of eliciting a secretory immune response in a human or other animal upon oral
administration of cellular material from said algae.
|
The claims as filed of the present PCT application recite:
- a method for the transformation of multicellular marine algae with
Agrobacterium by
-
- wounding the cuticle of the algae
- applying competent Agrobacterium containing a gene of interest to
the wounded alga; and
- co-culturing both Agrobacterium and algal cells allowing enough
time for the transformation process
- a stable transgenic marine alga capable of expressing a foreign sequence and
transferring such sequence to its progeny;
- transgenic strains of marine algae comprising:
-
- antigens as elicitors for human or animal immune response
- resistance to marine fungi
- a compound for health benefit
- a method to elicit human or animal immune response by orally administering a
transgenic alga or algal tissue containing an antigen that acts as an elicitor
of an immune response.
|
Northeastern University
|
| Remark |
The present PCT application has passed the deadline to enter national phase
(30 or 31 months from filing depending on the country), therefore will not have
any patents granted from this particular application.
|
|
Note: Patent information on this page was last updated on 9 February 2006.
Fungi
Summary
"Fungal" aspects
Fungi constitute one of the life kingdoms. Fungi are eukaryotic (eu=true;
karyon=nucleus) organisms with a cell wall like plants, but they do not have
chlorophyll. Fungi are not able to ingest their food like animals do, nor can
they manufacture their own food the way plants do. Instead, fungi feed by
absorption of nutrients from the surrounding environment. They accomplish this
by growing through and within the substrate on which they are feeding.
Fungi are divided into two big groups: yeasts and
moulds. Yeasts are solitary rounded forms that reproduce by
making more rounded forms through mechanisms such as budding or fission. Moulds,
on the other hand, have bodies composed of thread-like long cells called
hyphae. Thus, moulds are also known as filamentous
fungi. The filamentous cells are connected end-to-end and grow in a
branching fashion forming a network called mycelium. The
mycelium that grows over and within a substrate that is used as a source of
nourishment is called vegetative mycelium. In the life cycle,
the vegetative mycelium may give rise to a large organized reproductive
structure called fruit body, which bears the reproductive cells
or spores and is produced solely for the release of spores.
In taxonomic terms, moulds are present in all five divisions of Eumycota
(Eu=true; mycota=fungus): Mastigomycotina (e.g. Phytophtora ,
Achlya), Zygomycotina (e.g. Rhizopus, Mucur),
Ascomycotina (e.g. some species of Aspergillus, Neurospora ),
Basidiomycotina (e.g. Agaricus, Pleurotus) and Deuteromycotina
(e.g. Fusarium, Trichoderma).
Filamentous fungi or moulds are vital for the maintenance of ecosystems. By
breaking down dead organic material, they continue the cycle of nutrients
through ecosystems. Some of them act as plant pathogens causing severe crop
losses from disease and post-harvest food spoilage. In the reagent industry and
medicine areas, filamentous fungi are the source of commercial enzymes, organic
acids, and numerous drugs such as antibiotics (e.g. penicillin, cefalosporin).
Among filamentous fungi are highly appreciated edible fungi such as
Agaricus bisporus, the popular cultivated mushroom; Pleurotus
spp., the "oyster mushroom", Tuber spp., "truffles", and
Morchella spp., "Morels", among others. Thus, in many areas, the
industrial production of genetically engineered fungi has tremendous potential.
IP aspects
The selected patents and patent applications presented in this section are
directed to transformation of moulds or filamentous fungi with
Agrobacterium.
There are two institutions that have filed patent applications related to
Agrobacterium-mediated transformation of filamentous fungi:
Unilever N.V., in The Netherlands, has a granted United States
patent and several applications around the world, and The Penn State
Research Foundation, in the United States, has a PCT and a United
States patent application.
Unilever's invention is directed to a transformed mould with
A. tumefaciens having a vector containing an expressible gene between
T-DNA borders. Although the Penn State 's invention also refers
to the transformation of a mould, which the inventors called filamentous fungi,
they limit the invention to a particular tissue to be transformed: the
fruit body tissue of a filamentous fungi.
Unilever does not claim the transformation of
any tissue in particular, and their claims are therefore broader in that
respect. In addition, some of the claims filed in the Penn
State's applications are also directed to the transformation of a
particular filamentous fungus: Agaricus bisporus , the cultivated
mushroom.
In conclusion
- There is an overlap between the inventions as both refer to transformation
of any filamentous fungi or mould with Agrobacterium.
However, the invention disclosed by Penn State Research
Foundation is more defined as it encompasses a particular fungal tissue
to be transformed.
- It remains to be seen whether the claims as filed in the applications by
Penn State Research Foundation are granted as filed.
Unilever's United States patent is fairly broad, however, and
may pose freedom to operate problems if the species A. tumefaciens is
used for transforming any mould.
Granted patent and patent application filed by
Unilever Patent Holdings B.V.
Unilever discloses in its applications a process for
producing a transformed mould with A. tumefaciens. In the method, an
A. tumefaciens vector containing at least one expressible gene is
introduced into the mould.
Moulds are defined by the inventors to include fungi from all five
subdivisions of the division Eumycota. The examples in the disclosures include
fungi from the genera Aspergillus, Fusarium,
Trichoderma, Neurospora and Colletotrichum. The first
three genera contain species important in large scale fermentation and
production of homologous and heterologous proteins. Other species within these
genera are fungal pathogens and fungi that serve as important model organisms
for basic research.
Specific Patent Information
|
Patent Number
|
Title, Independent Claims and Summary of Claims
|
Assignee
|
|
US
6255115
- Earliest priority - 7 April 1997
- Filed - 7 October 1999
- Granted - 3 July 2001
- Expected expiry - 7 October 2019
|
Title - Agrobacterium-mediated transformation of
moulds, in particular those belonging to the genus Aspergillus
| Claim 1
A process for producing a transformed mould, comprising: A) inserting a DNA
fragment containing at least one expressible gene to be introduced into a mould
into a vector of Agrobacterium tumefaciens between the T-DNA borders
present in that vector; B) introducing the vector containing the DNA
fragment between the T-DNA borders into an Agrobacterium tumefaciens
strain containing a vir region in its DNA; C) inducing
vir genes to release T-DNA containing said DNA fragment from said
Agrobacterium tumefaciens, and incubating the Agrobacterium
tumefaciens strain with the mould to be transformed; and D) selecting
the transformed mould from the untransformed mould depending on the
characteristics of the introduced DNA or its expression product, and optionally
culturing the transformed mould.
|
The United States patent claims
- a method for producing a transgenic mould by inserting into it at least an
expressible gene carried in an A. tumefaciens vector. A.
tumefaciens containing the vector and the mould are co-cultivated and the
transformed mould is selected.
Note that although the title of the patent refers to the genus
Aspergillus, the independent claims are not limited to
this genus or any other genera of filamentous fungi.
|
Unilever Patent Holdings B.V.
|
|
EP
973917 B1
- Earliest priority - 7 April 1997
- Filed - 24 March 1998
- Granted - 3 March 2004
- Expected expiry - 23 March 2018
|
Title - Agrobacterium-mediated transformation of
moulds, in particular those belonging to the genus Aspergillus
| Claim 1
A process for producing a transformed mould, characterized in that:
1) a DNA fragment containing at least one expressible gene to be introduced
into a mould is first cloned into a vector of Agrobacterium tumefaciens
between the T-DNA borders present in that vector, wherein T-DNA borders
are 24 basepair imperfect direct repeats flanking the T-DNA;
2)
the vector containing the DNA fragment between the T-DNA borders is introduced
into an Agrobacterium tumefaciens strain containing a vir
region in its DNA; 3) release of T-DNA containing said DNA fragment from
said Agrobacterium tumefaciens by addition of a vir-inducing
compound, and the Agrobacterium tumefaciens strain is incubated with
the mould to be transformed; and 4) the transformed mould is selected from
the untransformed mould depending on the characteristics of the introduced DNA
or its expression product, and optionally the transformed mould is cultured.
|
The claims as filed in the granted EP patent are directed to the same subject
matter as the granted claims of the United States patent.
Designated contracting States at the time of grant are: Switzerland, Germany,
Spain, France, United Kingdom, Italy, Liechtenstein.
* As the independent claims of the United States patent and the European
patent application are worded slightly different, the claims are presented
independently. However, the claims have practically the same scope.
|
|
EP 973917 A1
- Earliest priority - 7 April 1997
- Filed - 24 March 1998
- Granted as EP 973917 B1 (see above)
|
Title - Agrobacterium-mediated transformation of
moulds, in particular those belonging to the genus Aspergillus
| Claim 1 (granted with minor changes)
A process for producing a transformed mould, characterized in that:
1) a DNA fragment containing at least one expressible gene to be introduced
into a mould is first cloned into a vector of Agrobacterium tumefaciens
between the T-DNA borders present in that vector; 2) the vector containing
the DNA fragment between the T-DNA borders is introduced into an
Agrobacterium tumefaciens strain containing a vir region in
its DNA; 3) release of T-DNA containing said DNA fragment from said
Agrobacterium tumefaciens by addition of a vir-inducing
compound, and the Agrobacterium tumefaciens strain is incubated with
the mould to be transformed; and 4) the transformed mould is selected from
the untransformed mould depending on the characteristics of the introduced DNA
or its expression product, and optionally the transformed mould is cultured.
|
|
|
Remarks
|
- Related applications also filed in Brazil (BR 9807941 A),
Indonesia (ID 22929), and South Africa (ZA 9802905
A).
- National phase entry of WO 1998/45455 in Australia (AU
74283/98) has lapsed on 23 December 1999.
- National phase entry of WO 1998/45455 in Canada (CA
2286307) and Japan (JP 2001/518786 T2) are still
pending.
- National phase entry of WO 1998/45455 in China (CN
1151264) has been granted on 26 May 2004.
- Related patent family of
WO
1999/32641 'A process for site-directed integration of multiple copies of a
gene in a mould' describes a method of site-specific transformation of mould
using a rare restriction endonuclease system. The first independent claim
does not recite transformation using Agrobacterium.
|
Note: Patent information on this page was last updated on 9 February 2006.
Patent applications filed by the Penn State Research Foundation
The present PCT and United States patent applications relate to the
transformation of the fruit body tissue of a filamentous fungus
with Agrobacterium. The genetically modified fungi can serve as
biofermentators for the mass production of commercial products. As examples of
filamentous fungi, the applicant mentions fungi belonging to phyla Ascomycota
and Basidiomycota such as Coprinus, Agaricus,
Morchella , and Coriolus, among others. In particular, the
invention contemplates the transformation of the cultivated mushroom
Agaricus bisporus, which accounts for 38% of the world production of
cultivated mushrooms.
Specific Patent Information
|
Patent Number
|
Specific Patent Information
|
Assignee
|
|
WO
2002/00896 A2
- Earliest priority - 28 June 2000
- Filed - 28 June 2001
- OPI - 3 January 2002
|
Title - Methods and compositions for highly effective
transformation of filamentous fungi
| Claim 1
A method of transforming filamentous fungi comprising:
introducing to a fruit body tissue cell of said fungi a polynucleotide
construct said construct comprising sequences for the expression of a structural
gene or for the inhibition of an endogenous gene, the presence of which is
desired in said fungi cell.
|
| Claim 16
A filamentous fungi transformation method comprising:
A) obtaining an Agrobacterium vector, said vector comprising a
polynucleotide sequence the presence of which is desired in a recipient
filamentous fungi cell; and B) introducing said vector to fruit body tissue
cells of said fungi in the presence of an active vir
Agrobacterium region and a vir inducing compound.
|
| Claim 26
A method for transforming a fungi cell comprising:
A) obtaining an Agrobacterium-derived Ti plasmid, said plasmid
comprising a polynucleotide sequence the expression of which is desired in a
host fungal cell; B) introducing said plasmid to said cell in the presence
of vir active genes and a vir inducing agent.
|
| Claim 30
A method for transformation of Agaricus bisporus cells comprising:
A) obtaining an Agrobacterium vector, said vector comprising a
polynucleotide sequence the presence of which is desired in a recipient
filamentous fungi cell; and B) introducing said vector to fruit body tissue
cells of said Agaricus bisporus cells in the presence of an active
vir Agrobacterium region and a vir inducing compound.
|
The claims as filed in the PCT application recite:
- a method for transforming any filamentous fungus by
introducing into the fruit body tissue a construct for the
expression of a structural gene or for the inhibition of an endogenous gene; and
- a method for transforming the fruit body tissue of
any filamentous fungus and Agaricus
bisporus in particular with an Agrobacterium vector in
the presence of a vir acting region and a vir inducing
compound.
Although these claims are fairly broad as they refer to the transformation of
any filamentous fungus without specifying a
method in one case and specifying Agrobacterium in another claim, an
apparent limitation lies in the type of fungal tissue to be transformed. The
invention recites only transformation of fruit body
tissue. It remains to be seen whether granted claims will have the same
breadth as the filed claims.
|
Penn State Research Foundation
|
|
US
6964866
- Earliest priority - 28 June 2000
- Filed - 28 June 2001
- Granted - 15 November 2005
- Expected expiry - 1 September 2022 (patent term adjustment: 431 days)
|
Title - Methods and compositions for highly efficient
transformation of filamentous fungi
Claim 1
A method of transforming Agaricus bisporus comprising:
(a) introducing to fruit body tissue cells of said Agaricus bisporus
a polynucleotide construct desired in said Agaricus bisporus, said
construct comprising a promoter sequence capable of regulating expression in
Agaricus bisporus cells, wherein said introducing is by
Agrobacterium-mediated transformation by co-cultivation of vir
induced Agrobacterium with Agaricus fruit body tissue cells;
and (b) thereafter regenerating a transgenic Agaricus bisporus
from said fruit body tissue cells.
|
Claim 7
An Agaricus bisporus transformation method comprising:
(a) obtaining an Agrobacterium vector, said vector comprising a
polynucleotide sequence the presence of which is desired in a recipient
Agaricus bisporus cell, said polynucleotide sequence operatively linked
to a promoter sequence capable of regulating expression in Agaricus
bisporus cells; (b) introducing said vector to fruit body tissue cells
of said Agaricus bisporus in the presence of an active vir
Agrobacterium region and a vir inducing compound by
co-cultivation of vir induced Agrobacterium with
Agaricus fruit body tissue cells; and (c) regenerating a
transgenic Agaricus bisporus from said fruit body cells.
|
Claim 14
A method for transformation of Agaricus bisporus fruit body tissue
cells comprising:
(a) obtaining an Agrobacterium vector, said vector comprising a
polynucleotide sequence the presence of which is desired in a recipient
Agaricus bisporus fruit body tissue cell, said polynucleotide sequence
operatively linked to a promoter sequence capable of regulating expression in
Agaricus bisporus cells and introducing said vector to said
Agaricus bisporus fruit body tissue cells in the presence of an active
vir Agrobacterium region and a vir inducing compound
by co-cultivation of vir induced Agrobacterium with
Agaricus fruit body tissue cells.
|
Granted United States patent US 6964866 recites an
Agrobacterium-mediated transformation method of Agaricus
bisporus, where fruit body tissue cells of A. bisporus are
introduced to a vir-induced Agrobacterium.
|
|
US
2005/70007 A1
- Earliest priority - 28 June 2000
- Filed - 30 September 2004
- Application pending
|
Title - Methods and compositions for highly efficient
transformation of filamentous fungi
Claim 1
A method of transforming filamentous fungi comprising:
- introducing to a fruit body tissue cells of said fungi a polynucleotide
construct said construct comprising sequences for the expression of a structural
gene or for inhibition of an endogenous gene, the presence of which is desired
in said fungi cell.
|
Claim 8
A filamentous fungi transformation method comprising:
(a) obtaining an Agrobacterium vector, said vector comprising a
polynucleotide sequence the presence of which is desired in a recipient
filamentous fungi cell, and (b) introducing said vector to fruit body
tissue cells of said fungi in the presence of an active vir
Agrobacterium region and a vir inducing compound.
|
Claim 10
A method for transforming a fungi cell comprising:
(a) obtaining an Agrobacterium derived ti-plasmid, said plasmid
comprising a polynucleotide sequence the expression of which is desired in a
host fungal cell, (b) introducing said plasmid to said cell in the presence
of vir active genes and a vir inducing agent.
|
United States patent application US 2005/070007 is a
divisional of now granted US 6964866 (see
above).
Independent claim 1 in this application recites a method of transforming
any filamentous fungus by using fruit tissue body
cells that is not limited to
Agrobacterium-mediated transformation.
|
| Remarks |
- National phase entry of WO 2002/000896 in Canada (CA 2452183) and Europe (EP
1409693) are pending.
- National phase entry of WO 2002/000896 in Australia (AU 2001271560) has
lapsed on 20 December 2003.
|
Download PDF Copy
This PDF copy is dated April 11, 2007. Changes may have been made to this
Technology Landscape after this date.
Download PDF (info)
The information contained in this page was believed to be
correct at the time it was collated. New patents and patent applications,
altered status of patents, and case law may have resulted in changes in the
landscape. CAMBIA makes no warranty that it is correct or up to date at this
time and accepts no liability for any use that might be made of it. Corrections
or updates to the information are welcome. Please send an email to
info@bios.net.
The information contained in this page was believed to be correct at the
time it was collated. New patents and patent applications, altered
status of patents, and case law may have resulted in changes in the
landscape. CAMBIA makes no warranty that it is correct or up to date at
this time and accepts no liability for any use that might be made of it.
Corrections or updates to the information are welcome, please send an email to
info@bios.net.